parent_name,parent_smiles,parent_inchi,metabolite_name,metabolite_smiles,metabolite_inchi,enzymes,fingerprint_similarity,reaction_type,generation
Ademetionine,C[S+](CCC(N)C(=O)[O-])CC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1O,"InChI=1S/C15H22N6O5S/c1-27(3-2-7(16)15(24)25)4-8-10(22)11(23)14(26-8)21-6-20-9-12(17)18-5-19-13(9)21/h5-8,10-11,14,22-23H,2-4,16H2,1H3,(H2-,17,18,19,24,25)/t7-,8+,10+,11+,14+,27?/m0/s1",S-Adenosylhomocysteine,NC1=C2N=CN(C3OC(CSCCC(N)C(=O)O)C(O)C3O)C2=NC=N1,ZJUKTBDSGOFHSH-WFMPWKQPSA-N,,0.98,,0
Biocytin,NC(CCCCNC(=O)CCCCC1SCC2NC(=O)NC21)C(=O)O,,Biotin,O=C(O)CCCCC1SCC2NC(=O)NC21,"InChI=1S/C10H16N2O3S/c13-8(14)4-2-1-3-7-9-6(5-16-7)11-10(15)12-9/h6-7,9H,1-5H2,(H,13,14)(H2,11,12,15)/t6-,7-,9-/m0/s1",,0.88,,0
Ascorbic acid,O=C1OC(C(O)CO)C(O)=C1O,"InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1",ascorbic acid-2-sulfate,O=C1OC(C(O)CO)C(O)=C1OS(=O)(=O)O,XDBMXUKHMOFBPJ-VVJJHMBFSA-N,,0.65,,0
Dihydrolipoamide,N=C(O)CCCCC(S)CCS,,Lipoic acid,O=C(O)CCCCC1CCSS1,"InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)/t7-/m1/s1","Dihydrolipoyl dehydrogenase, mitochondrial, Glycine cleavage system H protein, mitochondrial",0.4,,0
Folic acid,NC1=NC(=O)C2=NC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)=CN=C2N1,"InChI=1S/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s1",Tetrahydrofolic acid,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2)N1,"InChI=1S/C19H23N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,11-12,21,23H,5-8H2,(H,24,29)(H,27,28)(H,31,32)(H4,20,22,25,26,30)/t11?,12-/m0/s1",Dihydrofolate reductase,0.54,,0
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1","(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)",C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CC(OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(C)(C)O,USYNZBLVOOXNSN-ARRWHRBTSA-N,,0.44,,0
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",Vitamin D 25-hydroxylase,0.97,,0
Calcifediol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)(C)O,"InChI=1S/C27H44O2/c1-19-10-13-23(28)18-22(19)12-11-21-9-7-17-27(5)24(14-15-25(21)27)20(2)8-6-16-26(3,4)29/h11-12,20,23-25,28-29H,1,6-10,13-18H2,2-5H3/b21-11+,22-12-/t20-,23+,24-,25+,27-/m1/s1",Calcitriol,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1","25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",0.87,,0
Fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C(F)(F)F)C=C1,"InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+",fluvoxamino acid,NCCON=C(CCCC(=O)O)C1=CC=C(C(F)(F)F)C=C1,KUIZEDQDELAFQK-XDHOZWIPSA-N,Cytochrome P450 1A2,0.91,,0
Valsartan,CCCCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1)C(C(=O)O)C(C)C,"InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1",Valeryl-4-hydroxyvalsartan,CC(O)CCC(=O)N(CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1)C(C(=O)O)C(C)C,ICSQZMPILLPFKC-XLDIYJRPSA-N,Cytochrome P450 2C9,0.98,,0
Ramipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCC21,"InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1",Ramiprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCC21,KEDYTOTWMPBSLG-HILJTLORSA-N,Liver esterases,0.92,,0
Amphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,Cytochrome P450 2D6,0.73,,0
Amphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,Cytochrome P450 2D6,0.61,,0
4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.67,,0
Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.28,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",N-Methylnicotinium,CN1CCCC1C1=CC=C[N+](C)=C1,HIOROZIUERMMRQ-UHFFFAOYSA-N,,0.82,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,"Cytochrome P450 2A6, Cytochrome P450 2B6",0.56,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,,0.79,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.86,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine glucuronide,CN1CCCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,SAWAIULJDYFLPD-SOAFEQHCSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.38,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Norcotinine,O=C1CCC(C2=CN=CC=C2)N1,FXFANIORDKRCCA-UHFFFAOYSA-N,,0.73,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.75,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone,CN(CCCC(=O)C1=CC=CN=C1)N=O,FLAQQSHRLBFIEZ-UHFFFAOYSA-N,,0.39,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol,CN(CCCC(O)C1=CN=CC=C1)N=O,OGRXKBUCZFFSTL-UHFFFAOYSA-N,,0.38,,0
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",2'-Hydroxynicotine,CN1CCCC1(O)C1=CC=CN=C1,,Cytochrome P450 2A6,0.66,,0
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Aldehyde oxidase,0.5,,0
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.88,,0
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,Cytochrome P450 2A6,0.8,,0
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.67,,0
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,Dimethylaniline monooxygenase [N-oxide-forming] 3,0.65,,0
Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-9",0.46,,0
Lorazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2Cl)=NC1O,"InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)",Lorazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,IWOJSSFCRQKNKN-IFBJMGMISA-N,,0.52,,0
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 3A4",0.77,,0
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M34,CC(C)CC(=O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,WREPYMVPDVCLPX-HNNXBMFYSA-N,,0.8,,0
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M23 or M24 (1),CC(C)C=CNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,ISSYHCZWYPLNBR-FDMDGMSGSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.72,,0
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M23 or M24 (2),CC(C)=CCNC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,HRTUPFKOFWTBTM-INIZCTEOSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2D6",0.76,,0
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,,0.76,,0
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M5,CC(C)(O)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,OPMJHASCCIGLJS-GOEBONIOSA-N,,0.95,,0
Bortezomib metabolite M2,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-RDJZCZTQSA-N,Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Cytochrome P450 3A4,0.83,,0
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M25,CC(C)C(O)C(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,IVVZGLULYNUZDU-BZELLKQSSA-N,,0.91,,0
Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,Bortezomib metabolite M4,O=C(NC(CC1=CC=CC=C1)C(=O)O)C1=CN=CC=N1,DWYZPDHMMZGQAP-NSHDSACASA-N,,0.74,,0
Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,Bortezomib metabolite M33,NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,ASDAHTNZOSVDNQ-PXYINDEMSA-N,,0.79,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1","3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.45,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(3-hydroxyphenyl)-2-methyllactic acid,CC(O)(CC1=CC(O)=CC=C1)C(=O)O,DQCFPKHWBJEWFV-UHFFFAOYSA-N,,0.48,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(3-hydroxyphenyl)-2-methylpropionic acid,CC(CC1=CC(O)=CC=C1)C(=O)O,ZTHRBJCNTAYZRE-UHFFFAOYSA-N,,0.57,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1","3-(3,4-dihydroxyphenyl)-2-methylpropionic acid",CC(CC1=CC(O)=C(O)C=C1)C(=O)O,GIIOASILGOFVPI-UHFFFAOYSA-N,,0.67,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(4-hydroxy-3-methoxyphenyl)-2-methyllactic acid,COC1=C(O)C=CC(CC(C)(O)C(=O)O)=C1,YNNLUYGFVUZDAD-UHFFFAOYSA-N,,0.5,,0
Carbidopa,CC(CC1=CC(O)=C(O)C=C1)(NN)C(=O)O,"InChI=1S/C10H14N2O4/c1-10(12-11,9(15)16)5-6-2-3-7(13)8(14)4-6/h2-4,12-14H,5,11H2,1H3,(H,15,16)/t10-/m0/s1",3-(4-hydroxy-3-methoxyphenyl)-2-methylpropionic acid,COC1=C(O)C=CC(CC(C)C(=O)O)=C1,XUQXZROVMZNKPO-UHFFFAOYSA-N,,0.59,,0
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,Cytochrome P450 2D6,0.93,,0
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.97,,0
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,O-Desmethyl-tramado glucuronide,CN(C)CC1CCCCC1(O)C1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1,DSBGQRZOJXSECT-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-8",0.56,,0
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.97,,0
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,Cytochrome P450 2D6,0.93,,0
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.6,,0
"N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.92,,0
"N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.59,,0
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",Theobromine,CN1C=NC2=C1C(=O)NC(=O)N2C,"InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)","Cytochrome P450 1A2, Cytochrome P450 2E1",0.9,,0
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","Cytochrome P450 1A2, Cytochrome P450 2E1, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,,0
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,3,7-Trimethyluric acid",CN1C(=O)C2=C(NC(=O)N2C)N(C)C1=O,BYXCFUMGEBZDDI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2E1",0.95,,0
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,,0
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,"1,7-Dimethyluric acid",CN1C(=O)NC2=C(C1=O)N(C)C(=O)N2,NOFNCLGCUJJPKU-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6",0.95,,0
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.82,,0
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC=O)NC(=O)N(C)C1=O,RDZNZFGKEVDNPK-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.34,,0
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.88,,0
1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.94,,0
Sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)N3CCN(C)CC3)=CC=C1OCC)NC2=O,"InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)","N-Desmethyl sildenafil (UK-103,320)",CCCC1=NN(C)C2=C1NC(C1=C(OCC)C=CC(S(=O)(=O)N3CCNCC3)=C1)=NC2=O,UZTKBZXHEOVDRL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 2C9",0.99,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",2-Chloroticlopidine,ClC1=CC2=C(CCN(CC3=CC=CC=C3Cl)C2)S1,INYHLAYOOFHUNE-UHFFFAOYSA-N,Myeloperoxidase,0.85,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.32,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,"Myeloperoxidase, Cytochrome P450 3A4",0.32,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,SSVDYGNPKZJQKO-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2D6",0.33,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Dehydrogenated ticlopidine,ClC1=CC=CC=C1CN1C=CC2=C(C=CS2)C1,BNJVHGHQYHAEDJ-UHFFFAOYSA-N,Myeloperoxidase,0.56,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Ticlopidine N-oxide,[O-][N+]1(CC2=CC=CC=C2Cl)CCC2=C(C=CS2)C1,YEICEJCPALKCAT-UHFFFAOYSA-N,Myeloperoxidase,0.78,,0
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",7-Hydroxyticlopidine,OC1CN(CC2=CC=CC=C2Cl)CC2=C1SC=C2,GWHGEZHHJDSDMI-UHFFFAOYSA-N,,0.8,,0
2-Oxoticlopidine,O=C1C=C2CN(CC3=CC=CC=C3Cl)CCC2S1,DJZQIXWGIZIETJ-UHFFFAOYSA-N,Active metabolite of Ticlopidine,O=C(O)CC1CN(CC2=CC=CC=C2Cl)CCC1S,LDXFVLBQZWBGBA-UHFFFAOYSA-N,,0.44,,0
Ticlopidine S-oxide,O=S1C=CC2=C1CCN(CC1=CC=CC=C1Cl)C2,SSVDYGNPKZJQKO-UHFFFAOYSA-N,Ticlopidine S-oxide dimer,O=S1C2=C(CN(CC3=C(Cl)C=CC=C3)CC2)C2C1C1C3=C(CCN(CC4=C(Cl)C=CC=C4)C3)C2S1=O,YIQPCHDIFABADG-UHFFFAOYSA-N,,0.42,,0
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Thienopyridinium,ClC1=CC=CC=C1C[N+]1=CC2=C(C=C1)SC=C2,OQXLLGWEACZMFD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Myeloperoxidase",0.24,,0
Thienodihydropyridinium,ClC1=CC=CC=C1CN1C=C2C=C[S+]=C2CC1,RLTCLQFOWWSHJX-UHFFFAOYSA-N,Ticlopidine lactam analog (M8),O=C1C2=C(CCN1CC1=CC=CC=C1Cl)SC=C2,KQQBLQBNIVSMLU-UHFFFAOYSA-N,Cytochrome P450 3A4,0.32,,0
Midodrine,COC1=CC(C(O)CNC(=O)CN)=C(OC)C=C1,"InChI=1S/C12H18N2O4/c1-17-8-3-4-11(18-2)9(5-8)10(15)7-14-12(16)6-13/h3-5,10,15H,6-7,13H2,1-2H3,(H,14,16)",desglymidodrine,COC1=CC(C(O)CN)=C(OC)C=C1,VFRCNXKYZVQYLX-UHFFFAOYSA-N,,0.81,,0
Torasemide,CC1=CC(NC2=C(S(=O)(=O)NC(=O)NC(C)C)C=NC=C2)=CC=C1,"InChI=1S/C16H20N4O3S/c1-11(2)18-16(21)20-24(22,23)15-10-17-8-7-14(15)19-13-6-4-5-12(3)9-13/h4-11H,1-3H3,(H,17,19)(H2,18,20,21)",Torasemide M1 (hydroxytorsemide),CC(C)NC(=O)NS(=O)(=O)C1=CNC=CC1=NC1=CC=CC(CO)=C1,WCYVLAMJCQZUCR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.57,,0
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1",N-Desmethyleletriptan,O=S(=O)(CCC1=CC2=C(C=C1)NC=C2CC1CCCN1)C1=CC=CC=C1,HHTDENYTSCXDFO-GOSISDBHSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.96,,0
Eletriptan,CN1CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,"InChI=1S/C22H26N2O2S/c1-24-12-5-6-19(24)15-18-16-23-22-10-9-17(14-21(18)22)11-13-27(25,26)20-7-3-2-4-8-20/h2-4,7-10,14,16,19,23H,5-6,11-13,15H2,1H3/t19-/m1/s1",Eletriptan N-oxide,C[N+]1([O-])CCCC1CC1=CNC2=C1C=C(CCS(=O)(=O)C1=CC=CC=C1)C=C2,QXXCIRSBRHOOJE-PHSANKKPSA-N,Prostaglandin G/H synthase 1,0.91,,0
Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)C1=O,"InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-",Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cytochrome P450 2C9,0.97,,0
Cyclohexyl hydroxymethyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(CO)CC3)C=C2)C1=O,YUNQMQLWOOVHKI-UHFFFAOYSA-N,Cyclohexyl carboxyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C(=O)O)CC3)C=C2)C1=O,MMZLACCSCMGVHL-UHFFFAOYSA-N,Alcohol dehydrogenase [NADP(+)],0.97,,0
Indinavir,CC(C)(C)NC(=O)C1CN(CC2=CN=CC=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(=O)NC1C2=CC=CC=C2CC1O,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",Metabolite M6,CC(C)(C)N=C(O)C1CNCCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,MKMGKCALCCOODL-GVPWJHIJSA-N,Cytochrome P450 3A4,0.53,,0
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19",0.87,,0
Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.49,,0
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",12-Hydroxynevirapine,OCC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,SEBABOMFNCVZGF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 3A5",0.65,,0
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.64,,0
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 3A4",0.64,,0
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,Cytochrome P450 2B6,0.64,,0
2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,LFZSOJABLBVGRJ-UHFFFAOYSA-N,2-hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,RNMZKTLILDCQOC-KUSYAZKWSA-N,,0.82,,0
8-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC(O)=C3)N(C3CC3)C2=NC=C1,DZPVEPLRIKDBFC-UHFFFAOYSA-N,8-hydroxynevirapine glucuronide,CC1=CC=NC2=C1NC(=O)C1=C(N=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1)N2C1CC1,IVZWGLRSSHUFTI-WCYOCWRHSA-N,,0.66,,0
3-Hydroxynevirapine,CC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,DANIONWINZEYME-UHFFFAOYSA-N,3-hydroxynevirapine glucuronide,CC1=C2N=C(OC3OC(C(=O)O)C(O)C(O)C3O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,GDAAYOYNGMRKSI-IQSUWLOCSA-N,,0.81,,0
Cladribine,NC1=C2N=CN(C3CC(O)C(CO)O3)C2=NC(Cl)=N1,"InChI=1S/C10H12ClN5O3/c11-10-14-8(12)7-9(15-10)16(3-13-7)6-1-4(18)5(2-17)19-6/h3-6,17-18H,1-2H2,(H2,12,14,15)/t4-,5+,6+/m0/s1",2-chloro-2'-deoxyadenosine-5'-triphosphate,NC1=C2N=CN(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)C2=NC(Cl)=N1,PZCJNHCKXRBBNN-KVQBGUIXSA-N,,0.86,,0
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,Arylamine N-acetyltransferase 1,0.72,,0
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2E1, Cytochrome P450 3A4, Myeloperoxidase, Prostaglandin G/H synthase 2",0.87,,0
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",Monoacetyldapsone,CC(=O)NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,WDOCBIHNYYQINH-UHFFFAOYSA-N,Arylamine N-acetyltransferase 2,0.74,,0
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,,0.78,,0
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,,0.31,,0
Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.85,,0
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.39,,0
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 3A4, Epoxide hydrolase 1",0.96,,0
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,,0.31,,0
Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A7, Cytochrome P450 2B6, Cytochrome P450 2D6",0.37,,0
Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.44,,0
Anagrelide,O=C1CN2CC3=C(Cl)C(Cl)=CC=C3N=C2N1,"InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)","6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.85,,0
"6,7-dichloro-3-hydroxy-1,5 dihydro-imidazo[2,1-b]quinazolin-2-one",O=C1NC2=NC3=CC=C(Cl)C(Cl)=C3CN2C1O,KAXTUTDKZVOONF-UHFFFAOYSA-N,"2-amino-5,6-dichloro-3,4,-dihydroquinazoline",NC1=NCC2=C(C=CC(Cl)=C2Cl)N1,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,Cytochrome P450 1A2,0.4,,0
Metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,"InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3",alpha-Hydroxymetoprolol,COCC(O)C1=CC=C(OCC(O)CNC(C)C)C=C1,OFRYBPCSEMMZHR-UHFFFAOYSA-N,Cytochrome P450 2D6,0.83,,0
Ropinirole,CCCN(CCC)CCC1=C2CC(=O)NC2=CC=C1,"InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)",N-despropyl ropinirole,CCCNCCC1=CC=CC2=C1CC(=O)N2,VKDWFHAQOZYATG-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,,0
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",3-methylxanthine,CN1C(=O)NC(=O)C2=C1N=CN2,GMSNIKWWOQHZGF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.86,,0
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,RYYVLZVUVIJVGH-UHFFFAOYSA-N,,0.91,,0
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,3-dimethyluric acid",CN1C(=O)C2=C(NC(=O)N2)N(C)C1=O,OTSBKHHWSQYEHK-UHFFFAOYSA-N,Cytochrome P450 2E1,0.94,,0
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Monoiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C=C1)C(=O)O,,,0.88,,0
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Tiratricol,O=C(O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,"InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)",,0.69,,0
Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Triiodothyronine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C=C2)C(I)=C1)C(=O)O,XBQYQXVJBNDCGY-LBPRGKRZSA-N,,0.79,,0
Disopyramide,CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C,"InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)",mono-isopropyl-disopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,UWNSWIXIVDMCHZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,,0
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.72,,0
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 3A7",0.92,,0
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)","2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.34,,0
3-hydroxylidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC(O)=C1C,PMGUCIDDSCRAMY-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.95,,0
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.7,,0
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.37,,0
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,,0.88,,0
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.43,,0
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,"4-Hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,GCWYXRHXGLFVFE-UHFFFAOYSA-N,,0.61,,0
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,0.42,,0
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3","Cytochrome P450 2D6, Cytochrome P450 2C19",0.96,,0
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",N-Desmethylvenlafaxine,CNCC(C1=CC=C(OC)C=C1)C1(O)CCCCC1,MKAFOJAJJMUXLW-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.95,,0
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3","N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.95,,0
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3",O-Desmethylvenlafaxine glucuronide,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,VNRFTNKWISCOMJ-KUIQUDTGSA-N,,0.49,,0
"N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,"N,O-didesmethylvenlafaxine glucuronide",CNCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,UDNAJOOLWIWCAW-SQBZNDFJSA-N,,0.52,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.74,,0
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,0.99,,0
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.98,,0
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1","UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 1-3",0.9,,0
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1",0.79,,0
Ropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C17H26N2O/c1-4-11-19-12-6-5-10-15(19)17(20)18-16-13(2)8-7-9-14(16)3/h7-9,15H,4-6,10-12H2,1-3H3,(H,18,20)/t15-/m0/s1",3-hydroxyropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C(O)=CC=C1C,IXOVDWXTIIYVOJ-AWEZNQCLSA-N,Cytochrome P450 1A2,0.83,,0
Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N)N=CN=C21)OCOC(=O)OC(C)C,"InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1",Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase 2, mitochondrial, Adenylate kinase 4, mitochondrial",0.76,,0
Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,Tenofovir Diphosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,IACQCQDWSIQSRP-ZCFIWIBFSA-N,"Nucleoside diphosphokinase, Creatine Kinases",0.92,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",6-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CC(O)C4=CCCCC4C3C(=C)CC21CC,GHFIULBLMLVLDK-GDLCRWSOSA-N,,0.87,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",16-hydroxy-desogestrel,C#CC1(O)C(O)CC2C3CCC4=CCCCC4C3C(=C)CC21CC,QGTKZJGOIVJHGG-DVUPJZBUSA-N,,0.85,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",Desogestrel-17-sulfate,C#CC1(OS(=O)(=O)[O-])CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,XLVAWWOSRWJYBK-BPIQYHPVSA-M,,0.72,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",15-alpha-hydroxydesogestrel,C#CC1(O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,RWVQLLLACWCLQR-YBAWMFKNSA-N,,0.87,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",2-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CCC(O)CC4C3C(=C)C(CC)C21,OAJXJBAOKDVIQW-KSVDVDHBSA-N,,0.81,,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",3alpha-Hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,ZMLDTNLDYRJTAZ-JASYKLOUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.9,,0
3alpha-Hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,ZMLDTNLDYRJTAZ-JASYKLOUSA-N,Etonogestrel,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,"InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,0.8,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2A6, Cytochrome P450 2B6",0.67,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,ZIWBCJXKYKOLJK-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2B6",0.82,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6",0.56,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2B6",0.63,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,,0.24,,0
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",(3Z)-2-Propylpent-3-enoic acid (3Z-Ene-VPA),CC=CC(CCC)C(=O)O,WTMAHJABDOHPDJ-HYXAFXHYSA-N,,0.43,,0
4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,"2,4-Diene-VPA",C=CC=C(CCC)C(=O)O,UUILWXIBBZVJDU-FNORWQNLSA-N,,0.25,,0
4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,,0.54,,0
5-Hydroxyvalproic acid,CCCC(CCCO)C(=O)O,ZIWBCJXKYKOLJK-UHFFFAOYSA-N,2-Propylglutaric acid,CCCC(CCC(=O)O)C(=O)O,IFNXFIJXYVEYLF-UHFFFAOYSA-N,,0.85,,0
3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,PPYHXKUZTSZTQU-UHFFFAOYSA-N,,0.45,,0
2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,3-Hydroxyvalproic acid,CCCC(C(=O)O)C(O)CC,LLPFTSMZBSRZDV-UHFFFAOYSA-N,,0.19,,0
2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,2-Propylsuccinic acid,CCCC(CC(=O)O)C(=O)O,QLTZBYGZXPKHLF-UHFFFAOYSA-N,,0.65,,0
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Acetaminophen glucuronide,CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,IPROLSVTVHAQLE-BYNIDDHOSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 1-10",0.22,,0
Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Acetaminophen sulfate,CC(=O)NC1=CC=C(OS(=O)(=O)O)C=C1,IGTYILLPRJOVFY-UHFFFAOYSA-N,"Sulfotransferase 1A1, Sulfotransferase 1A3/1A4, Bile salt sulfotransferase",0.62,,0
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,Cytochrome P450 3A4,0.98,,0
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Cytochrome P450 2D6,0.99,,0
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B4",0.9,,0
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3","Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 2C8",0.99,,0
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2B6",0.73,,0
E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4",0.99,,0
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,Cytochrome P450 2D6,0.73,,0
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,Cytochrome P450 2C19,0.98,,0
E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.99,,0
Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,Cytochrome P450 2D6,0.72,,0
Floxuridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1F,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",5-fluorouracil,O=C1NC=C(F)C(=O)N1,GHASVSINZRGABV-UHFFFAOYSA-N,"Thymidine phosphorylase, Cytochrome P450 2A6",0.22,,0
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1",Hydromorphone-3-glucuronide,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(=O)CCC3C1C5,VLSHIBYUEOPPRX-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 2B7",0.87,,0
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1",Norhydromorphone,O=C1CCC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,SWIRXSKBBSJXGY-UIHHKEIPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,,0
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",5-Hydroxyindomethacin,CC1=C(CC(=O)O)C2=C(C=CC(O)=C2)N1C(=O)C1=CC=C(Cl)C=C1,KMLNWQPYFBIALN-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.97,,0
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",Indomethacin acyl glucuronide,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QCBWEVBGELGABM-CZLVRFMKSA-N,UDP-glucuronosyltransferase 1-1,0.8,,0
Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",Deacyl indomethacin,COC1=CC2=C(C=C1)NC(C)=C2CC(=O)O,TXWGINUZLBAKDF-UHFFFAOYSA-N,Liver carboxylesterase 1,0.6,,0
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,"InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18+,19?,21?",N-isopropylnortropium methobromide,C=C(C(=O)OC1CC2CCC(C1)[N+]2(C)C(C)C)C1=CC=CC=C1,APBFGXKTZSOWLK-JRJNBHHRSA-N,,0.72,,0
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,"InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18+,19?,21?",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.2,,0
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3","2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 2C9",0.45,,0
"2-Ethyl-1,5-dimethyl-3,3-diphenylpyrrolinium (EDDP)",CC=C1N(C)C(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,AJRJPORIQGYFMT-RMOCHZDMSA-N,"2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)",CCC1=NC(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,UPZKJIHNKKJIKX-UHFFFAOYSA-N,Cytochrome P450 3A7,0.4,,0
Olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",7-hydroxyolanzapine,CC1=CC2=C(NC3=C(C=C(O)C=C3)N=C2N2CCN(C)CC2)S1,SMNUCABXNXAPBY-UHFFFAOYSA-N,Cytochrome P450 1A2,0.96,,0
Olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",2-hydroxymethylolanzapine,CN1CCN(C2=NC3=CC=CC=C3NC3=C2C=C(CO)S3)CC1,FPDIERBPQFAFSI-UHFFFAOYSA-N,Cytochrome P450 2D6,0.95,,0
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",5-Hydroxyomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.94,,0
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",5'-O-Desmethyl omeprazole,COC1=C(C)C=NC(C[S+]([O-])C2=NC3=CC(O)=CC=C3N2)=C1C,TWXDTVZNDQKCOS-UHFFFAOYSA-N,Cytochrome P450 2C19,0.77,,0
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",Omeprazole sulfone,COC1=CC2=C(C=C1)N=C(S(=O)(=O)CC1=C(C)C(OC)=C(C)C=N1)N2,IXEQEYRTSRFZEO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)",3-Hydroxyomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=C(CO)C(OC)=C(C)C=N1)N2,IGVYIWUGJPECAJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.92,,0
Pyrazinamide,NC(=O)C1=NC=CN=C1,"InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",5-hydroxypyrazinamide,NC(=O)C1=CNC(=O)C=N1,XENWQEOTDAQROM-UHFFFAOYSA-N,Aldehyde oxidase,0.69,,0
Terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,"InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3",fexofenadine,CC(C)(C(=O)O)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,RWTNPBWLLIMQHL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.85,,0
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",N-desmethylclobazam,O=C1CC(=O)N(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N1,RRTVVRIFVKKTJK-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 3A5, Cytochrome P450 3A7, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2C18",0.85,,0
Clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-18-13-8-7-11(17)9-14(13)19(16(21)10-15(18)20)12-5-3-2-4-6-12/h2-9H,10H2,1H3",4'-hydroxyclobazam,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C2=C1C=CC(Cl)=C2,NKSXJAYACJZMBM-UHFFFAOYSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.95,,0
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.34,,0
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,Thiopurine S-methyltransferase,0.61,,0
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.96,,0
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.98,,0
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.93,,0
Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.98,,0
Chlorzoxazone,O=C1NC2=C(C=CC(Cl)=C2)O1,"InChI=1S/C7H4ClNO2/c8-4-1-2-6-5(3-4)9-7(10)11-6/h1-3H,(H,9,10)",6-hydroxychlorzoxazone,OC1=NC2=C(C=C(O)C(Cl)=C2)O1,AGLXDWOTVQZHIQ-UHFFFAOYSA-N,Cytochrome P450 2E1,0.52,,0
Mefloquine,OC(C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F)C1CCCCN1,"InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2","2,8-bis-trifluoromethyl-4-quinoline carboxylic acid",O=C(O)C1=CC(C(F)(F)F)=NC2=C1C=CC=C2C(F)(F)F,QJTJIQBSZLFWFS-UHFFFAOYSA-N,Cytochrome P450 3A4,0.65,,0
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",Clozapine N-oxide,C[N+]1([O-])CCN(C2=NC3=C(C=CC(Cl)=C3)NC3=CC=CC=C23)CC1,OGUCZBIQSYYWEF-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 2C19, Cytochrome P450 3A5, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2E1",0.95,,0
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",Clozapine 5-N-glucuronide,CN1CCN(C2=NC3=C(C=CC(Cl)=C3)N(C3OC(C(=O)O)C(O)C(O)C3O)C3=CC=CC=C23)CC1,YWWIDMPXCSUNRD-VZWAGXQNSA-N,"UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B10",0.6,,0
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",Norepinephrine sulfate,NCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,CVJMZWLHUCMEKO-ZETCQYMHSA-N,,0.63,,0
Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",3-Methoxy-4-Hydroxyphenylglycol sulfate,COC1=C(O)C=CC(C(CO)OS(=O)(=O)O)=C1,SBKADJXSGGTEPN-UHFFFAOYSA-N,,0.46,,0
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",mirtazapine-N-oxide,C[N+]1([O-])CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,GAFCUVMEBFTFQJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,,0
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",N-desmethylmirtazapine,C1=CC=C2C(=C1)CC1=C(N=CC=C1)N1CCNCC21,FGLAMNFOHWVQOH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.97,,0
Mirtazapine,CN1CCN2C3=C(C=CC=N3)CC3=CC=CC=C3C2C1,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",8-hydroxymirtazapine,CN1CCN2C3=NC=C(O)C=C3CC3=CC=CC=C3C2C1,DAWYIZBOUQIVNX-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.94,,0
Dydrogesterone,CC(=O)C1CCC2C3C=CC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H28O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4-5,12,16-19H,6-11H2,1-3H3/t16-,17+,18-,19+,20+,21+/m0/s1",20-dihydrodydrogesterone,C=C1C=C2C=CC3C(CCC4(C)C(C(C)C)CCC34)C2(C)CC1,YUDUQGLCBDGGNA-UHFFFAOYSA-N,,0.65,,0
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",2-hydroxymexiletine,CC1=C(OCC(C)N)C(CO)=CC=C1,XMJYSMLLWRQQAE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.77,,0
Mexiletine,CC1=C(OCC(C)N)C(C)=CC=C1,"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",p-hydroxymexiletine,CC1=C(OCC(C)N)C(C)=CC(O)=C1,YWOSWRCXWBDSRQ-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6",0.85,,0
Tacrine,NC1=C2CCCCC2=NC2=CC=CC=C12,"InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)",1-hydroxytacrine,N=C1C2=C(CCCC2O)NC2=CC=CC=C12,HLVVITIHAZBPKB-UHFFFAOYSA-N,Cytochrome P450 1A2,0.58,,0
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1",N-trifluoroacetyladriamycinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N=C(O)C(F)(F)F)C(O)C(C)O3)C2=C1O,TWMWXCYMYAQOTO-UHFFFAOYSA-N,,0.88,,0
Valrubicin,CCCCC(=O)OCC(=O)C1(O)CC2=C(O)C3=C(C(=O)C4=C(OC)C=CC=C4C3=O)C(O)=C2C(OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)C1,"InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22-,27+,33-/m0/s1",N-trifluoroacetyladriamycin,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(=O)CO)CC(OC3CC(NC(=O)C(F)(F)F)C(O)C(C)O3)C2=C1O,RQIOYWADAKTIJC-XUKKXQNXSA-N,,0.99,,0
Digoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,"InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1",Dihydrodigoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CC(O)C5(C)C(C7COC(=O)C7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,,0.71,,0
Carisoprodol,CCCC(C)(COC(N)=O)COC(=O)NC(C)C,"InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)",Meprobamate,CCCC(C)(COC(N)=O)COC(N)=O,"InChI=1S/C9H18N2O4/c1-3-4-9(2,5-14-7(10)12)6-15-8(11)13/h3-6H2,1-2H3,(H2,10,12)(H2,11,13)",Cytochrome P450 2C19,0.72,,0
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",6β-Hydroxyprogesterone,CC(=O)C1CCC2C3CC(O)C4=CC(=O)CCC4(C)C3CCC12C,PWCLWZOSAFOXFL-UHPWKVKZSA-N,Cytochrome P450 3A4,0.73,,0
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",Pregnanolone,CC(=O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,,,0.42,,0
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",Sorafenib N-oxide,CNC(=O)C1=[N+]([O-])C=CC(OC2=CC=C(NC(=O)NC3=CC=C(Cl)C(C(F)(F)F)=C3)C=C2)=C1,,Cytochrome P450 3A4,0.88,,0
Sorafenib,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)NC3=CC(C(F)(F)F)=C(Cl)C=C3)C=C2)=C1,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",Sorafenib beta-D-Glucuronide,CNC(=O)C1=NC=CC(OC2=CC=C(NC(=O)N(C3=CC(C(F)(F)F)=C(Cl)C=C3)C3OC(C(=O)O)C(O)C(O)C3O)C=C2)=C1,HALZWBPBJOJUOZ-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-9,0.53,,0
Griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(OC)=C1Cl,"InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1",6-methyl-griseofulvin,COC1=CC(=O)CC(C)C12OC1=C(C2=O)C(OC)=CC(C)=C1Cl,QNPINWFXONNRKM-XLFHBGCDSA-N,,0.97,,0
Eszopiclone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=NC=C(Cl)C=C2)CC1,"InChI=1S/C17H17ClN6O3/c1-22-6-8-23(9-7-22)17(26)27-16-14-13(19-4-5-20-14)15(25)24(16)12-3-2-11(18)10-21-12/h2-5,10,16H,6-9H2,1H3/t16-/m0/s1",Zopiclone N-oxide,C[N+]1([O-])CCN(C(=O)OC2C3=C(N=CC=N3)C(=O)N2C2=NC=C(Cl)C=C2)CC1,IPTIKKTXLHVRKN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2E1",0.98,,0
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",4-hydroxyalprazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,CEYGCFLPQFNPST-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C9",0.87,,0
Alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",alpha-Hydroxyalprazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,ZURUZYHEEMDQBU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 3A4",0.93,,0
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",Phenoxyacetic acid derivative of rosiglitazone,O=C(O)COC1=CC=C(CC2SC(=O)NC2=O)C=C1,SXAASESEPRXRTR-UHFFFAOYSA-N,,0.71,,0
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.56,,0
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.6,,0
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Despyridinyl rosiglitazone,CNCCOC1=CC=C(CC2SC(=O)NC2=O)C=C1,BPSKNLFJDYBECE-UHFFFAOYSA-N,,0.76,,0
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.58,,0
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.55,,0
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.6,,0
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.56,,0
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.59,,0
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,YDRMOALONMVDNG-TUCRDTSBSA-N,,0.52,,0
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,ortho-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=C(OS(=O)(=O)O)C=CC=N1,ZVSPRKOUHTZIGH-UHFFFAOYSA-N,,0.6,,0
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl glucuronide rosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)S1,NLGMKXBTZZJJFK-UHFFFAOYSA-N,,0.54,,0
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=N1,QGESYIGEZXWVIN-AZNQAGSMSA-N,,0.52,,0
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,para-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OS(=O)(=O)O)C=N1,WAGUBJKZLRLKGR-UHFFFAOYSA-N,,0.61,,0
N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.82,,0
N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.86,,0
Acetohexamide,CC(=O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,"InChI=1S/C15H20N2O4S/c1-11(18)12-7-9-14(10-8-12)22(20,21)17-15(19)16-13-5-3-2-4-6-13/h7-10,13H,2-6H2,1H3,(H2,16,17,19)",Hydroxyhexamide,CC(O)C1=CC=C(S(=O)(=O)NC(=O)NC2CCCCC2)C=C1,VQDAEOYLIBGCHE-UHFFFAOYSA-N,,0.85,,0
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,,0
Phenoxymethylpenicillin,CC1(C)SC2C(NC(=O)COC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.62,,0
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,"InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3",3-Hydroxypromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC(O)=CC=C21,FCWHSDRYYOAXGG-UHFFFAOYSA-N,,0.86,,0
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,"InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3",Promazine 5-sulfoxide,CN(C)CCCN1C2=CC=CC=C2S(=O)C2=CC=CC=C21,KSHDHDWHIWBNHA-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.81,,0
Promazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=CC=C21,"InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3",N-Desmethylpromazine,CNCCCN1C2=CC=CC=C2SC2=CC=CC=C21,WOCOVPRTRIBGFZ-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2C9",0.98,,0
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",Methoxyzolpidem derivative (M3),CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1,MKLBTYQCCMFWQI-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.98,,0
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2, Cytochrome P450 2D6",0.96,,0
Methoxyzolpidem derivative (M4),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(CO)C=CC3=N2)C=C1,OIIJRMHQIDOMPL-UHFFFAOYSA-N,Zolpidem carboxylic acid derivative (M2),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C(=O)O)C=CC3=N2)C=C1,RFUGIBAONXDHRM-UHFFFAOYSA-N,,0.95,,0
Famciclovir,CC(=O)OCC(CCN1C=NC2=CN=C(N)N=C21)COC(C)=O,"InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18)",6-oxo-famciclovir,CC(=O)OCC(CCN1C=NC2=C1NC(=N)N=C2O)COC(C)=O,KQURMIWGELPUHQ-UHFFFAOYSA-N,Aldehyde oxidase,0.65,,0
Trifluridine,O=C1NC(=O)N(C2CC(O)C(CO)O2)C=C1C(F)(F)F,"InChI=1S/C10H11F3N2O5/c11-10(12,13)4-2-15(9(19)14-8(4)18)7-1-5(17)6(3-16)20-7/h2,5-7,16-17H,1,3H2,(H,14,18,19)/t5-,6+,7+/m0/s1",5-carboxy-2'-deoxyuridine,O=C(O)C1=CN(C2CC(O)C(CO)O2)C(=O)N=C1O,GAGYTXTVUMXAOC-XVMARJQXSA-N,,0.69,,0
Allopurinol,OC1=NC=NC2=C1C=NN2,"InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)",oxypurinol,O=C1NC(=O)C2=C(NN=C2)N1,HXNFUBHNUDHIGC-UHFFFAOYSA-N,,0.43,,0
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1","2',2'-Difluorodeoxyuridine",O=C1N=C(O)C=CN1C1OC(CO)C(O)C1(F)F,,Cytidine deaminase,0.87,,0
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"Deoxycytidine kinase, Thymidine kinase 2, mitochondrial",0.92,,0
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,"2′,2′-difluorodeoxyuridine monophosphate",O=C1C=CN(C2OC(COP(=O)(O)O)C(O)C2(F)F)C(=O)N1,APSMIPKDENVCML-WETFRILZSA-N,Deoxycytidylate deaminase,0.89,,0
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,UMP-CMP kinase,0.95,,0
Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,Gemcitabine triphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,YMOXEIOKAJSRQX-QPPQHZFASA-N,Nucleoside diphosphate kinase A,0.97,,0
Teniposide catechol derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(O)=C1O,HFNGFXBXLSRAKX-LRXLMJOTSA-N,Teniposide o-quinone derivative,COC1=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C6=CC=CS6)OC5C(O)C3O)C3COC(=O)C23)OCO4)=CC(=O)C1=O,SUZOUIWTKWTHGX-LRXLMJOTSA-N,Myeloperoxidase,0.79,,0
Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,"InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)",Hydroxylansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC(O)=CC=C2N1,,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2C8",0.94,,0
Lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,"InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)",Lansoprazole sulfone,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)(=O)C1=NC2=CC=CC=C2N1,TVMJMCGRSSSSDJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",Liothyronine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",Thyroxine 5-deiodinase,0.99,,0
Loratadine,CCOC(=O)N1CCC(=C2C3=C(C=C(Cl)C=C3)CCC3=C2N=CC=C3)CC1,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",Descarboethoxyloratadine,ClC1=CC2=C(C=C1)C(=C1CCNCC1)C1=C(C=CC=N1)CC2,JAUOIFJMECXRGI-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C19, Cytochrome P450 1A1",0.91,,0
Prazosin,COC1=C(OC)C=C2C(N)=NC(N3CCN(C(=O)C4=CC=CO4)CC3)=NC2=C1,"InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)","2,4-diamino-6,7-dimethoxyquinazoline",COC1=C(OC)C=C2C(N)=NC(N)=NC2=C1,ZCIPYVXKMWNKLZ-UHFFFAOYSA-N,,0.63,,0
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,HCYAFALTSJYZDH-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 3A4",0.99,,0
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",2-hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,ROTCPJFWLNDKHU-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 3A4",0.86,,0
2-hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,ROTCPJFWLNDKHU-UHFFFAOYSA-N,2-hydroxy-imipramine glucuronide,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,CBEJFHYWZSCYSD-LYVDORBWSA-N,,0.56,,0
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,HCYAFALTSJYZDH-UHFFFAOYSA-N,2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,Cytochrome P450 2D6,0.86,,0
Ketorolac,O=C(C1=CC=CC=C1)C1=CC=C2C(C(=O)O)CCN12,"InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)",4-hydroxy ketorolac,O=C(C1=CC=C(O)C=C1)C1=CC=C2C(C(=O)O)CCN12,PIQMOWBWPFGZMW-UHFFFAOYSA-N,,0.97,,0
Quinine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1",3-hydroxyquinine,C=CC1(O)CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,BSRUJCFCZKMFMB-YGHPHNMRSA-N,Cytochrome P450 3A4,0.89,,0
Tenoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=CS2)S1(=O)=O,"InChI=1S/C13H11N3O4S2/c1-16-10(13(18)15-9-4-2-3-6-14-9)11(17)12-8(5-7-21-12)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)",5'-Hydroxytenoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=CS2)S1(=O)=O,INPPRTDYEGRTIU-RAXLEYEMSA-N,Cytochrome P450 2C9,0.63,,0
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 2C9",0.97,,0
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",7-beta-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,DJCKLUPKZRLTPE-CMVHYPBASA-N,Cytochrome P450 3A4,0.92,,0
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,,0
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1","9-alpha,10-alpha-epoxyhexahydrocannabinol",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC3(C)OC3C21,VSQGBNUBIDZRPJ-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 3A4",0.68,,0
8-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,INKUWBOHCFHXTJ-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.98,,0
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.92,,0
11-Hydroxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,YCBKSSAWEUDACY-UHFFFAOYSA-N,11-Nor-9-carboxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C(=O)O)=CC21,YOVRGSHRZRJTLZ-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,,0
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M1,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,SXJRVQZUUOADNS-FCHGAEMMSA-N,,0.75,,0
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M2a,CC(C)(O)C1=CC=CC=C1CCC(C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1)S(=O)CC1(CC(=O)O)CC1,QFTNWCBEAVHLQA-XNHCCDLUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6",0.91,,0
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M5a,CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,CHRNGXJVKOMERP-SIOAQITRSA-N,Cytochrome P450 3A4,0.94,,0
Montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,"InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",Montelukast metabolite M6a,CC(O)(CO)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=NC3=C(C=CC(Cl)=C3)C=C2)=C1,UFQIEVSCRCMNLW-SHISVWIYSA-N,Cytochrome P450 2C9,0.95,,0
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",Fluoxetine glucuronide,CN(CCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,ROQAUFRWFXOLOE-GDBUUVARSA-N,UDP-glucuronosyltransferases (UGTs),0.45,,0
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 3A5, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 2B6",0.95,,0
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.32,,0
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine alcohol,OCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WMLVVHKCLDWGLW-UHFFFAOYSA-N,,0.86,,0
4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.15,,0
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,4-Trifluoromethylphenol,OC1=CC=C(C(F)(F)F)C=C1,BAYGVMXZJBFEMB-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4",0.34,,0
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Norfluoxetine glucuronide,O=C(O)C1OC(ONCCC(OC2=CC=C(C(F)(F)F)C=C2)C2=CC=CC=C2)C(O)C(O)C1O,LUIHTMWIRNJSNW-FRYOACGXSA-N,UDP-glucuronosyltransferases (UGTs),0.46,,0
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",hydroxychlorpromazine,CN(C)CCCN1C2=C(C=C(O)C=C2)SC2=C1C=C(Cl)C=C2,HICFFJZGXWEIHN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,,0
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",chlorpromazine-N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,LFDFWIIFGRXCFR-UHFFFAOYSA-N,,0.98,,0
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",dedimethylchlorpromazine,NCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,ZTQZBABFEUDZFE-UHFFFAOYSA-N,,0.98,,0
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",demonomethylchlorpromazine,CNCCCN1C2=C(C=CC=C2)SC2=C1C=C(Cl)C=C2,YHFXGBOUSIKGMZ-UHFFFAOYSA-N,,0.99,,0
Celecoxib,CC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C8",0.98,,0
Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase 1B",0.96,,0
Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,Celecoxib glucuronide,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,BMBHPAUFWUKYDR-AVPDHNOJSA-N,UDP-glucuronosyltransferases (UGTs),0.69,,0
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,"InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)",2-oxobrimonidine,O=C1C=NC2=C(C=CC(NC3=NCCN3)=C2Br)N1,BUVCZMAMYHMOPB-UHFFFAOYSA-N,Aldehyde oxidase,0.9,,0
Brimonidine,BrC1=C(NC2=NCCN2)C=CC2=NC=CN=C12,"InChI=1S/C11H10BrN5/c12-9-7(17-11-15-5-6-16-11)1-2-8-10(9)14-4-3-13-8/h1-4H,5-6H2,(H2,15,16,17)",3-oxobrimonidine ,OC1=NC2=C(C=CC(NC3=NCCN3)=C2Br)NC1,VYULKJXHCILWPG-UHFFFAOYSA-N,Aldehyde oxidase,0.42,,0
Pefloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,"InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)",Norfloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCNCC3)C=C21,OGJPXUAPXNRGGI-UHFFFAOYSA-N,,0.99,,0
Pefloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,"InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)",Pefloxacin N-oxide,CC[N+]1([O-])C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,LJTKAUAKTFMWRP-UHFFFAOYSA-N,,0.46,,0
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",1-Pyrimidinylpiperazine,C1=CN=C(N2CCNCC2)N=C1,MRBFGEHILMYPTF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.42,,0
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",Buspirone N-oxide,O=C1CC2(CCCC2)CC(=O)N1CCCC[N+]1([O-])CCN(C2=NC=CC=N2)CC1,PXFOIYSPRVISSG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2D6",0.86,,0
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",3′-Hydroxybuspirone,O=C1CC2(CCC(O)C2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,RQGHABOPJRYOEZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,,0
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",5-Hydroxybuspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=C(O)C=N2)CC1,WKAUDMPUKWYRBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.92,,0
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",6'-Hydroxybuspirone,O=C1CC2(CCCC2)C(O)C(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,KOZNAHJIJGCFJJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.74,,0
Fosinopril,CCC(=O)OC(OP(=O)(CCCCC1=CC=CC=C1)CC(=O)N1CC(C2CCCCC2)CC1C(=O)O)C(C)C,"InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30+,39+/m1/s1",Fosinoprilat,O=C(O)C1CC(C2CCCCC2)CN1C(=O)CP(=O)(O)CCCCC1=CC=CC=C1,WOIWWYDXDVSWAZ-RTWAWAEBSA-N,,0.76,,0
Cefotaxime,CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(COC(C)=O)CSC12)C1=CSC(N)=N1,"InChI=1S/C16H17N5O7S2/c1-6(22)28-3-7-4-29-14-10(13(24)21(14)11(7)15(25)26)19-12(23)9(20-27-2)8-5-30-16(17)18-8/h5,10,14H,3-4H2,1-2H3,(H2,17,18)(H,19,23)(H,25,26)/b20-9-/t10-,14-/m1/s1",Desacetyl-cefotaxime,CON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(CO)CSC12)C1=CSC(=N)N1,FHYWAOQGXIZAAF-GHXIOONMSA-N,,0.76,,0
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",3'-azido-3'-deoxy-5'- O-beta-D-glucopyranuronosylthymidine,CC1=CN(C2CC(N=[N+]=[N-])C(COC3OC(C(=O)O)C(O)C(O)C3O)O2)C(=O)N=C1O,NFXAJWJJNLWLOV-OTQDERTISA-N,,0.69,,0
Zidovudine,CC1=CN(C2CC(N=[N+]=[N-])C(CO)O2)C(=O)NC1=O,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",3'-Aminothymidine,CC1=CN(C2CC(N)C(CO)O2)C(=O)NC1=O,ADVCGXWUUOVPPB-XLPZGREQSA-N,,0.93,,0
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,,0
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,,0.93,,0
oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,beta-oxymorphol,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3(O)C1C5,AABLHGPVOULICI-LQPBRMSDSA-N,,0.93,,0
oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,UQCNKQCJZOAFTQ-ISWURRPUSA-N,noroxymorphone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,HLMSIZPQBSYUNL-IPOQPSJVSA-N,Cytochrome P450 3A4,0.98,,0
noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,,0.92,,0
Flutamide,CC(C)C(=O)NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,"InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",2-hydroxyflutamide,CC(C)(O)C(O)=NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1,YPQLFJODEKMJEF-UHFFFAOYSA-N,Cytochrome P450 1A2,0.57,,0
Tolmetin,CC1=CC=C(C(=O)C2=CC=C(CC(=O)O)N2C)C=C1,"InChI=1S/C15H15NO3/c1-10-3-5-11(6-4-10)15(19)13-8-7-12(16(13)2)9-14(17)18/h3-8H,9H2,1-2H3,(H,17,18)",Tolmetin glucuronide,CC1=CC=C(C(=O)C2=CC=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C)C=C1,MEFIGCPEYJZFFC-ZFORQUDYSA-N,,0.64,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HPP+),O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.42,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",4-(4-chlorophenyl)-4-hydroxypiperidine,OC1(C2=CC=C(Cl)C=C2)CCNCC1,LZAYOZUFUAMFLD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.66,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,"Carbonyl reductase [NADPH] 1, Cytochrome P450 3A4",0.84,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",Haloperidol glucuronide,O=C(CCCN1CCC(OC2OC(C(=O)O)C(O)C(O)C2O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZFNLYKVTHNLKNZ-BFZHNPFYSA-N,UDP-glucuronosyltransferase 1-9,0.49,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2","Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.51,,0
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",fluorobenzoylpropionic acid,O=C(O)CCC(=O)C1=CC(F)=C(F)C=C1,GYDFFFKCUNUZEL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.37,,0
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,,0.39,,0
"Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,,0.45,,0
Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,Haloperidol pyridinium ion derivative,O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.27,,0
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Ritonavir metabolite M1,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(N)CC2=CC=CC=C2)C(C)C)=CS1,IQKWCORIMSRQGZ-AMEOFWRWSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,,0
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Ritonavir metabolite M11,CNC(=O)NC(C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1)C(C)C,UVQJGJZZUNOHCX-MNUOIFNESA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.8,,0
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",N-Desmethylritonavir,CC(C)C1=NC(CN=C(O)NC(C(O)=NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)N=C(O)OCC2=CN=CS2)C(C)C)=CS1,SQANVQYLDPEULW-QJANCWQKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2D6",0.51,,0
Ritonavir,CC(C)C1=NC(CN(C)C(=O)NC(C(=O)NC(CC2=CC=CC=C2)CC(O)C(CC2=CC=CC=C2)NC(=O)OCC2=CN=CS2)C(C)C)=CS1,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",Hydroxy Ritonavir,CC(C)C(NC(=O)N(C)CC1=CSC(C(C)(C)O)=N1)C(=O)NC(CC1=CC=CC=C1)CC(O)C(CC1=CC=CC=C1)NC(=O)OCC1=CN=CS1,CLEDZMPJHBBTNZ-QJANCWQKSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,,0
Dextrothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",Thyroxine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C(I)=C2)C(I)=C1)C(=O)O,QYXIJUZWSSQICT-LBPRGKRZSA-N,,0.79,,0
Dextrothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",Thyroxine glucuronide,NC(CC1=CC(I)=C(OC2=CC(I)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(I)=C2)C(I)=C1)C(=O)O,RGHRJBIKIYUHEV-SGPDEFQSSA-N,,0.48,,0
Aminocaproic acid,NCCCCCC(=O)O,"InChI=1S/C6H13NO2/c7-5-3-1-2-4-6(8)9/h1-5,7H2,(H,8,9)",Adipic acid,O=C(O)CCCCC(=O)O,WNLRTRBMVRJNCN-UHFFFAOYSA-N,,0.69,,0
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",Dextrorphan,CN1CCC23CCCCC2C1CC1=C3C=C(O)C=C1,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m1/s1","Cytochrome P450 2D6, Cytochrome P450 2C9",0.96,,0
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2D6, Cytochrome P450 2C9",0.94,,0
(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,Cytochrome P450 2D6,0.96,,0
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,"UDP-glucuronosyltransferases (UGTs), UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B17",0.65,,0
3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.87,,0
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,"InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)",albendazole sulfone,CCCS(=O)(=O)C1=CC2=C(C=C1)N=C(N=C(O)OC)N2,CLSJYOLYMZNKJB-UHFFFAOYSA-N,,0.57,,0
Albendazole,CCCSC1=CC2=C(C=C1)N=C(NC(=O)OC)N2,"InChI=1S/C12H15N3O2S/c1-3-6-18-8-4-5-9-10(7-8)14-11(13-9)15-12(16)17-2/h4-5,7H,3,6H2,1-2H3,(H2,13,14,15,16)",albendazole sulfoxide,CCCS(=O)C1=CC=C2NC(NC(=O)OC)=NC2=C1,VXTGHWHFYNYFFV-UHFFFAOYSA-N,,0.86,,0
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,"InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1",Trandolaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1C(C(=O)O)CC2CCCCC21,AHYHTSYNOHNUSH-HXFGRODQSA-N,,0.92,,0
Trandolapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21,"InChI=1S/C24H34N2O5/c1-3-31-24(30)19(14-13-17-9-5-4-6-10-17)25-16(2)22(27)26-20-12-8-7-11-18(20)15-21(26)23(28)29/h4-6,9-10,16,18-21,25H,3,7-8,11-15H2,1-2H3,(H,28,29)/t16-,18+,19-,20-,21-/m0/s1",Diketopiperazine,O=C1NC(CC2=CN=CN2)C(=O)N2CCCCC12,LCXWQHWWTPOAFI-UWVGGRQHSA-N,,0.4,,0
Carteolol,CC(C)(C)NCC(O)COC1=CC=CC2=C1CCC(=O)N2,"InChI=1S/C16H24N2O3/c1-16(2,3)17-9-11(19)10-21-14-6-4-5-13-12(14)7-8-15(20)18-13/h4-6,11,17,19H,7-10H2,1-3H3,(H,18,20)",8-Hydroxycarteolol,CC(C)(C)NCC(O)COC1=C2CCC(O)=NC2=C(O)C=C1,TVZJLAKRXHGVOK-UHFFFAOYSA-N,Cytochrome P450 2D6,0.55,,0
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 3A7",0.76,,0
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",Dechloroethyl cyclophosphamide,O=P1(NCCCl)NCCCO1,DZKGMGPLDJOVCX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A7",0.66,,0
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,4-Ketocyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,VBMZHOCORXMDJU-UHFFFAOYSA-N,Cytochrome P450 3A7,0.62,,0
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,,0.52,,0
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.92,,0
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,"Alcohol dehydrogenase 1A, Alcohol dehydrogenase [NADP(+)]",0.89,,0
Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.56,,0
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",S-Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,UDTWZFJEMMUFLC-NSHDSACASA-N,Cytochrome P450 2B6,0.34,,0
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",Nirvanol,CCC1(C2=CC=CC=C2)NC(=O)NC1=O,UDTWZFJEMMUFLC-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6",0.86,,0
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",S-4-Hydroxymephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C)C1=O,OQPLORUDZLXXPD-LBPRGKRZSA-N,Cytochrome P450 2C19,0.48,,0
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",5-Hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2O)C=C1,NCBVUSNBLYMFPP-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.85,,0
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",Dihydro-5-hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2C(O)OC(=O)C2C2=CC=CC=C2)C=C1,KETRNDQFHQCNAX-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.42,,0
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3","Rofecoxib-threo-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-HZPDHXFCSA-N,Prostaglandin G/H synthase 1,0.4,,0
"Rofecoxib-erythro-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-JKSUJKDBSA-N,cis-Dihydrorofecoxib,CS(=O)(=O)C1=CC=C(C2COC(=O)C2C2=CC=CC=C2)C=C1,PHCFUFKRCHEUTJ-CVEARBPZSA-N,,0.86,,0
5-Hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2O)C=C1,NCBVUSNBLYMFPP-UHFFFAOYSA-N,5-Hydroxyrofecoxib O-glucuronide,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,LHTQNDXIYIUWMV-JSXGDUDQSA-N,UDP-glucuronosyltransferases (UGTs),0.64,,0
Toremifene,CN(C)CCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,"InChI=1S/C26H28ClNO/c1-28(2)19-20-29-24-15-13-23(14-16-24)26(22-11-7-4-8-12-22)25(17-18-27)21-9-5-3-6-10-21/h3-16H,17-20H2,1-2H3/b26-25-",N-desmethyltoremifene,CNCCOC1=CC=C(C(=C(CCCl)C2=CC=CC=C2)C2=CC=CC=C2)C=C1,WKJKBQYEFAFHCY-IZHYLOQSSA-N,Cytochrome P450 3A4,0.98,,0
Benazepril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCC2=CC=CC=C2N(CC(=O)O)C1=O,"InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1",Benazeprilat,O=C(O)CN1C(=O)C(NC(CCC2=CC=CC=C2)C(=O)O)CCC2=CC=CC=C21,"InChI=1S/C22H24N2O5/c25-20(26)14-24-19-9-5-4-8-16(19)11-13-17(21(24)27)23-18(22(28)29)12-10-15-6-2-1-3-7-15/h1-9,17-18,23H,10-14H2,(H,25,26)(H,28,29)/t17-,18-/m0/s1",,0.94,,0
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,,0
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,,0.91,,0
Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.95,,0
Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,,0.91,,0
Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,,0.97,,0
Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.92,,0
Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.9,,0
Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",5'-Hydroxypiroxicam,CN1C(C(O)=NC2=NC=C(O)C=C2)=C(O)C2=CC=CC=C2S1(=O)=O,CCKOORANQAQKKV-UHFFFAOYSA-N,Cytochrome P450 2C9,0.69,,0
Lamotrigine,NC1=NC(N)=C(C2=C(Cl)C(Cl)=CC=C2)N=N1,"InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",lamotrigine-2-N-glucuronide,NC1=C(C2=C(Cl)C(Cl)=CC=C2)N=[N+](C2OC(C(=O)O)C(O)C(O)C2O)C(N)=N1,IEVMENHZPOWVGO-XPORZQOISA-O,UDP-glucuronosyltransferases (UGTs),0.48,,0
Hydroxyzine,OCCOCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,"InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2",Cetirizine,O=C(O)COCCN1CCN(C(C2=CC=CC=C2)C2=CC=C(Cl)C=C2)CC1,"InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)","Cytochrome P450 3A4, Cytochrome P450 3A5",0.95,,0
Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,"InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)",Bosentan metabolite Ro 48-5033,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,FAJQMBCLPZWTQJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,,0
Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,"InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)",Bosentan metabolite Ro 47-8634,CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,STTLKJGYAWXIPP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.99,,0
Bosentan metabolite Ro 48-5033,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)CO)C=C1,FAJQMBCLPZWTQJ-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.99,,0
Bosentan metabolite Ro 47-8634,CC(C)(C)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,STTLKJGYAWXIPP-UHFFFAOYSA-N,Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.98,,0
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4, Cytochrome P450 2C8",0.49,,0
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,,0.31,,0
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6",0.84,,0
3-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,QQCFBZCATDIWTH-UHFFFAOYSA-N,"2,3-Dihydroxycarbamazepine",NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21,YITIUNLDWDJVSI-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5",0.89,,0
"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,,0.33,,0
"10,11-Epoxycarbamazepine",NC(=O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,ZRWWEEVEIOGMMT-UHFFFAOYSA-N,"10,11-Dihydroxycarbamazepine",N=C(O)N1C2=CC=CC=C2C(O)C(O)C2=CC=CC=C21,PRGQOPPDPVELEG-KBPBESRZSA-N,Epoxide hydrolase 1,0.66,,0
2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,2-hydroxyiminostilbene,OC1=CC=C2NC3=CC=CC=C3C=CC2=C1,FKCUOSGTQJAUQX-UHFFFAOYSA-N,Cytochrome P450 3A4,0.62,,0
Cisatracurium,COC1=C(OC)C=C(CC2C3=C(C=C(OC)C(OC)=C3)CC[N+]2(C)CCC(=O)OCCCCCOC(=O)CC[N+]2(C)CCC3=C(C=C(OC)C(OC)=C3)C2CC2=CC(OC)=C(OC)C=C2)C=C1,"InChI=1S/C53H72N2O12/c1-54(22-18-38-32-48(62-7)50(64-9)34-40(38)42(54)28-36-14-16-44(58-3)46(30-36)60-5)24-20-52(56)66-26-12-11-13-27-67-53(57)21-25-55(2)23-19-39-33-49(63-8)51(65-10)35-41(39)43(55)29-37-15-17-45(59-4)47(31-37)61-6/h14-17,30-35,42-43H,11-13,18-29H2,1-10H3/q+2/t42-,43-,54-,55-/m1/s1",laudanosine,COC1=C(OC)C=C(CC2C3=CC(OC)=C(OC)C=C3CCN2C)C=C1,KGPAYJZAMGEDIQ-UHFFFAOYSA-N,,0.82,,0
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M1,C1=CC=C(C(C2=CC=CC=C2)N2CCNCC2)C=C1,NWVNXDKZIQLBNM-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.76,,0
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M2,OC1=CC=C(C=CCN2CCN(C(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,QFWMZESBHJUDQQ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.9,,0
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Benzophenone,O=C(C1=CC=CC=C1)C1=CC=CC=C1,RWCCWEUUXYIKHB-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.21,,0
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnarizine metabolite M4,OC1=CC=C(C(C2=CC=CC=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,UQMAKWWGLMGUQQ-UHFFFAOYSA-N,Cytochrome P450 2B6,0.89,,0
Cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,"InChI=1S/C26H28N2/c1-4-11-23(12-5-1)13-10-18-27-19-21-28(22-20-27)26(24-14-6-2-7-15-24)25-16-8-3-9-17-25/h1-17,26H,18-22H2/b13-10+",Cinnamaldehyde,O=CC=CC1=CC=CC=C1,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2A6",0.22,,0
Vinblastine,CCC1(O)CC2CN(CCC3=C(NC4=C3C=CC=C4)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(OC(C)=O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,"InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1",Desacetylvinblastine,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.99,,0
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)",Fenoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(OC2=CC=CC=C2)=C1,KXAAUVHIGIFUSM-RVLIQFCMSA-N,,0.38,,0
Fenoprofen,CC(C(=O)O)C1=CC(OC2=CC=CC=C2)=CC=C1,"InChI=1S/C15H14O3/c1-11(15(16)17)12-6-5-9-14(10-12)18-13-7-3-2-4-8-13/h2-11H,1H3,(H,16,17)",4'-hydroxyfenoprofen glucuronide,CC(C(=O)O)C1=CC(OC2=CC=C(OC3C(O)C(O)OC(C(=O)O)C3O)C=C2)=CC=C1,FPPVBAMKHUAIOP-OYQCQVHHSA-N,,0.4,,0
Fenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,"InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3",norfenfluramine,CC(N)CC1=CC(C(F)(F)F)=CC=C1,MLBHFBKZUPLWBD-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.88,,0
Clonidine,ClC1=CC=CC(Cl)=C1NC1=NCCN1,"InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",4-Hydroxyclonidine,OC1=CC(Cl)=C(NC2=NCCN2)C(Cl)=C1,NTWBRPXHGAXREI-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 3A5",0.84,,0
Valaciclovir,CC(C)C(N)C(=O)OCCOCN1C=NC2=C1NC(N)=NC2=O,"InChI=1S/C13H20N6O4/c1-7(2)8(14)12(21)23-4-3-22-6-19-5-16-9-10(19)17-13(15)18-11(9)20/h5,7-8H,3-4,6,14H2,1-2H3,(H3,15,17,18,20)/t8-/m0/s1",Acyclovir,NC1=NC(=O)C2=C(N1)N(COCCO)C=N2,"InChI=1S/C8H11N5O3/c9-8-11-6-5(7(15)12-8)10-3-13(6)4-16-2-1-14/h3,14H,1-2,4H2,(H3,9,11,12,15)",Valacyclovir hydrolase,0.87,,0
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,,0.84,,0
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.92,,0
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M5,O=S(=O)(NO)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,QUJNXRZCTHMBKO-UHFFFAOYSA-N,,0.96,,0
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M4,NS(=O)(=O)C1=CC=C(C2=C(C(=O)O)ON=C2C2=CC=CC=C2)C=C1,AEAVMNLZENBJSN-UHFFFAOYSA-N,,0.87,,0
Valdecoxib metabolite M1,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC=CC=C2)C=C1,UJSFKTUZOASIPA-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,,0.92,,0
Valdecoxib metabolite M9,CC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C2=CC(O)=CC=C2)=NO1,IAVWHASLRCBDDK-UHFFFAOYSA-N,Valdecoxib metabolite M3,NS(=O)(=O)C1=CC=C(C2=C(CO)ON=C2C2=CC(O)=CC=C2)C=C1,PESVSSPYDIXETJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,,0
Valdecoxib metabolite M7,CC1=C(C2=CC=C(S(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,MCGQPKHGAPQIDC-UHFFFAOYSA-N,Valdecoxib metabolite M8,CC1=C(C2=CC=C(S(=O)(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,LLWOSCPRJRUVST-UHFFFAOYSA-N,,0.96,,0
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,,0
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.96,,0
4-Hydroxyvoriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,BGPPSFHHAYWTMX-LRDDRELGSA-N,4-Hydroxyvoriconazole 4-O-glucuronide,O=C(O)C1OC(OCC(C2=NC=NC=C2F)C(O)(CN2C=NC=N2)C2=C(F)C=C(F)C=C2)C(O)C(O)C1O,RTNOBOYTQNLUHP-ORKWUBDLSA-N,,0.84,,0
Voriconazole N-Oxide,CC(C1=C(F)C=[N+]([O-])C=N1)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,KPLFPLUCFPRUHU-MGPLVRAMSA-N,"UK-51,060",O=C(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,XCHRPVARHBCFMJ-UHFFFAOYSA-N,,0.32,,0
"UK-215,364",OC(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,NQNSXRYFTHGTTO-UHFFFAOYSA-N,Voriconazole O-glucuronide derivative (1),O=C(O)C1OC(OC2=CC(F)=C(C(O)CN3C=NC=N3)C=C2)C(O)C(O)C1O,XNZQDIJYTGCNLO-SHIOMWLHSA-N,,0.43,,0
Levocarnitine,C[N+](C)(C)CC(O)CC(=O)[O-],"InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1",[3H]-gamma-Butyrobetaine,C[N+](C)(C)CCCC(=O)O,JHPNVNIEXXLNTR-UHFFFAOYSA-O,,0.63,,0
Enalapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CCCC1C(=O)O,"InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1",Enalaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CCCC1C(=O)O,LZFZMUMEGBBDTC-QEJZJMRPSA-N,,0.9,,0
Nizatidine,CNC(=C[N+](=O)[O-])NCCSCC1=CSC(CN(C)C)=N1,"InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3",N2-monodes-methylnizatidine,CNCC1=NC(CSCCNC(=C[N+](=O)[O-])NC)=CS1,QDLSRAPBCBFIQC-UXBLZVDNSA-N,,0.95,,0
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",4'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,KGVXVPRLBMWZLG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.87,,0
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",Diclofenac acyl glucuronide,O=C(CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl)OC1OC(C(=O)O)C(O)C(O)C1O,JXIKYYSIYCILNG-HBWRTXEVSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4",0.48,,0
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",3'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,HYPJZSYXUWYJDG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.8,,0
Fluticasone propionate,CCC(=O)OC1(C(=O)SCF)C(C)CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,"InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1",fluticasone 17beta-carboxylic acid,CC1CC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)O,QSVBUQTYFQFEHC-FULJYSEXSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7",0.74,,0
Thiopental,CCCC(C)C1(CC)C(=O)NC(=S)NC1=O,"InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",Pentobarbital,CCCC(C)C1(CC)C(=O)NC(=O)NC1=O,"InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",,0.74,,0
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",Sulindac sulfide,CSC1=CC=C(C=C2C(C)=C(CC(=O)O)C3=C2C=CC(F)=C3)C=C1,LFWHFZJPXXOYNR-MFOYZWKCSA-N,,0.97,,0
Sulindac,CC1=C(CC(=O)O)C2=CC(F)=CC=C2C1=CC1=CC=C(S(C)=O)C=C1,"InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",Sulindac sulfone,CC1=C(CC(=O)O)C2=C(C=CC(F)=C2)C1=CC1=CC=C(S(C)(=O)=O)C=C1,MVGSNCBCUWPVDA-UHFFFAOYSA-N,,0.98,,0
Ethionamide,CCC1=NC=CC(C(N)=S)=C1,"InChI=1S/C8H10N2S/c1-2-7-5-6(8(9)11)3-4-10-7/h3-5H,2H2,1H3,(H2,9,11)",Ethionamide sulphoxide,CCC1=NC=CC(C(N)=S=O)=C1,QDQQNGZRIJPDGA-UHFFFAOYSA-N,,0.87,,0
Amodiaquine,CCN(CC)CC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,"InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)",desethylamodiaquine,CCNCC1=C(O)C=CC(NC2=CC=NC3=CC(Cl)=CC=C23)=C1,VRXFDHAGFYWGHT-UHFFFAOYSA-N,Cytochrome P450 2C8,0.96,,0
Furazolidone,O=C1OCCN1N=CC1=CC=C([N+](=O)[O-])O1,"InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+",3-amino-2-oxazolidone,NN1CCOC1=O,KYCJNIUHWNJNCT-UHFFFAOYSA-N,,0.21,,0
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,"InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1",27-O-demethylrifabutin,CC(=O)OC1C(C)C(O)C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)N=C(O)C(C)=CC=CC(C)C(O)C(C)C(O)C1C)C(O)=C3C,BZRNSFHHZZYSST-VBSJQSPRSA-N,Cytochrome P450 3A4,0.95,,0
Rifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C)C(O)=C3C,"InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14-/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1",25-O-deacetylrifabutin,COC1C=COC2(C)OC3=C(C2=O)C2=C(C(=O)C(=C4NC5(CCN(CC(C)C)CC5)N=C42)NC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(O)C1C)C(O)=C3C,SCGFWNINBXENQT-FMPFFZOVSA-N,,0.99,,0
Paramethadione,CCC1(C)OC(=O)N(C)C1=O,"InChI=1S/C7H11NO3/c1-4-7(2)5(9)8(3)6(10)11-7/h4H2,1-3H3","5-ethyl-5-methyl-2,4-oxazolidinedione",CCC1(C)OC(=O)N=C1O,MGHNWMRNFGYJKE-UHFFFAOYSA-N,Cytochrome P450 2C9,0.2,,0
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",AFN911,CN1CCN(CC2=CC=C(C(=O)NC3=CC(NC4=NC=CC(C5=CN=CC=C5)=N4)C(CO)C=C3)C=C2)CC1,JBSTUPHUZMAVFU-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 1B1, Cytochrome P450 4F3",0.55,,0
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",Piperidine N-oxide imatinib,CC1=C(NC2=[NH+]C=CC(C3=C[N-][CH]C=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CC[N+](C)([O-])CC3)C=C2)C=C1,XCNZJTPSXKIWMO-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.58,,0
Imatinib,CC1=C(NC2=NC=CC(C3=CN=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",Pyridine N-oxide imatinib,CC1=C(NC2=NC=CC(C3=C[N+]([O-])=CC=C3)=N2)C=C(NC(=O)C2=CC=C(CN3CCN(C)CC3)C=C2)C=C1,QEQWNPDNPZKKNH-UHFFFAOYSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 3, Cytochrome P450 3A4",0.94,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1","Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 3A4",0.7,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Testosterone sulfate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,WAQBISPOEAOCOG-DYKIIFRCSA-N,,0.75,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,3-oxo-5-alpha-steroid 4-dehydrogenase 2,0.51,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Testosterone glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,NIKZPECGCSUSBV-HMAFJQTKSA-N,UDP-glucuronosyltransferase 2B17,0.49,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.32,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",6-beta-hydroxytestosterone,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,XSEGWEUVSZRCBC-ZVBLRVHNSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.81,,0
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Cytochrome P450 19A1,0.31,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.78,,0
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 19A1,0.31,,0
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.33,,0
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,5a-Dihydrotestosterone sulfate,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,KYVPWJSGFKNNLD-ABEVXSGRSA-N,,0.62,,0
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,"5alpha-androstane-3alpha,17beta-diol",CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2O,"InChI=1S/C19H32O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12-17,20-21H,3-11H2,1-2H3/t12-,13+,14-,15-,16-,17-,18-,19-/m0/s1",,0.77,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.78,,0
Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Niacinamide,NC(=O)C1=CC=CN=C1,,,0.47,,0
Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Trigonelline,C[N+]1=CC=CC(C(=O)[O-])=C1,,,0.7,,0
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Cytochrome P450 3A4,0.8,,0
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,,0.87,,0
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",p-Hydroxynordiazepam,O=C1CN=C(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C2N1,WVHIBVZUJQMFON-UHFFFAOYSA-N,,0.95,,0
Guanabenz,NC(N)=NN=CC1=C(Cl)C=CC=C1Cl,"InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+",Guanoxabenz,N=C(NO)NN=CC1=C(Cl)C=CC=C1Cl,"InChI=1S/C8H8Cl2N4O/c9-6-2-1-3-7(10)5(6)4-12-13-8(11)14-15/h1-4,15H,(H3,11,13,14)/b12-4+",Cytochrome P450 1A2,0.66,,0
Clofarabine,NC1=C2N=CN(C3OC(CO)C(O)C3F)C2=NC(Cl)=N1,"InChI=1S/C10H11ClFN5O3/c11-10-15-7(13)5-8(16-10)17(2-14-5)9-4(12)6(19)3(1-18)20-9/h2-4,6,9,18-19H,1H2,(H2,13,15,16)/t3-,4+,6-,9-/m1/s1",clofarabind-5'-monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3F)C2=NC(Cl)=N1,JEJRVFQHFJDNJN-CQOARYKOSA-N,Deoxycytidine kinase,0.94,,0
Prednisone,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Cytochrome P450 3A4,0.83,,0
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,"InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)",Tecastemizole,FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C32)C=C1,"InChI=1S/C19H21FN4/c20-15-7-5-14(6-8-15)13-24-18-4-2-1-3-17(18)23-19(24)22-16-9-11-21-12-10-16/h1-8,16,21H,9-13H2,(H,22,23)",Cytochrome P450 3A4,0.85,,0
Astemizole,COC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,"InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)",desmethylastemizole,OC1=CC=C(CCN2CCC(NC3=NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,LAGYWHSFHIMTPE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.98,,0
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",Adenosine monophosphate,NC1=C2N=CN(C3OC(COP(=O)(O)O)C(O)C3O)C2=NC=N1,UDMBCSSLTHHNCD-KQYNXXCUSA-N,Adenosine kinase,0.93,,0
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Adenosine deaminase,0.82,,0
Inosine,O=C1N=CNC2=C1N=CN2C1OC(CO)C(O)C1O,UGQMRVRMYYASKQ-KQYNXXCUSA-N,Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,Purine nucleoside phosphorylase,0.28,,0
Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.92,,0
Simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,"InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",simvastatin hydroxy acid,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,XWLXKKNPFMNSFA-HGQWONQESA-N,Cytochrome P450 3A4,0.93,,0
Mebendazole,COC(=O)NC1=NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,"InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)",2-amino-5-benzoylbenzimidazole,N=C1NC2=C(C=C(C(=O)C3=CC=CC=C3)C=C2)N1,GPMHHSJZGVOEFS-UHFFFAOYSA-N,,0.66,,0
Leucovorin,NC1=NC2=C(C(=O)N1)N(C=O)C(CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1)CN2,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12?,13-/m0/s1",5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.83,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,Cytochrome P450 3A4,0.85,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.76,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.69,,0
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.96,,0
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",m-chlorophenylpiperazine (m-CPP) ,ClC1=CC=CC(N2CCNCC2)=C1,VHFVKMTVMIZMIK-UHFFFAOYSA-N,Cytochrome P450 3A4,0.28,,0
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",triazolopyridinone epoxide,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C3OC3C=CN21,QFERKVDPWYTEPE-UHFFFAOYSA-N,,0.47,,0
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",4'-hydroxytrazodone ,O=C1N(CCCN2CCN(C3=CC(Cl)=C(O)C=C3)CC2)N=C2C=CC=CN12,FNUZSRSXQFIOPL-UHFFFAOYSA-N,,0.95,,0
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Cytochrome P450 2C8,0.88,,0
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 1A2",0.95,,0
O-Desmethylverapamil (D-702),COC1=C(O)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,OAAPYTCHFIIVON-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.86,,0
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,,0
Verapamil metabolite D-617,CNCCCC(C#N)(C1=CC(OC)=C(OC)C=C1)C(C)C,WLOBUUJURNEQCL-UHFFFAOYSA-N,Verapamil metabolite PR-25,CNCCCC(C#N)(C1=CC(OC)=C(O)C=C1)C(C)C,VNRFDZGJCSCHFU-UHFFFAOYSA-N,,0.98,,0
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-715 (PR-22),COC1=C(O)C=C(C(C#N)(CCCNCCC2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,VAUMWVGUBVPENJ-UHFFFAOYSA-N,Cytochrome P450 2C8,0.99,,0
Norverapamil,COC1=C(OC)C=C(CCNCCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,UPKQNCPKPOLASS-UHFFFAOYSA-N,Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,Cytochrome P450 2C8,0.9,,0
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Epinephrine sulfate,CNCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,AELFRHHZGTVYGJ-QMMMGPOBSA-N,,0.66,,0
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Metanephrine,CNCC(O)C1=CC(OC)=C(O)C=C1,,Catechol O-methyltransferase,0.82,,0
Epinephrine,CNCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",Epinephrine glucuronide,CNCC(O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,BLTFFSZSAZRUSC-FYRJOLOESA-N,UDP-glucuronosyltransferase 1-3,0.33,,0
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",2-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=C(O)C=C(Cl)C=C1,QRXRPQPWKRLTQX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.4,,0
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",3-Hydroxychlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC(O)=C(Cl)C=C1,RXFPYNAVFFDUJE-UHFFFAOYSA-N,,0.41,,0
Chlorpropamide,CCCNC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,"InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",4-Chlorobenzenesulfonylurea,NC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,AZEPYUPSYWCRBG-UHFFFAOYSA-N,,0.8,,0
Aprepitant,CC(OC1OCCN(CC2=NNC(=O)N2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1","(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,AFBDSAJOMZYQAI-CNOZUTPLSA-N,Cytochrome P450 3A4,0.74,,0
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,NYDCDZSEEAUOHN-IZHYLOQSSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1B1, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A5",0.98,,0
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",Tamoxifen N-oxide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,YAASNACECBQAFW-QPLCGJKRSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.95,,0
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.98,,0
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.84,,0
4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,,0
Endoxifen (4-hydroxy-N-desmethyltamoxifen),CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,MHJBZVSGOZTKRH-IZHYLOQSSA-N,4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase",0.82,,0
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.86,,0
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan N2-glucuronide,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)N=N2)C=C1,NGFMQMUIOUSHGR-RTCYWULBSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.68,,0
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.9,,0
Losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,FQZSMTSTFMNWQF-UHFFFAOYSA-N,Losartan carboxylic acid,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,ZEUXAIYYDDCIRX-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.9,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,BQSUFDMOXLLKQK-HNNXBMFYSA-N,Cytochrome P450 2C9,0.66,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC(O)=C2)OC1=O,IQWPEJBUOJQPDE-AWEZNQCLSA-N,Cytochrome P450 2C9,0.96,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",S-4'-Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,RRZWAMPDGRWRPF-OAHLLOKOSA-N,"Cytochrome P450 2C18, Cytochrome P450 2C19",0.98,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-10(S)-Hydroxywarfarin,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,BPZSPAZBZFZZBN-NVXWUHKLSA-N,Cytochrome P450 3A4,0.89,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,BHBOXPNWDGYJNB-CQSZACIVSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19",0.93,,0
Warfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3",R-7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,SKFYEJMLNMTTJA-OAHLLOKOSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C8",0.99,,0
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",1-hydroxymidazolam,OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,QHSMEGADRFZVNE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.95,,0
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,"InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",4-hydroxymidazolam,CC1=NC=C2C(O)N=C(C3=CC=CC=C3F)C3=C(C=CC(Cl)=C3)N21,ZYISITHKPKHPKG-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,,0
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+","Liver carboxylesterase 1, Carboxylic ester hydrolase",0.93,,0
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",Mycophenolic acid glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-10",0.66,,0
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",Hydroxyethylflurazepam,CCN(CCO)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C21,IRYBKIZHCXMFFO-UHFFFAOYSA-N,,0.98,,0
Flurazepam,CCN(CC)CCN1C(=O)CN=C(C2=CC=CC=C2F)C2=C1C=CC(Cl)=C2,"InChI=1S/C21H23ClFN3O/c1-3-25(4-2)11-12-26-19-10-9-15(22)13-17(19)21(24-14-20(26)27)16-7-5-6-8-18(16)23/h5-10,13H,3-4,11-12,14H2,1-2H3",Norflurazepam,O=C1CN=C(C2=C(F)C=CC=C2)C2=C(C=CC(Cl)=C2)N1,UVCOILFBWYKHHB-UHFFFAOYSA-N,,0.83,,0
Moexipril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC(OC)=C(OC)C=C2CC1C(=O)O,"InChI=1S/C27H34N2O7/c1-5-36-27(33)21(12-11-18-9-7-6-8-10-18)28-17(2)25(30)29-16-20-15-24(35-4)23(34-3)14-19(20)13-22(29)26(31)32/h6-10,14-15,17,21-22,28H,5,11-13,16H2,1-4H3,(H,31,32)/t17-,21-,22-/m0/s1",Moexiprilat,COC1=C(OC)C=C2CN(C(=O)C(C)NC(CCC3=CC=CC=C3)C(=O)O)C(C(=O)O)CC2=C1,CMPAGYDKASJORH-YSSFQJQWSA-N,,0.95,,0
Furosemide,NS(=O)(=O)C1=C(Cl)C=C(NCC2=CC=CO2)C(C(=O)O)=C1,"InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)",4-chloro-5-sulfamoylanthranilic acid,NC1=CC(Cl)=C(S(N)(=O)=O)C=C1C(=O)O,QQLJBZFXGDHSRU-UHFFFAOYSA-N,,0.75,,0
Nitrofurantoin,O=C1CN(N=CC2=CC=C([N+](=O)[O-])O2)C(=O)N1,"InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+",Aminofurantoin,NC1=CC=C(C=NN2CC(O)=NC2=O)O1,KLJOOBXQOIHZQM-UHFFFAOYSA-N,,0.48,,0
Nicergoline,COC12CC(COC(=O)C3=CN=CC(Br)=C3)CN(C)C1CC1=CN(C)C3=CC=CC2=C13,"InChI=1S/C24H26BrN3O3/c1-27-13-17-8-21-24(30-3,19-5-4-6-20(27)22(17)19)9-15(12-28(21)2)14-31-23(29)16-7-18(25)11-26-10-16/h4-7,10-11,13,15,21H,8-9,12,14H2,1-3H3/t15-,21-,24+/m1/s1","10-alpha-methoxy-9,10-dihydrolysergol",COC12CC(CO)CN(C)C1CC1=CNC3=CC=CC2=C13,JGQZSBLQHCTAJF-NFXPUDJFSA-N,Cytochrome P450 2D6,0.88,,0
Naltrexone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3CC1CC1,"InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",6-beta-naltrexol,OC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5CC2CC2)C=C1,JLVNEHKORQFVQJ-UHFFFAOYSA-N,,0.93,,0
Delavirdine,CC(C)NC1=C(N2CCN(C(=O)C3=CC4=C(C=CC(NS(C)(=O)=O)=C4)N3)CC2)N=CC=C1,"InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3",N-desalkyl delavirdine,CS(=O)(=O)NC1=CC=C2NC(C(=O)N3CCN(C4=C(N)C=CC=N4)CC3)=CC2=C1,MTEFFPTUUPAKOV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,,0
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine sulfoxide,NC1=NC(=O)N(C2CS(=O)C(CO)O2)C=C1,LJMQAXFNQNADRZ-FYZWQCAOSA-N,Sulfotransferase 1A1,0.87,,0
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine-monophosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)O)O2)C=C1,WUMZLKDCOINBEA-UHFFFAOYSA-N,,0.9,,0
Lamivudine,NC1=NC(=O)N(C2CSC(CO)O2)C=C1,"InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",Lamivudine-triphosphate,NC1=NC(=O)N(C2CSC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O2)C=C1,YLEQMGZZMCJKCN-UHFFFAOYSA-N,,0.78,,0
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",4'-Hydroxyflurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=C(O)C=C2)C=C1,GTSMMBJBNJDFRA-UHFFFAOYSA-N,Cytochrome P450 2C9,0.92,,0
Flurbiprofen,CC(C(=O)O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",Flurbiprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(F)=C(C2=CC=CC=C2)C=C1,PLPQBSOCUVSKTP-QGCNQZRGSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4",0.46,,0
Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C21)OCOC(=O)C(C)(C)C,"InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)",Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,,0.81,,0
Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.87,,0
Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,Adefovir Diphosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2=NC=N1,MELHEUHXJKQZNC-UHFFFAOYSA-N,"Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase B",0.91,,0
Procaine,CCN(CC)CCOC(=O)C1=CC=C(N)C=C1,"InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3",para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,Cholinesterase,0.57,,0
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M2/M3,CC(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,GMHTWYIGIMINLF-OKEQZYBDSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.96,,0
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.91,,0
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,,0.92,,0
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide glucuronide and isomers (M4/M5/M6),CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1,YTIRWNSTJVSCRW-VJQMJTOBSA-N,UDP-glucuronosyltransferases (UGTs),0.48,,0
Nateglinide metabolite M1,CC(C)(O)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IUMHIIXPABZGRF-YTPLPTRZSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.96,,0
Nateglinide metabolite M7,C=C(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,QKNIFXOGUWQRIF-YJEKIOLLSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.81,,0
Risperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCCC2=N1,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",9-hydroxyrisperidone,CC1=C(CCN2CCC(C3=NOC4=C3C=CC(F)=C4)CC2)C(=O)N2CCCC(O)C2=N1,PMXMIIMHBWHSKN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.94,,0
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",Active Metabolite of Esomeprazole,COC1=CC2=C(C=C1)N=C1N2SCC2=C(C)C(OC)=C(C)C=[N+]12,NNKKOITVFGCNKQ-UHFFFAOYSA-N,,0.52,,0
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",Omeprazole sulfone,COC1=CC2=C(C=C1)N=C(S(=O)(=O)CC1=C(C)C(OC)=C(C)C=N1)N2,IXEQEYRTSRFZEO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Esomeprazole,COC1=CC2=C(C=C1)NC(S(=O)CC1=NC=C(C)C(OC)=C1C)=N2,"InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)/t24-/m0/s1",5-hydroxyesomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,Cytochrome P450 2C19,0.94,,0
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",6-beta-hydrocortisol,CC12CCC(=O)C=C1C(O)CC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,GNFTWPCIRXSCQF-ZWJNAVLBSA-N,Cytochrome P450 3A Subfamily,0.89,,0
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1","Corticosteroid 11-beta-dehydrogenase isozyme 1, Corticosteroid 11-beta-dehydrogenase isozyme 2",0.83,,0
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Tetrahydrocortisone,CC12CCC(O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,,,0.66,,0
Cortisone,CC12CCC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-15,18,22,26H,3-8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",Dihydrocortisol,CC12CCC(=O)CC1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,,0.6,,0
Mannitol,OCC(O)C(O)C(O)C(O)CO,"InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1",Glycogen,OCC1OC(OCC2OC(OC3C(CO)OC(O)C(O)C3O)C(O)C(O)C2OC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O,BYSGBSNPRWKUQH-UJDJLXLFSA-N,,0.23,,0
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Hydroxyzileuton,CC(C1=CC2=C(C=C(O)C=C2)S1)N(O)C(=N)O,ZQQVPNNYZLDMMO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2",0.63,,0
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Zileuton sulfoxide,CC(C1=CC2=CC=CC=C2S1=O)N(O)C(=N)O,KWEAXQJUQDQMNY-UHFFFAOYSA-N,Cytochrome P450 3A4,0.23,,0
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.62,,0
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Zileuton O-glucuronide,CC(C1=CC2=CC=CC=C2S1)N(OC1OC(C(=O)O)C(O)C(O)C1O)C(=N)O,CYYKQHWQVGZJRJ-UPZRFPAJSA-N,UDP-glucuronosyltransferase 1-9,0.43,,0
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,CKVDCQYUEYONIA-UHFFFAOYSA-N,Dehydroxyzileuton sulfoxide,CC(NC(N)=O)C1=CC2=CC=CC=C2S1=O,KGUIRZVMBWMQQZ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.19,,0
Ethotoin,CCN1C(=O)NC(C2=CC=CC=C2)C1=O,"InChI=1S/C11H12N2O2/c1-2-13-10(14)9(12-11(13)15)8-6-4-3-5-7-8/h3-7,9H,2H2,1H3,(H,12,15)",p-Hydroxyl-ethotoin,CCN1C(=O)NC(C2=CC=C(O)C=C2)C1=O,UUBDNHDPPHJUHB-UHFFFAOYSA-N,,0.93,,0
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 3A7, Cytochrome P450 2C18, Cytochrome P450 4A11, Cytochrome P450 1A1, Cytochrome P450 2B6",0.75,,0
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",18-Hydroxyretinoic acid,CC(C=CC1=C(CO)CCCC1(C)C)=CC=CC(C)=CC(=O)O,XSJOIRFEYHJNAW-FCKHSPHMSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A7, Cytochrome P450 4A11, Cytochrome P450 2B6, Cytochrome P450 2A6, Cytochrome P450 2C9, Cytochrome P450 2C18, Cytochrome P450 3A4, Cytochrome P450 3A5",0.86,,0
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 2A6, Cytochrome P450 2B6, Cytochrome P450 3A4, Cytochrome P450 3A5",0.35,,0
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",Retinoyl beta-glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,MTGFYEHKPMOVNE-NEFMKCFNSA-N,UDP-glucuronosyltransferase 2B7,0.37,,0
4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,"Cytochrome P450 3A7, Cytochrome P450 2C18, Cytochrome P450 4A11, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2A6, Cytochrome P450 26A1",0.61,,0
"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.59,,0
2-Oxoclopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2SC(=O)C=C2C1,JBSAZVIMJUOBNB-WUJWULDRSA-N,Active Metabolite of Clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC(=O)O)C1,CXPJTQJWJQRBOF-HNNXBMFYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 2C9, Cytochrome P450 2C19",0.72,,0
Irinotecan,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,"InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1",SN-38,CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)C2(O)CC)C1=O,FJHBVJOVLFPMQE-QFIPXVFZSA-N,"Cholinesterase, Liver carboxylesterase 1, Cocaine esterase",0.96,,0
Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.72,,0
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,"InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-",N-desmethyl olopatadine,CNCCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,VQMJUHOJPCPUAM-IDUWFGFVSA-N,Cytochrome P450 3A4,0.99,,0
Olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,"InChI=1S/C21H23NO3/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24)/b18-8-",Olopatadine N-oxide,C[N+](C)([O-])CCC=C1C2=CC=CC=C2COC2=C1C=C(CC(=O)O)C=C2,TXKZPVWYFNGMCP-LSCVHKIXSA-N,"Dimethylaniline monooxygenase [N-oxide-forming] 1, Dimethylaniline monooxygenase [N-oxide-forming] 3",0.98,,0
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,"InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3",Malathion dicarboxylic acid,COP(=S)(OC)SC(CC(=O)O)C(=O)O,NIUNKPWHNGMQRE-UHFFFAOYSA-N,,0.75,,0
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,"InChI=1S/C10H19O6PS2/c1-5-15-9(11)7-8(10(12)16-6-2)19-17(18,13-3)14-4/h8H,5-7H2,1-4H3",Malathion monocarboxylic acid,CCOC(=O)C(CC(=O)O)SP(=S)(OC)OC,FARGSBYVTRDSKX-UHFFFAOYSA-N,,0.95,,0
Etoposide,COC1=C(O)C(OC)=CC(C2C3=CC4=C(C=C3C(OC3OC5COC(C)OC5C(O)C3O)C3COC(=O)C23)OCO4)=C1,"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",Etoposide glucuronide,COC1=CC(C2C3=C(C=C4OCOC4=C3)C(OC3OC4COC(C)OC4C(O)C3O)C3COC(=O)C23)=CC(OC)=C1OC1OC(C(=O)O)C(O)C(O)C1O,URCVASXWNJQAEH-UHFFFAOYSA-N,UDP-glucuronosyltransferase 1-1,0.91,,0
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",(R)-MHD,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=CC=CC=C21,BMPDWHIDQYTSHX-AWEZNQCLSA-N,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4",0.64,,0
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",(S)-MHD,NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,,"Aldo-keto reductase family 1 member C1, Aldo-keto reductase family 1 member C2, Aldo-keto reductase family 1 member C3, Aldo-keto reductase family 1 member C4, Carbonyl reductase [NADPH] 1, Carbonyl reductase [NADPH] 3",0.64,,0
Nalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=C1N=C(C)C=C2,"InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",Hydroxynalidixic acid,CCN1C=C(C(=O)O)C(=O)C2=CC=C(CO)N=C21,FRJDYPGZHOEEKU-UHFFFAOYSA-N,,0.96,,0
Phenelzine,NNCCC1=CC=CC=C1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.4,,0
Phenelzine,NNCCC1=CC=CC=C1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",,0.82,,0
Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.46,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,UDP-glucuronosyltransferases (UGTs),0.83,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,UDP-glucuronosyltransferases (UGTs),0.51,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,"Cytochrome P450 1B1, Cytochrome P450 3A5",0.68,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,UDP-glucuronosyltransferases (UGTs),0.55,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.52,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.61,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,UDP-glucuronosyltransferases (UGTs),0.56,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.75,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,Cytochrome P450 1B1,0.85,,0
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.73,,0
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Cytochrome P450 1A2,0.61,,0
4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.82,,0
2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,Catechol O-methyltransferase,0.79,,0
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 1A2",0.91,,0
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",Naproxen O-glucuronide,COC1=CC=C2C=C(C(C)C(=O)OC3OC(C(=O)O)C(C)C(C)C3C)C=CC2=C1,JPEWXHCASWOSRA-LQLJUYLHSA-N,,0.41,,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen sulfate,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OS(=O)(=O)O)C=C2,BNKMSCMOWGCUOF-UHFFFAOYSA-N,"Sulfotransferase 1A1, Estrogen sulfotransferase, Sulfotransferase family cytosolic 1B member 1",0.74,,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen acyl glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC2=C(C=C1)C=C(O)C=C2,WKYUVCYFVJKWHF-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-6, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 2B7",0.35,,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC2=CC=C(O)C=C2C=C1,XWJUDDGELKXYNO-UHFFFAOYSA-N,O-Desmethylnaproxen O-glucuronide,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,BFGOTVVWSNGSME-FVNSOWSRSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-10",0.34,,0
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,,0
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",,0.4,,0
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",Sulfapyridine,NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,"InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)",,0.61,,0
Candesartan cilexetil,CCOC1=NC2=C(C(C(=O)OC(C)OC(=O)OC3CCCCC3)=CC=C2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)",Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",,0.88,,0
Tazarotene,CCOC(=O)C1=CN=C(C#CC2=CC3=C(C=C2)SCCC3(C)C)C=C1,"InChI=1S/C21H21NO2S/c1-4-24-20(23)16-7-9-17(22-14-16)8-5-15-6-10-19-18(13-15)21(2,3)11-12-25-19/h6-7,9-10,13-14H,4,11-12H2,1-3H3",Tazarotenic acid,CC1(C)CCSC2=C1C=C(C#CC1=NC=C(C(=O)O)C=C1)C=C2,IQIBKLWBVJPOQO-UHFFFAOYSA-N,,0.93,,0
Alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,"InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3",AMX,CC1=NN(C2=CC(S(=O)(=O)O)=CC=C2)C(=O)C1N=NC1=C(S(=O)(=O)O)C=C(Cl)C(Cl)=C1,UOJXCGAWGJWRNV-FMQUCBEESA-N,Cytochrome P450 3A4,0.36,,0
Alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,"InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3",noralfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCNCC1,ULOZGJWEIWAWML-UHFFFAOYSA-N,Cytochrome P450 3A4,0.73,,0
Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",Lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1",,0.97,,0
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,,0
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,,0
Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.48,,0
Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Cytochrome P450 3A4,0.5,,0
Indapamide epoxide intermediate,CC1CC2=C(C=CC3OC23)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ZDRCVKKLZHUQLV-UHFFFAOYSA-N,Indapamide metabolite M6,CC1CC2=C(C=CC(O)C2O)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,CZPZKXRBEJAROA-UHFFFAOYSA-N,Epoxide hydrolase 1,0.93,,0
Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,Cytochrome P450 3A4,0.49,,0
Fentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1,"InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3",norfentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCNCC1,PMCBDBWCQQBSRJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.78,,0
Meloxicam,CC1=CN=C(NC(=O)C2=C(O)C3=C(C=CC=C3)S(=O)(=O)N2C)S1,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,,0.69,,0
5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,5'-carboxy meloxicam,CN1C(C(O)=NC2=NC=C(C(=O)O)S2)=C(O)C2=CC=CC=C2S1(=O)=O,MTQQFYLGAZXHTB-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,,0
Orciprenaline,CC(C)NCC(O)C1=CC(O)=CC(O)=C1,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",Orciprenaline-3-O-sulfate,CC(C)NCC(O)C1=CC(O)=CC(OS(=O)(=O)O)=C1,IJWHPUWEGCYHMQ-UHFFFAOYSA-N,,0.65,,0
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6",0.83,,0
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-9",0.25,,0
Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,,0.96,,0
4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-9",0.29,,0
4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,4-Quinol sulfate,CC(C)C1=CC(OS(=O)(=O)O)=CC(C(C)C)=C1O,RKAQPQOYAJQIAA-UHFFFAOYSA-N,,0.65,,0
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",desmethyldiazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,AKPLHCDWDRPJGD-UHFFFAOYSA-N,,0.87,,0
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Temazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3","Prostaglandin G/H synthase 1, Cytochrome P450 2C19",0.87,,0
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,Cytochrome P450 1A2,0.78,,0
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Nordiazepam O-glucuronide,O=C(O)C1OC(OC2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N2)C(O)C(O)C1O,HIENWGUIYHGOPI-QHKDLCCSSA-N,,0.54,,0
Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,"InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,"UDP-glucuronosyltransferase 2B15, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9",0.47,,0
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,"InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)",Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,DDBREPKUVSBGFI-UHFFFAOYSA-N,,0.84,,0
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.66,,0
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.93,,0
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2B6",0.71,,0
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 3A4",0.88,,0
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.32,,0
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,Carboxyterbinafine,CN(CC=CC#CC(C)(C)C(=O)O)CC1=CC=CC2=CC=CC=C12,DSPCPJFHUUUMEV-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.89,,0
Hydroxyterbinafine,CN(CC=CC#CC(C)(C)CO)CC1=CC=CC2=CC=CC=C12,GPEJUKJZTGFNKY-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2B6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 2C19",0.89,,0
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19",0.92,,0
1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,1-Naphthoic acid,O=C(O)C1=C2C=CC=CC2=CC=C1,LNETULKMXZVUST-UHFFFAOYSA-N,,0.7,,0
1-Naphthaldehyde,O=CC1=CC=CC2=CC=CC=C12,SQAINHDHICKHLX-UHFFFAOYSA-N,1-Naphthalenemethanol,OCC1=CC=CC2=CC=CC=C12,PBLNHHSDYFYZNC-UHFFFAOYSA-N,,0.58,,0
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.63,,0
N-Desmethylterbinafine,CC(C)(C)C#CC=CCNCC1=CC=CC2=CC=CC=C12,IZJZLXQHMWUCIC-XBXARRHUSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C9",0.68,,0
Terbinafine dihydrodiol derivative (1),CN(CC=CC#CC(C)(C)C)CC1=CC(O)=C(O)C2=CC=CC=C12,BSCJZDRHKPMNFX-WEVVVXLNSA-N,N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,,0
Terbinafine dihydrodiol derivative (2),CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=C(O)C(O)=CC=C12,OZUIZHMLRLTKOH-FNORWQNLSA-N,N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,"Cytochrome P450 1A2, Cytochrome P450 2B6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.92,,0
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,,0.47,,0
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",Methamphetamine,CNC(C)CC1=CC=CC=C1,MYWUZJCMWCOHBA-VIFPVBQESA-N,,0.56,,0
Alprenolol,C=CCC1=CC=CC=C1OCC(O)CNC(C)C,"InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3",4-hydroxy-alprenolol,C=CCC1=CC(O)=CC=C1OCC(O)CNC(C)C,HNXRWPIZRBNFDD-UHFFFAOYSA-N,,0.9,,0
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)",Suprofen S-oxide,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2=O)C=C1,BBVYLLCHKPXDCK-UHFFFAOYSA-N,Cytochrome P450 2C9,0.35,,0
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)","Thiophene-4,5-epoxide",CC(C(=O)O)C1=CC=C(C(=O)C2=CC3OC3S2)C=C1,SDGBIPHZPNRUFG-UHFFFAOYSA-N,Cytochrome P450 2C9,0.32,,0
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,"InChI=1S/C14H12O3S/c1-9(14(16)17)10-4-6-11(7-5-10)13(15)12-3-2-8-18-12/h2-9H,1H3,(H,16,17)",Suprofen glucuronide,CC(C(=O)OC(=O)C1OC(O)C(O)C(O)C1O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,JSDNVZNTHLHVBN-MMWQRLKXSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 2B7",0.5,,0
Guaifenesin,COC1=CC=CC=C1OCC(O)CO,"InChI=1S/C10H14O4/c1-13-9-4-2-3-5-10(9)14-7-8(12)6-11/h2-5,8,11-12H,6-7H2,1H3",beta-(2-methoxyphenoxy)-lactic acid,COC1=CC=CC=C1OCC(O)C(=O)O,MXVBBOLVTSAHEX-UHFFFAOYSA-N,,0.83,,0
Quinapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2=CC=CC=C2CC1C(=O)O,"InChI=1S/C25H30N2O5/c1-3-32-25(31)21(14-13-18-9-5-4-6-10-18)26-17(2)23(28)27-16-20-12-8-7-11-19(20)15-22(27)24(29)30/h4-12,17,21-22,26H,3,13-16H2,1-2H3,(H,29,30)/t17-,21-,22-/m0/s1",Quinaprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2=C(C=CC=C2)CC1C(=O)O,FLSLEGPOVLMJMN-YSSFQJQWSA-N,Liver carboxylesterase 1,0.94,,0
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",4-hydroxytriazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,YUQRFPYHTPARRM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.89,,0
Triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,"InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",1'-hydroxytriazolam,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(C=CC(Cl)=C3)N12,BHUYWUDMVCLHND-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.35,,0
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,,0.35,,0
Didanosine,O=C1N=CNC2=C1N=CN2C1CCC(CO)O1,"InChI=1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7+/m0/s1",Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,,0.33,,0
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",norcocaine,COC(=O)C1C2CCC(CC1C(=O)OC1=CC=CC=C1)N2,RERBBBLSJAMJFJ-UHFFFAOYSA-N,Cytochrome P450 3A4,0.47,,0
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",Benzoylecgonine,CN1C2CCC1C(C(=O)O)C(OC(=O)C1=CC=CC=C1)C2,"InChI=1S/C16H19NO4/c1-17-11-7-8-12(17)14(15(18)19)13(9-11)21-16(20)10-5-3-2-4-6-10/h2-6,11-14H,7-9H2,1H3,(H,18,19)/t11-,12+,13-,14+/m0/s1",,0.96,,0
Cocaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",Cocaethylene,CCOC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,NMPOSNRHZIWLLL-UHFFFAOYSA-N,,0.97,,0
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",2-sulfamoylacetylphenol,CCC1(O)CC2CN(CCC3=C(NC4=CC=CC=C34)C(C(=O)OC)(C3=C(OC)C=C4C(=C3)C35CCN6CC=CC(CC)(C(O)C(O)(C(=O)OC)C3N4C)C65)C2)C1,NDMPLJNOPCLANR-CYJJREDESA-N,Cytochrome P450 3A4,0.25,,0
Zonisamide,NS(=O)(=O)CC1=NOC2=CC=CC=C12,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",N-acetyl zonisamide,CC(=O)NS(=O)(=O)CC1=NOC2=C1C=CC=C2,HXFUTAFSEXINIW-UHFFFAOYSA-N,,0.82,,0
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",hydroxyrepaglinide,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=C1,OBMAZJVHPAVADF-UHFFFAOYSA-N,Cytochrome P450 2C8,0.69,,0
Repaglinide,CCOC1=C(C(=O)O)C=CC(CC(=O)NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=C1,"InChI=1S/C27H36N2O4/c1-4-33-25-17-20(12-13-22(25)27(31)32)18-26(30)28-23(16-19(2)3)21-10-6-7-11-24(21)29-14-8-5-9-15-29/h6-7,10-13,17,19,23H,4-5,8-9,14-16,18H2,1-3H3,(H,28,30)(H,31,32)/t23-/m0/s1",repaglinide aromatic amine,CCOC1=C(C(=O)O)C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N)=C1,OSCVKZCOJUTUFD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.57,,0
Almotriptan,CN(C)CCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,"InChI=1S/C17H25N3O2S/c1-19(2)10-7-15-12-18-17-6-5-14(11-16(15)17)13-23(21,22)20-8-3-4-9-20/h5-6,11-12,18H,3-4,7-10,13H2,1-2H3",N-desmethylalmotriptan,CNCCC1=CNC2=C1C=C(CS(=O)(=O)N1CCCC1)C=C2,IREINZNGILEJRP-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1, Cytochrome P450 2C8",0.99,,0
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",Ketotifen-N-glucuronide,C[N+]1(C2OC(C(=O)[O-])C(O)C(O)C2O)CCC(=C2C3=C(C=CC=C3)CC(=O)C3=C2C=CS3)CC1,WLTPAELNPGRIGG-AQTBWJFISA-N,"UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-4, UDP-glucuronosyltransferase 2B10",0.73,,0
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",10-alpha-hydroxyl Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(O)C3=C2C=CS3)CC1,TZHJFZBFWVCFAA-UHFFFAOYSA-N,,0.76,,0
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",Nor-ketotifen,O=C1CC2=CC=CC=C2C(=C2CCNCC2)C2=C1SC=C2,IYSYPCSSDZBWHN-UHFFFAOYSA-N,,0.99,,0
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1855,CC1CC(=O)NN=C1C1=CC=C(N)C=C1,GDMRFHZLKNYRRO-SSDOTTSWSA-N,,0.86,,0
Levosimendan,CC1CC(=O)NN=C1C1=CC=C(NN=C(C#N)C#N)C=C1,"InChI=1S/C14H12N6O/c1-9-6-13(21)19-20-14(9)10-2-4-11(5-3-10)17-18-12(7-15)8-16/h2-5,9,17H,6H2,1H3,(H,19,21)/t9-/m1/s1",OR-1896,CC(=O)NC1=CC=C(C2=NNC(=O)CC2C)C=C1,GDZXNMWZXLDEKG-MRVPVSSYSA-N,,0.78,,0
Cyclobenzaprine,CN(C)CCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,"InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3",desmethylcyclobenzaprine,CNCCC=C1C2=CC=CC=C2C=CC2=CC=CC=C12,XECQQDXTQRYYBH-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2D6, Cytochrome P450 3A4",0.98,,0
Maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,"InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3",demethylmaprotiline,NCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,IFHUOEQJTQWFGJ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.97,,0
Salmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCCC2=CC=CC=C2)=C1,"InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2",alpha-hydroxysalmeterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCCC(O)C2=CC=CC=C2)=C1,PGRMEHUQIPZHKM-UHFFFAOYSA-N,Cytochrome P450 3A4,0.94,,0
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",Gentisic acid,O=C(O)C1=C(O)C=CC(O)=C1,,Cytochrome P450 2C9,0.5,,0
Acetylsalicylic acid,CC(=O)OC1=CC=CC=C1C(=O)O,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",Salicyluric acid,O=C(O)CNC(=O)C1=C(O)C=CC=C1,,Medium-chain fatty-acid--CoA ligase,0.3,,0
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",4'-Hydroxy-R-phenprocoumon,CCC(C1=CC=C(O)C=C1)C1=C(O)C2=CC=CC=C2OC1=O,ZPNYHQZRGWFLST-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.98,,0
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",8-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(OC1=O)C(O)=CC=C2,DKNXIPNBVAVYAP-GFCCVEGCSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.92,,0
Phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=CC=C2)OC1=O,"InChI=1S/C18H16O3/c1-2-13(12-8-4-3-5-9-12)16-17(19)14-10-6-7-11-15(14)21-18(16)20/h3-11,13,19H,2H2,1H3",7-Hydroxy-R-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=C(C=C(O)C=C2)OC1=O,HBAPGROFUGJSGR-CYBMUJFWSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.98,,0
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)","2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,Cytochrome P450 2C19,0.55,,0
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",p-Hydroxyfelbamate,NC(=O)OCC(COC(N)=O)C1=CC=C(O)C=C1,PXBZEVLDFAKFLV-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.84,,0
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",2-Hydroxyfelbamate,NC(=O)OCC(O)(COC(N)=O)C1=CC=CC=C1,VTXNIAJKDLEHGX-UHFFFAOYSA-N,"Cytochrome P450 3A7, Cytochrome P450 2E1",0.66,,0
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.71,,0
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,Atropaldehyde,C=C(C=O)C1=CC=CC=C1,ZFBRJUBOJXNIQM-UHFFFAOYSA-N,,0.29,,0
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,,0.41,,0
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,"Aldehyde dehydrogenase, dimeric NADP-preferring",0.81,,0
"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,Alcohol dehydrogenase 1A,0.37,,0
"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.34,,0
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1","Cytochrome P450 2D6, Cytochrome P450 2B6, Cytochrome P450 2C19",0.99,,0
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",norhydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5)C=C1,JGORUXKMRLIJSV-ZWUPXRALSA-N,Cytochrome P450 3A4,0.98,,0
Zaleplon,CCN(C(C)=O)C1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,"InChI=1S/C17H15N5O/c1-3-21(12(2)23)15-6-4-5-13(9-15)16-7-8-19-17-14(10-18)11-20-22(16)17/h4-9,11H,3H2,1-2H3",desethylzaleplon,CCNC1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,QIBDHPGCTQWVTR-UHFFFAOYSA-N,Cytochrome P450 3A4,0.93,,0
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",Alpha-methyldopamine,CC(N)CC1=CC(O)=C(O)C=C1,KSRGADMGIRTXAF-UHFFFAOYSA-N,Aromatic-L-amino-acid decarboxylase,0.66,,0
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1","3,4-Dihydroxyphenylacetone",CC(=O)CC1=CC(O)=C(O)C=C1,JQXBETDGCMQLMK-UHFFFAOYSA-N,,0.51,,0
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,Catechol O-methyltransferase,0.74,,0
3-O-methyl-alpha-methyldopa,COC1=C(O)C=CC(CC(N)C(=O)O)=C1,PFDUUKDQEHURQC-ZETCQYMHSA-N,3-O-methyl-alpha-methyldopa sulfate,COC1=CC=C(CC(C)(N)C(=O)O)C=C1OS(=O)(=O)O,NKCGFFAMYYALPZ-NSHDSACASA-N,Sulfotransferase,0.56,,0
,CN1CCCC(N2N=C(CC3=CC=C(Cl)C=C3)C3=CC=CC=C3C2=O)CC1,"InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3",Desmethylazelastine,O=C1C2=CC=CC=C2C(CC2=CC=C(Cl)C=C2)=NN1C1CCCNCC1,WRYCMIFVXDQIKN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C19",0.98,,0
Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 3A5",0.96,,0
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",Diphenhydramine N-glucuronide,C[N+](C)(CCOC(C1=CC=CC=C1)C1=CC=CC=C1)C1OC(C(=O)O)C(O)C(O)C1O,OAIGZXXQYIJBLR-VAUIJEFBSA-O,UDP-glucuronosyltransferases (UGTs),0.28,,0
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,AGSLYHYWLYGAOU-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C19",0.96,,0
N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,AGSLYHYWLYGAOU-UHFFFAOYSA-N,"N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,,0
"N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,Diphenylmethoxyacetic acid,O=C(O)COC(C1=CC=CC=C1)C1=CC=CC=C1,KWGQOJWITMQEOT-UHFFFAOYSA-N,,0.77,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",6-Hydroxydopamine,NCCC1=C(O)C=C(O)C(O)=C1,DIVDFFZHCJEHGG-UHFFFAOYSA-N,,0.73,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine 4-sulfate,NCCC1=CC(O)=C(OS(=O)(=O)O)C=C1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,0.54,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine 3-O-sulfate,NCCC1=CC(OS(=O)(=O)O)=C(O)C=C1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,0.5,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Dopamine glucuronide,NCCC1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,CQASRCDNLNMIJY-BYNIDDHOSA-N,,0.22,,0
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,"Glutathione S-transferase Mu 1, Glutathione S-transferase A1, Glutathione S-transferase A2",0.23,,0
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-thiouric acid,OC1=NC2=C(N=C(O)N2)C(S)=N1,SXHQUGJSTGOXMD-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.36,,0
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,,0
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2",0.83,,0
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicinol deoxaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(O)CO)CC3)C(O)=C1C2=O,IGJIPNOEJDYNRR-QUXALOBESA-N,"NADPH--cytochrome P450 reductase, Xanthine dehydrogenase/oxidase, NAD(P)H dehydrogenase [quinone] 1",0.73,,0
Doxorubicinol,COC1=CC=CC2=C1C(=O)C1=C(C2=O)C(O)=C2CC(O)(C(O)CO)CC(OC3CC(N)C(O)C(C)O3)C2=C1O,NKZRZOVSJNSBFR-FEMMEMONSA-N,Doxorubicine hydroxyaglycone,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3O)C(O)=C1C2=O,IBZGBXXTIGCACK-CWKPULSASA-N,,0.78,,0
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",desmethyl frovatriptan,N=C(O)C1=CC=C2NC3=C(CC(N)CC3)C2=C1,FPYHQGKIVXULKF-DDWIOCJRSA-N,,0.8,,0
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",Hydroxylated N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=C(O)C=C(C(N)=O)C=C3C2C1,CDCOGHQILPZANE-UHFFFAOYSA-N,,0.37,,0
Frovatriptan,CNC1CCC2=C(C1)C1=C(C=CC(C(N)=O)=C1)N2,"InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)/t9-/m1/s1",N-acetyl desmethyl frovatriptan,CC(=O)NC1CCC2NC3=CC=C(C(N)=O)C=C3C2C1,CQIAKQMSTPQBAU-UHFFFAOYSA-N,,0.37,,0
Salbutamol,CC(C)(C)NCC(O)C1=CC(CO)=C(O)C=C1,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",Salbutamol 4-O-sulfate,CC(C)(C)NCC(O)C1=CC=C(OS(=O)(=O)O)C(CO)=C1,FPMLHYFHLRTRMB-UHFFFAOYSA-N,,0.68,,0
Ketoprofen,CC(C(=O)O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",Ketoprofen glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC(C(=O)C2=CC=CC=C2)=CC=C1,PBTXSZZKPHBHMA-LYFYOZKASA-N,,0.43,,0
Metyrapone,CC(C)(C(=O)C1=CN=CC=C1)C1=CC=CN=C1,"InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3",Metyrapol,CC(C)(C1=CN=CC=C1)C(O)C1=CN=CC=C1,DDFNHFXLQJLFSX-UHFFFAOYSA-N,,0.5,,0
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",Hydrocinnamic acid,O=C(O)CCC1=CC=CC=C1,XMIIGOLPHOKFCH-UHFFFAOYSA-N,,0.19,,0
Cinacalcet,CC(NCCCC1=CC(C(F)(F)F)=CC=C1)C1=CC=CC2=CC=CC=C12,"InChI=1S/C22H22F3N/c1-16(20-13-5-10-18-9-2-3-12-21(18)20)26-14-6-8-17-7-4-11-19(15-17)22(23,24)25/h2-5,7,9-13,15-16,26H,6,8,14H2,1H3/t16-/m1/s1",hydroxy-hydrocinnamic acid,O=C(O)CCC1=CC=CC(O)=C1,QVWAEZJXDYOKEH-UHFFFAOYSA-N,,0.18,,0
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",5-aminosalicylic acid,NC1=CC(C(=O)O)=C(O)C=C1,KBOPZPXVLCULAV-UHFFFAOYSA-N,NADPH azoreductase,0.54,,0
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",4-aminobenzoyl-(beta)-alanine,NC1=CC=C(C(=O)NCCC(=O)O)C=C1,VHAXWROFYVPXMZ-UHFFFAOYSA-N,,0.5,,0
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,,0.91,,0
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.88,,0
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",Sulfamethoxazole N4-hydroxylamine,CC1=CC(NS(=O)(=O)C2=CC=C(NO)C=C2)=NO1,MJAMPGKHIZXVFJ-UHFFFAOYSA-N,Cytochrome P450 2C9,0.95,,0
5-Hydroxysulfamethoxazole,NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,CECJOLRUXWTJHV-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.89,,0
N-acetylsulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,GXPIUNZCALHVBA-UHFFFAOYSA-N,N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,,0.92,,0
Sulfamethoxazole N4-hydroxylamine,CC1=CC(NS(=O)(=O)C2=CC=C(NO)C=C2)=NO1,MJAMPGKHIZXVFJ-UHFFFAOYSA-N,Nitroso-sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N=O)C=C2)=NO1,GHNQGDUYHCZZPT-UHFFFAOYSA-N,,0.92,,0
Glyburide,COC1=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)C=C(Cl)C=C1,"InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",3-trans-Hydroxycyclohexyl glyburide,COC1=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCCC(O)C3)C=C2)C=C(Cl)C=C1,,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A7, Cytochrome P450 3A5",0.48,,0
Isosorbide mononitrate,O=[N+]([O-])OC1COC2C(O)COC12,"InChI=1S/C6H9NO6/c8-3-1-11-6-4(13-7(9)10)2-12-5(3)6/h3-6,8H,1-2H2/t3-,4+,5+,6+/m0/s1",Isosorbide,OC1COC2C(O)COC12,"InChI=1S/C6H10O4/c7-3-1-9-6-4(8)2-10-5(3)6/h3-8H,1-2H2/t3-,4+,5-,6-/m1/s1",,0.52,,0
Phylloquinone,CC(=CCC1=C(C)C(=O)C2=C(C=CC=C2)C1=O)CCCC(C)CCCC(C)CCCC(C)C,"InChI=1S/C31H46O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,18-20,22-24H,9-17,21H2,1-6H3/b25-20+/t23-,24-/m1/s1",Menatetrenone,CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CCC1=C(C)C(=O)C2=CC=CC=C2C1=O,"InChI=1S/C31H40O2/c1-22(2)12-9-13-23(3)14-10-15-24(4)16-11-17-25(5)20-21-27-26(6)30(32)28-18-7-8-19-29(28)31(27)33/h7-8,12,14,16,18-20H,9-11,13,15,17,21H2,1-6H3/b23-14+,24-16+,25-20+",UbiA prenyltransferase domain-containing protein 1,0.96,,0
Felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=C(Cl)C(Cl)=CC=C1,"InChI=1S/C18H19Cl2NO4/c1-5-25-18(23)14-10(3)21-9(2)13(17(22)24-4)15(14)11-7-6-8-12(19)16(11)20/h6-8,15,21H,5H2,1-4H3",dehydrofelodipine,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=C(Cl)C(Cl)=CC=C1,REQRUBNOOIAHMG-UHFFFAOYSA-N,Cytochrome P450 3A4,0.33,,0
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",6-O-desmethyl-mycophenolic acid,CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,MHSRNZSBNXFMLF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4, Cytochrome P450 3A5",0.91,,0
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",Mycophenolic acid-7-O-glucuronide,COC1=C(CC=C(C)CCC(=O)O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)OCC2=C1C,BYFGTSAYQQIUCN-WTKPLQERSA-N,"UDP-glucuronosyltransferase 1-8, UDP-glucuronosyltransferase 1-10, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-7, UDP-glucuronosyltransferase 1-1",0.65,,0
Mycophenolic acid,COC1=C(CC=C(C)CCC(=O)O)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C17H20O6/c1-9(5-7-13(18)19)4-6-11-15(20)14-12(8-23-17(14)21)10(2)16(11)22-3/h4,20H,5-8H2,1-3H3,(H,18,19)/b9-4+",Mycophenolic acid-acyl glucuronide,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBMSTEZXAMABFF-UEARNRKISA-N,UDP-glucuronosyltransferase 2B7,0.72,,0
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",SR 49498,CCCCC(O)=NC1(C(O)=NCC2=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C2)CCCC1,PAKGYCNZUGIDHV-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.5,,0
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Cytochrome P450 2C9,0.98,,0
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M5,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SGLAKMDXJPVHBY-UHFFFAOYSA-N,Cytochrome P450 2C9,0.92,,0
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M3,O=C(O)CCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SQPSUXCOWHFKKF-UHFFFAOYSA-N,,0.98,,0
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,,0
Irbesartan derivative M7,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SGLAKMDXJPVHBY-UHFFFAOYSA-N,Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Cytochrome P450 2C9,0.99,,0
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,,0.97,,0
Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.98,,0
Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.93,,0
Mercaptopurine,S=C1N=CNC2=C1NC=N2,"InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Hypoxanthine-guanine phosphoribosyltransferase,0.19,,0
Mercaptopurine,S=C1N=CNC2=C1NC=N2,"InChI=1S/C5H4N4S/c10-5-3-4(7-1-6-3)8-2-9-5/h1-2H,(H2,6,7,8,9,10)",8-hydroxythioguanine,OC1=NC2=C(N1)C(=S)N=CN2,OIZCDCVIFRRJFF-UHFFFAOYSA-N,Aldehyde oxidase,0.73,,0
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.93,,0
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,,0
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,,0.93,,0
Thioxanthine monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,GMP synthase [glutamine-hydrolyzing],0.79,,0
6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Thiopurine S-methyltransferase,0.96,,0
6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,Adenosine kinase,0.93,,0
Procainamide,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,"InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)",N-Acetyl-3-hydroxyprocainamide,CCN(CC)CCN=C(O)C1=CC(O)=C(N=C(C)O)C=C1,REELIONXYPAEGO-UHFFFAOYSA-N,Cytochrome P450 2D6,0.22,,0
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.95,,0
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,Cytochrome P450 2D6,0.92,,0
N-Dealkylated tolterodine,CC1=CC(C(CCNC(C)C)C2=CC=CC=C2)=C(O)C=C1,CPLYUIYTJCFQJD-KRWDZBQOSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.91,,0
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.95,,0
5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1)C(C)C,DUXZAXCGJSBGDW-FQEVSTJZSA-N,5-Carboxylic acid tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(C(=O)O)=C1)C(C)C,NKTNTJFTBRPQIZ-LJQANCHMSA-N,,0.9,,0
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",Levmetamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m1/s1","Cytochrome P450 2B6, Cytochrome P450 2C19, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2C9, Cytochrome P450 3A4",0.68,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)","cis, trans-5'-Hydroxythalidomide",O=C1NC(=O)C(N2C(=O)C3=CC=CC=C3C2=O)CC1O,HHTOWVWIVBSOKC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.88,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 2E1",0.35,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,,0.84,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,,0.73,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,,0.7,,0
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,Cytochrome P450 2C19,0.9,,0
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,,0.73,,0
Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,,0.35,,0
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.93,,0
5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9, Cytochrome P450 1A1",0.98,,0
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.81,,0
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,,0.69,,0
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,,0.69,,0
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.29,,0
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,L-Glutamine,NC(=O)CCC(N)C(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",,0.2,,0
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.31,,0
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Isoglutamine,NC(=O)C(N)CCC(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1",,0.2,,0
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.31,,0
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.92,,0
2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.68,,0
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.81,,0
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.18,,0
2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.32,,0
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",Ibuprofen glucuronide,CC(C)CC1=CC=C(C(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,ABOLXXZAJIAUGR-JPMMFUSZSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7",0.29,,0
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",2-Hydroxyibuprofen,CC(C(=O)O)C1=CC=C(CC(C)(C)O)C=C1,UJHKVYPPCJBOSG-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.91,,0
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,HFAIHLSDLUYLQA-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 2C9",0.92,,0
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",1-hydroxyibuprofen,CC(C(=O)O)C1=CC=C(C(O)C(C)C)C=C1,RMOQYHYFRKTDRI-UHFFFAOYSA-N,,0.78,,0
3-Hydroxyibuprofen,CC(CO)CC1=CC=C(C(C)C(=O)O)C=C1,HFAIHLSDLUYLQA-UHFFFAOYSA-N,Carboxy-ibuprofen,CC(CC1=CC=C(C(C)C(=O)O)C=C1)C(=O)O,DIVLBIVDYADZPL-UHFFFAOYSA-N,Cytochrome P450 2C9,0.9,,0
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",6-aminopenicillanic acid,CC1(C)SC2C(N)C(=O)N2C1C(=O)O,NGHVIOIJCVXTGV-ALEPSDHESA-N,,0.85,,0
Benzylpenicillin,CC1(C)SC2C(NC(=O)CC3=CC=CC=C3)C(=O)N2C1C(=O)O,"InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",Penicilloic acid,CC1(C)SC(C(NC(=O)CC2=CC=CC=C2)C(=O)O)NC1C(=O)O,HCYWNSXLUZRKJX-UHFFFAOYSA-N,,0.71,,0
Oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,"InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3",N-desethyloxybutynin,CCNCC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,SNIBJKHIKIIGPR-UHFFFAOYSA-N,Cytochrome P450 3A4,0.99,,0
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 1A1, Cytochrome P450 2C19",0.75,,0
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,,0.91,,0
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 1A2",0.92,,0
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin sulfate,COC1=C(OS(=O)(=O)O)C=C2NC=C(CCN=C(C)O)C2=C1,QQEILXDLZRLTME-UHFFFAOYSA-N,,0.81,,0
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine sulfate,CC(=O)NCCC1=CNC2=C1C=C(OS(=O)(=O)O)C=C2,UCAJZNVFRVLULS-UHFFFAOYSA-N,,0.83,,0
N-Acetyl-5-hydroxytryptamine,CC(=O)NCCC1=CNC2=C1C=C(O)C=C2,MVAWJSIDNICKHF-UHFFFAOYSA-N,N-Acetyl-5-hydroxytryptamine glucuronide,CC(=O)NCCC1=CNC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,DRKQFNYKSNWOTC-PDHYLSHYSA-N,UDP-glucuronosyltransferases (UGTs),0.5,,0
6-Hydroxymelatonin,COC1=C(O)C=C2NC=C(CCN=C(C)O)C2=C1,OMYMRCXOJJZYKE-UHFFFAOYSA-N,6-Hydroxymelatonin glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCNC(C)=O,BIRHYNBRXCOXLU-OOHXRKOZSA-N,UDP-glucuronosyltransferases (UGTs),0.53,,0
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Pinoline,COC1=CC2=C(C=C1)NC1=C2CCNC1,QYMDEOQLJUUNOF-UHFFFAOYSA-N,,0.67,,0
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,,0.86,,0
Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,"N,N-Dimethyltryptamine",CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,,0.81,,0
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",3-cis-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCC(O)C3)C=C2)C=N1,GZLIUWBDTXQVBY-ZYMOGRSISA-N,,0.94,,0
Glipizide,CC1=NC=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCCCC3)C=C2)N=C1,"InChI=1S/C21H27N5O4S/c1-15-13-24-19(14-23-15)20(27)22-12-11-16-7-9-18(10-8-16)31(29,30)26-21(28)25-17-5-3-2-4-6-17/h7-10,13-14,17H,2-6,11-12H2,1H3,(H,22,27)(H2,25,26,28)",4-trans-Hydroxyglipizide,CC1=CN=C(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(O)CC3)C=C2)C=N1,WPQWQJBFAJEUHS-FITNRVMRSA-N,Cytochrome P450 2C9,0.97,,0
Perhexiline,C1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,"InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2",cis-Hydroxy Perhexiline,OC1CCC(C(CC2CCCCN2)C2CCCCC2)CC1,DZFRYNPJLZCKSC-BTRQGYIVSA-N,,0.8,,0
Atorvastatin,CC(C)C1=C(C(=O)NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",ortho-hydroxyatorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2O)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,CZBPKFICAYVHHM-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.78,,0
Emedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=CC=CC=C21,"InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3",5-hydroxyemedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=C1C=CC(O)=C2,JNLXTCQXMDMAOC-UHFFFAOYSA-N,,0.92,,0
Emedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=CC=CC=C21,"InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3",6-hydroxyemedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=C1C=C(O)C=C2,YDYQGSLFCJVMNN-UHFFFAOYSA-N,,0.9,,0
Benzocaine,CCOC(=O)C1=CC=C(N)C=C1,"InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3",Aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,"InChI=1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10)",,0.74,,0
Hesperetin,COC1=C(O)C=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1,"InChI=1S/C16H14O6/c1-21-13-3-2-8(4-10(13)18)14-7-12(20)16-11(19)5-9(17)6-15(16)22-14/h2-6,14,17-19H,7H2,1H3/t14-/m0/s1",eriodictyol,O=C1CC(C2=CC(O)=C(O)C=C2)OC2=C1C(O)=CC(O)=C2,SBHXYTNGIZCORC-ZDUSSCGKSA-N,Cytochrome P450 1A2,0.98,,0
Leflunomide,CC1=C(C(=O)NC2=CC=C(C(F)(F)F)C=C2)C=NO1,"InChI=1S/C12H9F3N2O2/c1-7-10(6-16-19-7)11(18)17-9-4-2-8(3-5-9)12(13,14)15/h2-6H,1H3,(H,17,18)",A771726,CC(O)=C(C#N)C(=O)NC1=CC=C(C(F)(F)F)C=C1,UTNUDOFZCWSZMS-JXMROGBWSA-N,Cytochrome P450 1A2,0.31,,0
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",N-Desmethylrosuvastatin,CC(C)C1=C(C=CC(O)CC(O)CC(=O)O)C(C2=CC=C(F)C=C2)=NC(NS(C)(=O)=O)=N1,,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.93,,0
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,"InChI=1S/C22H28FN3O6S/c1-13(2)20-18(10-9-16(27)11-17(28)12-19(29)30)21(14-5-7-15(23)8-6-14)25-22(24-20)26(3)33(4,31)32/h5-10,13,16-17,27-28H,11-12H2,1-4H3,(H,29,30)/b10-9+/t16-,17-/m1/s1",Rosuvastatin 5 S-lactone,CC(C)C1=C(C=CC2CC(O)CC(=O)O2)C(C2=CC=C(F)C=C2)=NC(N(C)S(C)(=O)=O)=N1,,Cytochrome P450 2C9,0.94,,0
Sertraline,CNC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",norsertraline,NC1CCC(C2=CC(Cl)=C(Cl)C=C2)C2=CC=CC=C21,SRPXSILJHWNFMK-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2B6",0.91,,0
Nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+](=O)[O-],"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3",dehydronifedipine,COC(=O)C1=C(C2=CC=CC=C2[N+](=O)[O-])C(C(=O)OC)=C(C)N=C1C,UMQHJQGNGLQJPF-UHFFFAOYSA-N,Cytochrome P450 3A4,0.35,,0
Amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=C(C=CC=C2)O1,"InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3",Desethylamiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCNCC)C(I)=C2)C2=CC=CC=C2O1,VXOKDLACQICQFA-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2D6, Cytochrome P450 2C8, Cytochrome P450 3A4",0.99,,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",7-β-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-ITGUQSILSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.51,,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",6-β-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-IACUBPJLSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.48,,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18",0.54,,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",7-α-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CC(O)CC3C2)C=C1,JMHDCYDSYHLATB-CLLJXQQHSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.9,,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",6-α-Hydroxygliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCC(O)C3C2)C=C1,VUUZEWXIRFGRFE-YUTCNCBUSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 2C18, Cytochrome P450 2C8",0.82,,0
Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,IHCHVBQHVIUSTM-BETUJISGSA-N,Carboxygliclazide,O=C(NN1CC2CCCC2C1)NS(=O)(=O)C1=CC=C(C(=O)O)C=C1,DSNDPTBTZSQWJS-TXEJJXNPSA-N,,0.56,,0
Tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(C)C=C1,"InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",4-Hydroxy tolbutamide,CCCCNC(=O)NS(=O)(=O)C1=CC=C(CO)C=C1,SJRHYONYKZIRPM-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.93,,0
Rabeprazole,COCCCOC1=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=NC=C1,"InChI=1S/C18H21N3O3S/c1-13-16(19-9-8-17(13)24-11-5-10-23-2)12-25(22)18-20-14-6-3-4-7-15(14)21-18/h3-4,6-9H,5,10-12H2,1-2H3,(H,20,21)",Active Metabolite of Rabeprazole,COCCCOC1=C(C)C=[N+]2C3=NC4=C(C=CC=C4)N3SCC2=C1,HGSXCFCOXJLVEZ-UHFFFAOYSA-N,,0.45,,0
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,"InChI=1S/C11H16ClN5/c1-7(2)15-10(13)17-11(14)16-9-5-3-8(12)4-6-9/h3-7H,1-2H3,(H5,13,14,15,16,17)",cycloguanil,CC1(C)N=C(N)N=C(N)N1C1=CC=C(Cl)C=C1,QMNFFXRFOJIOKZ-UHFFFAOYSA-N,Cytochrome P450 2C19,0.31,,0
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-I,O=C1NC(=O)C(CC2=CC=C(O)C=C2)S1,NKOHRVBBQISBSB-UHFFFAOYSA-N,,0.67,,0
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.89,,0
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.87,,0
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.94,,0
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.93,,0
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Mitoglitazone,CCC1=CN=C(C(=O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,,0.8,,0
Pioglitazone metabolite M-II,CCC1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,RMTFRGFLVHAYCI-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.97,,0
Pioglitazone metabolite M-V,O=C(O)CC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OIQJTMMAMWFMQR-UHFFFAOYSA-N,Pioglitazone metabolite M-VI,O=C1NC(=O)C(CC2=CC=C(OCCC3=NC=C(C(=O)O)C=C3)C=C2)S1,SLOBZACXYXBLIT-UHFFFAOYSA-N,,0.83,,0
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-III,CC(=O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,JMLKLMFMQRAJNI-UHFFFAOYSA-N,,0.87,,0
Pioglitazone metabolite M-IV,CC(O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,OXVFDZYQLGRLCD-UHFFFAOYSA-N,Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,"Cytochrome P450 2C8, Cytochrome P450 3A4",0.92,,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",8-Hydroxycarbazolylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=C(N2)C(O)=CC=C1,GPPVNZVFGNMPNR-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 1A1",0.91,,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",4'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=CC(O)=C1,ZCJHEORDHXCJNB-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 2C9, Cytochrome P450 3A4",0.94,,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",5'-Hydroxyphenylcarvedilol,COC1=C(OCCNCC(O)COC2=CC=CC3=C2C2=CC=CC=C2N3)C=C(O)C=C1,PVUVZUBTCLBJMT-UHFFFAOYSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",O-Desmethylcarvedilol,OC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,XAUKPPPYYOKVQJ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 2E1",0.98,,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",1-Hydroxyphenylcarvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=C(O)C2=C1C1=CC=CC=C1N2,UQJJKVKQRTUYJW-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2D6, Cytochrome P450 1A2, Cytochrome P450 1A1",0.89,,0
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,"InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2",Sulfinpyrazone sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,PLGXGMUJUXKCDD-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.93,,0
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,"InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2",Sulfinpyrazone sulfone,O=C1C(CCS(=O)(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,DQUYGWDNTAETLI-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.97,,0
Cefapirin,CC(=O)OCC1=C(C(=O)O)N2C(=O)C(NC(=O)CSC3=CC=NC=C3)C2SC1,"InChI=1S/C17H17N3O6S2/c1-9(21)26-6-10-7-28-16-13(15(23)20(16)14(10)17(24)25)19-12(22)8-27-11-2-4-18-5-3-11/h2-5,13,16H,6-8H2,1H3,(H,19,22)(H,24,25)/t13-,16-/m1/s1",Desacetylcephapirin,O=C(CSC1=CC=NC=C1)NC1C(=O)N2C(C(=O)O)=C(CO)CSC12,IOFHZPVEQXTSQW-UHFFFAOYSA-N,,0.95,,0
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2, Cytochrome P450 3A4",0.99,,0
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,,0.97,,0
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Cytochrome P450 2D6,0.93,,0
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Didesmethyl doxepin,NCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HLUSHBJOSPBFOC-OQLLNIDSSA-N,,0.99,,0
Doxepin N-oxide,C[N+](C)([O-])CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2,QJCSDPQQGVJGQY-GZTJUZNOSA-N,Doxepin N-oxide glucuronide,C[N+](C)(CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2)OC1OC(C(=O)O)C(O)C(O)C1O,NLZMYODDTAMNJM-GOSZAKIASA-O,,0.65,,0
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Hydroxydoxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,RECOUBTVNVWWDB-IUXPMGMMSA-N,,0.64,,0
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Cytochrome P450 2D6,0.93,,0
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,(E)-2-hydroxy-N-desmethyldoxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-FRKPEAEDSA-N,,0.99,,0
Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.64,,0
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,"InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",hydroxynefazodone,CC(O)C1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,VKGQYGXMUUBRBD-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,,0
Nefazodone,CCC1=NN(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,"InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",Cytochrome P450 3A4,0.26,,0
2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,2-hydroxy-desipramine glucuronide,CNCCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,XJHAOJJEVSPMBA-QMDPOKHVSA-N,,0.56,,0
Gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1CN,"InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",N-acetyl gemifloxacin,CON=C1CN(C2=NC3=C(C=C2F)C(=O)C(C(=O)O)=CN3C2CC2)CC1NC(C)=O,ZLRGFKRHAFQIIT-HZHRSRAPSA-N,,0.89,,0
Bupropion,CC(NC(C)(C)C)C(=O)C1=CC(Cl)=CC=C1,"InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3",S-Hydroxybupropion,CC(NC(C)(C)CO)C(=O)C1=CC(Cl)=CC=C1,AKOAEVOSDHIVFX-SECBINFHSA-N,"Cytochrome P450 2B6, Cytochrome P450 2E1, Cytochrome P450 3A4, Cytochrome P450 2C19",0.92,,0
Halothane,FC(F)(F)C(Cl)Br,"InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H",trifluoroacetic acid,O=C(O)C(F)(F)F,DTQVDTLACAAQTR-UHFFFAOYSA-N,Cytochrome P450 2E1,0.19,,0
Procarbazine,CNNCC1=CC=C(C(=O)NC(C)C)C=C1,"InChI=1S/C12H19N3O/c1-9(2)15-12(16)11-6-4-10(5-7-11)8-14-13-3/h4-7,9,13-14H,8H2,1-3H3,(H,15,16)",N-isopropylterephthalamic acid,CC(C)NC(=O)C1=CC=C(C(=O)O)C=C1,PRCGIFCKPACTDG-UHFFFAOYSA-N,,0.73,,0
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,"InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3",N-demethyl orphenadrine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1C,PNYKGCPSFKLFKA-UHFFFAOYSA-N,,0.97,,0
Orphenadrine,CC1=CC=CC=C1C(OCCN(C)C)C1=CC=CC=C1,"InChI=1S/C18H23NO/c1-15-9-7-8-12-17(15)18(20-14-13-19(2)3)16-10-5-4-6-11-16/h4-12,18H,13-14H2,1-3H3","N,N-didemethyl orphenadrine",CC1=C(C(OCCN)C2=CC=CC=C2)C=CC=C1,BJVWYJOLTICWGB-UHFFFAOYSA-N,,0.94,,0
Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,"InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,,0
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.88,,0
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.59,,0
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",3-Dechloroethylifosfamide,O=P1(NCCCl)NCCCO1,DZKGMGPLDJOVCX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2B6, Cytochrome P450 3A7",0.59,,0
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",Dechloroethylifosfamide,NP1(=O)OCCCN1CCCl,ROGLJLJCDSTWBN-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2B6, Cytochrome P450 3A7",0.83,,0
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,"Prostaglandin G/H synthase 1, Cytochrome P450 2B6, Cytochrome P450 3A4, Cytochrome P450 2A6, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A7",0.68,,0
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Ketoifosfamide,O=C1CCOP(=O)(NCCCl)N1CCCl,PEZLCTIXHCOEOG-UHFFFAOYSA-N,,0.56,,0
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,,0.32,,0
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,4-Thioifosfamide,NC(CCC(=O)NC(CSC1CCOP(=O)(NCCCl)N1CCCl)C(=O)NCC(=O)O)C(=O)O,UINSPYHKZALITP-XNZWOTSQSA-N,,0.42,,0
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.86,,0
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,Retinal dehydrogenase 1,0.89,,0
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.5,,0
Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.65,,0
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",N-desalkylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,HIGKMVIPYOFHBP-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,,0
Propafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=CC=C1,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",5-hydroxypropafenone,CCCNCC(O)COC1=C(C(=O)CCC2=CC=CC=C2)C=C(O)C=C1,LUTWDNUXHDYZRA-UHFFFAOYSA-N,Cytochrome P450 2D6,0.9,,0
Domperidone,O=C1NC2=CC=CC=C2N1CCCN1CCC(N2C(=O)NC3=C2C=CC(Cl)=C3)CC1,"InChI=1S/C22H24ClN5O2/c23-15-6-7-20-18(14-15)25-22(30)28(20)16-8-12-26(13-9-16)10-3-11-27-19-5-2-1-4-17(19)24-21(27)29/h1-2,4-7,14,16H,3,8-13H2,(H,24,29)(H,25,30)","5-Chloro-1,3-dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one",OC1=NC2=C(C=CC(Cl)=C2)N1C1CCNCC1,DOAYWDKFDPSTSV-UHFFFAOYSA-N,Cytochrome P450 3A4,0.7,,0
Desflurane,FC(F)OC(F)C(F)(F)F,"InChI=1S/C3H2F6O/c4-1(3(7,8)9)10-2(5)6/h1-2H",trifluoroacetic acid,O=C(O)C(F)(F)F,DTQVDTLACAAQTR-UHFFFAOYSA-N,Cytochrome P450 2E1,0.24,,0
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",noroxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5)C=C1,RIKMCJUNPCRFMW-ISWURRPUSA-N,Cytochrome P450 3A4,0.98,,0
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,Cytochrome P450 3A4,0.91,,0
Oxymorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3(O)C1C5,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",alpha-oxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,LHTAJTFGGUDLRH-FHHXKLHRSA-N,Cytochrome P450 2D6,0.93,,0
Flecainide,O=C(NCC1CCCCN1)C1=C(OCC(F)(F)F)C=CC(OCC(F)(F)F)=C1,"InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)",Meta-O-dealkylated flecainide,O=C(NCC1CCCCN1)C1=CC(O)=CC=C1OCC(F)(F)F,FVJPPEWHZCSTAC-UHFFFAOYSA-N,,0.96,,0
Captopril,CC(CS)C(=O)N1CCCC1C(=O)O,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",captopril-cysteine disulfide,CC(CSSCC(N)C(=O)O)C(=O)N1CCCC1C(=O)O,NEEBNBLVYKFVTK-VGMNWLOBSA-N,,0.81,,0
Clarithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,"InChI=1S/C38H69NO13/c1-15-26-38(10,45)31(42)21(4)28(40)19(2)17-37(9,47-14)33(52-35-29(41)25(39(11)12)16-20(3)48-35)22(5)30(23(6)34(44)50-26)51-27-18-36(8,46-13)32(43)24(7)49-27/h19-27,29-33,35,41-43,45H,15-18H2,1-14H3/t19-,20-,21+,22+,23-,24+,25+,26-,27+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",N-desmethylclarithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(OC)CC(C)C(=O)C(C)C(O)C1(C)O,CIJTVUQEURKBDL-ZVGWNXEOSA-N,Cytochrome P450 3A4,0.97,,0
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,"InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",4-hydroxy-estazolam,OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N2C=NN=C12,LJIJJCXFWLORDQ-UHFFFAOYSA-N,,0.88,,0
Finasteride,CC(C)(C)NC(=O)C1CCC2C3CCC4NC(=O)C=CC4(C)C3CCC12C,"InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1",omega-hydroxyfinasteride,CC(C)(O)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,LVMYOUOJYSDZSC-UHFFFAOYSA-N,Cytochrome P450 3A4,0.39,,0
Halofantrine,CCCCN(CCCC)CCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,"InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3",N-debutylhalofantrine,CCCCNCCC(O)C1=C2C=CC(C(F)(F)F)=CC2=C2C=C(Cl)C=C(Cl)C2=C1,FYHCHSNOXWVJJT-UHFFFAOYSA-N,Cytochrome P450 3A4,0.96,,0
Dantrolene,O=C1CN(N=CC2=CC=C(C3=CC=C([N+](=O)[O-])C=C3)O2)C(=O)N1,"InChI=1S/C14H10N4O5/c19-13-8-17(14(20)16-13)15-7-11-5-6-12(23-11)9-1-3-10(4-2-9)18(21)22/h1-7H,8H2,(H,16,19,20)/b15-7+",5-hydroxydantrolene,O=C1N=C(O)C(O)N1N=CC1=CC=C(C2=CC=C([N+](=O)[O-])C=C2)O1,PGORTQZSSAZLCK-VIZOYTHASA-N,,0.65,,0
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6, Cytochrome P450 3A4",0.84,,0
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",6-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,WAXHSFGMMWDOAE-UHFFFAOYSA-N,,0.83,,0
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",5-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,GJRAGJDIUMHOLU-UHFFFAOYSA-N,,0.89,,0
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",4-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,RHZRNGQIDYHQPV-UHFFFAOYSA-N,,0.85,,0
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.84,,0
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.87,,0
Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.81,,0
6-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,WAXHSFGMMWDOAE-UHFFFAOYSA-N,6-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.86,,0
5-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,GJRAGJDIUMHOLU-UHFFFAOYSA-N,5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.86,,0
4-Hydroxyketamine,CNC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,RHZRNGQIDYHQPV-UHFFFAOYSA-N,4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.86,,0
Levacetylmethadol,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1",noracymethadol,CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,VWCUGCYZZGRKEE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.97,,0
Nor-levomethadyl acetate (nor-LAAM),CCC(OC(C)=O)C(CC(C)NC)(C1=CC=CC=C1)C1=CC=CC=C1,VWCUGCYZZGRKEE-UWJYYQICSA-N,Dinor-levomethadyl acetate,CCC(OC(C)=O)C(CC(C)N)(C1=CC=CC=C1)C1=CC=CC=C1,FYQILXMAOLDNOY-JXFKEZNVSA-N,Cytochrome P450 3A7,0.94,,0
Paclitaxel,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1","6α, 3'-p-dihydroxypaclitaxel",CC(=O)OC1C(=O)C2(C)C(O)C(O)C3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)C3=CC=CC=C3)C3=CC=C(O)C=C3)C(C)=C1C2(O)O,VCMRTKHRFJRAJE-UHFFFAOYSA-N,Cytochrome P450 3A4,0.91,,0
Saquinavir,CC(C)(C)NC(=O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)NC(=O)C(CC(N)=O)NC(=O)C1=NC2=C(C=CC=C2)C=C1,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",M2 di-hydroxylated metabolite,CN=C(O)C(O)C1=CC2=C(C=CN2C2CCN(CCC3=CC=CC=C3F)CC2)C(O)=C1,KMSSEFLPBNDJAH-UHFFFAOYSA-N,Cytochrome P450 3A4,0.41,,0
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Aromatic-L-amino-acid decarboxylase,0.63,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",3-Methoxytyramine,COC1=C(O)C=CC(CCN)=C1,,Catechol O-methyltransferase,0.76,,0
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",Dopamine beta-hydroxylase,0.69,,0
Sevoflurane,FCOC(C(F)(F)F)C(F)(F)F,"InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2",Hexafluoroisopropanol,OC(C(F)(F)F)C(F)(F)F,BYEAHWXPCBROCE-UHFFFAOYSA-N,Cytochrome P450 2E1,0.59,,0
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1","6,15-Diketo-13,14-dihydro-PGF1-alpha",CCCCCC(=O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,VKPWUQVGTPVEMU-QVPQFPIISA-N,,0.47,,0
Epoprostenol,CCCCCC(O)C=CC1C(O)CC2OC(=CCCCC(=O)O)CC21,"InChI=1S/C20H32O5/c1-2-3-4-7-14(21)10-11-16-17-12-15(8-5-6-9-20(23)24)25-19(17)13-18(16)22/h8,10-11,14,16-19,21-22H,2-7,9,12-13H2,1H3,(H,23,24)/b11-10+,15-8-/t14-,16+,17+,18+,19-/m0/s1",6-Keto-PGF1-alpha,CCCCCC(O)C=CC1C(O)CC(O)C1CC(=O)CCCCC(=O)O,KFGOFTHODYBSGM-ZUNNJUQCSA-N,,0.52,,0
Gemfibrozil,CC1=CC(OCCCC(C)(C)C(=O)O)=C(C)C=C1,"InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)",Gemfibrozil 1-beta-glucuronide,CC1=CC(OCCCC(C)(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C(C)C=C1,CJMNXSKEVNPQOK-UHFFFAOYSA-N,"UDP-glucuronosyltransferase 1-1, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3, UDP-glucuronosyltransferase 2B4, UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 2B17",0.41,,0
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,Cytochrome P450 2D6,0.89,,0
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",clomipramine N-oxide,C[N+](C)([O-])CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,ARNOTLDVJSFYBP-UHFFFAOYSA-N,,0.97,,0
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,Cytochrome P450 2D6,0.85,,0
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2C19, Cytochrome P450 3A4",0.99,,0
Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,VPIXQGUBUKFLRF-UHFFFAOYSA-N,didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,LHDZEFLZJRLKPT-UHFFFAOYSA-N,Cytochrome P450 1A2,0.99,,0
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,Cytochrome P450 2D6,0.99,,0
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FHDAIUXAPWZOKI-LYVDORBWSA-N,,0.56,,0
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=CC(Cl)=C2)CCC2=C1C=CC(O)=C2OC1OC(C(=O)O)C(O)C(O)C1O,UQBOPEJATBRQRS-MDYSUIJBSA-N,,0.53,,0
8-hydroxyclomipramine,CN(C)CCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,PVKACZKLKCTAHR-UHFFFAOYSA-N,8-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,MRLCQGACIDFFSH-UHFFFAOYSA-N,,0.99,,0
2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FFAZHDSFJXPRMI-QMDPOKHVSA-N,,0.56,,0
Isocarboxazid,CC1=CC(C(=O)NNCC2=CC=CC=C2)=NO1,"InChI=1S/C12H13N3O2/c1-9-7-11(15-17-9)12(16)14-13-8-10-5-3-2-4-6-10/h2-7,13H,8H2,1H3,(H,14,16)",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.19,,0
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",,0.77,,0
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",Olsalazine-O-sulfate,O=C(O)C1=C(O)C=CC(N=NC2=CC(C(=O)O)=C(OS(=O)(=O)O)C=C2)=C1,VMGXLRXDXJZSTP-UHFFFAOYSA-N,,0.67,,0
Mesalazine,NC1=CC(C(=O)O)=C(O)C=C1,"InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.72,,0
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",Dextroamphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",,0.36,,0
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",Lysine,NCCCCC(N)C(=O)O,"InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1",,0.17,,0
Hydralazine,NNC1=NN=CC2=CC=CC=C12,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",Hydralazine acetone hydrazone,CC(C)=NNC1=NN=CC2=C1C=CC=C2,AKFJXINWDQGPHO-UHFFFAOYSA-N,,0.8,,0
Hydralazine,NNC1=NN=CC2=CC=CC=C12,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",Hydralazine pyruvate hydrazone,CC(=NNC1=NN=CC2=CC=CC=C12)C(=O)O,CXGHHASVNBBLOU-NTUHNPAUSA-N,,0.67,,0
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Adenosine deaminase,0.81,,0
9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",,0.36,,0
Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Guanine deaminase,0.61,,0
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,4'-Carboxylumiracoxib glucuronide (M22),CC1=CC=C(NC2=C(Cl)C=C(O)C=C2F)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,SEZLIFDZXOQYCW-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.62,,0
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,,0.61,,0
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,,0.96,,0
Lumiracoxib metabolite M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,RVWXBXJNQUDTIJ-UHFFFAOYSA-N,Lumiracoxib metabolite M25 glucuronide (M20),CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1F,SETAFJOLASRPRK-DAZJWRSOSA-N,UDP-glucuronosyltransferases (UGTs),0.73,,0
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,,0.93,,0
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M2,O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,NDKGEYRNJBCHHS-UHFFFAOYSA-N,Sulfotransferase,0.88,,0
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.65,,0
Lumiracoxib metabolite M15,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=CC=C1F,CYWNCAUMMWNHKA-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.94,,0
Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.92,,0
Cilazapril,CCOC(=O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,"InChI=1S/C22H31N3O5/c1-2-30-22(29)18(13-12-16-8-4-3-5-9-16)23-17-10-6-14-24-15-7-11-19(21(27)28)25(24)20(17)26/h3-5,8-9,17-19,23H,2,6-7,10-15H2,1H3,(H,27,28)/t17-,18-,19-/m0/s1",Cilazaprilat,O=C(O)C(CCC1=CC=CC=C1)NC1CCCN2CCCC(C(=O)O)N2C1=O,UVAUYSRYXACKSC-ULQDDVLXSA-N,,0.94,,0
Spirapril,CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N1CC2(CC1C(=O)O)SCCS2,"InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",Spiraprilat,CC(NC(CCC1=CC=CC=C1)C(=O)O)C(=O)N1CC2(CC1C(=O)O)SCCS2,FMMDBLMCSDRUPA-BPUTZDHNSA-N,,0.94,,0
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,"Cytochrome P450 2C19, Cytochrome P450 2C9",0.48,,0
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",Epoxy-hexobarbital,CN1C(=O)N=C(O)C(C)(C23CCCCC2O3)C1=O,WOWLNDOPAUTOTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.34,,0
3'-Hydroxyhexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,YHCGILGEMWNROZ-UHFFFAOYSA-N,3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,,0.49,,0
Mestranol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC)=C4)C3CCC21C,"InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1",Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",Cytochrome P450 2C9,0.94,,0
Ephedrine,CNC(C)C(O)C1=CC=CC=C1,"InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3/t8-,10-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.85,,0
Colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(NC(C)=O)CC2)C(OC)=C1OC,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",Colchiceine,COC1=C(OC)C(OC)=C2C(=C1)CCC(NC(C)=O)C1=CC(=O)C(O)=CC=C12,"InChI=1S/C21H23NO6/c1-11(23)22-15-7-5-12-9-18(26-2)20(27-3)21(28-4)19(12)13-6-8-16(24)17(25)10-14(13)15/h6,8-10,15H,5,7H2,1-4H3,(H,22,23)(H,24,25)",,0.99,,0
Drospirenone,CC12CCC(=O)C=C1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,"InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24+/m1/s1","4,5-dihydro-drospirenone-3-sulfate",CC12CCC(S(=O)(=O)O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,ZHIWICDXDMTIEM-AAQOLUSRSA-N,,0.59,,0
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,"InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",Ethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,CHNXZKVNWQUJIB-CEGNMAFCSA-N,,0.4,,0
Danazol,C#CC1(O)CCC2C3CCC4=CC5=C(C=NO5)CC4(C)C3CCC21C,"InChI=1S/C22H27NO2/c1-4-22(24)10-8-18-16-6-5-15-11-19-14(13-23-25-19)12-20(15,2)17(16)7-9-21(18,22)3/h1,11,13,16-18,24H,5-10,12H2,2-3H3/t16-,17+,18+,20+,21+,22+/m1/s1",17-hydroxymethylethisterone,C#CC1(O)CCC2C3CCC4=CC(=O)C(CO)CC4(C)C3CCC21C,JGJFMZZHCOKXHX-RIONBYPISA-N,,0.41,,0
Bambuterol,CN(C)C(=O)OC1=CC(C(O)CNC(C)(C)C)=CC(OC(=O)N(C)C)=C1,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",Terbutaline,CC(C)(C)NCC(O)C1=CC(O)=CC(O)=C1,"InChI=1S/C12H19NO3/c1-12(2,3)13-7-11(16)8-4-9(14)6-10(15)5-8/h4-6,11,13-16H,7H2,1-3H3",Cholinesterase,0.64,,0
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,"InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3",6-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC(O)=C2OC1=O,RXFXXWMNPIVMHP-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A2, Cytochrome P450 2C19",0.93,,0
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,"InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3",7-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,JTCREUDLEYTCAB-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.99,,0
Acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC=CC=C2OC1=O,"InChI=1S/C19H15NO6/c1-11(21)10-15(12-6-8-13(9-7-12)20(24)25)17-18(22)14-4-2-3-5-16(14)26-19(17)23/h2-9,15,22H,10H2,1H3",8-Hydroxy-R-acenocoumarol,CC(=O)CC(C1=CC=C([N+](=O)[O-])C=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,SUHPKJKJROTWOQ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.97,,0
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.78,,0
Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,3-alpha-Androstanediol glucuronide,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2O,GYNWSIBKBBWJJW-YMRFBRODSA-N,,0.3,,0
Aminophenazone,CC1=C(N(C)C)C(=O)N(C2=CC=CC=C2)N1C,"InChI=1S/C13H17N3O/c1-10-12(14(2)3)13(17)16(15(10)4)11-8-6-5-7-9-11/h5-9H,1-4H3",N-Desmethylaminopyrine,CNC1=C(C)N(C)N(C2=CC=CC=C2)C1=O,JILCEWWZTBBOFS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4, Cytochrome P450 2C18, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6",0.96,,0
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-PKBQDISRSA-N,"Liver carboxylesterase 1, Cocaine esterase",0.94,,0
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.46,,0
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.56,,0
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",Dextroamphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",Cytochrome P450 2D6,0.84,,0
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.64,,0
Metamfetamine,CNC(C)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",4-hydroxymethamphetamine,CNC(C)CC1=CC=C(O)C=C1,SBUQZKJEOOQSBV-UHFFFAOYSA-N,,0.77,,0
Phendimetrazine,CC1C(C2=CC=CC=C2)OCCN1C,"InChI=1S/C12H17NO/c1-10-12(14-9-8-13(10)2)11-6-4-3-5-7-11/h3-7,10,12H,8-9H2,1-2H3/t10-,12+/m0/s1",Phenmetrazine,CC1NCCOC1C1=CC=CC=C1,OOBHFESNSZDWIU-UHFFFAOYSA-N,,0.86,,0
Solifenacin,O=C(OC1CN2CCC1CC2)N1CCC2=CC=CC=C2C1C1=CC=CC=C1,"InChI=1S/C23H26N2O2/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19/h1-9,18,21-22H,10-16H2/t21-,22-/m0/s1",4R-hydroxy solifenacin,O=C(OC1CN2CCC1CC2)N1CC(O)C2=C(C=CC=C2)C1C1=CC=CC=C1,LRNNBJBAUXSVMH-NHNZYLEHSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1, Cytochrome P450 2D6",0.88,,0
Hydroxychloroquine,CCN(CCO)CCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",Desethylchloroquine,CCNCCCC(C)NC1=C2C=CC(Cl)=CC2=NC=C1,,Cytochrome P450 3A4,0.94,,0
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",Etoricoxib 1'-N'-oxide,CC1=[N+]([O-])C=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,KMLFAHIIJSUUPX-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,,0
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.95,,0
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib 1'-N'-oxide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=C[N+]([O-])=C(CO)C=C2)C=C1,SSTJTMIIIMAQMR-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 1A2",0.89,,0
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Carboxy-etoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(C(=O)O)C=C2)C=C1,QIHJKHCGJLIAGS-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.93,,0
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(CO)C=C2)C=C1,SCVWZQQMIZJGJY-UHFFFAOYSA-N,6-Hydroxymethyletoricoxib glucuronide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(COC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,UJWKCNOGFMSHNK-NDUFDKTRSA-N,UDP-glucuronosyltransferases (UGTs),0.68,,0
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=C1C(O)=CC(O)=C2,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H",3'-hydroxygenistein,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=C1C(O)=CC(O)=C2,IOYHCQBYQJQBSK-UHFFFAOYSA-N,Cytochrome P450 1A2,0.94,,0
Roflumilast,O=C(NC1=C(Cl)C=NC=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,"InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)",Roflumilast N-oxide,O=C(NC1=C(Cl)C=[N+]([O-])C=C1Cl)C1=CC(OCC2CC2)=C(OC(F)F)C=C1,PCGSQNPMMSALEJ-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A2",0.93,,0
Prasterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1",Dehydroepiandrosterone sulfate,CC12CCC3C(CC=C4CC(OS(=O)(=O)O)CCC43C)C1CCC2=O,CZWCKYRVOZZJNM-USOAJAOKSA-N,,0.77,,0
Prasterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1",Dehydroepiandrosterone 3-glucuronide,CC12CCC3C(CC=C4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,GLONBVCUAVPJFV-PCDHEYSGSA-N,,0.5,,0
Camphor,CC12CCC(CC1=O)C2(C)C,"InChI=1S/C10H16O/c1-9(2)7-4-5-10(9,3)8(11)6-7/h7H,4-6H2,1-3H3/t7-,10+/m1/s1",5-Exo-Hydroxycamphor,CC12CC(O)C(CC1=O)C2(C)C,"InChI=1S/C10H16O2/c1-9(2)6-4-8(12)10(9,3)5-7(6)11/h6-7,11H,4-5H2,1-3H3/t6-,7+,10-/m0/s1",Cytochrome P450 2D6,0.62,,0
Vorinostat,O=C(CCCCCCC(=O)NC1=CC=CC=C1)NO,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",4-anilino-4-oxobutanoic acid,O=C(O)CCC(O)=NC1=CC=CC=C1,KTFGFGGLCMGYTP-UHFFFAOYSA-N,,0.17,,0
Cholic Acid,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,"InChI=1S/C24H40O5/c1-13(4-7-21(28)29)16-5-6-17-22-18(12-20(27)24(16,17)3)23(2)9-8-15(25)10-14(23)11-19(22)26/h13-20,22,25-27H,4-12H2,1-3H3,(H,28,29)/t13-,14+,15-,16-,17+,18+,19-,20+,22+,23+,24-/m1/s1",Cholic acid glucuronide,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC4(C)C3CC(O)C12C,RBLDVEUUCHVWMW-SXYQVCRBSA-N,,0.34,,0
Fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(CCC=C(C)C)C(=O)O,"InChI=1S/C31H48O6/c1-17(2)9-8-10-20(28(35)36)26-22-15-24(34)27-29(5)13-12-23(33)18(3)21(29)11-14-30(27,6)31(22,7)16-25(26)37-19(4)32/h9,18,21-25,27,33-34H,8,10-16H2,1-7H3,(H,35,36)/b26-20-/t18-,21-,22-,23+,24+,25-,27-,29-,30-,31-/m0/s1",3-keto fusidic acid,CC(=O)OC1CC2(C)C(CC(O)C3C4(C)CCC(O)C(C)C4CCC32C)C1=C(C(=O)O)C(=O)CC=C(C)C,LOVQKVDREFGPKC-COCAZOITSA-N,,0.91,,0
Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1",17-Hydroxypregnenolone sulfate,CC(=O)C1(O)CCC2C3CC=C4CC(OS(=O)(=O)O)CCC4(C)C3CCC21C,OMOKWYAQVYBHMG-QUPIPBJSSA-N,,0.64,,0
Pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,"InChI=1S/C21H32O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h4,15-19,23H,5-12H2,1-3H3/t15-,16-,17+,18-,19-,20-,21+/m0/s1",Pregnenolone sulfate,CC(=O)C1CCC2C3CC=C4CC(OS(=O)(=O)O)CCC4(C)C3CCC12C,DIJBBUIOWGGQOP-QGVNFLHTSA-N,,0.76,,0
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-Oxo-androsterone glucuronide,CC12CC(=O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,QTXWOOLAHRQMGZ-UHFFFAOYSA-N,,0.28,,0
Stanolone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",11-beta-Hydroxyandrosterone-3-glucuronide,CC12CC(O)C3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,BRPLOVMHAFXVOQ-HUMIJZDLSA-N,,0.3,,0
Propanoyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t13-,17-,18-,19+,23-/m1/s1",(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",,0.98,,0
(R)-methylmalonyl-CoA,CC(C(=O)O)C(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C25H40N7O19P3S/c1-12(23(37)38)24(39)55-7-6-27-14(33)4-5-28-21(36)18(35)25(2,3)9-48-54(45,46)51-53(43,44)47-8-13-17(50-52(40,41)42)16(34)22(49-13)32-11-31-15-19(26)29-10-30-20(15)32/h10-13,16-18,22,34-35H,4-9H2,1-3H3,(H,27,33)(H,28,36)(H,37,38)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t12-,13-,16-,17-,18+,22-/m1/s1",Succinyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t13-,18-,19-,20+,24-/m1/s1",,0.97,,0
Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Cytochrome P450 1A2,0.77,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",5-HETE,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.51,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",7-HETE,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.74,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",10-HETE,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 3A4",0.77,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",13-HETE,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 3A4",0.74,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",17-HETE,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2",0.75,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",15-HETE,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8",0.62,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",12-HETE,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C9",0.62,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",9-HETE,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,,"Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.63,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",8-HETE,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,,"Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2C8, Cytochrome P450 2C9",0.62,,0
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.83,,0
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.65,,0
Quinestrol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC5CCCC5)=C4)C3CCC21C,"InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1",Ethinylestradiol,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4)C3CCC21C,"InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",,0.87,,0
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Aldosterone 18-glucuronide,CC12CCC(=O)C=C1CCC1C2C2CC3(C(OC4OC(C(=O)O)C(O)C(O)C4O)O2)C(C(=O)CO)CCC13,OMRIQCUHVVBJKI-ACOLCOCVSA-N,,0.52,,0
Aldosterone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C=O)C(C(=O)CO)CCC12,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",Tetrahydroaldosterone-3-glucuronide,CC12CCC(OC3OC(C(=O)O)C(O)C(O)C3O)CC1CCC1C2C2CC3(C(O)O2)C(C(=O)CO)CCC13,CGIURIOFMWUPSV-RUQPETGGSA-N,,0.38,,0
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",Licofelone metabolite M4,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,OCECVTMNVSFNIW-UHFFFAOYSA-N,"Cytochrome P450 2J2, Cytochrome P450 3A4, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 2D6",0.98,,0
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",Licofelone metabolite M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC(O)=C(Cl)C=C3)=C(CC(=O)O)N2C1,QUCLYFKWRYCDCG-UHFFFAOYSA-N,"Cytochrome P450 2J2, Cytochrome P450 2C9, Cytochrome P450 2C8",0.94,,0
Cyproterone acetate,CC(=O)OC1(C(C)=O)CCC2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,"InChI=1S/C24H29ClO4/c1-12(26)24(29-13(2)27)8-6-16-14-10-20(25)19-11-21(28)15-9-18(15)23(19,4)17(14)5-7-22(16,24)3/h10-11,14-18H,5-9H2,1-4H3/t14-,15+,16-,17-,18-,22-,23-,24-/m0/s1",15beta-hydroxycyproterone acetate,CC(=O)OC1(C(C)=O)CC(O)C2C3C=C(Cl)C4=CC(=O)C5CC5C4(C)C3CCC21C,HRANPRDGABOKNQ-RXHWKJIASA-N,,0.91,,0
Debrisoquine,N=C(N)N1CCC2=CC=CC=C2C1,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",4-Hydroxydebrisoquine,N=C(N)N1CC2=C(C=CC=C2)C(O)C1,,Cytochrome P450 2D6,0.74,,0
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,"InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+",Flunarizine metabolite M1,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCNCC2)C=C1,TTXIFFYPVGWLSE-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2A6, Cytochrome P450 1A1, Cytochrome P450 1A2",0.79,,0
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,"InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+",Flunarizine metabolite M2,OC1=CC=C(C=CCN2CCN(C(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C=C1,BORXUYRMIOAMIE-OWOJBTEDSA-N,Cytochrome P450 2D6,0.91,,0
Flunarizine,FC1=CC=C(C(C2=CC=C(F)C=C2)N2CCN(CC=CC3=CC=CC=C3)CC2)C=C1,"InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+",Flunarizine metabolite M3,O=C(C1=CC=C(F)C=C1)C1=CC=C(F)C=C1,LSQARZALBDFYQZ-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 1A1, Cytochrome P450 1A2, Cytochrome P450 2A6",0.28,,0
Tetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(=O)CC21,"InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3",b-dihydrotetrabenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-UHFFFAOYSA-N,,0.84,,0
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1",Lorcaserin sulfamate,CC1CN(S(=O)(=O)O)CCC2=C1C=C(Cl)C=C2,YZUNJIOOIHWHGQ-UHFFFAOYSA-N,,0.64,,0
Lorcaserin,CC1CNCCC2=CC=C(Cl)C=C21,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1",N-carbamoyl glucuronide lorcaserin,CC1CN(C(=O)OC2OC(C(=O)O)C(C)C(C)C2C)CCC2=C1C=C(Cl)C=C2,DGFKLWZCLRDMAF-IJQUCLSUSA-N,,0.37,,0
Trabectedin,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1",Trabectedin metabolite M9,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C(O)C(O)=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,WMQKTHWOQUOPDO-BUURXMNCSA-N,,0.99,,0
Trabectedin,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,"InChI=1S/C39H43N3O11S/c1-16-9-20-10-22-37(46)42-23-13-50-38(47)39(21-12-25(48-5)24(44)11-19(21)7-8-40-39)14-54-36(30(42)29(41(22)4)26(20)31(45)32(16)49-6)28-27(23)35-34(51-15-52-35)17(2)33(28)53-18(3)43/h9,11-12,22-23,29-30,36-37,40,44-46H,7-8,10,13-15H2,1-6H3/t22-,23-,29+,30+,36+,37-,39+/m0/s1",Trabectedin metabolite M16e,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(=O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,YHFJTMUFTQMMMD-PSCCWZGDSA-N,,0.97,,0
Trabectedin metabolite M8a,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,JJILVPKJCPIGNI-PBCNNVIESA-N,Trabectedin metabolite M16e,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(=O)C3CC4=CC(CC(=O)O)=C(OC)C(O)=C4C(C21)N3C,YHFJTMUFTQMMMD-PSCCWZGDSA-N,,0.97,,0
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",N-despropyl-rotigotine,OC1=CC=CC2=C1CCC(NCCC1=CC=CS1)C2,RDMWWGLKUMLLTG-UHFFFAOYSA-N,,0.91,,0
Rotigotine,CCCN(CCC1=CC=CS1)C1CCC2=C(O)C=CC=C2C1,"InChI=1S/C19H25NOS/c1-2-11-20(12-10-17-6-4-13-22-17)16-8-9-18-15(14-16)5-3-7-19(18)21/h3-7,13,16,21H,2,8-12,14H2,1H3/t16-/m0/s1",N-desthienylethyl-rotigotine,CCCNC1CCC2=C(C=CC=C2O)C1,VCYPZWCFSAHTQT-UHFFFAOYSA-N,,0.77,,0
Vandetanib,COC1=C(OCC2CCN(C)CC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,"InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",N-desmethyl vandetanib,COC1=C(OCC2CCNCC2)C=C2N=CN=C(NC3=C(F)C=C(Br)C=C3)C2=C1,HTCPERSEGREUFC-UHFFFAOYSA-N,,0.99,,0
Apremilast,CCOC1=CC(C(CS(C)(=O)=O)N2C(=O)C3=CC=CC(NC(C)=O)=C3C2=O)=CC=C1OC,"InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1",O-desmethyl Apremilast,CCOC1=C(O)C=CC(C(CS(C)(=O)=O)N2C(=O)C3=C(C2=O)C(N=C(C)O)=CC=C3)=C1,PEUJABWEZWJNBO-MRXNPFEDSA-N,"Cytochrome P450 3A4, Cytochrome P450 2A6, Cytochrome P450 1A2",0.83,,0
Abiraterone,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C3=CC=CN=C3)=CCC12,"InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1",N-oxide abiraterone sulfate,CC12CCC(OS(=O)(=O)O)CC1=CCC1C2CCC2(C)C(C3=CC=C[N+]([O-])=C3)=CCC12,AEEMBGRHVQPUBV-VJLLXTKPSA-N,Bile salt sulfotransferase,0.82,,0
Acetylcysteine,CC(=O)NC(CS)C(=O)O,"InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",Cysteine,NC(CS)C(=O)O,XUJNEKJLAYXESH-REOHCLBHSA-N,Aminoacylase-1,0.39,,0
Pentaerythritol tetranitrate,O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-],"InChI=1S/C5H8N4O12/c10-6(11)18-1-5(2-19-7(12)13,3-20-8(14)15)4-21-9(16)17/h1-4H2",Pentaerithrityl,OCC(CO)(CO)CO,"InChI=1S/C5H12O4/c6-1-5(2-7,3-8)4-9/h6-9H,1-4H2",Pentaerythritol tetranitrate reductase,0.28,,0
Romidepsin,CC=C1NC(=O)C2CSSCCC=CC(CC(=O)NC(C(C)C)C(=O)N2)OC(=O)C(C(C)C)NC1=O,"InChI=1S/C24H36N4O6S2/c1-6-16-21(30)28-20(14(4)5)24(33)34-15-9-7-8-10-35-36-12-17(22(31)25-16)26-23(32)19(13(2)3)27-18(29)11-15/h6-7,9,13-15,17,19-20H,8,10-12H2,1-5H3,(H,25,31)(H,26,32)(H,27,29)(H,28,30)/b9-7+,16-6-/t15-,17-,19-,20+/m1/s1",Romidepsin (active),CC=C1N=C(O)C(CS)N=C(O)C(C(C)C)CC(=O)CC(C=CCCS)OC(=O)C(C(C)C)N=C1O,UPCFDQLGZODPFB-BXJZLCHMSA-N,,0.41,,0
Rufinamide,NC(=O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,"InChI=1S/C10H8F2N4O/c11-7-2-1-3-8(12)6(7)4-16-5-9(10(13)17)14-15-16/h1-3,5H,4H2,(H2,13,17)",CGP-47292,O=C(O)C1=CN(CC2=C(F)C=CC=C2F)N=N1,OPJHWTKDQYKYHL-UHFFFAOYSA-N,,0.75,,0
Tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CN(C)C,"InChI=1S/C14H23NO/c1-5-14(11(2)10-15(3)4)12-7-6-8-13(16)9-12/h6-9,11,14,16H,5,10H2,1-4H3/t11-,14+/m0/s1",N-Desmethyl tapentadol,CCC(C1=CC(O)=CC=C1)C(C)CNC,PQQINTFVECNXLC-GXFFZTMASA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,,0
Prasugrel,CC(=O)OC1=CC2=C(CCN(C(C(=O)C3CC3)C3=CC=CC=C3F)C2)S1,"InChI=1S/C20H20FNO3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21/h2-5,10,13,19H,6-9,11H2,1H3",R-95913,O=C(C1CC1)C(C1=CC=CC=C1F)N1CCC2=C(C=C(O)S2)C1,MPLQNQUWLWGOET-UHFFFAOYSA-N,Cholinesterase,0.9,,0
Doripenem,CC(O)C1C(=O)N2C(C(=O)O)=C(SC3CNC(CNS(N)(=O)=O)C3)C(C)C12,"InChI=1S/C15H24N4O6S2/c1-6-11-10(7(2)20)14(21)19(11)12(15(22)23)13(6)26-9-3-8(17-5-9)4-18-27(16,24)25/h6-11,17-18,20H,3-5H2,1-2H3,(H,22,23)(H2,16,24,25)/t6-,7-,8+,9+,10-,11-/m1/s1",doripenem-M1,CC(O)C(C(=O)O)C1NC(C(=O)O)C(SC2CNC(CNS(N)(=O)=O)C2)C1C,PJNKVKHAJNEENW-OZULOKFQSA-N,Dipeptidase 1,0.52,,0
Lacosamide,COCC(NC(C)=O)C(=O)NCC1=CC=CC=C1,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1",O-Desmethyl lacosamide,CC(=O)NC(CO)C(=O)NCC1=CC=CC=C1,XRKSCJLQKGLSKU-LLVKDONJSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9, Cytochrome P450 2C19",0.88,,0
Udenafil,CCCOC1=C(C2=NC(=O)C3=C(N2)C(CCC)=NN3C)C=C(S(=O)(=O)NCCC2CCCN2C)C=C1,"InChI=1S/C25H36N6O4S/c1-5-8-20-22-23(31(4)29-20)25(32)28-24(27-22)19-16-18(10-11-21(19)35-15-6-2)36(33,34)26-13-12-17-9-7-14-30(17)3/h10-11,16-17,26H,5-9,12-15H2,1-4H3,(H,27,28,32)",N-desalkyludenafil,CCCOC1=C(C2=NC3=C(C(=O)N2)N(C)N=C3CCC)C=C(S(N)(=O)=O)C=C1,WQAFYWMRZOZKJD-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.93,,0
Dapagliflozin,CCOC1=CC=C(CC2=C(Cl)C=CC(C3OC(CO)C(O)C(O)C3O)=C2)C=C1,"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1",Dapagliflozin 3-O-glucuronide,CCOC1=CC=C(CC2=CC(C3OC(CO)C(O)C(OC4OC(C(=O)O)C(O)C(O)C4O)C3O)=CC=C2Cl)C=C1,ZYZULHSUKTZGTR-PTNNFGGUSA-N,UDP-glucuronosyltransferase 1-9,0.79,,0
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",Ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBHJFBFSJYTXDX-KFXNSFBMSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3",0.72,,0
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,PDUAYPFMBRYSNN-LJQANCHMSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C19, Cytochrome P450 3A5",0.96,,0
4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,PDUAYPFMBRYSNN-LJQANCHMSA-N,4-hydroxymethyl ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(CO)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,HYNPRXQATWYSER-UDFRSJDBSA-N,,0.74,,0
Ceftaroline fosamil,CCON=C(C(=O)NC1C(=O)N2C(C(=O)[O-])=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NSC(NP(=O)(O)O)=N1,"InChI=1S/C22H21N8O8PS4/c1-3-38-26-13(16-25-21(43-28-16)27-39(35,36)37)17(31)24-14-18(32)30-15(20(33)34)12(9-40-19(14)30)42-22-23-11(8-41-22)10-4-6-29(2)7-5-10/h4-8,14,19H,3,9H2,1-2H3,(H4-,24,25,27,28,31,33,34,35,36,37)/b26-13-/t14-,19-/m1/s1",ceftaroline,CCON=C(C(O)=NC1C(=O)N2C(C(=O)O)=C(SC3=NC(C4=CC=[N+](C)C=C4)=CS3)CSC12)C1=NC(=NP(=O)(O)O)SN1,ZCCUWMICIWSJIX-NQJJCJBVSA-O,,0.86,,0
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",CGP 52421,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4C(=C5C6=C(C=CC=C6)N2C5=C31)C(=O)NC4O,ZZSBPGIGIUFJRA-YMZPHHGTSA-N,Cytochrome P450 3A4,0.97,,0
Midostaurin,COC1C(N(C)C(=O)C2=CC=CC=C2)CC2OC1(C)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",CGP 62221,CN(C(=O)C1=CC=CC=C1)C1CC2OC(C)(C1O)N1C3=C(C=CC=C3)C3=C4CNC(=O)C4=C4C5=C(C=CC=C5)N2C4=C31,PXOCRDZEEXVZQC-AFUPZKSLSA-N,Cytochrome P450 3A4,0.98,,0
Isavuconazonium,CNCC(=O)OCC1=C(N(C)C(=O)OC(C)[N+]2=CN(CC(O)(C3=C(F)C=CC(F)=C3)C(C)C3=NC(C4=CC=C(C#N)C=C4)=CS3)N=C2)N=CC=C1,"InChI=1S/C35H35F2N8O5S/c1-22(33-42-30(18-51-33)25-9-7-24(15-38)8-10-25)35(48,28-14-27(36)11-12-29(28)37)19-45-21-44(20-41-45)23(2)50-34(47)43(4)32-26(6-5-13-40-32)17-49-31(46)16-39-3/h5-14,18,20-23,39,48H,16-17,19H2,1-4H3/q+1/t22-,23?,35+/m0/s1",Isavuconazole,CC(C1=NC(C2=CC=C(C#N)C=C2)=CS1)C(O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1,"InChI=1S/C22H17F2N5OS/c1-14(21-28-20(10-31-21)16-4-2-15(9-25)3-5-16)22(30,11-29-13-26-12-27-29)18-8-17(23)6-7-19(18)24/h2-8,10,12-14,30H,11H2,1H3/t14-,22+/m0/s1",Cholinesterase,0.82,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",O-Desmethylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCN(C(CO)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,KKISTQPVRGXETN-MBSDFSHPSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc hydroxylamine,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN(O)C3C)CC2)CC1C,CKBGTTZQHDIDOD-YZARGUDJSA-N,Cytochrome P450 3A4,0.58,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc N-oxide,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)[N+]([O-])=CN=C3C)CC2)CC1C,FJGWJMSLTFKZKY-CYFREDJKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",N-Desalkylvicriviroc,CC1=C(C(=O)N2CCC(C)(N3CCNC(C)C3)CC2)C(C)=NC=N1,JBIGWLFHMIEHKP-ZDUSSCGKSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.69,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1","N,N-Desalkylvicriviroc",COCC(NCCNC1(C)CCN(C(=O)C2=C(C)N=CN=C2C)CC1)C1=CC=C(C(F)(F)F)C=C1,VYTNUMGJUZTAEH-NRFANRHFSA-N,"Cytochrome P450 3A5, Cytochrome P450 3A4",0.88,,0
Vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",Vicriviroc carboxylic acid,CC1=C(C(=O)N2CCC(C)(N3CCN(C(C(=O)O)C4=CC=C(C(F)(F)F)C=C4)C(C)C3)CC2)C(C)=NC=N1,MBIPBXMGYUYGFC-NVHKAFQKSA-N,Cytochrome P450 3A4,0.91,,0
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M6 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C2=NC(C(=O)NCC(=O)O)CS2)CC1,UEBZMZSLTYWZTH-WKJLPXBYSA-N,,0.67,,0
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M9 (Odanacatib),CS(=O)(=O)C1=CC=C(C2=CC=C(C(OC3OC(C(=O)O)C(O)C(O)C3O)C(F)(F)F)C=C2)C=C1,ARJFPVWOMJKCQD-DOZWFGMRSA-N,,0.43,,0
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M10 (Odanacatib),CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,CLXDIFUURVULNN-WTOYAVKFSA-N,,0.58,,0
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C8",0.95,,0
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M3 (Odanacatib),CC(F)(COC1OC(C(=O)O)C(O)C(O)C1O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,XHSMOYVDHUJUTE-XNMFSWTPSA-N,,0.75,,0
M8 (Odanacatib),CC(F)(CO)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,JCZDLZKSPMKOPS-MMBKUXRPSA-N,M7-B (Odanacatib),CC(F)(C=O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,HJVPPQGUHTYYIX-MMBKUXRPSA-N,,0.91,,0
Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",Ritalinic acid,O=C(O)C(C1=CC=CC=C1)C1CCCCN1,INGSNVSERUZOAK-UHFFFAOYSA-N,Carboxylesterase,0.89,,0
Lumefantrine,CCCCN(CCCC)CC(O)C1=C2C(=CC(Cl)=C1)C(=CC1=CC=C(Cl)C=C1)C1=C2C=CC(Cl)=C1,"InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-",desbutyl-lumefantrine,CCCCNCC(O)C1=CC(Cl)=CC2=C1C1=C(C=C(Cl)C=C1)C2=CC1=CC=C(Cl)C=C1,YLBUTQNEBVPTES-NHDPSOOVSA-N,Cytochrome P450 3A4,0.98,,0
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,OLBCVFGFOZPWHH-UHFFFAOYSA-N,,0.57,,0
Lornoxicam,CN1C(C(=O)NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,"InChI=1S/C13H10ClN3O4S2/c1-17-10(13(19)16-9-4-2-3-5-15-9)11(18)12-7(23(17,20)21)6-8(14)22-12/h2-6,18H,1H3,(H,15,16,19)",5'-Hydroxylornoxicam,CN1C(=C(O)NC2=NC=C(O)C=C2)C(=O)C2=C(C=C(Cl)S2)S1(=O)=O,CDAPXAMBZODQBD-JLHYYAGUSA-N,Cytochrome P450 2C9,0.68,,0
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,0.85,,0
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.94,,0
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Reduced ketobemidone,CCC(O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,CUWNYXLTWXEDNK-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.61,,0
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 3A4",0.95,,0
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Ketobemidone N-oxide,CCC(=O)C1(C2=CC(O)=CC=C2)CC[N+](C)([O-])CC1,HFMYBXUKKOZQHG-UHFFFAOYSA-N,Prostaglandin G/H synthase 1,0.89,,0
Norketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCNCC1,BJTDPLRIKDSWIS-UHFFFAOYSA-N,Dihydroxy norketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCNCC1,XOZROGPZDNSCPU-UHFFFAOYSA-N,,0.94,,0
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,p-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(OC)=C(O)C=C2)CCN(C)CC1,QNSHRSXJXIHEDC-UHFFFAOYSA-N,,0.91,,0
Dihydroxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCN(C)CC1,MDTMDEIAXKFDTH-UHFFFAOYSA-N,m-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(OC)C=C2)CCN(C)CC1,YMCUUJLOWHXMHJ-UHFFFAOYSA-N,,0.94,,0
Betaine,C[N+](C)(C)CC(=O)[O-],"InChI=1S/C5H11NO2/c1-6(2,3)4-5(7)8/h4H2,1-3H3","N,N-dimethylglycine",CN(C)CC(=O)O,"InChI=1S/C4H9NO2/c1-5(2)3-4(6)7/h3H2,1-2H3,(H,6,7)",Betaine--homocysteine S-methyltransferase 1,0.81,,0
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",γ-hydroxybendamustine (Bendamustine metabolite M3),CN1C(C(O)CCC(=O)O)=NC2=C1C=CC(N(CCCl)CCCl)=C2,GPYWLSZJZNELNN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.88,,0
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",N-desmethyl-bendamustine (Bendamustine metabolite M4),O=C(O)CCCC1=NC2=C(C=CC(N(CCCl)CCCl)=C2)N1,BPZIKXXNXMYQPN-UHFFFAOYSA-N,Cytochrome P450 1A2,0.76,,0
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,,0.96,,0
monohydroxy-bendamustine (bendamustine metabolite HP1),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCCl)=C2,PFTRYOMJJKBZKV-UHFFFAOYSA-N,dihydroxy-bendamustine (bendamustine metabolite HP2),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCO)=C2,XQMDIDKYVZPCNV-UHFFFAOYSA-N,,0.96,,0
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1",Docetaxel,CC(=O)OC12COC1CC(O)C1(C)C(=O)C(O)C3=C(C)C(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,ZDZOTLJHXYCWBA-VCVYQWHSSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,,0
Cabazitaxel,COC1C(=O)C2(C)C(OC)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C3=CC=CC=C3)C(C)=C1C2(C)C,"InChI=1S/C45H57NO14/c1-24-28(57-39(51)33(48)32(26-17-13-11-14-18-26)46-40(52)60-41(3,4)5)22-45(53)37(58-38(50)27-19-15-12-16-20-27)35-43(8,36(49)34(55-10)31(24)42(45,6)7)29(54-9)21-30-44(35,23-56-30)59-25(2)47/h11-20,28-30,32-35,37,48,53H,21-23H2,1-10H3,(H,46,52)/t28-,29-,30+,32-,33+,34+,35-,37-,43+,44-,45+/m0/s1",RPR123142,COC1CC2OCC2(OC(C)=O)C2C(OC(=O)C3=CC=CC=C3)C3(O)CC(OC(=O)C(O)C(NC(=O)OC(C)(C)C)C4=CC=CC=C4)C(C)=C(C(O)C(=O)C12C)C3(C)C,CIHAXHLPSYZREI-BGKJQISDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5, Cytochrome P450 2C8",0.99,,0
Phenylbutyric acid,O=C(O)CCCC1=CC=CC=C1,"InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)",Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,,0.41,,0
Phenylacetic acid,O=C(O)CC1=CC=CC=C1,WLJVXDMOQOGPHL-UHFFFAOYSA-N,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.24,,0
Tiopronin,CC(S)C(=O)NCC(=O)O,"InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)",2-mercaptopropionic acid,CC(S)C(=O)O,PMNLUUOXGOOLSP-UHFFFAOYSA-N,,0.21,,0
Triethylenetetramine,NCCNCCNCCN,"InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2",N1-acetyltriethylenetetramine,CC(=O)NCCNCCNCCN,GMXQUOKWLVCFEG-UHFFFAOYSA-N,Diamine acetyltransferase 1,0.52,,0
Chloramphenicol succinate,O=C(O)CCC(=O)OCC(NC(=O)C(Cl)Cl)C(O)C1=CC=C([N+](=O)[O-])C=C1,"InChI=1S/C15H16Cl2N2O8/c16-14(17)15(24)18-10(7-27-12(22)6-5-11(20)21)13(23)8-1-3-9(4-2-8)19(25)26/h1-4,10,13-14,23H,5-7H2,(H,18,24)(H,20,21)/t10-,13-/m1/s1",Chloramphenicol,O=C(NC(CO)C(O)C1=CC=C([N+](=O)[O-])C=C1)C(Cl)Cl,"InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",,0.78,,0
Harmine,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NC=C1,"InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3",Harmol,CC1=C2NC3=C(C=CC(O)=C3)C2=CC=N1,,"Cytochrome P450 2D6, Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 1A2",0.93,,0
Nandrolone decanoate,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,"InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1",Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1","cAMP-specific 3',5'-cyclic phosphodiesterase 7B",0.76,,0
Nandrolone,CC12CCC3C4CCC(=O)C=C4CCC3C1CCC2O,"InChI=1S/C18H26O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h10,13-17,20H,2-9H2,1H3/t13-,14+,15+,16-,17-,18-/m0/s1",19-Norandrosterone,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,,,0.39,,0
Bupranolol,CC1=CC(OCC(O)CNC(C)(C)C)=C(Cl)C=C1,"InChI=1S/C14H22ClNO2/c1-10-5-6-12(15)13(7-10)18-9-11(17)8-16-14(2,3)4/h5-7,11,16-17H,8-9H2,1-4H3","carboxybupranolol, 4-chloro-3-[3-(1,1-dimethylethylamino)-2-hydroxy-propyloxy]benzoic acid",CCCCNCC(O)COC1=C(Cl)C=CC(C(=O)O)=C1,IZPPAHZRVDTEHO-UHFFFAOYSA-N,,0.71,,0
Triflusal,CC(=O)OC1=C(C(=O)O)C=CC(C(F)(F)F)=C1,"InChI=1S/C10H7F3O4/c1-5(14)17-8-4-6(10(11,12)13)2-3-7(8)9(15)16/h2-4H,1H3,(H,15,16)",2-hydroxy-4-trifluoromethyl benzoic acid,O=C(O)C1=C(O)C=C(C(F)(F)F)C=C1,XMLFPUBZFSJWCN-UHFFFAOYSA-N,,0.66,,0
Lurasidone,O=C1C2C3CCC(C3)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=CC=CC=C23)CC1,"InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18-,19+,20-,21-,24+,25-/m0/s1",ID14326,O=C1C2C3CCC(C3O)C2C(=O)N1CC1CCCCC1CN1CCN(C2=NSC3=C2C=CC=C3)CC1,VKVBDORNIIAKBR-UJKUZCFGSA-N,,0.91,,0
Tafluprost,CC(C)OC(=O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,"InChI=1S/C25H34F2O5/c1-18(2)32-24(30)13-9-4-3-8-12-20-21(23(29)16-22(20)28)14-15-25(26,27)17-31-19-10-6-5-7-11-19/h3,5-8,10-11,14-15,18,20-23,28-29H,4,9,12-13,16-17H2,1-2H3/b8-3-,15-14+/t20-,21-,22+,23-/m1/s1",Tafluprost free acid,O=C(O)CCCC=CCC1C(O)CC(O)C1C=CC(F)(F)COC1=CC=CC=C1,KIQXRQVVYTYYAZ-MTNCBHNASA-N,,0.92,,0
Icosapent ethyl,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC,"InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-",EPA,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,JAZBEHYOTPTENJ-JLNKQSITSA-N,,0.69,,0
Formestane,CC12CCC3C(CCC4=C(O)C(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1",4-Hydroxyandrostenedione glucuronide,CC12CCC3C(CCC4=C(OC5OC(C(=O)O)C(O)C(O)C5O)C(=O)CCC43C)C1CCC2=O,JIKFCHILHFFTSH-NRIFOQJISA-N,,0.49,,0
Dimethyl fumarate,COC(=O)C=CC(=O)OC,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",,0.97,,0
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.76,,0
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,,0.38,,0
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Carveol,C=C(C)C1CC=C(C)C(O)C1,,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.58,,0
Perillyl alcohol,C=C(C)C1CC=C(CO)CC1,NDTYTMIUWGWIMO-UHFFFAOYSA-N,Perillyl acid,C=C(C)C1=CCC(CO)CC1,HBYMEORZYADIJJ-UHFFFAOYSA-N,,0.43,,0
Uroterpenol,CC1=CCC(C(C)(O)CO)CC1,ZJALAEQNHJQSTN-UHFFFAOYSA-N,Uroterpenol-O-glucuronide,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,QLUXQCRCCGIUTP-LVSORJHWSA-N,,0.34,,0
Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC1=CC=CC=C1,"InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1",GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,"Carboxylesterase, Lysosomal protective protein",0.93,,0
GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,Histidine triad nucleotide-binding protein 1,0.87,,0
GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,GS-461203,CC1(F)C(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1N1C=CC(O)=NC1=O,IPHULAIUXUVCHH-WDKMEHGUSA-N,"UMP-CMP kinase, Nucleoside diphosphate kinase A",0.85,,0
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1",amine metabolite (M19),CC1OC(=O)C2CC3CC(N)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,GTYWVNGLHQVHBJ-FRGGEYDCSA-N,Cytochrome P450 3A4,0.91,,0
Vorapaxar,CCOC(=O)NC1CCC2C(C1)CC1C(=O)OC(C)C1C2C=CC1=CC=C(C2=CC(F)=CC=C2)C=N1,"InChI=1S/C29H33FN2O4/c1-3-35-29(34)32-23-10-11-24-20(14-23)15-26-27(17(2)36-28(26)33)25(24)12-9-22-8-7-19(16-31-22)18-5-4-6-21(30)13-18/h4-9,12-13,16-17,20,23-27H,3,10-11,14-15H2,1-2H3,(H,32,34)/b12-9+/t17-,20+,23-,24-,25+,26-,27+/m1/s1",monohydroxy-vorapaxar (M20),CC1OC(=O)C2CC3CC(N=C(O)OCCO)CCC3C(C=CC3=NC=C(C4=CC(F)=CC=C4)C=C3)C12,ZHYYTGYLGLSISZ-VERGWIBFSA-N,"Cytochrome P450 3A4, Cytochrome P450 2J2",0.85,,0
Miltefosine,CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C,"InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3",Choline,C[N+](C)(C)CCO,"InChI=1S/C5H14NO/c1-6(2,3)4-5-7/h7H,4-5H2,1-3H3/q+1",Phospholipase D1,0.17,,0
Tedizolid phosphate,CN1N=NC(C2=CC=C(C3=CC=C(N4CC(COP(=O)(O)O)OC4=O)C=C3F)C=N2)=N1,"InChI=1S/C17H16FN6O6P/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(30-17(24)25)9-29-31(26,27)28/h2-7,12H,8-9H2,1H3,(H2,26,27,28)/t12-/m1/s1",Tedizolid,CN1N=NC(C2=NC=C(C3=C(F)C=C(N4CC(CO)OC4=O)C=C3)C=C2)=N1,"InChI=1S/C17H15FN6O3/c1-23-21-16(20-22-23)15-5-2-10(7-19-15)13-4-3-11(6-14(13)18)24-8-12(9-25)27-17(24)26/h2-7,12,25H,8-9H2,1H3/t12-/m1/s1",,0.93,,0
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3",Desmethyl Netupitant,CC1=CC=CC=C1C1=CC(N2CCNCC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,SRVSDBHUBFLSFE-UHFFFAOYSA-N,Cytochrome P450 3A43,0.99,,0
Netupitant,CC1=CC=CC=C1C1=CC(N2CCN(C)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C30H32F6N4O/c1-19-8-6-7-9-23(19)24-17-26(40-12-10-38(4)11-13-40)37-18-25(24)39(5)27(41)28(2,3)20-14-21(29(31,32)33)16-22(15-20)30(34,35)36/h6-9,14-18H,10-13H2,1-5H3",N-oxide Netupitant,CC1=CC=CC=C1C1=CC(N2CCC(C)(O)CC2)=NC=C1N(C)C(=O)C(C)(C)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,GMWVPBPDWXVQEG-UHFFFAOYSA-N,Cytochrome P450 3A43,0.91,,0
Idelalisib,CCC(NC1=NC=NC2=C1N=CN2)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,"InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1",GS-563117,CCC(NC1=NC=NC2NC(=O)N=C12)C1=NC2=CC=CC(F)=C2C(=O)N1C1=CC=CC=C1,MMFWEWZUIJPIPC-KTQQKIMGSA-N,"Aldehyde oxidase, Cytochrome P450 3A Subfamily",0.74,,0
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",Vortioxetine Metabolite 1,CC1=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=CC(CO)=C1,INVFGIUFVDSKAT-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.93,,0
Vortioxetine,CC1=CC=C(SC2=CC=CC=C2N2CCNCC2)C(C)=C1,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",M8,CC1=CC(C)=C(SC2=CC(O)=CC=C2N2CC[NH2+]CC2)C=C1,GZGSAICCNTYGOF-UHFFFAOYSA-O,"Cytochrome P450 2D6, Cytochrome P450 2C9",0.87,,0
Nintedanib,COC(=O)C1=CC=C2C(=C(NC3=CC=C(N(C)C(=O)CN4CCN(C)CC4)C=C3)C3=CC=CC=C3)C(=O)NC2=C1,"InChI=1S/C31H33N5O4/c1-34-15-17-36(18-16-34)20-27(37)35(2)24-12-10-23(11-13-24)32-29(21-7-5-4-6-8-21)28-25-14-9-22(31(39)40-3)19-26(25)33-30(28)38/h4-14,19,32H,15-18,20H2,1-3H3,(H,33,38)/b29-28-",BIBF 1202,CN1CCN(CC(=O)N(C)C2=CC=C(NC(=C3C(O)=NC4=C3C=CC(C(=O)O)=C4)C3=CC=CC=C3)C=C2)CC1,KEHNCEDHZGQSNP-DQSJHHFOSA-N,,0.69,,0
Olodaterol,COC1=CC=C(CC(C)(C)NCC(O)C2=C3OCC(=O)NC3=CC(O)=C2)C=C1,"InChI=1S/C21H26N2O5/c1-21(2,10-13-4-6-15(27-3)7-5-13)22-11-18(25)16-8-14(24)9-17-20(16)28-12-19(26)23-17/h4-9,18,22,24-25H,10-12H2,1-3H3,(H,23,26)/t18-/m0/s1",O-demethylated olodaterol,CC(C)(CC1=CC=C(O)C=C1)NCC(O)C1=C2OCC(O)=NC2=CC(O)=C1,OSJGFHCFUOVFPN-KRWDZBQOSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8",0.68,,0
Vilanterol,OCC1=C(O)C=CC(C(O)CNCCCCCCOCCOCC2=C(Cl)C=CC=C2Cl)=C1,"InChI=1S/C24H33Cl2NO5/c25-21-6-5-7-22(26)20(21)17-32-13-12-31-11-4-2-1-3-10-27-15-24(30)18-8-9-23(29)19(14-18)16-28/h5-9,14,24,27-30H,1-4,10-13,15-17H2/t24-/m0/s1",M29 (GW630200),OCCOCCCCCCNCC(O)C1=CC(CO)=C(O)C=C1,BOBWIDWDXFEGNK-KRWDZBQOSA-N,,0.76,,0
Tetracaine,CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1,"InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3",para-aminobenzoic acid,NC1=CC=C(C(=O)O)C=C1,ALYNCZNDIQEVRV-UHFFFAOYSA-N,,0.48,,0
Benzoyl peroxide,O=C(OOC(=O)C1=CC=CC=C1)C1=CC=CC=C1,InChI=1S/C14H10O4/c15-13(11-7-3-1-4-8-11)17-18-14(16)12-9-5-2-6-10-12/h1-10H,Benzoyloxyl radical,O=C([O-])C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-M,,0.54,,0
Coenzyme M,O=S(=O)(O)CCS,"InChI=1S/C2H6O3S2/c3-7(4,5)2-1-6/h6H,1-2H2,(H,3,4,5)",dimesna,O=S(=O)(O)CCSSCCS(=O)(=O)O,BYUKOOOZTSTOOH-UHFFFAOYSA-N,,0.54,,0
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,,0.81,,0
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,,0.64,,0
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Eslicarbazepine-O-glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=C1C=CC=C2,NRSIPYUVLOFFHV-GOEBONIOSA-N,,0.56,,0
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,Eslicarbazepine,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=C1C=CC=C2,"InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1",,0.64,,0
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine sulfate,NC(=O)N1C2=CC=CC=C2CC(OS(=O)(=O)O)C2=CC=CC=C21,DQCMJSSQBFEDHL-UHFFFAOYSA-N,,0.57,,0
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,10-hydroxycarbazepine glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=CC=CC=C21,NRSIPYUVLOFFHV-LBAUFKAWSA-N,,0.54,,0
Uridine triacetate,CC(=O)OCC1OC(N2C=CC(=O)NC2=O)C(OC(C)=O)C1OC(C)=O,"InChI=1S/C15H18N2O9/c1-7(18)23-6-10-12(24-8(2)19)13(25-9(3)20)14(26-10)17-5-4-11(21)16-15(17)22/h4-5,10,12-14H,6H2,1-3H3,(H,16,21,22)/t10-,12-,13-,14-/m1/s1",Uridine,O=C1C=CN(C2OC(CO)C(O)C2O)C(=O)N1,DRTQHJPVMGBUCF-XVFCMESISA-N,,0.82,,0
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,"InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1",[18F]AV-160 (desmethyl-[18F]AV-45),NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,HWDCMGOFOLKQBU-YHRRMKGCSA-N,,0.95,,0
Florbetapir (18F),CNC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,"InChI=1S/C20H25FN2O3/c1-22-19-7-4-17(5-8-19)2-3-18-6-9-20(23-16-18)26-15-14-25-13-12-24-11-10-21/h2-9,16,22H,10-15H2,1H3/b3-2+/i21-1",[18F]AV-267 (N-acetyl–[18F]AV-160),CC(=O)NC1=CC=C(C=CC2=CN=C(OCCOCCOCCF)C=C2)C=C1,KWNBGGMKKPCFDH-FWZJPQCDSA-N,,0.91,,0
Etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,"InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3",m-Chlorophenylpiperazine,ClC1=CC(N2CCNCC2)=CC=C1,"InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2",,0.29,,0
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",,0.98,,0
Droxicam,CN1C2=C(OC(=O)N(C3=CC=CC=N3)C2=O)C2=CC=CC=C2S1(=O)=O,"InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3",Piroxicam,CN1C(C(=O)NC2=NC=CC=C2)=C(O)C2=C(C=CC=C2)S1(=O)=O,"InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",,0.54,,0
Artesunate,CC1CCC2C(C)C(OC(=O)CCC(=O)O)OC3OC4(C)CCC1C32OO4,"InChI=1S/C19H28O8/c1-10-4-5-13-11(2)16(23-15(22)7-6-14(20)21)24-17-19(13)12(10)8-9-18(3,25-17)26-27-19/h10-13,16-17H,4-9H2,1-3H3,(H,20,21)/t10-,11-,12+,13+,16-,17-,18-,19-/m1/s1",Dihydroartemisinin (DHA),CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4,BJDCWCLMFKKGEE-AGQWIWFJSA-N,,0.9,,0
Molsidomine,CCOC(=O)[N-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C9H14N4O4/c1-2-16-9(14)10-8-7-13(11-17-8)12-3-5-15-6-4-12/h7H,2-6H2,1H3",Linsidomine,[NH-]C1=C[N+](N2CCOCC2)=NO1,"InChI=1S/C6H10N4O2/c7-6-5-10(8-12-6)9-1-3-11-4-2-9/h5,7H,1-4H2","cGMP-specific 3',5'-cyclic phosphodiesterase",0.64,,0
Propacetamol,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)",Acetaminophen,CC(=O)NC1=CC=C(O)C=C1,"InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",Cholinesterase,0.5,,0
Rolapitant,CC(OCC1(C2=CC=CC=C2)CCC2(CCC(=O)N2)CN1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C25H26F6N2O2/c1-16(17-11-19(24(26,27)28)13-20(12-17)25(29,30)31)35-15-23(18-5-3-2-4-6-18)10-9-22(14-32-23)8-7-21(34)33-22/h2-6,11-13,16,32H,7-10,14-15H2,1H3,(H,33,34)/t16-,22-,23-/m1/s1",Rolapitant metabolite M19,CC(OCC1(C2=CC=CC=C2)CCC2(CN1)NC(=O)CC2O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,FCWJCWUZMPITLV-OYGALRCHSA-N,Cytochrome P450 3A4,0.92,,0
Sacubitril,CCOC(=O)C(C)CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O,"InChI=1S/C24H29NO5/c1-3-30-24(29)17(2)15-21(25-22(26)13-14-23(27)28)16-18-9-11-20(12-10-18)19-7-5-4-6-8-19/h4-12,17,21H,3,13-16H2,1-2H3,(H,25,26)(H,27,28)/t17-,21+/m1/s1",Sacubitrilat (LBQ657),CC(CC(CC1=CC=C(C2=CC=CC=C2)C=C1)NC(=O)CCC(=O)O)C(=O)O,DOBNVUFHFMVMDB-BEFAXECRSA-N,,0.91,,0
Tenofovir,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,Tenofovir Monophosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)O,BQDRSOMUPPCKPB-ZCFIWIBFSA-N,"Adenylate kinase isoenzyme 1, Adenylate kinase 2, mitochondrial",0.88,,0
Dexpanthenol,CC(C)(CO)C(O)C(=O)NCCCO,"InChI=1S/C9H19NO4/c1-9(2,6-12)7(13)8(14)10-4-3-5-11/h7,11-13H,3-6H2,1-2H3,(H,10,14)/t7-/m0/s1",Pantothenic acid,CC(C)(CO)C(O)C(=O)NCCC(=O)O,"InChI=1S/C9H17NO5/c1-9(2,5-11)7(14)8(15)10-4-3-6(12)13/h7,11,14H,3-5H2,1-2H3,(H,10,15)(H,12,13)/t7-/m0/s1",,0.9,,0
Xylose,O=CC(O)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1",Xylitol,OCC(O)C(O)C(O)CO,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+",,0.58,,0
Xylitol,OCC(O)C(O)C(O)CO,"InChI=1S/C5H12O5/c6-1-3(8)5(10)4(9)2-7/h3-10H,1-2H2/t3-,4+,5+",D-Xylulose,O=C(CO)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m0/s1",,0.44,,0
Cetyl alcohol,CCCCCCCCCCCCCCCCO,"InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3",Palmitic Acid,CCCCCCCCCCCCCCCC(=O)O,"InChI=1S/C16H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H,17,18)",Alcohol dehydrogenase [NADP(+)],0.52,,0
Methyl salicylate,COC(=O)C1=CC=CC=C1O,"InChI=1S/C8H8O3/c1-11-8(10)6-4-2-3-5-7(6)9/h2-5,9H,1H3",Salicylic acid,COC(=O)C1=C(O)C=C(C)C=C1,UITFCFWKYAOJEJ-UHFFFAOYSA-N,Liver esterases,0.84,,0
Arbutin,OCC1OC(OC2=CC=C(O)C=C2)C(O)C(O)C1O,"InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12-/m1/s1",D-glucose,O=CC(O)C(O)C(O)C(O)CO,"InChI=1S/C6H12O6/c7-1-3(9)5(11)6(12)4(10)2-8/h1,3-6,8-12H,2H2/t3-,4+,5+,6+/m0/s1",,0.16,,0
Prezatide,NCCCCC(NC(=O)C(CC1=CNC=N1)NC(=O)CN)C(=O)O,"InChI=1S/C14H24N6O4/c15-4-2-1-3-10(14(23)24)20-13(22)11(19-12(21)6-16)5-9-7-17-8-18-9/h7-8,10-11H,1-6,15-16H2,(H,17,18)(H,19,21)(H,20,22)(H,23,24)/t10-,11-/m0/s1",Histidyl-lysine,NCCCCC(NC(=O)C(N)CC1=CNC=N1)C(=O)O,,,0.8,,0
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","Elongation of very long chain fatty acids protein 5, Elongation of very long chain fatty acids protein 4",0.85,,0
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Prostaglandin E1,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,,"Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2",0.22,,0
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Fatty acid desaturase 2,0.75,,0
Selexipag,CC(C)N(CCCCOCC(=O)NS(C)(=O)=O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,"InChI=1S/C26H32N4O4S/c1-20(2)30(16-10-11-17-34-19-24(31)29-35(3,32)33)23-18-27-25(21-12-6-4-7-13-21)26(28-23)22-14-8-5-9-15-22/h4-9,12-15,18,20H,10-11,16-17,19H2,1-3H3,(H,29,31)",ACT-333679,CC(C)N(CCCCOCC(=O)O)C1=NC(C2=CC=CC=C2)=C(C2=CC=CC=C2)N=C1,OJQMKCBWYCWFPU-UHFFFAOYSA-N,Liver carboxylesterase 1,0.87,,0
Alectinib,CCC1=CC2=C(C=C1N1CCC(N3CCOCC3)CC1)C(C)(C)C1=C(C2=O)C2=CC=C(C#N)C=C2N1,"InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3",M4,CCC1=CC2=C(C=C1N1CCC(NCCO)CC1)C(C)(C)C1=C(C2=O)C2=C(C=C(C#N)C=C2)N1,XNKBNGIKXNABDO-UHFFFAOYSA-N,Cytochrome P450 3A4,0.99,,0
Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Beta-glucosidase,0.36,,0
Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.95,,0
Benzyl alcohol,OCC1=CC=CC=C1,"InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,,0.6,,0
Levoleucovorin,NC1=NC(=O)C2=C(NCC(CNC3=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C3)N2C=O)N1,"InChI=1S/C20H23N7O7/c21-20-25-16-15(18(32)26-20)27(9-28)12(8-23-16)7-22-11-3-1-10(2-4-11)17(31)24-13(19(33)34)5-6-14(29)30/h1-4,9,12-13,22H,5-8H2,(H,24,31)(H,29,30)(H,33,34)(H4,21,23,25,26,32)/t12-,13-/m0/s1",5-Methyltetrahydrofolate,CN1C2=C(N=C(N)NC2=O)NCC1CNC1=CC=C(C(=O)NC(CCC(=O)O)C(=O)O)C=C1,ZNOVTXRBGFNYRX-ZGTCLIOFSA-N,,0.95,,0
Fostemsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2COP(=O)(O)O,"InChI=1S/C25H26N7O8P/c1-16-27-14-32(28-16)23-21-20(19(39-2)12-26-23)18(13-31(21)15-40-41(36,37)38)22(33)25(35)30-10-8-29(9-11-30)24(34)17-6-4-3-5-7-17/h3-7,12-14H,8-11,15H2,1-2H3,(H2,36,37,38)",Temsavir,COC1=CN=C(N2C=NC(C)=N2)C2=C1C(C(=O)C(=O)N1CCN(C(=O)C3=CC=CC=C3)CC1)=CN2,"InChI=1S/C24H23N7O4/c1-15-27-14-31(28-15)22-20-19(18(35-2)13-26-22)17(12-25-20)21(32)24(34)30-10-8-29(9-11-30)23(33)16-6-4-3-5-7-16/h3-7,12-14,25H,8-11H2,1-2H3",Intestinal-type alkaline phosphatase,0.88,,0
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1",NBI-136110,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)(C)O)CC21,RPHPRWCGGJGIHI-WGQQHEPDSA-N,"Cytochrome P450 3A4, Cytochrome P450 3A5",0.97,,0
Valbenazine,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(OC(=O)C(N)C(C)C)CC21,"InChI=1S/C24H38N2O4/c1-14(2)9-17-13-26-8-7-16-10-21(28-5)22(29-6)11-18(16)19(26)12-20(17)30-24(27)23(25)15(3)4/h10-11,14-15,17,19-20,23H,7-9,12-13,25H2,1-6H3/t17-,19-,20-,23+/m1/s1",[+]-α-HTBZ,COC1=C(OC)C=C2C(=C1)CCN1CC(CC(C)C)C(O)CC21,WEQLWGNDNRARGE-DJIMGWMZSA-N,,0.85,,0
Diacerein,CC(=O)OC1=CC=CC2=C1C(=O)C1=C(OC(C)=O)C=C(C(=O)O)C=C1C2=O,"InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.37,,0
Telotristat ethyl,CCOC(=O)C(N)CC1=CC=C(C2=NC(N)=NC(OC(C3=CC=C(Cl)C=C3N3C=CC(C)=N3)C(F)(F)F)=C2)C=C1,"InChI=1S/C27H26ClF3N6O3/c1-3-39-25(38)20(32)12-16-4-6-17(7-5-16)21-14-23(35-26(33)34-21)40-24(27(29,30)31)19-9-8-18(28)13-22(19)37-11-10-15(2)36-37/h4-11,13-14,20,24H,3,12,32H2,1-2H3,(H2,33,34,35)/t20-,24+/m0/s1",Telotristat,CC1=NN(C2=CC(Cl)=CC=C2C(OC2=NC(N)=NC(C3=CC=C(CC(N)C(=O)O)C=C3)=C2)C(F)(F)F)C=C1,"InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1","Liver carboxylesterase 1, Cocaine esterase",0.98,,0
Brincidofovir,CCCCCCCCCCCCCCCCOCCCOP(=O)(O)COC(CO)CN1C=CC(N)=NC1=O,"InChI=1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1",Cidofovir,NC1=NC(=O)N(CC(CO)OCP(=O)(O)O)C=C1,"InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1",,0.83,,0
Lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H20N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8-9,18H,4-7H2,1-3H3/t9-/m1/s1",Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",Cytochrome P450 1A2,0.97,,0
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,"InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3",Mephentermine,CNC(C)(C)CC1=CC=CC=C1,"InChI=1S/C11H17N/c1-11(2,12-3)9-10-7-5-4-6-8-10/h4-8,12H,9H2,1-3H3",,0.43,,0
Oxetacaine,CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)CC1=CC=CC=C1)C(C)(C)CC1=CC=CC=C1,"InChI=1S/C28H41N3O3/c1-27(2,19-23-13-9-7-10-14-23)29(5)25(33)21-31(17-18-32)22-26(34)30(6)28(3,4)20-24-15-11-8-12-16-24/h7-16,32H,17-22H2,1-6H3",Phentermine,CC(C)(N)CC1=CC=CC=C1,"InChI=1S/C10H15N/c1-10(2,11)8-9-6-4-3-5-7-9/h3-7H,8,11H2,1-2H3",,0.35,,0
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)","Cytochrome P450 3A4, Cytochrome P450 2B6",0.96,,0
Nicoboxil,CCCCOCCOC(=O)C1=CN=CC=C1,"InChI=1S/C12H17NO3/c1-2-3-7-15-8-9-16-12(14)11-5-4-6-13-10-11/h4-6,10H,2-3,7-9H2,1H3",Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",Serum albumin,0.58,,0
Darolutamide,CC(CN1C=CC(C2=CC=C(C#N)C(Cl)=C2)=N1)NC(=O)C1=NNC(C(C)O)=C1,"InChI=1S/C19H19ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11-12,27H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-,12?/m0/s1",Ketodarolutamide,CC(=O)C1=CC(C(=O)NC(C)CN2C=CC(C3=CC=C(C#N)C(Cl)=C3)=N2)=NN1,"InChI=1S/C19H17ClN6O2/c1-11(22-19(28)18-8-17(12(2)27)23-24-18)10-26-6-5-16(25-26)13-3-4-14(9-21)15(20)7-13/h3-8,11H,10H2,1-2H3,(H,22,28)(H,23,24)/t11-/m0/s1","Cytochrome P450 3A4, UDP-glucuronosyltransferase 1-9",0.91,,0
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.31,,0
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,,0.74,,0
Oxabolone cipionate,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H38O4/c1-26-15-14-18-17-9-11-22(27)25(29)20(17)8-7-19(18)21(26)10-12-23(26)30-24(28)13-6-16-4-2-3-5-16/h16-19,21,23,29H,2-15H2,1H3/t17-,18-,19-,21+,23+,26+/m1/s1",Oxabolone,CC12CCC3C4CCC(=O)C(O)=C4CCC3C1CCC2O,"InChI=1S/C18H26O3/c1-18-9-8-11-10-4-6-15(19)17(21)13(10)3-2-12(11)14(18)5-7-16(18)20/h10-12,14,16,20-21H,2-9H2,1H3/t10-,11-,12-,14+,16+,18+/m1/s1",,0.81,,0
Dichlorobenzyl alcohol,OCC1=C(Cl)C=C(Cl)C=C1,"InChI=1S/C7H6Cl2O/c8-6-2-1-5(4-10)7(9)3-6/h1-3,10H,4H2",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.15,,0
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",Indomethacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)O,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",,0.96,,0
Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1","Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2, Phospholipase A2, membrane associated",0.2,,0
Harmaline,COC1=CC2=C(C=C1)C1=C(N2)C(C)=NCC1,"InChI=1S/C13H14N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-4,7,15H,5-6H2,1-2H3",Harmalol,CC1=NCCC2=C1NC1=C2C=CC(O)=C1,,"Cytochrome P450 2D6, Cytochrome P450 1A2",0.96,,0
Methyl nicotinate,COC(=O)C1=CN=CC=C1,"InChI=1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3",Niacin,O=C(O)C1=CN=CC=C1,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",,0.8,,0
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.77,,0
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",,0.77,,0
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.86,,0
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.78,,0
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.85,,0
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.74,,0
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",,0.85,,0
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",Docosahexaenoic acid,CCC=CCC=CCC=CCC=CCC=CCC=CCCC(=O)O,,,0.56,,0
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",Eicosapentaenoic acid,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.71,,0
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",,0.73,,0
Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,"InChI=1S/C17H34O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-17(18)19-16(2)3/h16H,4-15H2,1-3H3",Myristic acid,CCCCCCCCCCCCCC(=O)O,"InChI=1S/C14H28O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14(15)16/h2-13H2,1H3,(H,15,16)",Carboxylesterase,0.5,,0
Baloxavir marboxil,COC(=O)OCOC1=C2C(=O)N3CCOCC3N(C3C4=CC=CC=C4SCC4=C(F)C(F)=CC=C43)N2C=CC1=O,"InChI=1S/C27H23F2N3O7S/c1-36-27(35)39-14-38-25-19(33)8-9-31-24(25)26(34)30-10-11-37-12-21(30)32(31)23-15-6-7-18(28)22(29)17(15)13-40-20-5-3-2-4-16(20)23/h2-9,21,23H,10-14H2,1H3/t21-,23+/m1/s1",Baloxavir,O=C1C2=C(O)C(=O)C=CN2N(C2C3=C(C=CC=C3)SCC3=C2C=CC(F)=C3F)C2COCCN12,"InChI=1S/C24H19F2N3O4S/c25-16-6-5-13-15(20(16)26)12-34-18-4-2-1-3-14(18)21(13)29-19-11-33-10-9-27(19)24(32)22-23(31)17(30)7-8-28(22)29/h1-8,19,21,31H,9-12H2/t19-,21+/m1/s1",,0.97,,0
Cinnamyl alcohol,OCC=CC1=CC=CC=C1,"InChI=1S/C9H10O/c10-8-4-7-9-5-2-1-3-6-9/h1-7,10H,8H2/b7-4+",Cinnamaldehyde,O=CC=CC1=CC=CC=C1,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,,0.72,,0
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",6-beta-hydroxy-mometasone furoate,CC1CC2C3C(O)CC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,NVZADOUZVHKHSK-PWHXNIGKSA-N,,0.96,,0
Mometasone furoate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(OC(=O)C1=CC=CO1)C(=O)CCl,"InChI=1S/C27H30Cl2O6/c1-15-11-19-18-7-6-16-12-17(30)8-9-24(16,2)26(18,29)21(31)13-25(19,3)27(15,22(32)14-28)35-23(33)20-5-4-10-34-20/h4-5,8-10,12,15,18-19,21,31H,6-7,11,13-14H2,1-3H3/t15-,18+,19+,21+,24+,25+,26+,27+/m1/s1",Mometasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC2(C)C1(O)C(=O)CCl,"InChI=1S/C22H28Cl2O4/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,24)17(26)10-20(16,3)22(12,28)18(27)11-23/h6-7,9,12,15-17,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",,0.74,,0
Betamethasone phosphate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,"InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",Betamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",,0.9,,0
Diroximel fumarate,COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O,"InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+",Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",Liver esterases,0.24,,0
Monomethyl fumarate,COC(=O)C=CC(=O)O,"InChI=1S/C5H6O4/c1-9-5(8)3-2-4(6)7/h2-3H,1H3,(H,6,7)/b3-2+",Fumaric acid,O=C(O)C=CC(=O)O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",,0.65,,0
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",,0.8,,0
Prednisolone acetate,CC(=O)OCC(=O)C1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC21C,"InChI=1S/C23H30O6/c1-13(24)29-12-19(27)23(28)9-7-17-16-5-4-14-10-15(25)6-8-21(14,2)20(16)18(26)11-22(17,23)3/h6,8,10,16-18,20,26,28H,4-5,7,9,11-12H2,1-3H3/t16-,17-,18-,20+,21-,22-,23-/m0/s1",Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",,0.89,,0
Melphalan flufenamide,CCOC(=O)C(CC1=CC=C(F)C=C1)NC(=O)C(N)CC1=CC=C(N(CCCl)CCCl)C=C1,"InChI=1S/C24H30Cl2FN3O3/c1-2-33-24(32)22(16-18-3-7-19(27)8-4-18)29-23(31)21(28)15-17-5-9-20(10-6-17)30(13-11-25)14-12-26/h3-10,21-22H,2,11-16,28H2,1H3,(H,29,31)/t21-,22-/m0/s1",Melphalan,NC(CC1=CC=C(N(CCCl)CCCl)C=C1)C(=O)O,"InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)/t12-/m0/s1",Aminopeptidase N,0.5,,0
Serdexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1C(=O)OC[N+]1=CC=CC(C(=O)NC(CO)C(=O)[O-])=C1,"InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/t19-,20+,21+/m0/s1",Dexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",,0.54,,0
acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,CYP1A2; CYP2E1; CYP3A4; CYP2A6; CYP2C9; CYP2D6; CYP1A1,0.06,Oxidation of p-substituted anilides,0
acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,CYP2A6 (major); CYP2E1; CYP1A2; CYP2C8; CYP2C9; CYP3A4,0.7,Hydroxylation of benzene on carbon orhto to a strongly electron donating group,0
pinoline,COC1=CC=C2NC3=C(CCNC3)C2=C1,,"1H,2H,3H,4H,9H‐pyrido[3,4‐b]indol‐6‐ol",OC1=CC=C2NC3=C(CCNC3)C2=C1,,CYP2D6,0.95,O-aryl demethylation,0
1-(3-Trifluoromethylphenyl)piperazine,FC(F)(F)C1=CC=CC(N2CCNCC2)=C1,,HO-TFMPP,OC1=CC=C(N2CCNCC2)C=C1C(F)(F)F,,CYP2D6; CYP1A2; CYP3A4,0.77,Aromatic Hydroxylation,0
"2-Amino-3-methylimidazo(4,5-F)quinoline",CN1C(=N)NC2=C3C=CC=NC3=CC=C21,,"N-OH-2-amino-3-methylimidazo[4,5-f]quinoline (N-OH-IQ)",CN1C(NO)=NC2=C3C=CC=NC3=CC=C21,,CYP1A2; CYP1A1,0.65,N-Hydroxylation,0
"5-Methoxy-N,N-diisopropyltryptamine",COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1,,5-OH-DIPT,CC(C)N(CCC1=CNC2=CC=C(O)C=C12)C(C)C,,CYP2D6,0.92,O-Demethylation,0
"5-Methoxy-N,N-diisopropyltryptamine",COC1=CC=C2NC=C(CCN(C(C)C)C(C)C)C2=C1,,5-MeO-IPT,COC1=CC=C2NC=C(CCNC(C)C)C2=C1,,CYP1A2;CYP3A4;CYP2C9;CYP2C19,0.95,N-deisopropylation,0
(R)-halothane,FC(F)(F)C(Cl)Br,,"1-chloro-2,2,2-trifluoroethanide",FC(F)(F)[CH-]Cl,,CYP2A6; CYP3A4; CYP2B6; CYP2C9; CYP2D6,0.55,Reduction of terminal aliphatic trihalide,0
"(R)-3,4-Methylenedioxymethamphetamine",CNC(C)CC1=CC=C2OCOC2=C1,,"N-Methyl-3,4- dihydroxyamphetamine",CNC(C)CC1=CC=C(O)C(O)=C1,,CYP1A2; CYP2D6,0.69,Methylenedioxy ring opening,0
"(R)-3,4-Methylenedioxymethamphetamine",CNC(C)CC1=CC=C2OCOC2=C1,,"3,4-Methylenedioxymethamphetamine",CC(N)CC1=CC=C2OCOC2=C1,,CYP2D6 (major); CYP1A2; CYP2B6; CYP3A4,0.95,N-dealkylation of acyclic secondary amine,0
"(4R)-5-(methoxycarbonyl)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3-carboxylic acid",COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1C1=CC=CC([N+](=O)[O-])=C1,,OPC-13463,COC(=O)C1=C(C)N=C(C)C(C(=O)O)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.32,Dehydrogenation,0
Homo-Tienilic Alcohol,O=C(C1=CC=CS1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,,O=C(C1=CC=C(O)S1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,CYP2C8;CYP2C9;CYP2C19,0.93,Aliphatic Hydroxylation,0
Homo-Tienilic Alcohol,O=C(C1=CC=CS1)C1=CC=C(OCCCO)C(Cl)=C1Cl,,,O=C(C1=CC=CS1)C1=CC=C(O)C(Cl)=C1Cl,,CYP2C8;CYP2C9;CYP2C19,0.86,O-Demethylation,0
(R)-1-(4-Methoxyphenyl)propan-2-amine,COC1=CC=C(CC(C)N)C=C1,,,CC(N)CC1=CC=C(O)C=C1,,CYP2D6,0.83,O-Demethylation,0
"1-Methyl-10-alpha-methoxy-9,10-dihydrolysergol",COC12CC(CO)CN(C)C1CC1=CN(C)C3=CC=CC2=C13,,MDL,COC12CC(CO)CN(C)C1CC1=CNC3=CC=CC2=C13,,CYP2D6,0.94,N-Demethylation,0
"(S)-2-(2,6-Dichlorobenzamido)-3-(2',6'-dimethoxy-[1,1'-biphenyl]-4-yl)propanoic acid",COC1=CC=CC(OC)=C1C1=CC=C(CC(N=C(O)C2=C(Cl)C=CC=C2Cl)C(=O)O)C=C1,,,COC1=CC=CC(O)=C1C1=CC=C(CC(N=C(O)C2=C(Cl)C=CC=C2Cl)C(=O)O)C=C1,,CYP2C9,0.99,O-Desmethylation,0
Rabeprazole (rabeprazole_thioether),COCCCOC1=CC=NC(CSC2=NC3=CC=CC=C3N2)=C1C,,Rabeprazole,COCCCOC1=CC=NC(CS(=O)C2=NC3=CC=CC=C3N2)=C1C,,CYP1A2;CYP2A6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.86,S-OXIDATION,0
Rabeprazole (rabeprazole_thioether),COCCCOC1=CC=NC(CSC2=NC3=CC=CC=C3N2)=C1C,,Desmethylrabeprazole-thioether,CC1=C(OCCCO)C=CN=C1CSC1=NC2=CC=CC=C2N1,,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.99,O-Desmethylation,0
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,,Dehydroxyzyleuton sulfoxide,CC(NC(=N)O)C1=CC2=CC=CC=C2S1=O,,CYP3A4,0.2,Thiohene S-oxidation,0
Dehydroxyzyleuton,CC(NC(=N)O)C1=CC2=CC=CC=C2S1,,(1S)â€1â€(6â€hydroxyâ€1â€benzothiophenâ€2â€yl)ethylurea,CC(NC(=N)O)C1=CC2=CC=C(O)C=C2S1,,CYP1A2; CYP2C9,0.86,Aromatic hydroxylation of fused benzene ring,0
"(2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,aprepitant_M2,CC(OC1OCC=NC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4,0.72,Dehydrogenation,0
2-Methoxy-5-trifluoromethoxybenzylamine,COC1=CC=C(OC(F)(F)F)C=C1CN,,"CP-919,230",NCC1=CC(OC(F)(F)F)=CC=C1O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.93,O-Demethylation,0
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC(O)=CO2)N1C,,CYP1A2,0.98,Aliphatic Hydroxylation,0
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=C(O)C=CO2)N1C,,CYP1A2,0.96,Aliphatic Hydroxylation,0
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=C(O)O2)N1C,,CYP1A2,0.96,Aliphatic Hydroxylation,0
"3-(furan-2-ylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2=CC=CO2)N1C,,,CN1C(=O)C2=C(N=C(CO)N2C)N(CC2=CC=CO2)C1=O,,CYP1A2,0.96,Aliphatic Hydroxylation,0
(-)-ethosuximide,CCC1(C)CC(O)=NC1=O,,,CC(O)C1(C)CC(O)=NC1=O,,CYP2E1;CYP3A4,0.69,Alphatic Hydroxylation,0
(-)-etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,6-Hydroxyetodolac,CCC1=CC(O)=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,CYP2C9,0.94,Aromatic hydroxylation of fused benzene ring,0
(-)-etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,7-Hydroxyetodolac,CCC1=C(O)C=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,CYP2C9,0.93,Aromatic hydroxylation of fused benzene ring,0
(-)-pseudococaine,COC(=O)C1C(OC(=O)C2=CC=CC=C2)CC2CCC1N2C,,Norcocaine,COC(=O)C1C2CCC(CC1OC(=O)C1=CC=CC=C1)N2,,CYP3A4,0.94,N-dealkylation of alicyclic tertiary amine,0
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,"cis, trans-5'-OH-thalidomide",O=C1N=C(O)C(N2C(=O)C3=CC=CC=C3C2=O)CC1O,,CYP2C19,0.62,Alpha hydroxylation of carbonyl group,0
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,5-OH-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=C(O)C=C2C1=O,,CYP2C19,0.9,Aromatic hydroxylation of fused benzene ring,0
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,(-)-thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,,CYP1A1; CYP1A2; CYP2C19; CYP2E1,0.44,ARENE_EPOXIDATION,0
(+)-3-carene,CC1=CCC2C(C1)C2(C)C,,3-Caren-10-ol,CC1(C)C2CC=C(CO)CC21,,CYP2B6; CYP2C19; CYP2D6,0.78,Hydroxlation of methyl carbon adjacent to an aliphatic ring,0
(+)-3-carene,CC1=CCC2C(C1)C2(C)C,,Carene epoxide,CC12CC3C(CC1O2)C3(C)C,,CYP1A2,0.24,EPOXIDATION_OF_112_TRISUBSTITUTED_ALKLENE,0
(+)-bisoprolol,CC(C)NCC(O)COC1=CC=C(COCCOC(C)C)C=C1,,"(+)-bisoprolol, O-deisopropyl",CC(C)NCC(O)COC1=CC=C(COCCO)C=C1,,CYP2D6; CYP3A4,0.94,O-deisopropylation,0
(+)-fipronil,N#CC1=NN(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)C(N)=C1S(=O)C(F)(F)F,,f ipronil sulfone,N#CC1=NN(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)C(N)=C1S(=O)(=O)C(F)(F)F,,CYP3A4,0.96,S-oxidation of sulfoxide to sulfone,0
(+)-halofantrine,CCCCN(CCCC)CCC(O)C1=CC2=C(Cl)C=C(Cl)C=C2C2=CC(C(F)(F)F)=CC=C12,,"(+)-halofantrine, N-desbutyl",CCCCNCCC(O)C1=CC2=C(Cl)C=C(Cl)C=C2C2=CC(C(F)(F)F)=CC=C12,,CYP3A4,0.96,N-dealkylation of acyclic tertiary amine,0
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,4-hydroxy-isothujone,CC(C)C12CC(=O)C(C)(O)C1C2,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.55,Hydroxylation of penultimate aliphatic tertiary carbon,0
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,7-hydroxy-isothujone,CC1C(=O)CC2(C(C)(C)O)CC12,,CYP2A6; CYP2B6; CYP2D6; CYP3A4,0.61,Hydroxylation of penultimate aliphatic tertiary carbon,0
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,Estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,CYP2C19(major);CYP2C9;CYP1A2;CYP3A4,0.94,O-Demethylation,0
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,CC(N)CC1=CC=CC=C1O,,CYP2D6,0.77,O-Demethylation,0
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,COC1=C(O)C=CC=C1CC(C)N,,CYP2D6,0.76,Aromatic Hydroxylation,0
(2r)-1-(2-methoxyphenyl)propan-2-amine,COC1=CC=CC=C1CC(C)N,,,COC1CCC(O)CC1CC(C)N,,CYP2D6,0.08,Aromatic Hydroxylation,0
(2r)-2-[4-(3-methylthiophen-2-yl)phenyl]propanoic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC(=O)C1,,CYP2C9,0.3,C-Oxidation,0
Saquinavir,CC(C)(C)N=C(O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,"(2S)-N-[(2S,3R)-4-[(3S,4aR,8aS)-3-(tert-butylcarbamoyl)-6-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",CC(C)(C)N=C(O)C1CC2CC(O)CCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,CYP3A4,0.99,Hydroxylation of alicyclic secondary carbon,0
Saquinavir,CC(C)(C)N=C(O)C1CC2CCCCC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-7-hydroxy-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide",CC(C)(C)N=C(O)C1CC2CCC(O)CC2CN1CC(O)C(CC1=CC=CC=C1)N=C(O)C(CC(=N)O)NC(=O)C1=CC=C2C=CC=CC2=N1,,CYP3A4,0.98,Hydroxylation of alicyclic secondary carbon,0
"(3z)-5-[(1alpha,4alpha)-3beta-[(phenylsulfonyl)amino]bicyclo[2.2.1]heptan-2alpha-yl]-3-pentenoic acid",O=C(O)CC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,(3Z)â€5â€{3â€benzenesulfonamidoâ€6â€hydroxybicyclo[2.2.1]heptanâ€2â€yl}pentâ€3â€enoic acid,O=C(O)CC=CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9;CYP3A4,0.85,Aliphatic Hydroxylation,0
"(3z)-5-[(1alpha,4alpha)-3beta-[(phenylsulfonyl)amino]bicyclo[2.2.1]heptan-2alpha-yl]-3-pentenoic acid",O=C(O)CC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,(3Z)â€5â€{3â€benzenesulfonamidoâ€5â€hydroxybicyclo[2.2.1]heptanâ€2â€yl}pentâ€3â€enoic acid,O=C(O)CC=CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.82,Aliphatic Hydroxylation,0
(r)-(+)-felodipine,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC(Cl)=C1Cl,,Dehydrofelodipine,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC(Cl)=C1Cl,,CYP3A4,0.33,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine",0
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, p-hydroxyl",CC1=CC(O)=CC(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.85,HYDROXYLATION_OF_AROMATIC_CARBON; HYDROXYLATION_OF_BENZENE_PARA_TO_EDG,0
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, m-hydroxyl",CC1=CC=C(O)C(C)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.78,HYDROXYLATION_OF_AROMATIC_CARBON; HYDROXYLATION_OF_BENZENE_ORTHO_TO_EDG,0
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, 2-OH-hydroxymethyl",CC1=CC=CC(CO)=C1OCC(C)N,,CYP1A2 (minor); CYP2D6 (major),0.77,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,"(R)-(-)-Mexiletine, N-hydroxy",CC1=CC=CC(C)=C1OCC(C)NO,,CYP1A2 (major); CYP2B6; CYP2E1,0.91,N-hydroxylation of primary or secondary aliphatic amine,0
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-1-(3-chlorophenyl)-2-[(1-hydroxy-2-methylpropan-2-yl)amino]propan-1-one,CC(NC(C)(C)CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2B6; CYP3A4,0.92,Hydroxylation of terminal methyl,0
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-2-(tert-butylamino)-1-(3-chlorophenyl)-3-hydroxypropan-1-one,CC(C)(C)NC(CO)C(=O)C1=CC=CC(Cl)=C1,,CYP2C19,0.86,Hydroxylation of terminal methyl,0
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)-2-(tert-butylamino)-1-(3-chloro-4-hydroxyphenyl)propan-1-one,CC(NC(C)(C)C)C(=O)C1=CC=C(O)C(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.82,Hydroxylation of aromatic carbon ortho to halide group,0
(r)-bupropion,CC(NC(C)(C)C)C(=O)C1=CC=CC(Cl)=C1,,(2R)â€2â€(tertâ€butylamino)â€1â€(3â€chloroâ€5â€hydroxyphenyl)propanâ€1â€one,CC(NC(C)(C)C)C(=O)C1=CC(O)=CC(Cl)=C1,,CYP2B6;CYP2C19; CYP2E1,0.78,Hydroxylation of aromatic carbon meta to halide group,0
(r)-chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,"(r)-chloroquine, N-desethyl",CCNCCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,CYP2C8; CYP2D6; CYP3A4; CYP3A5,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES,0
(r)-enflurane,FC(F)OC(F)(F)C(F)Cl,,"2-(difluoromethoxy)-2,2-difluoroacetyl fluoride",O=C(F)C(F)(F)OC(F)F,,CYP2E1,0.45,Oxidation of halotrifluoroethane,0
(r)-ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,,Norketamine,NC1(C2=CC=CC=C2Cl)CCCCC1=O,,CYP2C9; CYP2B6; CYP3A4 ,0.84,N-dealkylation of acyclic secondary amine,0
(r)-mda,CC(N)CC1=CC=C2OCOC2=C1,,Alpha-methyldopamine,CC(N)CC1=CC=C(O)C(O)=C1,,CYP2D6;CYP3A4,0.66,O-Demethylation,0
(r)-metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,,O-Demethylmetoprolol,CC(C)NCC(O)COC1=CC=C(CCO)C=C1,,CYP2D6; CYP3A4,0.96,O-dealkylation of dialkylether,0
(r)-metoprolol,COCCC1=CC=C(OCC(O)CNC(C)C)C=C1,,N_DEISOPROPYLATION,COCCC1=CC=C(OCC(O)CN)C=C1,,CYP2C19,0.87,N-deisopropylation,0
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CNCC(C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,CYP2C19,0.98,N-demethylation,0
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CC(CN(C)C)CN1C2=CC=CC=C2CC(O)C2=CC=CC=C21,,CYP2D6,0.76,Aliphatic Hydroxylation,0
(r)-trimipramine,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC=CC=C21,,,CC(CN(C)C)CN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,,CYP2D6,0.87,Aliphatic Hydroxylation,0
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,4'-OH-carvedilol,COC1=CC(O)=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor),0.94,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,5'-OH-carvedilol,COC1=CC=C(O)C=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,CYP2D6 (major); CYP2E1 (minor); CYP2C9 (minor); CYP3A4 (minor),0.93,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
(s)-(-)-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,8-OH-carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC(O)=C1N2,,CYP1A2 (major); CYP3A4 (minor); CYP1A1 (minor),0.91,Aromatic hydroxylation of fused benzene ring,0
(s)-fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,,3-(methylamino)-1-phenylpropan-1-one,CNCCC(=O)C1=CC=CC=C1,,CYP2C19; CYP3A4,0.27,O-dealkylation,0
(s)-flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,4-OH-S-flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=C(O)C=C2)C(F)=C1,,CYP2C9,0.92,p-Hydroxylation of monosubstituted benzene,0
(s)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CCCCC2)C1=O,,3'-OH-(S)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,,CYP2C9; CYP2C19,0.95,Allylic hydroxylation,0
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,4-hydroxymephobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)N(C)C(=O)N=C1O,,CYP2C19,0.97,Aromatic Hydroxylation,0
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,CYP2B6,0.46,N-demethylation,0
(s)-norfenfluramine,CC(N)CC1=CC=CC(C(F)(F)F)=C1,,,NCCC1=CC=CC(C(F)(F)F)=C1,,CYP1A2,0.83,C-DEALKLYATION,0
(s)-oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,2-cyclohexyl-2-phenylglycolic acid,O=C(O)C(O)(C1=CC=CC=C1)C1CCCCC1,,CYP3A4,0.76,HYDROLYSIS_OF_CARBOXYLIC_ESTER,0
(s)-oxybutynin,CCN(CC)CC#CCOC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,4-(diethylamino)but-2-yn-1-ol,CCN(CC)CC#CCO,,CYP3A4,0.08,HYDROLYSIS_OF_CARBOXYLIC_ESTER,0
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-5-Hydroxypropafenone,CCCNCC(O)COC1=CC=C(O)C=C1C(=O)CCC1=CC=CC=C1,,CYP2D6,0.9,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-N-Despropylpropafenone,NCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,CYP1A2; CYP3A4,0.94,N-dealkylation of acyclic secondary amine,0
(s)-propafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=CC=C1,,(S)-4'-Hydroxypropafenone,CCCNCC(O)COC1=CC=CC=C1C(=O)CCC1=CC=C(O)C=C1,,CYP2D6 (implied),0.98,p-Hydroxylation of monosubstituted benzene,0
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,4'-hydroxy-o-aminoazotoJuene,CC1=CC(N=NC2=CC=C(O)C=C2C)=CC=C1N,,CYP1A2,0.77,AROMATIC HYDROXYLATION,0
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,2'-hydroxymethyl-3-raethyl-4-aminoazoberizene,CC1=CC(N=NC2=CC=CC=C2CO)=CC=C1N,,CYP1A2,0.81,ALIPHATIC HYDROXYLATION,0
[2-methyl-4-(o-tolylazo)phenyl]amine,CC1=CC(N=NC2=CC=CC=C2C)=CC=C1N,,N-hydroxy-oaminoazotohiene,CC1=CC=CC=C1N=NC1=CC=C(NO)C(C)=C1,,CYP1A2,0.83,N-HYDROXYLATION,0
1_4_cineole,CC(C)C12CCC(C)(CC1)O2,,,CC(C)C12CCC(C)(O1)C(O)C2,,CYP3A4,0.59,Hydroxylation of alicyclic secondary carbon,0
1_8_cineole,CC12CCC(CC1)C(C)(C)O2,,"2alpha-hydroxy-1,8-cineole",CC1(C)OC2(C)CCC1CC2O,,CYP3A4,0.67,Hydroxylation of alicyclic secondary carbon,0
1_8_cineole,CC12CCC(CC1)C(C)(C)O2,,"3alpha-hydroxy-1,8-cineole",CC12CCC(C(O)C1)C(C)(C)O2,,CYP3A4,0.71,Hydroxylation of alicyclic secondary carbon,0
1-(3-chlorophenyl)piperazine,ClC1=CC=CC(N2CCNCC2)=C1,,2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,CYP2D6,0.77,Hydroxylation of aromatic carbon ortho to halide group,0
1-(4-methoxyphenyl)piperazine,COC1=CC=C(N2CCNCC2)C=C1,,1-(4-hydroxyphenyl)piperazine,OC1=CC=C(N2CCNCC2)C=C1,,CYP2D6,0.87,O-aryl dealkylation not adjacent to substituted carbon,0
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,3-OH-1-nitropyrene,O=[N+]([O-])C1=CC(O)=C2C=CC3=CC=CC4=CC=C1C2=C34,,CYP3A4,0.66,HYDROXYLATION_OF_AROMATIC_CARBON,0
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,"trans-4,5- Dihydrodiol- 1-nitropyrene",O=[N+]([O-])C1=CC=C2C3=C1C=CC1=CC=CC(=C13)C1OC21,,CYP3A4,0.39,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,6-OH-1- nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=C(O)C=CC4=CC=C1C2=C43,,CYP3A4; CYP1A2,0.78,HYDROXYLATION_OF_AROMATIC_CARBON,0
1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,8-OH-1-nitropyrene,O=[N+]([O-])C1=CC=C2C=CC3=CC=C(O)C4=CC=C1C2=C34,,CYP1A2,0.78,HYDROXYLATION_OF_AROMATIC_CARBON,0
"1-propanol, 3-[3-(1-piperidinylmethyl)phenoxy]-",OCCCOC1=CC=CC(CN2CCCCC2)=C1,,,OC1=CC=CC(CN2CCCCC2)=C1,,CYP2D6,0.74,O-dealkylation,0
"1-propanol, 3-[3-(1-piperidinylmethyl)phenoxy]-",OCCCOC1=CC=CC(CN2CCCCC2)=C1,,,OCCCOC1=CC=CC(CN2CCCCC2O)=C1,,CYP2D6,0.78,Aliphatic Hydroxylation,0
"1,2-dichlorobenzene",ClC1=CC=CC=C1Cl,,"2,3-dichlorophenol",OC1=CC=CC(Cl)=C1Cl,,CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4,0.42,Hydroxylation of aromatic carbon ortho to halide group,0
"1,2-dichlorobenzene",ClC1=CC=CC=C1Cl,,"3,4-dichlorophenol",OC1=CC=C(Cl)C(Cl)=C1,,CYP1A1; CYP1A2; CYP2E1 (major); CYP3A4,0.47,Hydroxylation of aromatic carbon para to halide group,0
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,3,5-trichlorophenol",OC1=CC(Cl)=CC(Cl)=C1Cl,,CYP2E1 (major),0.48,Hydroxylation of aromatic carbon ortho to halide group,0
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,3,6-trichlorophenol",OC1=C(Cl)C=CC(Cl)=C1Cl,,CYP3A4 (major),0.47,Hydroxylation of aromatic carbon ortho to halide group,0
"1,2,4-trichlorobenzene",ClC1=CC=C(Cl)C(Cl)=C1,,"2,4,5-trichlorophenol",OC1=CC(Cl)=C(Cl)C=C1Cl,,CYP2E1 (major); CYP1A1,0.48,Hydroxylation of aromatic carbon ortho to halide group,0
1'-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,,O=NN1C(O)CCC1C1=CC=CN=C1,,CYP2A6;CYP2D6;CYP2E1;CYP3A4,0.79,Aliphatic Hydroxylation,0
1'-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,,O=NN1CCCC1(O)C1=CC=CN=C1,,CYP2A6;CYP2D6;CYP2E1;CYP3A4,0.67,Aliphatic Hydroxylation,0
2-(1-piperazinyl)pyrimidine,C1=CN=C(N2CCNCC2)N=C1,,,OC1=CN=C(N2CCNCC2)N=C1,,CYP2D6,0.82,Aromatic Hydroxylation,0
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,N-Hydroxy-2-acetamidofluorene,CC(=O)N(O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,CYP1A2,0.59,N-hydroxylation of secondary arylamide,0
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,1-OH-AFF,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC(O)=C12,,CYP1A2,0.77,Aromatic Hydroxylation,0
2-acetamidofluorene,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,5-OH-AFF,CC(O)=NC1=CC=C2C3=CC=CCC3(O)CC2=C1,,CYP1A2,0.3,Aromatic Hydroxylation,0
2-acetylbenzothiophene,CC(=O)C1=CC2=CC=CC=C2S1,,,CC(O)C1CC2CCCCC2S1=O,,CYP1A2;CYP2B6;CYP2E1;CYP3A4,0.09,S-Oxidation,0
"2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide",N=C(O)C1=C2CCCCN2C(C2=CC=CN=C2)=C1Cl,,rac-RPR 127025,N=C(O)C1=C2C(O)CCCN2C(C2=CC=CN=C2)=C1Cl,,CYP1A2;CYP2C8;CYP2C9;CYP3A4,0.92,Aliphatic Hydroxylation,0
"2-chloro-3-pyridin-3-yl-5,6,7,8-tetrahydroindolizine-1-carboxamide",N=C(O)C1=C2CCCCN2C(C2=CC=CN=C2)=C1Cl,,RPR 122701,N=C(O)C1=C2CCCCN2C(C2=CC=C[N+]([O-])=C2)=C1Cl,,CYP2C8,0.97,N-Oxidation,0
2-naphthylamine,NC1=CC=C2C=CC=CC2=C1,,N-Hydroxy-2-naphthalenamine,ONC1=CC=C2C=CC=CC2=C1,,CYP1A2,0.75,N-hydroxylation of primary arylamine,0
2-nitropyrene,O=[N+]([O-])C1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,2-aminopyrene,NC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,CYP1A1; CYP1A2,0.56,REDUCTION_OF_NITRO_TO_AMINE,0
2-oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,3-Hydroxy-2-oxoquazepam,O=C1C(O)N=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,CYP3A4; CYP2C9,0.9,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine",0
2-oxoquazepam,O=C1CN=C(C2=CC=CC=C2F)C2=CC(Cl)=CC=C2N1CC(F)(F)F,,N-Desalkyl-2-oxoquazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2F)=NC1,,CYP3A4; CYP2C9,0.55,N-dealkylation of tertiary carboxamide,0
2-phenylphenol,OC1=CC=CC=C1C1=CC=CC=C1,,"2,5-dihydroxybiphenyl",OC1=CC=C(O)C(C2=CC=CC=C2)=C1,,CYP1A2; CYP2B6; CYP2D6; CYP2E1; CYP3A4,0.81,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCCC1=CC=C2C(=N1)C=CC1OC21,,CYP2C9;CYP2E1;CYP3A4,0.22,Epoxidation,0
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCCC1=CC=C2C=CC3OC3C2=N1,,CYP2C9;CYP2E1;CYP3A4,0.24,Epoxidation,0
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,OCCCC1=CC=C2C=CC=CC2=N1,,CYP2A6;CYP2C9;CYP2C19;CYP2E1;CYP3A4,0.94,Aliphatic Hydroxylation,0
2-propylquinoline,CCCC1=CC=C2C=CC=CC2=N1,,,CCC(O)C1=CC=C2C=CC=CC2=N1,,CYP2A6;CYP2C9;CYP2C19;CYP2E1;CYP3A4,0.77,Aliphatic Hydroxylation,0
"2,2',4,5,5'-pentachlorobiphenyl",ClC1=CC=C(Cl)C(C2=CC(Cl)=C(Cl)C=C2Cl)=C1,,"2,2',4',5,5'-pentachloro-[1,1'-biphenyl]-4-ol",OC1=CC(Cl)=C(C2=CC(Cl)=C(Cl)C=C2Cl)C=C1Cl,,CYP2A6; CYP3A4; CYP2C18,0.74,Hydroxylation of aromatic carbon meta to halide group,0
"2,6-dichlorobenzonitrile",N#CC1=C(Cl)C=CC=C1Cl,,,N#CC1=C(Cl)C2OC2C=C1Cl,,CYP2A6,0.06,Epoxidation,0
"2,6-dichlorobenzonitrile",N#CC1=C(Cl)C=CC=C1Cl,,,N#CC1C(Cl)=CC=C2OC21Cl,,CYP2A6,0.06,Epoxidation,0
2'-methoxyacetophenone,COC1=CC=CC=C1C(C)=O,,2'-Hydroxyacetophenone,CC(=O)C1=CC=CC=C1O,,CYP2A6,0.75,O-Demethylation,0
"2h-1-benzopyran-2-one, 4-(chloromethyl)-7-ethoxy-",CCOC1=CC=C2C(CCl)=CC(=O)OC2=C1,,4-(Chloromethyl)-7-hydroxychromen-2-one,O=C1C=C(CCl)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.89,O-Deethylation,0
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCC(O)CCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.96,Aliphatic Hydroxylation,0
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.97,Aliphatic Hydroxylation,0
"2h-1-benzopyran-2-one, 7-(pentyloxy)-",CCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCCC(O)OC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.9,Aliphatic Hydroxylation,0
3-cyano-7-ethoxycoumarin,CCOC1=CC=C2C=C(C#N)C(=O)OC2=C1,,3-Cyano-7-hydroxycoumarin,N#CC1=CC2=CC=C(O)C=C2OC1=O,,"CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19,CYP2D6;CYP2E1",0.89,O-Demethylation,0
"3,5-pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, ethyl methyl ester, (4r)-",CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC([N+](=O)[O-])=C1,,,CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP3A4 ,0.32,Dehydrogenation,0
"3alpha,12beta-dihydroxy-5alpha-cholan-24-oic acid",CC(CCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CC(O)C12C,,hyocholic acid (HCA),CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CC(O)C12C,,CYP3A4 ,0.8,Aliphatic Hydroxylation,0
"3alpha,7beta,12beta-trihydroxy-5alpha-cholan-24-oic acid",CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(=O)CCC4(C)C3CC(O)C12C,,CYP3A4,0.85,Dehydrogenation,0
3s14s-ochratoxin a,CC1CC2=C(Cl)C=C(C(O)=NC(CC3=CC=CC=C3)C(=O)O)C(O)=C2C(=O)O1,,,CC1OC(=O)C2=C(O)C(C(O)=NC(CC3=CC=CC=C3)C(=O)O)=CC(Cl)=C2C1O,,CYP1A2;CYP2C9;CYP3A4,0.9,ALIPHATIC HYDROXYLATION,0
4-(butylaminomethyl)-7-methoxycoumarin,CCCCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,BHAMC,CCCCNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C9;CYP2C19;CYP2D6,0.94,O-Demethylation,0
4-(butylaminomethyl)-7-methoxycoumarin,CCCCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,CYP1A2,0.89,N-Demethylation,0
4-(ethylaminomethyl)-7-methoxycoumarin,CCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,EHAMC,CCNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,O-Demethylation,0
4-(ethylaminomethyl)-7-methoxycoumarin,CCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,MAMC,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,CYP1A2,0.92,N-Dealkylation,0
"4-(trifluoromethyl)-7-[2,5-bis(trifluoromethyl)benzyloxy]coumarin",O=C1C=C(C(F)(F)F)C2=CC=C(OCC3=CC(C(F)(F)F)=CC=C3C(F)(F)F)C=C2O1,,HFC,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP3A4,0.72,O-Dealklyation,0
"4-[(s)-alpha-(trichloromethyl)-4-methoxybenzyl]-1,2-benzenediol",COC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,Tris-OH-M methoxychlor,OC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.92,O-demethylation,0
4-aminobiphenyl,NC1=CC=C(C2=CC=CC=C2)C=C1,,"4-aminobiphenyl, N-oxide",ONC1=CC=C(C2=CC=CC=C2)C=C1,,CYP1A2,0.78,N-hydroxylation of primary arylamine,0
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,"3,4-Dihydroxy-Tamoxifen",CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(O)C(O)=C1)C1=CC=CC=C1,,CYP3A4,0.86,Aromatic Hydroxylation,0
4-methylaminomethyl-7-methoxycoumarin,CNCC1=CC(=O)OC2=CC(OC)=CC=C12,,N-methyl 7-hydroxy-4-(aminomethyl)-coumarin,CNCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2D6,0.93,N-Dealkylation,0
4-nitro-3-(trifluoromethyl)aniline,NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,2-amino5-nitro-4-(trifluoromethyl)phenol,NC1=CC(C(F)(F)F)=C([N+](=O)[O-])C=C1O,,CYP1A2;CYP2A6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.75,Aromatic Hydroxylation,0
4-nitro-3-(trifluoromethyl)aniline,NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,N-[4-nitro-3-(trifluoromethyl)phenyl]-acetamide,C[NH+]([O-])C1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,CYP1A2;CYP2A6;CYP2C9;CYP3A4,0.8,N-Hydroxylation; N-Oxidation,0
4-nitroanisole,COC1=CC=C([N+](=O)[O-])C=C1,,P-Nitrophenol,O=[N+]([O-])C1=CC=C(O)C=C1,,CYP1A2;CYP2A6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.83,O-Demethylation,0
4-nitropyrene,O=[N+]([O-])C1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,4-aminopyrene,NC1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,CYP1A2; CYP3A4,0.53,REDUCTION_OF_NITRO_TO_AMINE,0
4-nitropyrene,O=[N+]([O-])C1=CC2=CC=CC3=CC=C4C=CC=C1C4=C32,,,O=[N+]([O-])C1=CC2=CC=CC3=C2C2=C(C=CC=C12)C(O)C3O,,CYP1A2,0.41,Epoxidation of arene,0
"4,4'-methylenebis(2-chloroaniline)",NC1=CC=C(CC2=CC=C(N)C(Cl)=C2)C=C1Cl,,,NC1=CC=C(CC2=CC=C(N[O-])C(Cl)=C2)C=C1Cl,,CYP2A6;CYP3A4,0.84,N-Oxidation,0
"4'-hydroxy-5,6,7,8-tetramethoxyflavone (tangeretin_T27)",COC1=C(OC)C(OC)=C2C(=O)C=C(C3=CC=C(O)C=C3)OC2=C1OC,,OROBOL,COC1=C(OC)C(OC)=C2C(=O)C=C(C3=CC=C(O)C(O)=C3)OC2=C1OC,,CYP1A2;CYP3A4,0.97,Aromatic Hydroxylation,0
5-hydroxydiclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,"4',5-Dihydroxydiclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,CYP2C9,0.94,Aromatic Hydroxylation,0
5-methoxytryptamine,COC1=CC=C2NC=C(CCN)C2=C1,,Serotonin,NCCC1=CNC2=CC=C(O)C=C12,,CYP2D6,0.91,O-demethylation,0
5-methylchrysene,CC1=CC2=CC=CC=C2C2=CC=C3C=CC=CC3=C12,,"5-Methyl-1,2-dihydrochrysene-1,2-diol",CC1=CC2=CC=CC=C2C2=CC=C3C(=C12)C=CC(O)C3O,,CYP1A2;CYP2D6;CYP2E1;CYP3A4,0.19,Aromatic Hydroxylation,0
58c80,CC(C)(C)C1CCC(C2=C(O)C(=O)C3=CC=CC=C3C2=O)CC1,,298C84,CC(C)(CO)C1CCC(C2=C(O)C(=O)C3=CC=CC=C3C2=O)CC1,,CYP2C9,0.98,Hydroxylation of terminal methyl,0
6-chrysenamine,NC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"6-MeC-1,2-diol",NC1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2A6;CYP2B6;CYP2D6;CYP3A4,0.19,Aromatic Hydroxylation,0
6-methylchrysene,CC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"6-MeC-1,2-diol",CC1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2D6;CYP2E1;CYP3A4,0.2,Epoxidation,0
6-nitrochrysene,O=[N+]([O-])C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,N-hydroxy-6-AC,O[NH2+]C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.71,Aromatic Hydroxylation,0
6-nitrochrysene,O=[N+]([O-])C1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,"1,2-DHD-6-NC ",O=[N+]([O-])C1=CC2=C3C=CC(O)C(O)C3=CC=C2C2=CC=CC=C12,,CYP2E1;CYP3A4,0.32,Reduction,0
7-benzyloxyquinoline,C1=CC=C(COC2=CC=C3C=CC=NC3=C2)C=C1,,7-Hydroxyquinoline,O=C1C=CC2=CC=CN=C2C1,,CYP1A2;CYP3A4,0.17,O-dealkylation,0
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCC(O)OC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation,0
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCOC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation,0
7-butoxy-2h-chromen-2-one,CCCCOC1=CC=C2C=CC(=O)OC2=C1,,,OCCCCOC1CCC2CCC(O)OC2C1,,CYP3A4,0.09,Aliphatic Hydroxylation,0
7-ethoxycoumarin,CCOC1=CC=C2C=CC(=O)OC2=C1,,Umbelliferone,O=C1C=CC2=CC=C(O)C=C2O1,,CYP1A1 (major); CYP2B6; CYP2E1; CYP1A2; CYP2A6; CYP3A7; CYP2C9; CYP2C19,0.82,O-aryl dealkylation not adjacent to substituted carbon,0
7-ethoxycoumarin,CCOC1=CC=C2C=CC(=O)OC2=C1,,,CCOC1=CC=C2C(O)=CC(=O)OC2=C1,,CYP1A1 (major); CYP2B6; CYP2E1; CYP1A2; CYP2A6; CYP3A7; CYP2C9; CYP2C19,0.87,Aromatic Hydroxylation,0
7-ethoxyresorufin,CCOC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A2; CYP1A1,0.93,O-aryl dealkylation not adjacent to substituted carbon,0
7-methoxycoumarin,COC1=CC=C2C=CC(=O)OC2=C1,,Umbelliferone,O=C1C=CC2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6,0.87,O-dealkylation,0
7-methoxycoumarin,COC1=CC=C2C=CC(=O)OC2=C1,,4-Hydroxy-7-methoxycoumarin,COC1=CC=C2C(O)=CC(=O)OC2=C1,,CYP1A2;CYP2A6,0.86,Aromatic Hydroxylation,0
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C(=NC3=C1C=CC1=CC=CC=C13)C=CC(O)C2O,,CYP1A2;CYP3A4,0.31,Aromatic Hydroxylation,0
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=NC2=C1C(O)=C(O)C1=CC=CC=C12,,CYP1A2;CYP3A4,0.58,Aromatic Hydroxylation,0
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=NC2=C1C=CC1=C(O)C(O)=CC=C12,,CYP1A2;CYP3A4,0.73,Aromatic Hydroxylation,0
7-methylbenz(c)acridine,CC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,,OCC1=C2C=CC=CC2=NC2=C1C=CC1=CC=CC=C12,,CYP1A2;CYP3A4,0.84,Aliphatic Hydroxylation,0
8-hydroxyefavirenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,"8,14-diOH-efavirenz",OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2(O)CC2)(C(F)(F)F)O1,,CYP2B6,0.97,HYDROXYLATION_OF_ALICYCLIC_SECONDARY_CARBON; HYDROXYLATION_OF_ALICYCLIC_SECONDARY_CARBON_PATTERN1,0
9-anthraldehyde,O=CC1=C2C=CC=CC2=CC2=CC=CC=C12,,,O=C(O)C1=C2C=CC=CC2=CC2=CC=CC=C12,,CYP2A6;CYP2B6;CYP2C19;CYP2E1;CYP3A4,0.71,Aliphatic Hydroxylation,0
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,4-hydroxy-9-cis-retinals,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,CYP1A2;CYP2C19;CYP3A4,0.9,Aliphatic Hydroxylation,0
"Lopinavir, D-valine diastereomer-",CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCCN=C1O,,,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCC(O)N=C1O,,CYP3A4,0.95,Aliphatic Hydroxylation,0
abt_378,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCCN=C1O,,,CC1=CC=CC(C)=C1OCC(O)=NC(CC1=CC=CC=C1)C(O)CC(CC1=CC=CC=C1)N=C(O)C(C(C)C)N1CCC(O)=NC1=O,,CYP3A4,0.75,C-Oxidation,0
1â€[(2S)â€4â€(5â€benzylthiophenâ€2â€yl)butâ€3â€ynâ€2â€yl]â€1â€hydroxyurea,CC(C#CC1=CC=C(CC2=CC=CC=C2)S1)N(O)C(=N)O,,ABT-515,CC(C#CC1=CC=C(C(O)C2=CC=CC=C2)S1)N(O)C(=N)O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.81,Aliphatic Hydroxylation,0
"1-[Amino-(3,4-dichloroanilino)methylidene]-2-propan-2-ylguanidine",CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,,,CC(C)(O)NC(=N)NC(=N)NC1=CC=C(Cl)C(Cl)=C1,,CYP2C19;,0.88,Aliphatic Hydroxylation,0
ac1ldic9,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(C=CS2)C1,,2-oxo-clopidogrel,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(CC(=O)S2)C1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2C1;CYP3A4,0.54,C-Oxidation,0
ac1mip3e,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,N-deethylated  ac1mip3e,CCNCC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,CYP3A4,0.99,N-deethylation,0
[5-(Diethylamino)-2-methylpent-3-yn-2-yl] (2S)-2-cyclohexyl-2-hydroxy-2-phenylacetate,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCCCC1,,4-cis-OH ac1mip3e,CCN(CC)CC#CC(C)(C)OC(=O)C(O)(C1=CC=CC=C1)C1CCC(O)CC1,,CYP3A4,0.98,Aliphatic Hydroxylation,0
ac1ocg1j,CNC(C)CC1=CC=CC=C1OC,,,CNC(C)CC1=CC=CC=C1O,,CYP2D6,0.79,O-demethylation,0
ac1ocg1j,CNC(C)CC1=CC=CC=C1OC,,,CNC(C)CC1=CC(O)=CC=C1OC,,CYP2D6,0.86,Aromatic Hydroxylation,0
pimobendan,COC1=CC=C(C2=NC3=CC(C4=NN=C(O)CC4C)=CC=C3N2)C=C1,,,CC1CC(O)=NN=C1C1=CC=C2NC(C3=CC=C(O)C=C3)=NC2=C1,,CYP1A2;CYP3A4,0.98,N-demethylation,0
aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,4'-OH-aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,CYP2C9,0.89,Hydroxylation of aromatic carbon meta to halide group,0
aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,5-OH-aceclofenac,O=C(O)COC(=O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP2C9,0.87,HYDROXYLATION_OF_AROMATIC_CARBON; HYDROXYLATION_OF_BENZENE_PARA_TO_EDG,0
acetanilide,CC(O)=NC1=CC=CC=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A2; CYP2E1,0.73,p-Hydroxylation of anilide,0
acetanilide,CC(O)=NC1=CC=CC=C1,,N-Hydroxy-N-phenylacetamide,CC(=O)N(O)C1=CC=CC=C1,,CYP2E1,0.16,N-hydroxylation of anilide,0
adinazolam,CN(C)CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N21,,N-demethyladinazolam,CNCC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N21,,CYP2C19;CYP3A4,0.98,N-demethylation,0
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,," Aflatoxin B1- exo-8,9-oxide ",COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC2OC21,,CYP1A2; CYP3A5; CYP3A4; CYP2A13 ,0.88,Epoxidation of vinyl ether,0
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,,Aflatoxin M1 ,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1(O)C=COC1O2,,CYP1A2 ,0.92,Allylic hydroxylation,0
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,,Aflatoxin Q1 ,COC1=CC2=C(C3=C1C1=C(C(=O)CC1O)C(=O)O3)C1C=COC1O2,,CYP3A4 ,0.95,Allylic hydroxylation,0
albendazole,CCCSC1=CC=C2N=C(N=C(O)OC)NC2=C1,,,CCCS(=O)C1=CC=C2N=C(N=C(O)OC)NC2=C1,,CYP1A2;CYP3A4,0.85,S-Oxidation,0
alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,,N-phenylpropionamide,CCC(O)=NC1=CC=CC=C1,,CYP3A4,0.09,N-dealkylation of tertiary carboxamide,0
alfentanil,CCC(=O)N(C1=CC=CC=C1)C1(COC)CCN(CCN2N=NN(CC)C2=O)CC1,,"2‐(4‐ethyl‐5‐oxo‐1,2,3,4‐tetrazol‐1‐yl)acetaldehyde",CCN1N=NN(CC=O)C1=O,,CYP3A4,0.25,N-dealkylation of alicyclic tertiary amine,0
alilusem,CC1=CC=CC=C1C(=O)N1CCC(=NOS(=O)(=O)O)C2=CC=C(Cl)C=C21,,,O=C(C1=CC=CC=C1CO)N1CCC(=NOS(=O)(=O)O)C2=CC=C(Cl)C=C21,,CYP2C9;CYP3A4,0.97,Aliphatic Hydroxylation,0
alpha_dihydroergocryptine,CC(C)C1(N=C(O)C2CC3C4=CC=CC5=C4C(=CN5)CC3N(C)C2)OC2(O)C3CCCN3C(=O)CN2C1=O,,,CC(C)C1(N=C(O)C2CC3C4=CC=CC5=C4C(=CN5)CC3N(C)C2)OC2(O)C3CCC(O)N3C(=O)CN2C1=O,,CYP3A4,0.99,Aliphatic Hydroxylation,0
alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,4-Hydroxyalprazolam,CC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,CYP3A4 (major); CYP2C9 (minor),0.87,Hydroxylation of heteroalicyclic secondary carbon,0
alprazolam,CC1=NN=C2CN=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N12,,Beta-Hydroxyalprazolam,OCC1=NN=C2C(O)N=C(C3=CC=CC=C3)C3=CC=CC=C3N12,,CYP2C9 (minor); CYP2C19 (minor); CYP3A4 (minor),0.8,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
ambroxol,NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1,,"4-Aminocyclohexanol, cis-",NC1CCC(O)CC1,,CYP3A4,0.17,N-dealkylation of acyclic secondary amine,0
ambroxol,NC1=C(Br)C=C(Br)C=C1CNC1CCC(O)CC1,,"2-Amino-3,5-dibromobenzaldehyde",NC1=C(Br)C=C(Br)C=C1C=O,,CYP3A4,0.46,N-dealkylation of acyclic secondary amine,0
Ametryn,CCN=C1N=C(SC)NC(=NC(C)C)N1,,,CSC1=NC(=N)NC(=NC(C)C)N1,,CYP1A1; CYP1A2; CYP2C19; CYP3A4,0.98,N-dealkylation of secondary arylalkylamine,0
Ametryn,CCN=C1N=C(SC)NC(=NC(C)C)N1,,,CCN=C1NC(SC)=NC(=N)N1,,CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.91,N-deisopropylation,0
amiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCN(CC)CC)C(I)=C2)C2=CC=CC=C2O1,,N-Desethylamiodarone,CCCCC1=C(C(=O)C2=CC(I)=C(OCCNCC)C(I)=C2)C2=CC=CC=C2O1,,CYP3A4; CYP2C8; CYP2C9; CYP1A2; CYP2D6,0.99,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES,0
androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,,6beta-hydroxy-androstenedione,CC12CCC3C(CC(O)C4=CC(=O)CCC43C)C1CCC2=O,,CYP3A4,0.73,Hydroxylation of carbon gamma to conjugated carbonyl,0
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"5‐oxo‐1,4‐dihydro‐1,2,4‐triazole‐3‐carbaldehyde",O=CC1=NNC(O)=N1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.13,N-dealkylation of alicyclic tertiary amine,0
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"(2R,3S)‐2‐[(1R)‐1‐[3,5‐bis(trifluoromethyl)phenyl]ethoxy]‐3‐(4‐fluorophenyl)morpholine",CC(OC1OCCNC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.74,N-dealkylation of alicyclic tertiary amine,0
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"1‐[3,5‐bis(trifluoromethyl)phenyl]ethanone",CC(=O)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.21,O-dealkylation of dialkylether,0
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,"5‐{[(2S,3S)‐3‐(4‐fluorophenyl)‐2‐hydroxymorpholin‐4‐yl]methyl}‐2,4‐dihydro‐1,2,4‐triazol‐3‐one",OC1=NNC(CN2CCOC(O)C2C2=CC=C(F)C=C2)=N1,,CYP3A4; CYP3A5; CYP1A2; CYP2C19,0.75,O-dealkylation of dialkylether,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,20-HETE,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,,CYP1A1; CYP1A2; CYP2A6,0.96,Hydroxylation of terminal methyl,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,19-HETE,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2C8; CYP2C9; CYP2C19; CYP2E1,0.89,Hydroxylation of penultimate aliphatic secondary carbon,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,18-HETE,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2E1,0.81,Hydroxylation of acyclic aliphatic secondary carbon,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,16-HETE,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2,0.72,Allylic hydroxylation,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"14,15-EET",CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.47,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"11,12-EET",CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.53,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"8,9-EET",CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.53,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,"5,6-EET",CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,,CYP1A1; CYP1A2; CYP2B6 (minor); CYP2D6,0.38,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
arachidonic acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,,11-HETE,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,,CYP1A1; CYP1A2; CYP2C8,0.63,"Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene",0
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,dehydro-aripiprazole,OC1=CC=C2C=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC2=N1,,CYP3A4,0.54,"Dehydrogenation of alpha,beta-unsaturated amide",0
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,4-Hydroxyaripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=C(O)C(Cl)=C4Cl)CC3)=CC=C2CC1,,CYP2D6,0.94,Hydroxylation of aromatic carbon ortho to halide group,0
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,"2,3‐dichlorophenylpiperazine",ClC1=CC=CC(N2CCNCC2)=C1Cl,,CYP3A4,0.41,N-dealkylation of alicyclic tertiary amine,0
aripiprazole,OC1=NC2=CC(OCCCCN3CCN(C4=CC=CC(Cl)=C4Cl)CC3)=CC=C2CC1,,"4‐[(2‐oxo‐3,4‐dihydro‐1H‐quinolin‐7‐yl)oxy]butanal",O=CCCCOC1=CC=C2CCC(O)=NC2=C1,,CYP3A4,0.66,N-dealkylation of alicyclic tertiary amine,0
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"(2R)-5-{[2-(3,4-dimethoxyphenyl)ethyl]amino}-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile",COC1=CC=CC(C(C#N)(CCCNCCC2=CC=C(OC)C(OC)=C2)C(C)C)=C1,,CYP2C8; CYP3A4; CYP2D6,0.99,O-aryl dealkylation adjacent to substituted carbon,0
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,(2R)-5-amino-2-(3-methoxyphenyl)-2-(propan-2-yl)pentanenitrile,COC1=CC=CC(C(C#N)(CCCN)C(C)C)=C1,,CYP2C8; CYP3A4; CYP2D6,0.79,N-dealkylation of acyclic secondary amine,0
arverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,"2-(3,4-dimethoxyphenyl)acetaldehyde",COC1=CC=C(CC=O)C=C1OC,,CYP2C8; CYP3A4; CYP2D6,0.41,N-dealkylation of acyclic secondary amine,0
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,6-Hydroxyastemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=C(O)C=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6; CYP3A4 (minor),0.93,Aromatic hydroxylation of fused benzene ring,0
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,6-desmethylastermizole,OC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6,0.98,O-aryl dealkylation not adjacent to substituted carbon,0
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,norastemizole,FC1=CC=C(CN2C(=NC3CCNCC3)NC3=CC=CC=C32)C=C1,,CYP3A4 (minor),0.85,N-dealkylation of alicyclic tertiary amine,0
astemizole,COC1=CC=C(CCN2CCC(N=C3NC4=CC=CC=C4N3CC3=CC=C(F)C=C3)CC2)C=C1,,2-(4-hydroxyphenyl)acetaldehyde,O=CCC1=CC=C(O)C=C1,,CYP3A4 (minor),0.13,N-dealkylation of alicyclic tertiary amine,0
atorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,,CC(C)C1=C(C(O)=NC2=CC=CC=C2O)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,CYP3A4,0.99,Aromatic Hydroxylation,0
atorvastatin,CC(C)C1=C(C(O)=NC2=CC=CC=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,,CC(C)C1=C(C(=O)NC2=CC=C(O)C=C2)C(C2=CC=CC=C2)=C(C2=CC=C(F)C=C2)N1CCC(O)CC(O)CC(=O)O,,CYP3A4,0.78,Aromatic Hydroxylation,0
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCNC2)C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.93,N-dealkylation,0
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)NC(C)=C(C(=O)O)C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.83,O-dealkylation,0
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,,COC(=O)C1=C(C)N=C(C)C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP2A6;CYP2D6;CYP3A4,0.45,Dehydrogenation,0
"benzeneethanol, 2-[(2,6-dichlorophenyl)amino]- (reduced_diclofenac)",OCCC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,,OCCC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.84,Aromatic Hydroxylation,0
"benzo(a)pyrene-7,8-diol",OC1=CC=C2C(=C1O)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,OC1=C(O)C2=C(O2)C2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,CYP1A2,0.36,Epoxidation,0
bergapten,COC1=C2C=COC2=CC2=C1C=CC(=O)O2,,,COC1=C2C(=CC3=C1C=CC(=O)O3)OC1OC21,,CYP2D6,0.44,Epoxidation,0
beta_arteether,CCOC1OC2OC3(C)CCCC4C(C)CCC(C1C)C24OO3,,DIHYDROQINGHAOSU,CC1CCC2C(C)C(O)OC3OC4(C)CCCC1C32OO4,,CYP2B6;CYP3A4,0.99,O-dealkylation,0
beta-artelinic acid,CC1CCC2C(C)C(OCC3=CC=C(C(=O)O)C=C3)OC3OC4(C)CCC1C32OO4,,Dihydroqinghaosu (DQHS),CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4,,CYP3A4,0.81,O-Debenzylation,0
beta-methylstyrene,CC=CC1=CC=CC=C1,,2-methyl-3-phenyloxirane,CC1OC1C1=CC=CC=C1,,CYP1A2;CYP2E1;CYP3A4,0.18,Epoxidation,0
beta-methylstyrene,CC=CC1=CC=CC=C1,,,OCC=CC1=CC=CC=C1,,CYP1A2;CYP2E1;CYP3A4,0.83,Aliphatic Hydroxylation,0
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2C9;CYP2C19; CYP2D6; CYP2E1,0.96,O-Demethylation,0
bms_275183,COC(=O)OC12COC1CC(O)C1(C)C(=O)C(OC(C)=O)C3=C(C)C(OC(=O)C(O)C(N=C(O)OC(C)(C)C)C(C)(C)C)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,,,COC(=O)OC12COC1CC(O)C1(C)C(=O)C(OC(C)=O)C3=C(C)C(OC(=O)C(O)C(N=C(O)OC(C)(C)C)C(C)(C)CO)CC(O)(C(OC(=O)C4=CC=CC=C4)C21)C3(C)C,,CYP3A4,0.99,Aliphatic Hydroxylation,0
brn 4201400,CC1=NC2=C(N1)N(CC1CCCCC1)C(=O)N(C)C2=O,,,CN1C(=O)C2=C(NC(CO)=N2)N(CC2CCCCC2)C1=O,,CYP1A2,0.96,Aliphatic Hydroxylation,0
brofaromine,COC1=CC(Br)=C2OC(C3CCNCC3)=CC2=C1,,O-desmethyl-brofaromine,OC1=CC(Br)=C2OC(C3CCNCC3)=CC2=C1,,CYP2D6,0.95,O-aryl demethylation,0
bromocriptine,CC(C)CC1C(=O)N2CCCC2C2(O)OC(N=C(O)C3C=C4C5=CC=CC6=C5C(=C(Br)N6)CC4N(C)C3)(C(C)C)C(=O)N12,,,CC(C)CC1C(=O)N2CC(O)CC2C2(O)OC(N=C(O)C3C=C4C5=CC=CC6=C5C(=C(Br)N6)CC4N(C)C3)(C(C)C)C(=O)N12,,CYP3A4,0.99,Aliphatic Hydroxylation,0
bropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC=C2)N1,,m-hydroxybropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC(O)=C2)N1,,CYP1A2,0.88,m-Hydroxylation of monosubstituted benzene,0
bropirimine,N=C1N=C(O)C(Br)=C(C2=CC=CC=C2)N1,,p-hydroxybropirimine,N=C1NC(C2=CC=C(O)C=C2)=C(Br)C(=O)N1,,CYP1A2,0.61,p-Hydroxylation of monosubstituted benzene,0
brotizolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,alpha-OH-BRT,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,CYP3A4,0.95,Aliphatic Hydroxylation,0
brotizolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,6-OH-BRT,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=C(SC(Br)=C3)N12,,CYP3A4,0.91,Aliphatic Hydroxylation,0
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Paraxanthine,CN1C(O)=NC2=C(C1=O)N(C)C=N2,,CYP1A2,0.62,N-dealkylation of N-acylurea,0
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Theobromine,CC1C(O)=NC(=O)C2=C1N=CN2C,,CYP1A2 (major); CYP2E1 (minor),0.27,N-dealkylation of N-acylurea,0
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,Theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor),0.91,N-dealkylation of mixed tertiary amine,0
caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,,"1,3,7-Trimethyluric acid",CN1C(=O)C2=C(N=C(O)N2C)N(C)C1=O,,CYP1A2 (major); CYP2C8 (minor); CYP2C9 (minor); CYP3A4 (minor); CYP2E1 (minor),0.85,HYDROXYLATION_OF_AROMATIC_CARBON_ADJACENT_TO_N,0
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,," Carbamazepine 10,11-epoxide ",N=C(O)N1C2=CC=CC=C2C2OC2C2=CC=CC=C21,,CYP3A4; CYP2C8 ,0.51,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,2-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,,CYP3A4; CYP2C8,0.87,Aromatic hydroxylation of fused benzene ring,0
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,3-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=CC=C(O)C=C21,,CYP3A4; CYP2C8 ,0.85,Aromatic hydroxylation of fused benzene ring,0
carbamazepine,N=C(O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,,9-Hydroxycarbamazepine ,N=C(O)N1C2=CC=CC=C2C=CC2=C(O)C=CC=C21,,CYP3A4; CYP2C8 ,0.78,Aromatic hydroxylation of fused benzene ring,0
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,4-hydroxycarbaryl,CN=C(O)OC1=CC=CC2=C(O)C=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.91,Aromatic Hydroxylation,0
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,5-hydroxycarbaryl,CN=C(O)OC1=CC=C(O)C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.92,Aromatic Hydroxylation,0
carbaryl,CN=C(O)OC1=CC=CC2=CC=CC=C12,,carbaryl methylol,OCN=C(O)OC1=CC=CC2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C19;CYP3A4,0.93,Aliphatic Hydroxylation,0
Carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2,,e-hydroxy-carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2O,,CYP1A2; CYP2C19; CYP3A4,0.79,Hydroxylation of alicyclic secondary carbon,0
cerivastatin,COCC1=C(C(C)C)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,,CC(C)C1=NC(C(C)C)=C(CO)C(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,,CYP2C8;CYP3A4,0.96,O-Demethylation ,0
cerivastatin,COCC1=C(C(C)C)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,,COCC1=C(C(C)CO)N=C(C(C)C)C(C=CC(O)CC(O)CC(=O)O)=C1C1=CC=C(F)C=C1,,CYP2C8,0.95,Aliphatic Hydroxylation,0
cevimeline,CC1OC2(CS1)CN1CCC2CC1,,,CC1OC2(CN3CCC2CC3)CS1=O,,CYP2C19;CYP2D6;CYP3A4;CYP1A2;CYP2A6;CYP2E1,0.82,S-Oxidation,0
(R)-colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,2-demethyicolchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1O,,CYP3A4,0.99,O-demethylation ,0
(R)-colchicine,COC1=CC2=C(C3=CC=C(OC)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,Colchiceine,COC1=CC2=C(C3=CC=C(O)C(=O)C=C3C(N=C(C)O)CC2)C(OC)=C1OC,,CYP3A4,0.99,O-demethylation ,0
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CC(NC1=CC(C2=C(C3=CC=C(F)C=C3)N=C(S(C)(=O)=O)N2)=CC=N1)C1=CC=CC=C1,,CYP1A2;CYP2C19;CYP2D6;CYP3A4,0.92,S-OXIDATION,0
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CS(=O)C1=NC(C2=CC=C(F)C=C2)=C(C2=CC(=N)NC=C2)N1,,CYP3A4,0.57,N-dealkylation,0
{4-[5-(4-Fluoro-phenyl)-2-methylsulfanyl-3H-imidazol-4-yl]-pyridin-2-yl}-(1-phenyl-ethyl)-amine,CSC1=NC(C2=CC=C(F)C=C2)=C(C2=CC=NC(NC(C)C3=CC=CC=C3)=C2)N1,,,CC(NC1=CC(C2=C(C3=CC=C(F)C=C3)N=C(S(C)=O)N2)=CC=[N+]1O)C1=CC=CC=C1,,CYP3A4,0.86,N-oxidation,0
reduced_haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,CPHP,OC1(C2=CC=C(Cl)C=C2)CCNCC1,,CYP3A4,0.72,N-Demethylation,0
reduced_haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,CYP3A4,0.84,Dehydrogenation,0
DRF_4367,COC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C(CO)=C2)C=C1,,,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(O)C=C2)C=C1CO,,CYP2C19;CYP2D6,0.99,O-demethylation,0
benzodioxolyl-butanamine (BDB),CCC(N)CC1=CC=C2OCOC2=C1,,DHABB,CCC(N)CC1=CC=C(O)C(O)=C1,,CYP2C19;CYP2D6;CYP3A4,0.69,O-demethylenation,0
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,Hydroxy-iteraconazole,CC(O)C(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,CYP3A4,0.98,Aliphatic Hydroxylation,0
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,keto-iteraconazole ,CC(=O)C(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,CYP3A4,0.97,C-Oxidation,0
itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=CC=C(Cl)C=C6Cl)O5)C=C4)CC3)C=C2)C1=O,,N-Desalkyl-iteraconazole,OC1=NN=CN1C1=CC=C(N2CCN(C3=CC=C(OCC4COC(CN5C=NC=N5)(C5=CC=C(Cl)C=C5Cl)O4)C=C3)CC2)C=C1,,CYP3A4,0.85,N-Desalkylation,0
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC(O)=C2)=C1,,CYP2D6;CYP3A4,0.98,Aromatic Hydroxylation,0
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCNCCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.93,N-DEMETHYLATION,0
NE-100,CCCN(CCC)CCC1=CC=C(OC)C(OCCC2=CC=CC=C2)=C1,,,CCCN(CCC)CCC1=CC=C(O)C(OCCC2=CC=CC=C2)=C1,,CYP2C9;CYP2C19;CYP2D6,0.96,O-DEMETHYLATION,0
(R)-m-Methoxyamphetamine,COC1=CC=CC(CC(C)N)=C1,,,CC(N)CC1=CC=CC(O)=C1,,CYP2D6,0.8,O-DEMETHYLATION,0
(R)-m-Methoxyamphetamine,COC1=CC=CC(CC(C)N)=C1,,,COC1=CC(CC(C)N)=CC=C1O,,CYP2D6,0.8,Aromatic Hydroxylation,0
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=C(O)C=C1)C1=C(O)C2=CC=CC=C2OC1=O,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.98,Aromatic Hydroxylation,0
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=CC=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,,CYP2C9;CYP2C19;CYP3A4,0.96,Aromatic Hydroxylation,0
(R)-phenprocoumon,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=CC=C2OC1=O,,,CCC(C1=CC=CC=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,,CYP2C9;CYP2C19;CYP3A4,0.98,Aromatic Hydroxylation,0
pantoprazole,COC1=CC=NC(CS(=O)C2=NC3=CC=C(OC(F)F)C=C3N2)=C1OC,,,COC1=C(OCO)C=CN=C1CS(=O)C1=NC2=CC=C(OC(F)F)C=C2N1,,CYP2C19,0.98,Aliphatic Hydroxylation,0
"(2S,3R)-3-(4-Hydroxy-phenyl)-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-2,3-dihydro-benzo[1,4]oxathiin-6-ol",OC1=CC=C(C2SC3=CC(O)=CC=C3OC2C2=CC=C(OCCN3CCCCC3)C=C2)C=C1,,,O=S1C2=CC(O)=CC=C2OC(C2=CC=C(OCCN3CCCCC3)C=C2)C1C1=CC=C(O)C=C1,,CYP3A4,0.84,S-Oxidation,0
"(2S,3R)-3-(4-Hydroxy-phenyl)-2-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-2,3-dihydro-benzo[1,4]oxathiin-6-ol",OC1=CC=C(C2SC3=CC(O)=CC=C3OC2C2=CC=C(OCCN3CCCCC3)C=C2)C=C1,,,CCCCCNCCOC1=CC=C(C2OC3=CC=C(O)C=C3SC2C2=CC=C(O)C=C2)C=C1,,CYP3A4,0.98,S-Dealkylation,0
PNU-96391,CCCN1CCCC(C2=CC=CC(S(C)(=O)=O)=C2)C1,,,CS(=O)(=O)C1=CC=CC(C2CCCNC2)=C1,,CYP1A2;CYP2C19;CYP2D6;CYP3A4,0.9,N-dealkylation,0
4Ã¢â‚¬Â[(dimethylamino)methyl]Ã¢â‚¬Â7Ã¢â‚¬ÂmethoxychromenÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C(CN(C)C)=CC(=O)OC2=C1,,,CNCC1=CC(=O)OC2=CC(OC)=CC=C12,,CYP1A2,0.98,N-dealkylation,0
4Ã¢â‚¬Â[(dimethylamino)methyl]Ã¢â‚¬Â7Ã¢â‚¬ÂmethoxychromenÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C(CN(C)C)=CC(=O)OC2=C1,,,CN(C)CC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,N-dealkylation,0
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=CC(O)=CC=C23)=CC(O)=C1OC,,CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation,0
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC=C2C(C(=O)C3=CC(OC)=C(O)C(OC)=C3)=CNC2=C1,,CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation,0
bpr-0L075,COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=CC(O)=CC=C23)=CC(OC)=C1OC,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.98,O-Demethylation,0
"(6-methoxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone",COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC(C(=O)C2=CNC3=C(O)C(OC)=CC=C23)=CC(OC)=C1OC,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.9,Aliphatic Hydroxylation,0
"(6-methoxy-1H-indol-3-yl)-(3,4,5-trimethoxyphenyl)methanone",COC1=CC=C2C(C(=O)C3=CC(OC)=C(OC)C(OC)=C3)=CNC2=C1,,,COC1=CC2=C(C=C1O)C(C(=O)C1=CC(OC)=C(OC)C(OC)=C1)=CN2,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.95,Aliphatic Hydroxylation,0
CTK0G1203,CC(NC(=NC#N)N=C1C=CNC=C1)C(C)(C)C,,,CC(NC(=NC#N)NC1=CC=[N+]([O-])C=C1)C(C)(C)C,,CYP3A4,0.39,N-Oxidation,0
CTK0G1203,CC(NC(=NC#N)N=C1C=CNC=C1)C(C)(C)C,,,CC(N=C(N=C1C=CNC=C1)NC(=N)O)C(C)(C)C,,CYP3A4,0.52,C-Oxidation,0
N-(1-Phenyl-1H-pyrazole-5-yl)-p-toluenesulfonamide,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=CC=C2)C=C1,,,O=S(=O)(NC1=CC=NN1C1=CC=CC=C1)C1=CC=C(CO)C=C1,,CYP2C8;CYP2C9;CYP2C19,0.97,Aliphatic Hydroxylation,0
N-(1-Phenyl-1H-pyrazole-5-yl)-p-toluenesulfonamide,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=CC=C2)C=C1,,,CC1=CC=C(S(=O)(=O)NC2=CC=NN2C2=CC=C(O)C=C2)C=C1,,CYP2C8;CYP2C19,0.95,Aliphatic Hydroxylation,0
terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,hydroxyterfenadine,CC(C)(CO)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,CYP2D6;CYP3A4,0.93,Aliphatic Hydroxylation,0
terfenadine,CC(C)(C)C1=CC=C(C(O)CCCN2CCC(C(O)(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,azacyclonol,OC(C1=CC=CC=C1)(C1=CC=CC=C1)C1CCNCC1,,CYP3A4,0.86,N-Dealkylation,0
2prime_hydroxy_indomethacin_phenethylamide,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,CYP2C19;CYP2D6,0.98,O-Demethylation,0
2prime_hydroxy_indomethacin_phenethylamide,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NCC(=O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,CYP3A4,0.95,Dehydrogenation,0
"(2S)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2-butanamine",CCC(CC1=CC=C2OCOC2=C1)NC,,,CCC(N)CC1=CC=C2OCOC2=C1,,CYP1A2;CYP2B6;CYP2C19;CYP2D6;CYP3A4,0.94,N-Demethylation,0
"(2S)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2-butanamine",CCC(CC1=CC=C2OCOC2=C1)NC,,,CCC(CC1=CC=C(O)C(O)=C1)NC,,CYP1A2;CYP2B6;CYP2C19;CYP2D6;CYP3A4,0.71,O-Demethylation,0
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,5-OH-seratrodast,CC1=C(CO)C(=O)C(C)=C(C(CCCCCC(=O)O)C2=CC=CC=C2)C1=O,,CYP2C19; CYP2C9; CYP2C8; CYP3A4; CYP2B6,0.91,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,4'-OH-seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=C(O)C=C2)=C(C)C1=O,,CYP2C19; CYP2C9; CYP2C8,0.95,p-Hydroxylation of monosubstituted benzene,0
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,7-Hydroxychlorpromazine,CN(C)CCCN1C2=CC=C(O)C=C2SC2=CC=C(Cl)C=C21,,CYP2D6; CYP1A2,0.89,Aromatic hydroxylation of fused benzene ring,0
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,Chlorpromazine S-oxide,CN(C)CCCN1C2=CC=CC=C2S(=O)C2=CC=C(Cl)C=C21,,CYP3A4,0.84,S-oxidation of diarylthioether to sulfoxide,0
chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,"Chlorpromazine, N-desmethyl",CNCCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,CYP1A2,0.99,N-dealkylation of acyclic tertiary amine,0
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,2-OH-chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1O,,CYP2C9 (major); CYP2C19 (minor); CYP2C8 (minor); CYP1A2 (minor); CYP3A4 (minor),0.72,Hydroxylation of benzene on carbon ortho to an electron donating group,0
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,3-OH-chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C(O)=C1,,CYP2D6,0.77,Hydroxylation of aromatic carbon ortho to halide group,0
chlorpropamide,CCCN=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,p-Chlorobenzene sulfonylurea,N=C(O)NS(=O)(=O)C1=CC=C(Cl)C=C1,,CYP2D6,0.81,N-dealkylation of urea,0
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,"3,5,6-Trichloro-2-pyridinol",OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP2C19; CYP2B6; CYP3A4,0.47,Dearylation of organphosphosulfur compound,0
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Diethyl phosphorothioate,CCOP(=O)(O)OCC,,CYP2C19; CYP2B6; CYP3A4,0.07,Dearylation of organphosphosulfur compound,0
Chlorpyrifos,CCOP(=S)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP1A2; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4,0.71,Desulfuration of organophosphothioates,0
chlorzoxazone,OC1=NC2=CC(Cl)=CC=C2O1,,6-Hydroxychlorzoxazone,OC1=NC2=CC(Cl)=C(O)C=C2O1,,CYP2E1; CYP1A2; CYP1A1; CYP2A6; CYP2D6; CYP3A4,0.77,Aromatic hydroxylation of fused benzene ring,0
cilostazol,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,,OPC-13326,OC1=NC2=CC=C(OCCCCC3=NN=NN3C3CCCCC3)C=C2C(O)C1,,CYP1A2;CYP2D6;CYP3A4,0.67,Aliphatic Hydroxylation,0
cilostazol,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCCCC3)=CC=C2N1,,OPC-13217,O=C1CCC2=CC(OCCCCC3=NN=NN3C3CCC(O)CC3)=CC=C2N1,,CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation,0
cinnarizine,C(=CC1=CC=CC=C1)CN1CCN(C(C2=CC=CC=C2)C2=CC=CC=C2)CC1,,1-Cinnamylpiperazine,C(=CC1=CC=CC=C1)CN1CCNCC1,,CYP2C9; CYP1A2; CYP2A6,0.45,OXIDATIVE_DEAMINATION_OF_TERTIARY_AMINES; N_DEALKYLATION_OF_ALICYCLIC_TERTIARY_AMINES_PATTERN1,0
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,Norcisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCNCC1OC,,CYP3A4; CYP2C8; CYP2B6,0.9,N-dealkylation of alicyclic tertiary amine,0
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,3-(4-fluorophenoxy)propanal,O=CCCOC1=CC=C(F)C=C1,,CYP3A4; CYP2C8; CYP2B6,0.17,N-dealkylation of alicyclic tertiary amine,0
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,3-Fluoro-4-hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(O)C(F)=C2)CC1OC,,CYP2C8,0.94,Hydroxylation of benzene on carbon para to an electron donating group,0
cisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2)CC1OC,,4-Fluoro-2- hydroxycisapride,COC1=CC(N)=C(Cl)C=C1C(O)=NC1CCN(CCCOC2=CC=C(F)C=C2O)CC1OC,,CYP3A4,0.95,Hydroxylation of benzene on carbon ortho to an electron donating group,0
"(2R,3S)â€2â€(diphenylmethyl)â€Nâ€{[2â€methoxyâ€5â€(propâ€1â€enâ€2â€yl)phenyl]methyl}â€1â€azabicyclo[2.2.2]octanâ€3â€amine",C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,"CP-611,781",COC1=CC=C(C(C)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.92,Aliphatic Hydroxylation,0
"(2R,3S)â€2â€(diphenylmethyl)â€Nâ€{[2â€methoxyâ€5â€(propâ€1â€enâ€2â€yl)phenyl]methyl}â€1â€azabicyclo[2.2.2]octanâ€3â€amine",C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,"CP-616,762",COC1=CC=C(C(C)(O)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.86,Aliphatic Hydroxylation,0
clindamycin,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)N(C)C1,,N-desmethyclindamycin,CCCC1CNC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)C1,,CYP3A4,0.97,N-Dealkylation,0
clindamycin,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(SC)C(O)C(O)C2O)N(C)C1,,clindamycin sulfoxide,CCCC1CC(C(O)=NC(C(C)Cl)C2OC(S(C)=O)C(O)C(O)C2O)N(C)C1,,CYP3A4,0.94,S-Oxidation,0
clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,N-desmethylclobazam,O=C1CC(O)=NC2=CC=C(Cl)C=C2N1C1=CC=CC=C1,,CYP2C9;CYP2C19,0.58,N-desmethylation,0
clobazam,CN1C(=O)CC(=O)N(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,4-Hydroxyclobazam,CN1C(=O)CC(=O)N(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C21,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.95,Aromatic Hydroxylation,0
clomethiazole,CC1=C(CCCl)SC=N1,,NLA-715,CC1=C(C(O)CCl)SC=N1,,CYP2A6,0.64,Aliphatic Hydroxylation,0
clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,Clozapine-N-oxide,C[N+]1([O-])CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,CYP3A4; CYP1A2; CYP2C8; CYP2C19; CYP3A5,0.95,N-oxidation of alicyclic tertiary amine,0
compound_1,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=CN=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,M2,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=C[N+]([O-])=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,CYP3A4,0.95,N-Oxidation,0
compound_1,O=S(=O)(NC1=CC=C(CCNCC(O)C2=CC=CN=C2)C=C1)C1=CC=C(C2=NC(C3=CC=C(C(F)(F)F)C=C3)=CC2)C=C1,,M4,NCCC1=CC=C(NS(=O)(=O)C2=CC=C(C3=NC(C4=CC=C(C(F)(F)F)C=C4)=CC3)C=C2)C=C1,,CYP3A4,0.86,N-Dealkylation,0
cotinine,CN1C(=O)CCC1C1=CC=CN=C1,,trans-3'-hydroxycotinine,CN1C(=O)C(O)CC1C1=CC=CN=C1,,CYP2A6,0.8,Hydroxylation of heteroalicyclic secondary carbon,0
cotinine,CN1C(=O)CCC1C1=CC=CN=C1,,Norcotinine,OC1=NC(C2=CC=CN=C2)CC1,,CYP2A6,0.4,N-dealkylation of tertiary carboxamide,0
cotinine,CN1C(=O)CCC1C1=CC=CN=C1,,5'-hydroxycotinine,CN1C(=O)CCC1(O)C1=CC=CN=C1,,CYP2A6,0.69,Hydroxylation of  carbon next to amide,0
coumarin,O=C1C=CC2=CC=CC=C2O1,,7-Hydroxycoumarin,O=C1C=CC2=CC=C(O)C=C2O1,,CYP2A6; CYP2B6; CYP1A1; CYP1A2,0.73,7-Hydroxylation of coumarin,0
coumarin,O=C1C=CC2=CC=CC=C2O1,,3-Hydroxycoumarin,O=C1OC2=CC=CC=C2C=C1O,,CYP3A4,0.65,7-Hydroxylation of coumarin,0
coumarin,O=C1C=CC2=CC=CC=C2O1,,"Coumarin 3,4-epoxide",O=C1OC2=CC=CC=C2C2OC12,,CYP1A1; CYP1A2; CYP2E1,0.13,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,CYP2D6,0.97,O-Demethylation,0
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,,COC1=CC=C(OC(F)(F)F)C=C1CN,,CYP3A4,0.42,N-Dealkylation,0
cp_125_611,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,"CP-919,230",NCC1=CC(OC(F)(F)F)=CC=C1O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.41,N-Dealkylation,0
cp_125_611,OC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,quinone,O=C1CC=C(O)C=C1CNC1CCCNC1C1=CC=CC=C1,,CYP1A2;CYP3A4,0.53,O-Detrifluoromethylation,0
cp-199331,COC1=CC=C(NS(=O)(=O)C(F)(F)F)C=C1CC1COC2=CC=C(OCC3=NC4=CC(F)=C(F)C=C4S3)C=C2C1O,,,O=S(=O)(NC1=CC=C(O)C(CC2COC3=CC=C(OCC4=NC5=CC(F)=C(F)C=C5S4)C=C3C2O)=C1)C(F)(F)F,,CYP3A4,0.99,O-Demethylation,0
"cyclohexene, 4-ethenyl-, (s)-",C=CC1CC=CCC1,,,C1=CCC(C2CO2)CC1,,CYP2B6;CYP2E1,0.28,Epoxidation,0
"cyclohexene, 4-ethenyl-, (s)-",C=CC1CC=CCC1,,,C=CC1CCC2OC2C1,,CYP2B6;CYP2E1,0.22,Epoxidation,0
dacarbazine,CN(C)NN=C1N=CN=C1C(N)=O,,MTIC,CNNN=C1N=CN=C1C(N)=O,,CYP1A2;CYP2E1,0.96,N-demethylation,0
debrisoquine,N=C(N)N1CCC2=CC=CC=C2C1,,4-Hydroxydebrisoquine,N=C(N)N1CC2=CC=CC=C2C(O)C1,,CYP2D6,0.74,Hydroxylation of heteroalicyclic secondary carbon,0
dehydroepiandrosterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,,,CC12CCC3C(CC=C4CC(O)CCC43C)C1CC(O)C2=O,,CYP3A4,0.88,Aliphatic Hydroxylation,0
dehydroepiandrosterone,CC12CCC3C(CC=C4CC(O)CCC43C)C1CCC2=O,,,CC12CCC3C(C(O)C=C4CC(O)CCC43C)C1CCC2=O,,CYP3A4,0.85,Aliphatic Hydroxylation,0
delavirdine,CC(C)NC1=CC=CN=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,,CC(C)NC1=CC=C(O)N=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,CYP3A4,0.94,Aromatic Hydroxylation,0
delavirdine,CC(C)NC1=CC=CN=C1N1CCN(C(=O)C2=CC3=CC(NS(C)(=O)=O)=CC=C3N2)CC1,,,CS(=O)(=O)NC1=CC=C2NC(C(=O)N3CCN(C4=NC=CC=C4N)CC3)=CC2=C1,,CYP2D6;CYP3A4,0.93,N-desalkylation,0
deoxypodophyllotoxin,COC1=CC(C2C3=CC4=C(C=C3CC3COC(=O)C32)OCO4)=CC(OC)=C1OC,,,COC1=CC(C2C3=CC(O)=C(O)C=C3CC3COC(=O)C32)=CC(OC)=C1OC,,CYP2C19;CYP3A4,0.96,O-Demethylation,0
deoxypodophyllotoxin,COC1=CC(C2C3=CC4=C(C=C3CC3COC(=O)C32)OCO4)=CC(OC)=C1OC,,,COC1=CC(C2C3=CC4=C(C=C3C(O)C3COC(=O)C23)OCO4)=CC(OC)=C1OC,,CYP2C19;CYP3A4,0.84,Aliphatic Hydroxylation,0
deoxypodophyllotoxin,COC1=CC(C2C3=CC4=C(C=C3CC3COC(=O)C32)OCO4)=CC(OC)=C1OC,,,COC1=CC(C2C3=CC4=C(C=C3CC3COC(=O)C32)OCO4)=CC(OC)=C1O,,CYP3A4,0.99,O-Demethylation,0
deramciclane,CN(C)CCOC1(C2=CC=CC=C2)CC2CCC1(C)C2(C)C,,,CNCCOC1(C2=CC=CC=C2)CC2CCC1(C)C2(C)C,,CYP3A4,0.99,N-demethylation,0
desmethylcitalopram,CNCCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,"N,N-Didesmethylcitalopram",N#CC1=CC=C2C(=C1)COC2(CCCN)C1=CC=C(F)C=C1,,CYP2D6,0.99,N-dealkylation of acyclic secondary amine,0
dexamethasone,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,6-alpha-OH DEXAMETHASONE,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,CYP3A4,0.9,Hydroxylation of carbon gamma to conjugated carbonyl,0
dexfenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,,nordexfenfluramine,CC(N)CC1=CC=CC(C(F)(F)F)=C1,,CYP1A2;CYP2D6,0.88,N-dealkylation,0
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,NCC(O)COC1=CC=CC2=CC=CC=C12,,CYP1A2;CYP2D6,0.86,N-DESISOPROPYLATION,0
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(O)COC1=CC=CC2=C(O)C=CC=C12,,CYP1A2;CYP2D6,0.93,AROMATIC HYDROXYLATION,0
dexpropranolol (propranolol),CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(O)COC1=CC=C(O)C2=CC=CC=C12,,CYP1A2;CYP2D6,0.94,AROMATIC HYDROXYLATION,0
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,Dextrorphan,CN1CCC23CCCCC2C1CC1=CC=C(O)C=C13,,CYP2D6 (major); CYP2C9 (minor); CYP3A4 (minor),0.96,O-dealkylation,0
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,3-methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,,CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor); CYP2B6 (minor); CYP2C19 (minor),0.94,N-dealkylation of alicyclic tertiary amine,0
dextropropoxyphene,CCC(=O)OC(CC1=CC=CC=C1)(C1=CC=CC=C1)C(C)CN(C)C,,Nordextropropoxyphene,CCC(=O)OC(CC1=CC=CC=C1)(C1=CC=CC=C1)C(C)CNC,,CYP3A4,0.98,N-demethylation,0
diallyl disulfide,C=CCSSCC=C,,DADSO,C=CCSS(=O)CC=C,,CYP2A6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.46,S-Oxidation,0
Diazinon,CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Pyrimidinol,CC1=CC(O)=NC(C(C)C)=N1,,CYP2C19,0.48,Dearylation of organphosphosulfur compound,0
Diazinon,CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Diethyl thiophosphate,CCOP(O)(=S)OCC,,CYP2C19,0.11,Dearylation of organphosphosulfur compound,0
Diazinon,CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Diazoxon,CCOP(=O)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6; CYP3A4,0.71,Desulfuration of organophosphothioates,0
"dibenzo[a,l]pyrene",C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=C5C=CC=CC5=C2C1=C34,,,C1=CC=C2C(=C1)C1=CC=CC3=CC=C4C=C5C(=C2C4=C31)C=CC1=C5O1,,CYP1A2;CYP2B6;CYP2C9;CYP3A4,0.28,Epoxidation,0
dibenzylfluorescein,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,Fluorescein benzyl ester,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(O)=CC=C12,,CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.95,O-aryl dealkylation not adjacent to substituted carbon,0
dibenzylfluorescein,O=C(OCC1=CC=CC=C1)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,2-[6-(benzyloxy)-3-oxo-3H-xanthen-9-yl]benzoic acid,O=C(O)C1=CC=CC=C1C1=C2C=CC(=O)C=C2OC2=CC(OCC3=CC=CC=C3)=CC=C12,,CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.95,HYDROLYSIS_OF_CARBOXYLIC_ESTER,0
diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,,5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.85,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
digitoxin,CC1OC(OC2C(O)CC(OC3C(O)CC(OC4CCC5(C)C(CCC6C5CCC5(C)C(C7=CC(=O)OC7)CCC65O)C4)OC3C)OC2C)CC(O)C1O,,Digoxigenin Bisdigitoxoside,CC1OC(OC2C(O)CC(OC3CCC4(C)C(CCC5C4CC(O)C4(C)C(C6=CC(=O)OC6)CCC54O)C3)OC2C)CC(O)C1O,,CYP3A4,0.97,O-dealkylation,0
dihydrocodeine,COC1=CC=C2CC3C4CCC(O)C5OC1=C2C45CCN3C,,,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3C1C5,,CYP2D6,0.99,O-dementhylation,0
dihydrocodeine,COC1=CC=C2CC3C4CCC(O)C5OC1=C2C45CCN3C,,,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)CCC35,,CYP3A4,0.98,N-dementhylation,0
diltiazem,COC1=CC=C(C2SC3=CC=CC=C3N(CCN(C)C)C(=O)C2OC(C)=O)C=C1,,N-Demethyldiltiazem,CNCCN1C(=O)C(OC(C)=O)C(C2=CC=C(OC)C=C2)SC2=CC=CC=C21,,CYP3A4 (major); CYP2C8 (minor); CYP2C9 (minor),0.99,N-dealkylation of acyclic tertiary amine,0
diltiazem,COC1=CC=C(C2SC3=CC=CC=C3N(CCN(C)C)C(=O)C2OC(C)=O)C=C1,,O-Demethyldiltiazem,CC(=O)OC1C(=O)N(CCN(C)C)C2=CC=CC=C2SC1C1=CC=C(O)C=C1,,CYP2D6,0.98,O-aryl dealkylation not adjacent to substituted carbon,0
disopiramide,CC(C)N(CCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1)C(C)C,,mono-N-desalkyldisopyramide,CC(C)NCCC(C(=N)O)(C1=CC=CC=C1)C1=CC=CC=N1,,CYP3A4,0.97,N-desalkylation,0
domitroban,O=C(O)CCCC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCCC=CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9,0.86,Aliphatic Hydroxylation,0
domitroban,O=C(O)CCCC=CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCCC=CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.82,Aliphatic Hydroxylation,0
domperidone,OC1=NC2=CC=CC=C2N1CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,,OC1=CC=C2C(=C1)N=C(O)N2CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,CYP1A2;CYP2B6;CYP2C8;CYP2D6;CYP3A4,0.9,Aromatic Hydroxylation,0
domperidone,OC1=NC2=CC=CC=C2N1CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,,OC1=NC2=CC(Cl)=CC=C2N1C1CCNCC1,,CYP3A4,0.96,N-dealkylation,0
domperidone,OC1=NC2=CC=CC=C2N1CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,,CCCN1C(O)=NC2=CC=CC=C21,,CYP3A4,0.65,N-dealkylation,0
doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,2-OH-doxepin,CN(C)CCC=C1C2=CC(O)=CC=C2COC2=CC=CC=C12,,CYP2D6,0.93,Aromatic hydroxylation of fused benzene ring,0
ebastine,CC(C)(C)C1=CC=C(C(=O)CCCN2CCC(OC(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,Deslakylebastine,CC(C)(C)C1=CC=C(C(=O)CCC=O)C=C1,,CYP3A4,0.42,N-dealkylation of alicyclic tertiary amine,0
ebastine,CC(C)(C)C1=CC=C(C(=O)CCCN2CCC(OC(C3=CC=CC=C3)C3=CC=CC=C3)CC2)C=C1,,4-(4-tert-butylphenyl)-4-oxobutanal,C1=CC=C(C(OC2CCNCC2)C2=CC=CC=C2)C=C1,,CYP3A4,0.59,N-dealkylation of alicyclic tertiary amine,0
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,6-hydroxy-ecabapide,CN=C(O)C1=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=CC=C1O,,CYP3A4,0.86,Hydroxylation of benzene on carbon orhto to a strongly electron donating group,0
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,5-amino-2-hydroxy-N-methylbenzamide,CN=C(O)C1=CC(N)=CC=C1O,,CYP3A4,0.4,N-dealkylation of secondary arylalkylamine,0
ecabapide,CN=C(O)C1=CC=CC(NCC(O)=NCCC2=CC=C(OC)C(OC)=C2)=C1,,"N-[2-(3,4-dimethoxyphenyl)ethyl]-2-oxoacetamide",COC1=CC=C(CCNC(=O)C=O)C=C1OC,,CYP3A4,0.44,N-dealkylation of secondary arylalkylamine,0
efavirenz,OC1=NC2=CC=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,8-OH-efavirenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,CYP2B6; CYP1A2; CYP3A4,0.89,Aromatic hydroxylation of fused benzene ring,0
eicosapentaenoic acid,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O,,,CCC=CCC=CCC=CCCCCC=CCCCC(=O)O,,CYP2C8;CYP2C9;CYP2C11;CYP2C23,0.93,Epoxidation,0
eplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,6beta-hydroxyeplerenone,COC(=O)C1C(O)C2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,CYP3A4,0.9,Hydroxylation of carbon gamma to conjugated carbonyl,0
eplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CCC(=O)O4)C13,,21-hydroxyeplerenone,COC(=O)C1CC2=CC(=O)CCC2(C)C23OC2CC2(C)C(CCC24CC(O)C(=O)O4)C13,,CYP3A4,0.94,Alpha hydroxylation of carbonyl group,0
erythromycin,CCC1OCC(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)CC(C)C(O)C1(C)O,,N-Desmethylerythromycin,CCC1OCC(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(NC)C2O)C(C)(O)CC(C)CC(C)C(O)C1(C)O,,CYP3A4; CYP2B6,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1,0
estazolam,ClC1=CC=C2C(=C1)C(C1=CC=CC=C1)=NCC1=NN=CN21,,4-hydroxyestazolam,OC1N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N2C=NN=C12,,CYP3A4,0.88,Hydroxylation of heteroalicyclic secondary carbon,0
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,2-Hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,CYP1A2; CYP3A4; CYP1A1,0.96,Aromatic hydroxylation of fused benzene ring,0
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,4-Hydroxyestradiol ,CC12CCC3C4=CC=C(O)C(O)=C4CCC3C1CCC2O,,CYP1B1 ,0.85,Aromatic hydroxylation of fused benzene ring,0
eszopiclone,CN1CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,N-oxide-zopiclone,C[N+]1([O-])CCN(C(=O)OC2C3=NC=CN=C3C(=O)N2C2=CC=C(Cl)C=N2)CC1,,CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.98,N-Oxidation,0
ethiprole,CCS(=O)C1=C(N)N(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)N=C1C#N,,Ethiprole Sulfone,CCS(=O)(=O)C1=C(N)N(C2=C(Cl)C=C(C(F)(F)F)C=C2Cl)N=C1C#N,,CYP3A4,0.96,S-oxidation of sulfoxide to sulfone,0
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Norethylmorphine,CCOC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,,CYP2D6,0.98,N-Demethylation,0
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,,CYP3A4,0.99,O-dealkylation,0
etizolam,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,,,CCC1=CC2=C(S1)N1C(C)=NN=C1C(O)N=C2C1=CC=CC=C1Cl,,CYP2B6;CYP2C19;CYP3A4,0.91,Aliphatic Hydroxylation,0
etizolam,CCC1=CC2=C(S1)N1C(C)=NN=C1CN=C2C1=CC=CC=C1Cl,,,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=C(SC(C(C)O)=C3)N12,,CYP2B6;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation,0
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCCN1N=C(CC)N(CC)C1=O,,CYP3A4,0.69,N-Dealkylation,0
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.29,N-Dealkylation,0
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CC,,CYP3A4,0.94,Aromatic Hydroxylation,0
etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,,,CCN1C(C(C)O)=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C1=O,,CYP3A4,0.9,Aliphatic Hydroxylation,0
etoricoxib,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=N1,,6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(CO)N=C2)C=C1,,CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor),0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
etoricoxib,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=N1,,Etoricoxib 1'-N'-oxide,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=[N+]1[O-],,CYP3A4 (major); CYP2C9 (minor); CYP2D6 (minor); CYP1A2 (minor),0.89,Pyridine N-oxidation,0
eugenol,C=CCC1=CC=C(O)C(OC)=C1,,Hydroxychavicol,C=CCC1=CC=C(O)C(O)=C1,,CYP1A2;CYP2C9;CYP2D6;CYP2E1,0.76,O-demethylation,0
eupatilin,COC1=CC=C(C2=CC(=O)C3=C(O)C(OC)=C(O)C=C3O2)C=C1OC,,Jaceosidine,COC1=CC(C2=CC(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1O,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.99,O-demethylation,0
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,C=C(C)C1=CC=C(OC)C(CNC2C3CCN(CC3)C2C(C2=CC=CC=C2)C2=CC=CC=C2)=C1,,CYP2D6;CYP3A4,0.94,Dehydrogenation,0
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,COC1=CC=C(C(C)(C)O)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.94,Dehydrogenation,0
fentanyl,CCC(=O)N(C1=CC=CC=C1)C1CCN(CCC2=CC=CC=C2)CC1,,Phenylacetaldehyde,O=CCC1=CC=CC=C1,,CYP3A4,0.13,N-dealkylation of alicyclic tertiary amine,0
finasteride,CC(C)(C)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,,,CC(C)(CO)N=C(O)C1CCC2C3CCC4N=C(O)C=CC4(C)C3CCC12C,,CYP3A4,0.98,Alipathic Hydroxylation,0
flosequinan,CN1C=C(S(C)=O)C(=O)C2=CC=C(F)C=C21,,flosequinan sulfone,CN1C=C(S(C)(=O)=O)C(=O)C2=CC=C(F)C=C21,,CYP3A4,0.95,S-oxidation of sulfoxide to sulfone,0
fluphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(C(F)(F)F)C=C32)CC1,,10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-5ÃŽÂ»Ã¢ÂÂ´-phenothiazin-5-one,O=S1C2=CC=CC=C2N(CCCN2CCN(CCO)CC2)C2=CC(C(F)(F)F)=CC=C21,,CYP2D6,0.87,S-oxidation of diarylthioether to sulfoxide,0
flunitrazepam,CN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,desmethylflunitrazepam,O=[N+]([O-])C1=CC=C2N=C(O)CN=C(C3=CC=CC=C3F)C2=C1,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.62,N-DEMETHYLATION ,0
flunitrazepam,CN1C(=O)CN=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,3-hydroxyflunitrazepam,CN1C(=O)C(O)N=C(C2=CC=CC=C2F)C2=CC([N+](=O)[O-])=CC=C21,,CYP2A6;CYP3A4,0.91,Aliphatic Hydroxylation,0
flutamide,CC(C)C(O)=NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,2-OH-flutamide,CC(C)(O)C(O)=NC1=CC=C([N+](=O)[O-])C(C(F)(F)F)=C1,,CYP1A2; CYP1B1,0.92,Alpha hydroxylation of carbonyl group,0
fluvoxamine,COCCCCC(=NOCCN)C1=CC=C(C(F)(F)F)C=C1,,Fluvoxamino alcohol,NCCON=C(CCCCO)C1=CC=C(C(F)(F)F)C=C1,,CYP2D6 (major); CYP1A2 (minor),0.97,O-dealkylation of dialkylether,0
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,CYP1A2,0.96,O-aryl dealkylation not adjacent to substituted carbon,0
furafylline,CC1=NC2=C(N1)N(CC1=CC=CO1)C(=O)N(C)C2=O,,"3-[(furan-2-yl)methyl]-8-hydroxy-1-methyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione   ",CN1C(=O)C2=C(NC(CO)=N2)N(CC2=CC=CO2)C1=O,,CYP1A2,0.97,ALKYL_HYDROXYLATION,0
galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,4'-OH-galangin,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,CYP1A2 ; CYP2C9,0.98,p-Hydroxylation of monosubstituted benzene,0
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,O-Desmethylgalantamine,CN1CCC23C=CC(O)CC2OC2=C(O)C=CC(=C23)C1,,CYP2D6,0.99,O-aryl dealkylation not adjacent to substituted carbon,0
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,Galantamine N-oxide,COC1=CC=C2C[N+](C)([O-])CCC34C=CC(O)CC3OC1=C24,,CYP3A4,0.96,N-oxidation of alicyclic tertiary amine,0
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,N-desmethylgalantamine,COC1=CC=C2CNCCC34C=CC(O)CC3OC1=C24,,CYP2D6,0.98,N-dealkylation of alicyclic tertiary amine,0
gefitinib,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,,OC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,CYP2D6,0.97,O-dementhylation,0
gefitinib,COC1=CC2=NC=NC(NC3=CC=C(F)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,,COC1=CC2=NC=NC(NC3=CC=C(O)C(Cl)=C3)=C2C=C1OCCCN1CCOCC1,,CYP3A4,0.91,oxidative defluorination,0
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,Orobol,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2E1,0.94,Aromatic Hydroxylation,0
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=C(O)C=N3)CC2)C(=O)C1O,,CYP3A4,0.69,Hydroxylation,0
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=C(O)C=N3)CC2)C(=O)C1,,CYP3A4,0.91,Aromatic Hydroxylation,0
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1O,,CYP3A4,0.74,Aliphatic Hydroxylation,0
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,1-(2-pyrimidinyl)-piperazine (1-PP),C1=CN=C(N2CCNCC2)N=C1,,CYP3A4,0.46,N-Dealkylation,0
granisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC=C13)C2,,7-Hydroxygranisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC(O)=C13)C2,,CYP1A1,0.86,HYDROXYLATION_OF_AROMATIC_CARBON,0
granisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=CC=CC=C13)C2,,9'-Desmethylgranisetron,CN1C2CCCC1CC(NC(=O)C1=NNC3=CC=CC=C13)C2,,CYP3A4 (major); CYP1A1; CYP2D6; CYP3A5,0.85,N-dealkylation of alicyclic tertiary amine,0
gts-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(OC)=C1,,4-OH-GTS-21,COC1=CC(O)=CC=C1C=C1CCCN=C1C1=CC=CN=C1,,CYP1A2;CYP2E1;CYP3A4,0.99,O-Demethylation,0
gts-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(OC)=C1,,2-OH-GTS-21,COC1=CC=C(C=C2CCCN=C2C2=CC=CN=C2)C(O)=C1,,CYP1A2;CYP2E1;CYP3A4,0.97,O-Demethylation,0
guanabenz,N=C(N)NN=CC1=C(Cl)C=CC=C1Cl,,Guanoxabenz,N=C(NO)NN=CC1=C(Cl)C=CC=C1Cl,,CYP1A2,0.93,N-hyroxylation of guanidine or aminohydrazone,0
haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,,p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine,O=C(O)CCC(=O)C1=CC=C(F)C=C1,,CYP3A4; CYP2D6,0.4,N-dealkylation of alicyclic tertiary amine,0
harmaline,COC1=CC=C2C3=C(NC2=C1)C(C)=NCC3,,Harmalol,CC1=NCCC2=C1NC1=CC(O)=CC=C21,,CYP2D6 (major); CYP1A2 (minor),0.96,O-aryl demethylation,0
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,Harmol,COC1=CC2=C(C=C1O)C1=CC=NC(C)=C1N2,,CYP2D6 (major); CYP2C9 (minor); CYP2C19 (minor); CYP1A2 (minor),0.91,Aromatic hydroxylation of fused benzene ring,0
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,CYP2D6,0.93,O-aryl demethylation,0
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxy-a-methylbenzene methanol",COC1=CC(C(C)O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,CYP1A2;CYP2E1;CYP3A4,0.91,Reduction ,0
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]- propoxy]-3-hydroxyphenyl]ethanone",CC(=O)C1=CC=C(OCCCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(O)=C1,,CYP3A4,0.97,O-Demethylation,0
iloperidone,COC1=CC(C(C)=O)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,"1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]-2-hydroxyethanone",COC1=CC(C(=O)CO)=CC=C1OCCCN1CCC(C2=NOC3=CC(F)=CC=C23)CC1,,CYP2D6,0.97,Aliphatic Hydroxylation,0
imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,5-hydroxy-imidacloprid,O=[N+]([O-])NC1=NCC(O)N1CC1=CC=C(Cl)N=C1,,CYP3A4,0.82,Aliphatic Hydroxylation,0
imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,olefin,O=[N+]([O-])NC1=NC=CN1CC1=CC=C(Cl)N=C1,,CYP3A4,0.27,Dehydrogenation,0
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=C[N+]([O-])=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.98,N-Oxidation,0
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CNCCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.91,N-Dealkylation,0
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=C(O)C=C1)C(O)=NC1C2=CC=CC=C2CC1O,,CYP3A4,0.98,Aromatic Hydroxylation,0
indinavir,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2CC1O,,,CC(C)(C)N=C(O)C1CN(CC2=CC=CN=C2)CCN1CC(O)CC(CC1=CC=CC=C1)C(O)=NC1C2=CC=CC=C2C(O)C1O,,CYP3A4,0.92,Aliphatic Hydroxylation,0
indiplon,CC(=O)N(C)C1=CC=CC(C2=CC=NC3=C(C(=O)C4=CC=CS4)C=NN23)=C1,,N-Desmethylindiplon,CC(O)=NC1=CC=CC(C2=CC=NC3=C(C(=O)C4=CC=CS4)C=NN23)=C1,,CYP3A4; CYP1A2,0.9,N-dealkylation of tertiary carboxamide,0
indole,C1=CC=C2NC=CC2=C1,,,OC1=CNC2=CC=CC=C12,,CYP2A6;CYP2C19;CYP2E1,0.57,Aliphatic Hydroxylation,0
indole,C1=CC=C2NC=CC2=C1,,,OC1=NC2=CC=CC=C2C1,,CYP2A6;CYP2C19;CYP2E1,0.06,C-Oxidation,0
indole,C1=CC=C2NC=CC2=C1,,,OC1=CC=C2C=CNC2=C1,,CYP2A6;CYP2C19;CYP2E1,0.64,Aromatic Hydroxylation,0
indomethacin,COC1=CC=C2C(=C1)C(CC(=O)O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,O-Desmethylindomethacin,CC1=C(CC(=O)O)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,CYP2C9 (major); CYP2C19 (minor); CYP2D6 (minor); CYP1A2 (minor),0.97,O-aryl demethylation,0
"invega, invega sustenna, 9-hydroxyrisperidone, paliperidone",CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCC(O)C2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CC(O)CC(O)C2=N1,,CYP2D6,0.95,Aliphatic Hydroxylation,0
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,O=C1C(C2=CC=CC=C2)=COC2=CC(O)=CC=C12,,CYP1A2;CYP2C9;CYP2C19;CYP3A4,0.89,O-dealkylation,0
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,CC(CO)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,CYP1A2;CYP2C9;CYP2C19,0.98,Aliphatic Hydroxylation,0
ipriflavone,CC(C)OC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1,,,CC(C)OC1=CC=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,CYP1A2;CYP2C9;CYP2C19,0.98,Aromatic Hydroxylation,0
isoquinoline,C1=CC=C2C=NC=CC2=C1,,isoquinoline N-oxide,[O-][N+]1=CC=C2C=CC=CC2=C1,,CYP3A4; CYP2E1,0.71,N-Oxidation,0
isotretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,,CC(C=CC(O)=C(C)C=CC1=C(C)CCCC1(C)C)=CC(=O)O,,CYP2B6;CYP2C8;CYP3A4,0.83,Hydroxylation,0
ivermectin,COC1CC(OC2C(C)OC(OC3C(C)=CCC4CCC(CC5(CCC(C(C)C)CO5)O4)OC(=O)C4C=C(C)C(O)C5CCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,,,COC1CC(OC2(O)C(C)OC(OC3C(C)=CCC4CCC(CC5(CCC(C(C)C)CO5)O4)OC(=O)C4C=C(C)C(O)C5CCC(=CC=CC3C)C45O)CC2OC)OC(C)C1O,,CYP3A4,0.95,Aliphatic Hydroxylation,0
k-11777,CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,N-oxide k-11777,C[N+]1([O-])CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,CYP3A4,0.96,N-Oxidation,0
"N-[(2S)-1-[[(E,3S)-1-(benzenesulfonyl)-5-phenylpent-1-en-3-yl]amino]-1-oxo-3-phenylpropan-2-yl]-4-methylpiperazine-1-carboxamide",CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)CCC2=CC=CC=C2)CC1,,b-hydroxy-homoPhe K11777,CN1CCN(C(O)=NC(CC2=CC=CC=C2)C(O)=NC(C=CS(=O)(=O)C2=CC=CC=C2)C(O)CC2=CC=CC=C2)CC1,,CYP3A4,0.91,Aliphatic Hydroxylation,0
ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Norketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCNCC1,,CYP3A4; CYP2C9,0.95,N-dealkylation of alicyclic tertiary amine,0
"2â€(3â€{4â€[2â€(3â€fluorophenyl)ethyl]piperazinâ€1â€yl}propyl)â€5â€(1,2,4â€triazolâ€4â€yl)â€1Hâ€indole",FC1=CC=CC(CCN2CCN(CCCC3=CC4=CC(N5C=NN=C5)=CC=C4N3)CC2)=C1,,,OC(CN1CCN(CCCC2=CC3=CC(N4C=NN=C4)=CC=C3N2)CC1)C1=CC=CC(F)=C1,,CYP2C8;CYP3A4,0.91,Aliphatic Hydroxylation,0
l_775606,FC1=CC=CC(CCN2CCN(CCCC3=CC4=CC(N5C=NN=C5)=CC=C4N3)CC2)=C1,,,CN1CCN(CCCC2=CC3=CC(N4C=NN=C4)=CC=C3N2)CC1,,CYP2C8;CYP3A4,0.85,N-dealkylation,0
l-trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,,l-ifosfamide,O=P1(N(CCCl)CCCl)OCCC(O)N1CCCl,,CYP3A4; CYP2B6; CYP2A6; CYP2C9,0.68,4-alkyl hydroxylation of oxoazaphosphorine,0
l-trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,,l-cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,,CYP3A4; CYP2B6,0.87,N-dechloroethylation,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4-hydroxy-N-(4-hydroxyphenyl)-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=C(O)C=C1,,CYP3A4,0.99,p-Hydroxylation of anilide,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN1C(=O)C(C(O)=NC2=CC=CC=C2)=C(O)C2=C(Cl)C=CC=C21,,CYP3A4,0.66,N-dealkylation of secondary carboxamide,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4-hydroxy-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)N=C2C=CC=C(Cl)C2=C1O)C1=CC=CC=C1,,CYP3A4,0.74,N-dealkylation of secondary carboxamide,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,8-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=CC(O)=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.95,Aromatic hydroxylation of fused benzene ring,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,7-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C=C(O)C=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.98,Aromatic hydroxylation of fused benzene ring,0
laquinimod,CCN(C(=O)C1=C(O)C2=C(Cl)C=CC=C2N(C)C1=O)C1=CC=CC=C1,,"5-chloro-N-ethyl-4,6-dihydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CCN(C(=O)C1=C(O)C2=C(Cl)C(O)=CC=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.97,Aromatic hydroxylation of fused benzene ring,0
levobupivacaine,CCCCN1CCCCC1C(O)=NC1=C(C)C=CC=C1C,,,CC1=CC=CC(C)=C1N=C(O)C1CCCCN1,,CYP2C19;CYP2D6;CYP3A4,0.88,N-demethylation,0
licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,licofelone M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)O)N2C1,,CYP2C8; CYP2C9,0.94,Hydroxylation of aromatic carbon ortho to halide group,0
licofelone_M1,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OCC3OC(O)C(O)C(O)C3O)N2C1,,,CC1(CO)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OCC3OC(O)C(O)C(O)C3O)N2C1,,CYP2C8;CYP2C9,0.97,Aliphatic Hydroxylation,0
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,CYP1A2; CYP3A4; CYP3A5; CYP2C8; CYP2C18; CYP2B6; CYP2A6,0.92,N-dealkylation of acyclic tertiary amine,0
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,3-Hydroxylidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.73,Hydroxylation of benzene on carbon ortho to an electron donating group,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,8-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=CC(O)=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.93,Aromatic hydroxylation of fused benzene ring,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,7-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=C(O)C=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.99,Aromatic hydroxylation of fused benzene ring,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4,6-dihydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC(O)=CC=C2N(C)C1=O)C1=CC=CC=C1,,CYP3A4,0.97,Aromatic hydroxylation of fused benzene ring,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-N-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)N=C2C=CC=CC2=C1O)C1=CC=CC=C1,,CYP3A4,0.68,N-dealkylation of tertiary carboxamide,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-1-methyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide",CN1C(=O)C(C(O)=NC2=CC=CC=C2)=C(O)C2=CC=CC=C21,,CYP3A4,0.6,N-dealkylation of tertiary carboxamide,0
linomide,CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=CC=C1,,"4-hydroxy-N-(4-hydroxyphenyl)-N,1-dimethyl-2-oxo-1,2-dihydroquinoline-3-carboxamide",CN(C(=O)C1=C(O)C2=CC=CC=C2N(C)C1=O)C1=CC=C(O)C=C1,,CYP3A4,0.99,Hydroxylation of benzene on carbon para to an electron donating group,0
lisofylline,CC(O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,"lisofylline 4,5-diol",CC(O)C(O)CCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,CYP3A4; CYP2A6,0.98,Hydroxylation of acyclic aliphatic secondary carbon,0
loperamide,CN(C)C(=O)C(CCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,,N-Desmethyloperamide,CN=C(O)C(CCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)(C1=CC=CC=C1)C1=CC=CC=C1,,CYP3A4; CYP2D6; CYP2C8; CYP2B6,0.58,N-dealkylation of tertiary carboxamide,0
loratadine,CCOC(=O)N1CCC(=C2C3=CC=C(Cl)C=C3CCC3=CC=CN=C23)CC1,,,ClC1=CC=C2C(=C3CCNCC3)C3=NC=CC=C3CCC2=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.91,N_DEALKYLATION,0
lornoxicam,CN1C(C(O)=NC2=CC=CC=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,,5'-Hydroxylornoxicam,CN1C(C(O)=NC2=CC=C(O)C=N2)=C(O)C2=C(C=C(Cl)S2)S1(=O)=O,,CYP2C9 ,0.99,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,E-3174,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP2C9; CYP3A4; CYP3A5,0.9,OXIDATION_OF_PRIM_ALCOHOL_TO_CARBOXYLIC_ACID,0
losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCC(O)C1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP3A4,0.89,Aliphatic Hydroxylation,0
losartan carboxaldehyde,CCCCC1=NC(Cl)=C(C=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=NC(Cl)=C(C(=O)O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,CYP3A4,0.9,Aliphatic Hydroxylation,0
lovastatin,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'beta-Hydroxylovastatin,CCC(C)C(=O)OC1CC(C)(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4,0.9,Hydroxylation of penultimate aliphatic tertiary carbon,0
lovastatin,CCC(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,3-Hydroxylovastatin,CCC(O)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4,0.93,Hydroxylation of acyclic aliphatic secondary carbon,0
m-xylene,CC1=CC=CC(C)=C1,,"2,4-Dimethylphenol",CC1=CC=C(O)C(C)=C1,,CYP1A2,0.44,"2-Hydroxylation of 1,4-disubstituted benzene",0
m-xylene,CC1=CC=CC(C)=C1,,3-Methylbenzylalcohol,CC1=CC=CC(CO)=C1,,CYP2E1,0.58,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,,3-OH-maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=C(O)C=C12,,CYP2D6; CYP1A2,0.85,Aromatic hydroxylation of fused benzene ring,0
maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC=CC=C12,,2-OH-maprotiline,CNCCCC12CCC(C3=CC=CC=C31)C1=CC(O)=CC=C12,,CYP2D6; CYP1A2,0.85,Aromatic hydroxylation of fused benzene ring,0
mefenamic acid,CC1=CC=CC(NC2=CC=CC=C2C(=O)O)=C1C,,3-hydroxymethyl mefenamic aci,CC1=C(CO)C=CC=C1NC1=CC=CC=C1C(=O)O,,CYP2C9 ,0.91,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
meiqx,CC1=CN=C2C=CC3=C(NC(=N)N3C)C2=N1,,N-OH-MeIQX,CC1=CN=C2C=CC3=C(N=C(NO)N3C)C2=N1,,CYP1A2,0.67,N-hydroxylation of primary arylamine,0
meiqx,CC1=CN=C2C=CC3=C(NC(=N)N3C)C2=N1,,IQx-8-COOH,CN1C(=N)NC2=C3N=C(C(=O)O)C=NC3=CC=C21,,CYP1A2,0.86,OXIDATION_OF_METHYL_TO_CARBOXYLIC_ACID,0
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,6-Hydroxymelatonin,COC1=CC2=C(C=C1O)NC=C2CCN=C(C)O,,CYP1A1; CYP1A2; CYP2C19 (minor); CYP2E1,0.88,Aromatic hydroxylation of fused benzene ring,0
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,N-Acetyl-5-hydroxytryptamine,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,CYP2C19 (major); CYP1A2; CYP2E1,0.93,O-aryl demethylation,0
meloxicam,CC1=CN=C(N=C(O)C2=C(O)C3=CC=CC=C3S(=O)(=O)N2C)S1,,,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,,CYP2C9;CYP3A4,0.98,Aliphatic Hydroxylation,0
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=CC(O)=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,CYP3A4,0.94,Aromatic Hydroxylation,0
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=C(O)C=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,CYP3A4,0.91,Aromatic Hydroxylation,0
methaqualone,CC1=CC=CC=C1N1C(C)=NC2=CC=CC=C2C1=O,,hydroxy-methaqualone,CC1=NC2=CC=CC=C2C(=O)N1C1=CC=CC=C1CO,,CYP3A4,0.95,Aliphatic Hydroxylation,0
methoxsalen,COC1=C2OC=CC2=CC2=C1OC(=O)C=C2,,,COC1=C2OC3OC3C2=CC2=C1OC(=O)C=C2,,CYP2A6,0.41,Epoxidation,0
methyleugenol,C=CCC1=CC=C(OC)C(OC)=C1,,1Ã¢â‚¬Ëœ-hydroxylate methyleugenol,C=CC(O)C1=CC=C(OC)C(OC)=C1,,CYP1A2;CYP2C9;CYP2C19;CYP2D6,0.75,Aliphatic Hydroxylation,0
metoclopramide,CCN(CC)CCN=C(O)C1=CC(Cl)=C(N)C=C1OC,,monodeethylmetoclopramide,CCNCCN=C(O)C1=CC(Cl)=C(N)C=C1OC,,CYP1A2;CYP2C8;CYP2C19;CYP2D6;CYP3A4,0.98,N-dealkylation,0
midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,1'-Hydroxymidazolam,OCC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,CYP3A4; CYP3A5; CYP3A7; CYP2B6,0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,4-Hydroxymidazolam,CC1=NC=C2C(O)N=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,CYP3A4; CYP3A5; CYP3A7,0.91,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine",0
mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N(C)C)C=C3)CC21C,,Monodemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(NC)C=C3)CC21C,,CYP3A4,0.99,N-dealkylation of mixed tertiary amine,0
mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N(C)C)C=C3)CC21C,,17alpha-hydroxymifepristone ,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)C#CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.99,Aliphatic hydroxylation of methyl carbon adjacent to alkyne ring,0
minaprine,CC1=CC(C2=CC=CC=C2)=NNC1=NCCN1CCOCC1,,4-Hydroxyminaprine,CC1=CC(C2=CC=C(O)C=C2)=NNC1=NCCN1CCOCC1,,CYP2D6,0.94,p-Hydroxylation of monosubstituted benzene,0
miocamycin,CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(OC(C)=O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(OC(C)=O)C(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC,,,CCC(=O)OC1CC(=O)OC(C)CC=CC=CC(OC(C)=O)C(C)CC(CC=O)C(OC2OC(C)C(OC3CC(C)(OC(C)=O)C(O)(OC(=O)CC)C(C)O3)C(N(C)C)C2O)C1OC,,CYP3A4,0.93,Aliphatic Hydroxylation,0
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,montelukast sulfoxide,CC(C)(O)C1=CC=CC=C1CCC(C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1)S(=O)CC1(CC(=O)O)CC1,,CYP3A4; CYP2A6,0.91,S-oxidation of dialkylthioether to sulfoxide,0
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,21-Hydroxymontelukast,CC(C)(O)C1=CC=CC=C1C(O)CC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,CYP3A4,0.94,Hydroxylation of acyclic aliphatic secondary carbon,0
montelukast,CC(C)(O)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,"[1Ã¢â‚¬Â({[(1R)Ã¢â‚¬Â1Ã¢â‚¬Â{3Ã¢â‚¬Â[(E)Ã¢â‚¬Â2Ã¢â‚¬Â(7Ã¢â‚¬ÂchloroquinolinÃ¢â‚¬Â2Ã¢â‚¬Âyl)ethenyl]phenyl}Ã¢â‚¬Â3Ã¢â‚¬Â[2Ã¢â‚¬Â(1,2Ã¢â‚¬ÂdihydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)phenyl]propyl]sulfanyl}methyl)cyclopropyl]aceticacid",CC(O)(CO)C1=CC=CC=C1CCC(SCC1(CC(=O)O)CC1)C1=CC=CC(C=CC2=CC=C3C=CC(Cl)=CC3=N2)=C1,,CYP2C9,0.95,Hydroxylation of terminal methyl,0
morphine,CN1CC2CC3=CC=C(O)C4=C3C3(C1)C2C=CC(O)C3O4,,Normorphine,OC1=CC=C2CC3CNCC45C2=C1OC4C(O)C=CC35,,CYP2C8;CYP3A4,0.98,O-Demethylation,0
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(CO)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.94,Aliphatic Hydroxylation,0
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCC(O)C3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,CYP3A4,0.88,Aliphatic Hydroxylation,0
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=C(O)C=C4)=N3)C=C2)C=C1,,CYP2C19,0.99,Aromatic Hydroxylation,0
muraglitazar,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(OCCC3=C(C)OC(C4=CC=CC=C4)=N3)C=C2)C=C1,,,COC1=CC=C(OC(=O)N(CC(=O)O)CC2=CC=C(O)C=C2)C=C1,,CYP2C8;CYP2D6;CYP3A4,0.51,Aromatic Hydroxylation,0
mycophenolic acid,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)O,,6-O-desmethyl-MPA (DM-MPA),CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,,CYP3A4,0.91,O-Desmethylation,0
myristicin,C=CCC1=CC(OC)=C2OCOC2=C1,,"5-allyl-1-methoxy-2,3-dihydroxybenzene",C=CCC1=CC(O)=C(O)C(OC)=C1,,CYP3A4;CYP1A2,0.75,Nifedipine Oxidation,0
n_ac_dfec,CC(O)=NC(CSC(F)(F)C(OCF)C(F)F)C(=O)O,,N-Ac-DFEC-SO,CC(O)=NC(CS(=O)C(F)(F)C(OCF)C(F)F)C(=O)O,,CYP3A4,0.76,S-Oxidation,0
n_ac_ffvc,CC(O)=NC(CSC(F)=C(OCF)C(F)F)C(=O)O,,N-Ac-FFVC-SO,CC(O)=NC(CS(=O)C(F)=C(OCF)C(F)F)C(=O)O,,CYP3A4,0.76,S-Oxidation,0
n_ac_pcbc,NC(CSC(Cl)=C(Cl)C(Cl)=C(Cl)Cl)C(=O)O,,N-Ac-PCBC-SO,NC(CS(=O)C(Cl)=C(Cl)C(Cl)=C(Cl)Cl)C(=O)O,,CYP3A4,0.71,S-Oxidation,0
n-({4-[(5-bromopyrimidin-2-yl)oxy]-3-methylphenyl}carbamoyl)-2-(dimethylamino)benzamide,CC1=CC(NC(=O)N=C(O)C2=CC=CC=C2N(C)C)=CC=C1OC1=NC=C(Br)C=N1,,mmBPU,CNC1=CC=CC=C1C(O)=NC(=O)NC1=CC=C(OC2=NC=C(Br)C=N2)C(C)=C1,,CYP1A1;CYP2D6;CYP2C9;CYP3A4;CYP3A5;CYP3A7,0.96,N-Demethylation,0
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,CYP2C19;CYP3A4,0.97,Aliphatic Hydroxylation,0
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NC(O)CC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,CYP3A4,0.98,Aliphatic Hydroxylation,0
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCCC2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,CYP2C9;CYP2C19;CYP2D6,0.98,O-Demethylation,0
n-nitroso-n-methylaniline (NMPhA),CN(N=O)C1=CC=CC=C1,,,O=NN(CO)C1=CC=CC=C1,,CYP2A6,0.76,Aliphatic Hydroxylation,0
n-nitrosodibutylamine,CCCCN(CCCC)N=O,,,CCCCN(N=O)C(O)CCC,,CYP2A6;CYP2E1,0.47,Aliphatic Hydroxylation,0
"n,n-diethyl-n'-(1-ethyl-6-methylergolin-8alpha-yl)sulfamide",CCN(CC)S(=O)(=O)NC1CC2C3=CC=CC4=C3C(=CN4CC)CC2N(C)C1,,,CCNS(=O)(=O)NC1CC2C3=CC=CC4=C3C(=CN4CC)CC2N(C)C1,,CYP3A4,0.98,N-Dealkylation,0
"n,n-dimethyl-5-methoxytryptamine",COC1=CC=C2NC=C(CCN(C)C)C2=C1,,Bufotenine,CN(C)CCC1=CNC2=CC=C(O)C=C12,,CYP2D6,0.92,O-demethylation,0
naphthalene,C1=CC=C2C=CC=CC2=C1,,2-Naphthol,OC1=CC=C2C=CC=CC2=C1,,CYP3A4,0.48,Aromatic Hydroxylation,0
naphthalene,C1=CC=C2C=CC=CC2=C1,,1-Naphthol,OC1=CC=CC2=CC=CC=C12,,CYP1A2,0.42,Aromatic Hydroxylation,0
naphthalene,C1=CC=C2C=CC=CC2=C1,,dihydrodiol,OC1=CC=C2C=CC=CC2=C1O,,CYP1A2,0.32,Aromatic Hydroxylation,0
naphthalene,C1=CC=C2C=CC=CC2=C1,,"naphthalene-1,2 Expodation",C1=CC2OC2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.05,Epoxidation,0
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,Desmethylnaproxen ,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,CYP2C9 (major); CYP1A2 ,0.91,O-aryl dealkylation not adjacent to substituted carbon,0
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.96,Aromatic Hydroxylation,0
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CC(O)C1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.91,Aliphatic Hydroxylation,0
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.26,N-Dealkylation,0
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,CCC1=NN(CCCO)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.75,N-Dealkylation,0
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,2-OH-nevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP3A4,0.93,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,8-OH-nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC(O)=CN=C1N2C1CC1,,CYP2D6 (major); CYP2B6 (minor); CYP3A4 (minor),0.95,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,3-OH-nevirapine,CC1=C(O)C=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP2B6,0.93,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,12-OH-nevirapine,OCCC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,CYP3A4 (major); CYP2D6 (minor); CYP2C9 (minor),0.96,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
nicotine,CN1CCCC1C1=CC=CN=C1,,"(S)-Nicotine ÃŽâ€1Ã¢â‚¬Â²,5Ã¢â‚¬Â²-iminium ion",C[N+]1=CCCC1C1=CC=CN=C1,,CYP2A6 (major); CYP2B6; CYP2A13,0.56,Formation of iminium from pyrrolidine ring,0
nicotine,CN1CCCC1C1=CC=CN=C1,,2Ã¢â‚¬Â²-Hydroxynicotine,CN1CCCC1(O)C1=CC=CN=C1,,CYP2A6,0.66,Hydroxylation of heteroalicyclic secondary carbon,0
nicotine,CN1CCCC1C1=CC=CN=C1,,Nornicotine,C1=CN=CC(C2CCCN2)=C1,,CYP2A6; CYP2B6; CYP2A13,0.86,N_DEALKYLATION_OF_CYCLIC_TERTIARY_AMINES; N_DEALKYLATION_OF_ALICYCLIC_TERTIARY_AMINES_PATTERN1,0
nifedipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+](=O)[O-],,Oxidized nifedipine,COC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC=C1[N+](=O)[O-],,CYP3A4,0.35,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine",0
nnal,CN(CCC(O)C(=O)C1=CC=CN=C1)N=O,,,CN(CCC(O)C(=O)C1=CC=C[N+]([O-])=C1)N=O,,CYP3A4,0.86,N-Oxidation,0
nnal,CN(CCC(O)C(=O)C1=CC=CN=C1)N=O,,,CN(N=O)C(O)CC(O)C(=O)C1=CC=CN=C1,,CYP3A4,0.84,Aliphatic Hydroxylation,0
nordiazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1,,OXAZEPAM,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,CYP1A2;CYP2C19;CYP3A4,0.87,Aliphatic Hydroxylation,0
o-xylene,CC1=CC=CC=C1C,,"2,3-Dimethylphenol",CC1=CC=C(O)C=C1C,,CYP2E1,0.47,Aromatic Hydroxylation,0
o-xylene,CC1=CC=CC=C1C,,"3,4-Dimethylphenol",CC1=CC=CC(O)=C1C,,CYP2E1,0.42,Aromatic Hydroxylation,0
o-xylene,CC1=CC=CC=C1C,,2 Methylbenzylalcohol,CC1=CC=CC=C1CO,,CYP2E1,0.58,Aliphatic Hydroxylation,0
olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,,,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CC[N+](C)([O-])CC2)S1,,CYP1A2;CYP2D6;CYP3A4,0.97,N-OXIDATION,0
olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCN(C)CC2)S1,,,CC1=CC2=C(NC3=CC=C(O)C=C3N=C2N2CCN(C)CC2)S1,,CYP1A2;CYP2D6,0.96,AROMATIC HYDROXYLATION,0
oleic acid,CCCCCCCCC=CCCCCCCCC(=O)O,,,CC(O)CCCCCCC=CCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.89,Aliphatic Hydroxylation,0
olopatadine,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(CC(=O)O)C=C12,,N-monodemethylolopatadine,CNCCC=C1C2=CC=CC=C2COC2=CC=C(CC(=O)O)C=C12,,CYP3A4,0.99,N-Dementhylation,0
onapristone,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)CCCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,,CNC1=CC=C(C2CC3(C)C(CCC3(O)CCCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.98,N-Demethylation,0
opc-13448,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC=CC2=CC=CC=C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,OPC-13463,COC(=O)C1=C(C)N=C(C)C(C(=O)O)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP1A2;CYP2D6;CYP3A4,0.92,N-Demethylation,0
org_30659,C#CC1(O)C=CC2C3CCC4=CC(=O)CCC4C3C(=C)CC21C,,,C#CC1(O)C=CC2C3C(O)CC4=CC(=O)CCC4C3C(=C)CC21C,,CYP3A4,0.92,Aliphatic Hydroxylation,0
oxycodone,COC1=CC=C2CC3N(C)CCC45C2=C1OC4C(=O)CCC35O,,noroxycodone,COC1=CC=C2CC3NCCC45C2=C1OC4C(=O)CCC35O,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.98,N-demethylation,0
p-cresol,CC1=CC=C(O)C=C1,,4-methyl-hydroquinone,CC1=CC=C(O)C(O)=C1,,CYP2E1,0.62,Aromatic Hydroxylation,0
p-cresol,CC1=CC=C(O)C=C1,,,CC1C=CC(=O)C=C1,,CYP1A2;CYP2C19;CYP2D6;CYP2E1,0.01,Dehydrogenation,0
p-cresol,CC1=CC=C(O)C=C1,,,OCC1=CC=C(O)C=C1,,CYP1A2;CYP2C19;CYP2D6;CYP2E1,0.71,Aliphatic Hydroxylation,0
p-xylene,CC1=CC=C(C)C=C1,,4-Methylbenzylalcohol,CC1=CC=C(CO)C=C1,,CYP2E1,0.6,Aliphatic Hydroxylation,0
p-xylene,CC1=CC=C(C)C=C1,,"2,5-dimethylphenol",CC1=CC=C(C)C(O)=C1,,CYP2E1,0.38,Aliphatic Hydroxylation,0
palmitic acid,CCCCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation,0
pentachlorobenzene,ClC1=CC(Cl)=C(Cl)C(Cl)=C1Cl,,PCP,OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,CYP3A4,0.46,Aromatic Hydroxylation,0
pentoxyresorufin,CCCCCOC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2; CYP1B1,0.91,O-aryl dealkylation not adjacent to substituted carbon,0
perazine,CN1CCN(CCCN2C3=CC=CC=C3SC3=CC=CC=C32)CC1,,,CN1CCN(CCCN2C3=CC=CC=C3S(=O)C3=CC=CC=C32)CC1,,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.83,S-Oxidation,0
perphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C32)CC1,,N-Dealkylated perphenazine,ClC1=CC=C2SC3=CC=CC=C3N(CCCN3CCNCC3)C2=C1,,CYP1A2; CYP3A4; CYP2C9; CYP2C19; CYP2D6 ,0.98,N-dealkylation of alicyclic tertiary amine,0
perphenazine,OCCN1CCN(CCCN2C3=CC=CC=C3SC3=CC=C(Cl)C=C32)CC1,,Perphenazine sulfoxide,O=S1C2=CC=CC=C2N(CCCN2CCN(CCO)CC2)C2=CC(Cl)=CC=C21,,CYP2D6,0.85,S-oxidation of diarylthioether to sulfoxide,0
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A1; CYP1A2; CYP2E1; CYP2D6; CYP2C19; CYP2C9; CYP2A6,0.78,O-dealkylation,0
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,N-OH-phenacetin,CCOC1=CC=C(N(O)C(C)=O)C=C1,,CYP1A1; CYP1A2,0.36,N-hydroxylation of secondary arylamide,0
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=CC=C2C(=C1O)C=CC1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation,0
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=CC=C2C=CC3=CC=CC=C3C2=C1O,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation,0
phenanthrene,C1=CC=C2C(=C1)C=CC1=CC=CC=C12,,,OC1=C(O)C2=CC=CC=C2C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.37,Aromatic Hydroxylation,0
phencyclidine,C1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1,,PCHP,OC1CCN(C2(C3=CC=CC=C3)CCCCC2)CC1,,CYP3A4,0.93,Aliphatic Hydroxylation,0
phencyclidine,C1=CC=C(C2(N3CCCCC3)CCCCC2)C=C1,,c-PPC/t-PPC,OC1CCC(C2=CC=CC=C2)(N2CCCCC2)CC1,,CYP3A4,0.89,Aliphatic Hydroxylation,0
phenformin,N=C(N)NC(=N)NCCC1=CC=CC=C1,,,N=C(N)NC(=N)NCCC1=CC=C(O)C=C1,,CYP2D6,0.81,Aromatic Hydroxylation,0
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,3'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=CC(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.86,m-Hydroxylation of monosubstituted benzene,0
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,4'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,CYP2C9 (major); CYP2C19 (minor),0.93,p-Hydroxylation of monosubstituted benzene,0
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,"5Ã¢â‚¬Â(3,4Ã¢â‚¬ÂdihydroxycyclohexaÃ¢â‚¬Â1,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl)Ã¢â‚¬Â5Ã¢â‚¬ÂphenylimidazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",OC1=NC(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)C(O)=N1,,CYP2C9; CYP2C19,0.4,DIHYDROXYLATION_OF_DOUBLE_BOND,0
pilocarpine,CCC1C(=O)OCC1CC1=CN=CN1C,,3-hydroxypilocarpine,CCC1(O)C(=O)OCC1CC1=CN=CN1C,,CYP2A6,0.82,Aliphatic Hydroxylation,0
pimozide,OC1=NC2=CC=CC=C2N1C1CCN(CCCC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1,,"1,3- dihydro-1-(4-piperidinyl)-2H-benzimidazol-2-one (DHPBI)",OC1=NC2=CC=CC=C2N1C1CCNCC1,,CYP1A2;CYP3A4,0.76,N-dealkylation,0
piroxicam,CN1C(C(O)=NC2=CC=CC=N2)=C(O)C2=CC=CC=C2S1(=O)=O,,5'-Hydroxypiroxicam,CN1C(C(O)=NC2=CC=C(O)C=N2)=C(O)C2=CC=CC=C2S1(=O)=O,,CYP2C9,0.98,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
pradefovir,NC1=NC=NC2=C1N=CN2CCOCP1(=O)OCCC(C2=CC=CC(Cl)=C2)O1,,PMEA,NC1=NC=NC2=C1N=CN2CCOCP(=O)(O)O,,CYP3A4,0.63,Oxidation,0
pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,,,CC(=O)C1C(O)CC2C3CC=C4CC(O)CCC4(C)C3CCC21C,,CYP2C19;CYP3A4,0.85,Aliphatic Hydroxylation,0
pregnenolone,CC(=O)C1CCC2C3CC=C4CC(O)CCC4(C)C3CCC12C,,,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C(=O)CO)CCC12,,CYP2C19;CYP2D6,0.96,Aliphatic Hydroxylation,0
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,2beta-OH-progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)C(O)CC4(C)C3CCC12C,,CYP3A4,0.73,Alpha hydroxylation of carbonyl group,0
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,16beta-OH-progesterone,CC(=O)C1C(O)CC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,CYP3A4; CYP1A1; CYP2D6; CYP2C19,0.77,Hydroxylation of alicyclic secondary carbon,0
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,17beta-OH-progesterone,CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,CYP2D4; CYP2D6; CYP2C19 ,0.71,Alpha hydroxylation of carbonyl group,0
progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,,21-OH-progesterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(C(=O)CO)CCC12,,CYP2C9,0.9,Alpha hydroxylation of carbonyl group,0
psoralen,O=C1C=CC2=CC3=C(C=C2O1)OC=C3,,,O=C1C=CC2=CC3=C(C=C2O1)OC1OC31,,CYP2A6,0.3,Epoxidation,0
Stearic Acid,CCCCCCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation,0
qttnoskslatgqb-uhfffaoysa-n,O=C(O)CCC1=C2CC3=C(CC(=O)O)C(CCC(=O)O)=C(CC4=C(CC(=O)O)C(CCC(=O)O)=C(CC5=C(CC(=O)O)C(CCC(=O)O)=C(CC(=C1CC(=O)O)N2)N5)N4)N3,,uroporphyrin,O=C(O)CCC1=C2CC3=C(CC(=O)O)C(CCC(=O)O)=C(N3)C(O)C3=C(CC(=O)O)C(CCC(=O)O)=C(CC4=C(CC(=O)O)C(CCC(=O)O)=C(CC(=C1CC(=O)O)N2)N4)N3,,CYP1A2;CYP2E1;CYP3A4,0.82,Aliphatic Hydroxylation,0
quetiapine,OCCOCCN1CCN(C2=NC3=CC=CC=C3SC3=CC=CC=C23)CC1,,,O=S1C2=CC=CC=C2N=C(N2CCN(CCOCCO)CC2)C2=CC=CC=C21,,CYP3A4,0.88,S-Oxidation,0
quetiapine,OCCOCCN1CCN(C2=NC3=CC=CC=C3SC3=CC=CC=C23)CC1,,,OCCOCCN1CCN(C2=NC3=CC=C(O)C=C3SC3=CC=CC=C23)CC1,,CYP2D6,0.93,Aromatic Hydroxylation,0
quinidine,C=CC1CN2CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,Quinidine-N-oxide,C=CC1C[N+]2([O-])CCC1CC2C(O)C1=CC=NC2=CC=C(OC)C=C12,,CYP3A4; CYP2C9; CYP2E1,0.88,Oxidation of nitrogen in a strained ring system,0
quinoline,C1=CC=C2N=CC=CC2=C1,,"Q-8,6-epoxide",C1=CC2OC2C2=CC=CN=C12,,CYP1A2;CYP2A6;CYP2D6;CYP2E1;,0.09,EPOXIDATION,0
quinoline,C1=CC=C2N=CC=CC2=C1,,Quinoline 1-oxide,[O-][N+]1=CC=CC2=CC=CC=C21,,CYP1A2;CYP2A6;CYP2E1;CYP3A4,0.69,N-OXIDATION,0
quinoline,C1=CC=C2N=CC=CC2=C1,,3OHQ,OC1=CN=C2C=CC=CC2=C1,,CYP1A2;CYP2A6;CYP2E1,0.62,AROMATIC HYDROXYLATION,0
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, N-Desmethyl",C1=CC=C2C(=C1)CC1=CC=CC=C1N1CCNCC21,,CYP2D6; CYP1A2; CYP3A4; CYP2B6,0.96,N-dealkylation of alicyclic tertiary amine,0
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, 8-hydroxy",CN1CCN2C3=CC(O)=CC=C3CC3=CC=CC=C3C2C1,,CYP2D6; CYP3A4,0.93,Aromatic hydroxylation of fused benzene ring,0
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, N-oxide",C[N+]1([O-])CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,CYP3A4,0.91,N-oxidation of alicyclic tertiary amine,0
raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=C(O)C(O)=CC=C12,,CYP2D6,0.92,Aromatic Hydroxylation,0
raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C(O)=C2)SC2=CC(O)=CC=C12,,CYP2D6,0.95,Aromatic Hydroxylation,0
ranitidine,CNC(=C[N+](=O)[O-])NCCSCC1=CC=C(CN(C)C)O1,,Desmethylranitidine,CNCC1=CC=C(CSCCNC(=C[N+](=O)[O-])NC)O1,,CYP2C19; CYP1A2; CYP2D6,0.96,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES,0
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,Dolasetron N-oxide,O=C(OC1CC2CC3CC(C1)[N+]2([O-])CC3O)C1=CNC2=CC=CC=C12,,CYP3A4,0.91,Oxidation of nitrogen in a strained ring system,0
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,6-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC(O)=CC=C12,,CYP2D6 (major); CYP3A4; CYP2C9,0.93,Aromatic hydroxylation of fused benzene ring,0
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,5-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=C(O)C=C12,,CYP2D6; CYP2C9,0.92,Aromatic hydroxylation of fused benzene ring,0
reduced_dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,7-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=C(O)C=CC=C12,,CYP2D6; CYP2C9,0.88,Aromatic hydroxylation of fused benzene ring,0
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.96,Aliphatic Hydroxylation,0
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)(C)O)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.95,Aliphatic Hydroxylation,0
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CC(C)CC(N=C(O)CC1=CC=C(C(=O)O)C(O)=C1)C1=CC=CC=C1N1CCCCC1,,CYP3A4,0.92,O-Demethylation,0
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.82,N-dealkylation,0
repaglinide,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCCC2)=CC=C1C(=O)O,,,CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2NCCCCO)=CC=C1C(=O)O,,CYP2C8;CYP3A4,0.92,N-dealkylation,0
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,All-trans-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,CYP1A1; CYP1A2; CYP3A4; CYP1B1,0.88,Oxidation of primary alcohol to aldehyde,0
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,4-Hydroxyretinol,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CCO,,CYP2C8,0.72,Aliphatic Hydroxylation,0
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,riddelliine N-Oxide,C=C1CC(=CC)C(=O)OC2CC[N+]3([O-])CC=C(COC(=O)C1(O)CO)C23,,CYP3A4,0.89,N-Oxidation,0
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23O,,CYP3A4,0.84,Aliphatic Hydroxylation,0
riddelliine,C=C1CC(=CC)C(=O)OC2CCN3CC=C(COC(=O)C1(O)CO)C23,,,C=C1CC(=CC)C(=O)OC2CCN3C(O)C=C(COC(=O)C1(O)CO)C23,,CYP3A4,0.91,Aliphatic Hydroxylation,0
rifabutin,COC1C=COC2(C)OC3=C(C)C(O)=C4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5C4=C3C2=O)CC(=O)C(C)=CC=CC(C)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,,COC1C=COC2(C)OC3=C(C)C(O)=C4C(=O)C(=C5NC6(CCN(CC(C)C)CC6)N=C5C4=C3C2=O)CC(=O)C(C)=CC=CC(C)(O)C(O)C(C)C(O)C(C)C(OC(C)=O)C1C,,CYP3A4,0.99,Aliphatic Hydroxylation,0
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,4-OH-riluzole,N=C1NC2=C(O)C=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.82,Aromatic hydroxylation of fused benzene ring,0
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,5-OH-riluzole,N=C1NC2=CC(O)=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.82,Aromatic hydroxylation of fused benzene ring,0
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,7-OH-riluzole,N=C1NC2=CC=C(OC(F)(F)F)C(O)=C2S1,,CYP1A2; CYP1A1,0.74,Aromatic hydroxylation of fused benzene ring,0
riluzole,N=C1NC2=CC=C(OC(F)(F)F)C=C2S1,,N-OH-riluzole,ONC1=NC2=CC=C(OC(F)(F)F)C=C2S1,,CYP1A1,0.66,N-hydroxylation of primary arylamine,0
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CC(O)CCC2=N1,,CYP2D6;CYP3A4,0.95,Aliphatic Hydroxylation,0
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCC(O)C2=N1,,CYP2D6,0.94,Aliphatic Hydroxylation,0
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=C4C=CC(F)=CC4=[O+]N3O)CC2)C(=O)N2CCCC(C)C2=N1,,CYP2D6,0.92,N-Hydroxylation,0
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,FC1=CC=C2C(C3CCNCC3)=NOC2=C1,,CYP3A4,0.51,N-Dealkylation,0
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CCC1=C(C)N=C2C(C)CCCN2C1=O,,CYP3A4,0.66,N-Dealkylation,0
ropinirole,CCCN(CCC)CCC1=CC=CC2=C1CC(O)=N2,,,CCCNCCC1=CC=CC2=C1CC(O)=N2,,CYP1A2;CYP3A4,0.96,N-Despropylation,0
ropinirole,CCCN(CCC)CCC1=CC=CC2=C1CC(O)=N2,,,CCCN(CCC)CCC1=CC=C(O)C2=C1CC(O)=N2,,CYP1A2;CYP3A4,0.79,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC(O)=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.97,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=C(O)C=CC=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.93,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=C(O)C=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.97,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC(O)=CC=C1N3,,CYP2C9;CYP2D6;CYP3A4,0.96,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC(O)=C1N3,,CYP1A2;CYP2C9;CYP2D6;CYP3A4,0.93,Aromatic Hydroxylation,0
rutaecarpine,O=C1C2=CC=CC=C2N=C2C3=C(CCN21)C1=CC=CC=C1N3,,,O=C1C2=CC=CC=C2N=C2C3=C(C4=CC=CC=C4N3)C(O)CN21,,CYP3A4,0.9,Aliphatic Hydroxylation,0
s-methyl diethylthiocarbamate,CCN(CC)C(=O)SC,,MeDTC sulfoxide,CCN(CC)C(=O)S(C)=O,,CYP3A4; CYP2A6; CYP2C9; CYP1A2; CYP2B6; CYP2E1; CYP2D6,0.64,S-oxidation of thiocarbamate,0
s-metolachlor,CCC1=CC=CC(C)=C1N(C(=O)CCl)C(C)COC,,,CCC1=CC=CC(C)=C1N(C(=O)CCl)C(C)CO,,CYP2B6;CYP3A4,0.94,O-demethylation,0
salicylic acid,O=C(O)C1=CC=CC=C1O,,5-hydroxylation,O=C(O)C1=CC(O)=CC=C1O,,CYP2E1;CYP3A4,0.79,Aromatic Hydroxylation,0
schembl12998564,COC1=CC=CC=C1N=C(O)C(=NNC1=CC=C([N+](=O)[O-])C=C1OC)C(C)=O,,py74-M1,COC1=CC(O)=CC=C1N=C(O)C(=NNC1=CC=C([N+](=O)[O-])C=C1OC)C(C)=O,,CYP3A4,0.95,Aromatic Hydroxylation,0
schembl14141926,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(CC(=O)S2)C1,,,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC=O)C1,,CYP2B6;CYP2C9;CYP2C19;CYP3A4,0.87,Unknown reaction,0
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCCC(O)CCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.95,Aliphatic Hydroxylation,0
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CCC(O)CCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.96,Aliphatic Hydroxylation,0
schembl14329530,CCCCCCOC1=CC=C2C=CC(=O)OC2=C1,,,CC(O)CCCCOC1=CC=C2C=CC(=O)OC2=C1,,CYP3A4,0.97,Aliphatic Hydroxylation,0
schembl149458,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,Sulphoridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,CYP2D6,0.92,S-REDUCTION,0
schembl17043265,CCC(C(=O)C1=CC=C(C)C=C1)N1CCCC1,,HO-MPBP,CCC(C(=O)C1=CC=C(CO)C=C1)N1CCCC1,,CYP1A2;CYP2C19;CYP2D6,0.94,Aliphatic Hydroxylation,0
schembl237672,CC[N+](C)(CC)CCC1=C(C)C2=CC=C(OC)C=C2OC1=O,,"AMHC (3-[2-(N,N-diethyl-Nmethylammonium)ethyl]-7-hydroxy-4-methylcoumarin)",CC[N+](C)(CC)CCC1=C(O)OC2=CC(=O)C=CC2=C1C,,CYP1A2;CYP2D6;CYP2B6,0.42,O-Demethylation,0
schembl29464,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,Oxazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.51,N-dementhylation,0
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,COC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1N,,CYP1A2;CYP3A4,0.98,N-dealkylation,0
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1O,,CYP1A2;CYP3A4,0.98,O-dealkylation,0
schembl3207291,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)=CN(C4=NC=CS4)C3=N2)CC1OC,,,CNC1CN(C2=CC=C3C(=O)C(C(=O)O)CN(C4=NC=CS4)C3=N2)CC1OC,,CYP1A2;CYP2D6;CYP3A4,0.62,Hydrogenation,0
schembl4023988,COC(OC)C1(C)OC2=CC=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,hydroxy-KR-31543,CN1N=NC(CNC2=CC=C(Cl)C=C2)=N1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.21,N-Demethylation,0
schembl4023988,COC(OC)C1(C)OC2=CC=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,N-(4-chlorophenyl)-N-(2-methyl-2H-tetrazol-5-ylmethyl)amine,COC(OC)C1(C)OC2=CC(O)=C(N)C=C2C(N(CC2=NN(C)N=N2)C2=CC=C(Cl)C=C2)C1O,,CYP3A4,0.97,Aromatic Hydroxylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,DA-8164,CCCOC1=CC=C(S(N)(=O)=O)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,CYP3A4,0.93,N-Dealkylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,N-Demethyl-DA-8159,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(CCC)NN=C2C(=O)N1,,CYP3A4,0.93,N-Demethylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2C(O)CC,,CYP3A4,0.95,Aliphatic Hydroxylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CC(C)O,,CYP3A4,0.97,Aliphatic Hydroxylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCCO,,CYP3A4,0.99,Aliphatic Hydroxylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)NCCC3CCCN3C)=CC=C1OC(O)CC)NC2=O,,CYP3A4,0.98,Aliphatic Hydroxylation,0
schembl69463,CCCOC1=CC=C(S(=O)(=O)NCCC2CCCN2C)C=C1C1=NC2=C(C(=O)N1)N(C)N=C2CCC,,Hydroxy-DA-8164,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)NCCC3CCCN3C)=CC=C1OCC(C)O)NC2=O,,CYP3A4,0.99,Aliphatic Hydroxylation,0
schembl7562446,CC(C)(C)C1=CC(CC2SCN=C2O)=CC(C(C)(C)C)=C1O,,,CC(C)(C)C1=CC(CC2C(O)=NCS2=O)=CC(C(C)(C)C)=C1O,,CYP3A4,0.84,S-Oxidation,0
schembl895799,CC(C#CC1=CC=C(CC2=CC=CC=C2)S1)NC(=N)O,,ABT-438 Hydroxy,CC(C#CC1=CC=C(C(O)C2=CC=CC=C2)S1)NC(=N)O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4;CYP2E1,0.79,Aliphatic Hydroxylation,0
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,M28,O=C1N=C(O)C(O)(CC2=CC=C(C(O)=NCC3=CC=C(C(F)(F)F)C=C3)C(O)=C2)S1,,CYP2C9;CYP2C19,0.79,O-Demethylation,0
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,M24,COC1=CC(CC2(O)SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,CYP3A4,0.84,Aliphatic Hydroxylation,0
schembl896413,COC1=CC(CC2SC(=O)N=C2O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,,COC1=CC(CC2C(O)=NC(=O)S2=O)=CC=C1C(O)=NCC1=CC=C(C(F)(F)F)C=C1,,CYP3A4,0.88,S-Oxidation,0
schembl9652240,CC1SC(C2=CC=CN=C2)N(C)C1=O,,,CC1C(=O)N(C)C(C2=CC=CN=C2)S1=O,,CYP2A6,0.79,S-Oxidation,0
selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,,Desmethylselegiline,C#CCNC(C)CC1=CC=CC=C1,,CYP2B6 (major); CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4,0.83,N-dealkylation of acyclic tertiary amine,0
serotonin,NCCC1=CNC2=CC=C(O)C=C12,,,CCC1=CNC2=CC=C(O)C=C12,,CYP2B6 (major); CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4,0.92,Unknown Reduction,0
sertindole,OC1=NCCN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,,OC1=NC(O)CN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,CYP2D6,0.94,Aliphatic Hydroxylation,0
sertindole,OC1=NCCN1CCN1CCC(C2=CN(C3=CC=C(F)C=C3)C3=CC=C(Cl)C=C23)CC1,,,FC1=CC=C(N2C=C(C3CCNCC3)C3=CC(Cl)=CC=C32)C=C1,,CYP2D6,0.88,N-dealkylation,0
sertraline,CNC1CCC(C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C21,,N-desmethylsertraline,NC1CCC(C2=CC=C(Cl)C(Cl)=C2)C2=CC=CC=C21,,CYP1A2;CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.91,N-desmethylation,0
sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC(S(=O)(=O)N3CCN(C)CC3)=CC=C1OCC)NC2=O,,N-Desmethyl sildenafil,CCCC1=NN(C)C2=C1N=C(C1=CC([SH](=O)=O)=CC=C1OCC)NC2=O,,CYP3A4; CYP2C9; CYP2C19; CYP2D6,0.9,N-dealkylation of sulfonamide,0
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'-ÃŽÂ²-Hydroxysimvastatin ,CCC(C)(C)C(=O)OC1CC(C)(O)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4; CYP3A5,0.91,Allylic hydroxylation,0
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,"3', 5'-Dihydrodiol",CCC(C)(C)C(=O)OC1CC(C)C(O)C2=CC(O)C(C)C(CCC3CC(O)CC(=O)O3)C21,,CYP3A4; CYP3A5,0.75,"Aliphatic hydroxylation of acyclic 1,2-disubstituted alkene",0
simvastatin,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C21,,6'-exomethylene,C=C1C=C2C=CC(C)C(CCC3CC(O)CC(=O)O3)C2C(OC(=O)C(C)(C)CC)C1,,CYP3A4; CYP3A5,0.93,Terminal desaturation,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,16-O-Desmethylsirolimus,COC1CC(CC(C)C2CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C(C)C(O)CC3CCC(C)C(O)(O3)C(=O)C(=O)N3CCCCC3C(=O)O2)CCC1O,,CYP3A4,0.98,O-dealkylation of dialkylether,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,12-OH-sirolimus,COC1CC2CC(O)C(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CYP3A4,0.97,Hydroxylation of heteroalicyclic secondary carbon,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,11-OH-sirolimus,COC1CC2CCC(C)(O)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,CYP3A4,0.93,Hydroxylation of alkyl methine,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,25-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)(O)CC(C)C=CC=CC=C1C,,CYP3A4,0.97,Hydroxylation of alkyl methine,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,24-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)C(O)C(C)C=CC=CC=C1C,,CYP3A4,0.98,Hydroxylation of heteroalicyclic secondary carbon,0
sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(C)CC(C)C=CC=CC=C1C,,46-OH-sirolimus,COC1CC2CCC(C)C(O)(O2)C(=O)C(=O)N2CCCCC2C(=O)OC(C(C)CC2CCC(O)C(OC)C2)CC(=O)C(C)C=C(C)C(O)C(OC)C(=O)C(CO)CC(C)C=CC=CC=C1C,,CYP3A4,0.99,Hydroxylation of terminal methyl,0
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC12CCCCN1CC1CC2CN2CCCCC12,,CYP2D6,0.53,Aliphatic Hydroxylation,0
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC1CCCC2C3CC(CN12)C1CCCCN1C3,,CYP2D6,0.71,Aliphatic Hydroxylation,0
sparteine,C1CCN2CC3CC(CN4CCCCC34)C2C1,,,OC1CCCN2CC3CC(CN4CCCCC34)C12,,CYP2D6,0.65,Aliphatic Hydroxylation,0
styrene,C=CC1=CC=CC=C1,,"Styrene 7,8-oxide",C1=CC=C(C2CO2)C=C1,,CYP2E1,0.23,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
sulfadiazine,NC1=CC=C(S(=O)(=O)NC2=NC=CC=N2)C=C1,,,O=S(=O)(NC1=NC=CC=N1)C1=CC=C(NO)C=C1,,CYP2B6;CYP2C8;CYP2C9;CYP2C19,0.93,Hydroxylation,0
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,N4-hydroxylamine,N=C1C2=C(CCCC2O)NC2=CC=CC=C12,,CYP1A2,0.82,Hydroxylation of alicyclic secondary carbon,0
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,4- Hydroxytacrine,NC1=C2CCCC(O)C2=NC2=CC=CC=C12,,CYP1A2,0.57,Hydroxylation of alicyclic secondary carbon,0
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,2-Hydroxytacrine,N=C1C2=C(CCC(O)C2)NC2=CC=CC=C12,,CYP1A2,0.88,Hydroxylation of alicyclic secondary carbon,0
tacrine,N=C1C2=C(CCCC2)NC2=CC=CC=C12,,7-Hydroxytacrine,NC1=C2CCCCC2=NC2=C(O)C=CC=C12,,CYP1A2,0.58,Aromatic hydroxylation of fused benzene ring,0
tamarixetin,COC1=CC=C(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,QUERCETIN,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2C9;CYP3A4,0.97,O-dealkylation,0
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,4'-Hydroxytamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(O)C=C1,,CYP2D6; CYP2B6,0.99,p-Hydroxylation of monosubstituted benzene,0
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,alpha-Hydroxytamoxifen,CC(O)C(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,CYP3A4; CYP2D6; CYP2B6 (give smaller amounts of ÃŽÂ±-hydroxylation); CYP2C9  (give smaller amounts of ÃŽÂ±-hydroxylation); CYP2C19 (give smaller amounts of ÃŽÂ±-hydroxylation); CYP3A5 (give smaller amounts of ÃŽÂ±-hydroxylation),0.86,Hydroxylation of penultimate aliphatic secondary carbon,0
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,3-Hydroxytamoxifen,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC(O)=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5; CYP2B6,0.89,m-Hydroxylation of monosubstituted benzene,0
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,CCOC1=CC=C(O)C=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,CYP2D6,0.95,Aromatic Hydroxylation,0
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(O)C(S(N)(=O)=O)=C1,,CYP2D6,0.94,O-Dementhylation,0
tamsulosin,CCOC1=CC=CC=C1OCCNC(C)CC1=CC=C(OC)C(S(N)(=O)=O)=C1,,,COC1=CC=C(CC(C)NCCOC2=CC=CC=C2O)C=C1S(N)(=O)=O,,CYP3A4,0.99,O-dealkylation,0
tangeretin,COC1=CC=C(C2=CC(=O)C3=C(OC)C(OC)=C(OC)C(OC)=C3O2)C=C1,,,COC1=CC=C(C2=CC(=O)C3=C(O)C(O)=C(OC)C(OC)=C3O2)C=C1,,CYP3A4,0.96,O-dealkylation,0
tauromustine,CN(C)S(=O)(=O)CCN=C(O)N(CCCl)N=O,,,CNS(=O)(=O)CCN=C(O)N(CCCl)N=O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.94,N-Dealkylation,0
tauromustine,CN(C)S(=O)(=O)CCN=C(O)N(CCCl)N=O,,,CN(C)S(=O)(=O)CCNC(O)=NCCCl,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.47,Denitrosation,0
taxol,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,6ÃŽÂ±-Hydroxypaclitaxel ,CC(=O)OC1C(=O)C2(C)C(O)C(O)C3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,CYP2C8,0.99,Hydroxylation of alicyclic secondary carbon,0
taxol,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=CC=C3)C(C)=C1C2(C)C,,3Ã¢â‚¬Â²-pHydroxypaclitaxel ,CC(=O)OC1C(=O)C2(C)C(O)CC3OCC3(OC(C)=O)C2C(OC(=O)C2=CC=CC=C2)C2(O)CC(OC(=O)C(O)C(N=C(O)C3=CC=CC=C3)C3=CC=C(O)C=C3)C(C)=C1C2(C)C,,CYP3A4 ,0.98,p-Hydroxylation of monosubstituted benzene,0
tecalcet,COC1=CC=CC(C(C)NCCCC2=CC=CC=C2Cl)=C1,,,CC(NCCCC1=CC=CC=C1Cl)C1=CC=CC(O)=C1,,CYP2D6,0.88,O-Dementhylation,0
tegaserod,CCCCCNC(=N)NN=CC1=CNC2=CC=C(OC)C=C12,,,CCCCCNC(=N)NN=CC1=CNC2=CC=C(O)C=C12,,CYP1A2;CYP2D6,0.93,O-desmethylation,0
tenoxicam,CN1C(=C(O)NC2=CC=CC=N2)C(=O)C2=C(C=CS2)S1(=O)=O,,5'-Hydroxytenoxicam,CN1C(=C(O)NC2=CC=C(O)C=N2)C(=O)C2=C(C=CS2)S1(=O)=O,,CYP2C9,0.98,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
tentoxin,CC(C)CC1N=C(O)C(C)N(C)C(=O)CN=C(O)C(=CC2=CC=CC=C2)N(C)C1=O,,,CC(C)CC1N=C(O)C(C)N(C)C(=O)CN=C(O)C(=CC2=CC=CC=C2)N=C1O,,CYP3A4,0.58,N-Dementhylation,0
territrem a,COC1=CC(C2=CC3=C(CC4(O)C(C)(CCC5(O)C(C)(C)C=CC(=O)C54C)O3)C(=O)O2)=CC2=C1OCO2,,,COC1=CC(C2=CC3=C(CC4(O)C(C)(CCC5(O)C(C)(CO)C=CC(=O)C54C)O3)C(=O)O2)=CC2=C1OCO2,,CYP2C9;CYP2D6;CYP3A4,0.99,Aliphatic Hydroxylation,0
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,2ÃŽÂ±-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,CYP3A4 ,0.82,Alpha hydroxylation of carbonyl group,0
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,15ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon,0
testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,16ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,CYP3A4; CYP2B6 ,0.92,Hydroxylation of alicyclic secondary carbon,0
tetradecanoic acid,CCCCCCCCCCCCCC(=O)O,,,CC(O)CCCCCCCCCCCC(=O)O,,CYP2E1;CYP4A11,0.84,Aliphatic Hydroxylation,0
tetranor-(+)-s-145,O=C(O)CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCC1C2CC(O)C(C2)C1NS(=O)(=O)C1=CC=CC=C1,,CYP2C9,0.83,Aliphatic Hydroxylation,0
tetranor-(+)-s-145,O=C(O)CCC1C2CCC(C2)C1NS(=O)(=O)C1=CC=CC=C1,,,O=C(O)CCC1C2CC(CC2O)C1NS(=O)(=O)C1=CC=CC=C1,,CYP3A4,0.87,Aliphatic Hydroxylation,0
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C=NC2=NC(O)=NC(O)=C21,,CYP1A2;CYP2E1,0.57,N-demethylation,0
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C(=O)N=C(O)C2=C1NC=N2,,CYP2E1,0.87,N-demethylation,0
theobromine,CN1C=NC2=C1C(O)=NC(=O)N2C,,,CN1C(O)=NC2=C1C(O)=NC(=O)N2C,,CYP2E1,0.86,Aliphatic Hydroxylation,0
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,"1,3-Dimethyluric acid",CN1C(=O)C2=C(NC(O)=N2)N(C)C1=O,,CYP1A2; CYP1A1 ,0.87,HYDROXYLATION_OF_HETEROAROMATIC_CARBON; HYDROXYLATION_OF_AROMATIC_CARBON_ADJACENT_TO_N,0
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,1-Methylxanthine ,CN1C(O)=NC2=C(N=CN2)C1=O,,CYP1A2,0.58,N-dealkylation of N-acylurea,0
theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,3-Methylxanthine ,CN1C(=O)N=C(O)C2=C1NC=N2,,CYP1A2,0.57,N-dealkylation of N-acylurea,0
thiabendazole,C1=CC=C2NC(C3=CSC=N3)=NC2=C1,,5-hydroxythiabendazole ,OC1=CC=C2N=C(C3=CSC=N3)NC2=C1,,CYP1A2,0.82,Aromatic hydroxylation of fused benzene ring,0
ticrynafen,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl,,Tienilic acid-s-oxide,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2=O)C(Cl)=C1Cl,,CYP2C8; CYP2C9 (major),0.48,Thiohene S-oxidation,0
ticrynafen,O=C(O)COC1=CC=C(C(=O)C2=CC=CS2)C(Cl)=C1Cl,,"Thiophene-4,5-epoxide",O=C(O)COC1=CC=C(C(=O)C2=CC3OC3S2)C(Cl)=C1Cl,,CYP2C8; CYP2C9 (major); CYP2C18; CYP2C19,0.47,Epoxidation of thiophene,0
timolol,CC(C)(C)NCC(O)COC1=NSN=C1N1CCOCC1,,,CC(C)(C)NCC(O)COC1=NSN=C1N1CCOC(O)C1,,CYP2D6,0.92,Aliphatic Hydroxylation,0
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,CYP3A4,0.9,Aliphatic Hydroxylation,0
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCC(O)C3)=N2)CC1,,CYP3A4,0.95,Aliphatic Hydroxylation,0
tirilazad,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCCC3)=NC(N3CCCC3)=N2)CC1,,,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3=CCC2(C)C1C(=O)CN1CCN(C2=CC(N3CCC(O)C3)=NC(N3CCCC3)=N2)CC1,,CYP3A4,0.94,Aliphatic Hydroxylation,0
tolbutamide,CCCCN=C(O)NS(=O)(=O)C1=CC=C(C)C=C1,,4-Hydroxytolbutamide,CCCCN=C(O)NS(=O)(=O)C1=CC=C(CO)C=C1,,CYP2C9; CYP2C19,0.94,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
tolterodine,CC1=CC=C(O)C(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C1,,N-Dealkylated tolterodine,CC1=CC=C(O)C(C(CCNC(C)C)C2=CC=CC=C2)=C1,,CYP3A4 (major); CYP2C9 (minor); CYP2C19 (minor),0.95,N-deisopropylation,0
tolterodine,CC1=CC=C(O)C(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C1,,5-Hydroxymethyl tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=CC(CO)=CC=C1O)C(C)C,,CYP2D6,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
tozasertib,CC1=CC(=NC2=CC(N3CCN(C)CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,,CC1=CC(=NC2=CC(N3CC[N+](C)([O-])CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,CYP3A4,0.96,N-Oxidation,0
tozasertib,CC1=CC(=NC2=CC(N3CCN(C)CC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,,CC1=CC(=NC2=CC(N3CCNCC3)=NC(SC3=CC=C(NC(=O)C4CC4)C=C3)=N2)NN1,,CYP2C8;CYP3A4,0.98,N-demethylation,0
tpa-023,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)C,,,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)CO,,CYP3A4,0.97,Aliphatic Hydroxylation,0
tpa-023,CCN1N=CN=C1COC1=NN2C(C3=CC=CC=C3F)=NN=C2C=C1C(C)(C)C,,,CC(C)(C)C1=CC2=NN=C(C3=CC=CC=C3F)N2N=C1OCC1=NNC=N1,,CYP3A4,0.94,N-demethylation,0
tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,,N-desmethyltramadol,CNCC1CCCCC1(O)C1=CC=CC(OC)=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.97,N-demethylation,0
tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,,O-desmethyl-tramadol,CN(C)CC1CCCCC1(O)C1=CC=CC(O)=C1,,CYP1A2;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.93,O-demethylation,0
traxoprodil,CC(C(O)C1=CC=C(O)C=C1)N1CCC(O)(C2=CC=CC=C2)CC1,,,CC(C(O)C1=CC=C(O)C(O)=C1)N1CCC(O)(C2=CC=CC=C2)CC1,,CYP2D6,0.88,Aromatic Hydroxylation,0
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,m-CPP,ClC1=CC=CC(N2CCNCC2)=C1,,CYP3A4,0.28,N-dealkylation of alicyclic tertiary amine,0
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,p-Hydroxytrazodone,O=C1N(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)N=C2C=CC=CN12,,CYP3A4,0.95,Hydroxylation of aromatic carbon ortho to halide group,0
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,Trazodone epoxide,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C3OC3C=CN21,,CYP3A4,0.47,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,,OCC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,CYP3A4,0.94,Aliphatic Hydroxylation,0
triazolam,CC1=NN=C2CN=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,,CC1=NN=C2C(O)N=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N12,,CYP3A4,0.89,Aliphatic Hydroxylation,0
trihydroxycoprostane,CC(C)CCCC(C)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCCC(C)(C)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,CYP2B6;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation,0
trimethadione,CN1C(=O)OC(C)(C)C1=O,,,CC1(C)OC(=O)N=C1O,,CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.17,N-demethylation,0
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=C(O)C=C13)C2,,CYP2D6,0.91,Aromatic Hydroxylation,0
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,CN1C2CCC1CC(OC(=O)C1=CNC3=CC(O)=CC=C13)C2,,CYP2D6,0.92,Aromatic Hydroxylation,0
tropisetron,CN1C2CCC1CC(OC(=O)C1=CNC3=CC=CC=C13)C2,,,O=C(OC1CC2CCC(C1)N2)C1=CNC2=CC=CC=C12,,CYP3A4,0.95,N-demethylation,0
tyramine,NCCC1=CC=C(O)C=C1,,,NCCC1=CC=C(O)C(O)=C1,,CYP2D6,0.68,Aromatic Hydroxylation,0
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3CCCNC3=N2)C1=O,,CYP2D6,0.97,O-Demethylation,0
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3CCC(O)NC3=N2)C1=O,,CYP2D6;CYP3A4,0.92,Aromatic Hydroxylation,0
MK-429,COC1=CC=C(C(CC(=O)O)N2CCN(CCCC3=CC=C4CCCNC4=N3)C2=O)C=N1,,,O=C(O)CC(C1=CC=C(O)N=C1)N1CCN(CCCC2=CC=C3C(=N2)NCCC3O)C1=O,,CYP2D6;CYP3A4,0.91,Aromatic Hydroxylation,0
(R)-(+)-Rebamipide,O=C(NC(CC1=CC(O)=NC2=CC=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,8-Hydroxyrebamipide,O=C(NC(CC1=CC(O)=NC2=C(O)C=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,CYP3A4,0.9,Aromatic Hydroxylation,0
(R)-(+)-Rebamipide,O=C(NC(CC1=CC(O)=NC2=CC=CC=C12)C(=O)O)C1=CC=C(Cl)C=C1,,6-Hydroxyrebamipide,O=C(NC(CC1=CC(O)=NC2=CC=C(O)C=C12)C(=O)O)C1=CC=C(Cl)C=C1,,CYP3A4,0.93,Aromatic Hydroxylation,0
"p-Methoxymethamphetamine, R-(-)-",CNC(C)CC1=CC=C(OC)C=C1,,HO-MA,CNC(C)CC1=CC=C(O)C=C1,,CYP2D6,0.86,O-Demethylation,0
(S)-Methylenedioxyethylamphetamine,CCNC(C)CC1=CC=C2OCOC2=C1,,"3,4-methylenedioxyamphetamine",CC(N)CC1=CC=C2OCOC2=C1,,CYP1A2;CYP2B6;CYP3A4,0.92,N-Dealylation,0
(S)-Methylenedioxyethylamphetamine,CCNC(C)CC1=CC=C2OCOC2=C1,,"N-methyl-3,4-methylenedioxyamphetamine",CCNC(C)CC1=CC=C(O)C(O)=C1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2E1;CYP3A4,0.7,Demethylenation,0
unii-3es85mm31y,CCCOC1=CC=C(S(=O)(=O)N2CCN(CC)CC2)C=C1C1=NC2=C(CC)N(CC3=CC=CC=N3)N=C2C(=O)N1,,,CCCOC1=CC=C(S(=O)(=O)N2CCNCC2)C=C1C1=NC2=C(CC)N(CC3=CC=CC=N3)N=C2C(=O)N1,,CYP3A4,0.99,N-dealkylation,0
Fenproporex,CC(CC1=CC=CC=C1)NCCC#N,,amphetamine,CC(N)CC1=CC=CC=C1,,CYP1A2;CYP2B6;CYP2D6;CYP3A4,0.64,N-dealkylation,0
RPR-106541,CCCC1OC2CC3C4CC(F)C5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(SC)O1,,,CCCC1OC2CC3C4CC(F)C5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)C2(S(C)=O)O1,,CYP3A4;CYP3A5,0.91,S-Oxidation,0
"Desmethylsibutramine, (S)-",CNC(CC(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine,CC(C)CC(N)C1(C2=CC=C(Cl)C=C2)CCC1,,CYP2B6,0.86,N-demethylation,0
"4'-Methoxy-alpha-pyrrolidinopropiophenone, (S)-",COC1=CC=C(C(=O)C(C)N2CCCC2)C=C1,,,CC(C(=O)C1=CC=C(O)C=C1)N1CCCC1,,CYP2C19;CYP2D6,0.93,O-demethylation,0
unii-s5969b6237 component anucdxcticzjrh-zmzpimszsa-n,CC1COC2(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C(O)CN12,,,CC1(O)COC2(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C(O)CN12,,CYP3A4,0.92,Aliphatic Hydroxylation,0
(S)-Sibutramine,CC(C)CC(N(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,,CNC(CC(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,CYP2B6;CYP2C19;CYP3A4,0.92,N-demethylation,0
CP-195543,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1)C2O,,M1 and M2,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(C(O)C1=CC=CC=C1)C2O,,CYP3A4 ,0.99,Aliphatic Hydroxylation,0
CP-195543,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1)C2O,,M3,O=C(O)C1=CC=C(C(F)(F)F)C=C1C1=CC=C2C(=C1)OCC(CC1=CC=CC=C1O)C2O,,CYP3A4 ,0.99,Aromatic Hydroxylation,0
(R)-Bunitrolol,CC(C)(C)NCC(O)COC1=CC=CC=C1C#N,,,CC(C)(C)NCC(O)COC1=CC=C(O)C=C1C#N,,CYP2D6,0.89,Aromatic Hydroxylation,0
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCC(O)C3)=C2)C=N1,,CYP2C9;CYP3A4;,0.98,Aliphatic Hydroxylation,0
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,CCNC1=C2N=C(C(C)(C)O)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,CYP2C9;CYP3A4;,0.95,Aliphatic Hydroxylation,0
v11294,CCNC1=C2N=C(C(C)C)N=C2N(CC2=CC=C(OC)C(OC3CCCC3)=C2)C=N1,,,COC1=CC=C(CN2C=NC(N)=C3N=C(C(C)C)N=C32)C=C1OC1CCCC1,,CYP2C9;CYP2C19;CYP2D6;CYP3A4;,0.93,N-desethylation,0
vanoxerine,FC1=CC=C(C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C2=CC=C(F)C=C2)C=C1,,,OC1=CC=C(CCCN2CCN(CCOC(C3=CC=C(F)C=C3)C3=CC=C(F)C=C3)CC2)C=C1,,CYP2D6,0.92,Aromatic Hydroxylation,0
vanoxerine,FC1=CC=C(C(OCCN2CCN(CCCC3=CC=CC=C3)CC2)C2=CC=C(F)C=C2)C=C1,,,OC(CCN1CCN(CCOC(C2=CC=C(F)C=C2)C2=CC=C(F)C=C2)CC1)C1=CC=CC=C1,,CYP2D6,0.9,Aromatic Hydroxylation,0
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,N-Desalkylvicriviroc ,CC1=NC=NC(C)=C1C(=O)N1CCC(C)(N2CCNC(C)C2)CC1,,CYP3A4; CYP3A5,0.69,N-dealkylation of alicyclic tertiary amine,0
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,O-Desmethylvicriviroc ,CC1=NC=NC(C)=C1C(=O)N1CCC(C)(N2CCN(C(CO)C3=CC=C(C(F)(F)F)C=C3)C(C)C2)CC1,,CYP2C9; CYP3A4; CYP3A5,0.97,O-dealkylation of dialkylether,0
vicriviroc,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=CN=C3C)CC2)CC1C,,Vicriviroc N-oxide ,COCC(C1=CC=C(C(F)(F)F)C=C1)N1CCN(C2(C)CCN(C(=O)C3=C(C)N=C[N+]([O-])=C3C)CC2)CC1C,,CYP3A4; CYP3A5,0.88,N-oxidation of pyrimidine,0
vitamin_d2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)(O)C(C)C,,CYP3A4,0.9,Aliphatic Hydroxylation,0
voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,Hydroxymethyl Voriconazole,OCC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,CYP3A4,0.96,Hydroxylation of terminal methyl,0
voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,Voriconazole N-Oxide,CC(C1=NC=[N+]([O-])C=C1F)C(O)(CN1C=NC=N1)C1=CC=C(F)C=C1F,,CYP2C9 (major); CYP2C19 (major); CYP3A4 (minor),0.96,N-oxidation of pyrimidine,0
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,10-Hydroxywarfarin,CC(=O)C(O)C(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP3A4,0.9,Alpha hydroxylation of carbonyl group,0
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=C(O)C=C2C1=O,,CYP1A2; CYP1A1; CYP2C19,0.95,Aromatic hydroxylation of fused benzene ring,0
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=C(O)C=CC=C2C1=O,,CYP1A2; CYP1A1; CYP2C19,0.9,HYDROXYLATION_OF_AROMATIC_CARBON,0
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,#NAME?,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC(O)=CC=C2C1=O,,CYP1A2; CYP1A1; CYP2C8,0.96,Aromatic hydroxylation of fused benzene ring,0
warfarin-r,CC(=O)CC(C1=CC=CC=C1)C1=C(O)OC2=CC=CC=C2C1=O,,4'- Hydroxywarfarin,CC(=O)CC(C1=CC=C(O)C=C1)C1=C(O)OC2=CC=CC=C2C1=O,,CYP2C9; CYP2C18,0.98,p-Hydroxylation of monosubstituted benzene,0
7-Ethoxy-4-trifluoromethylcoumarin,CCOC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,7-Hydroxy-4-trifluoromethylcourmarin,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2; CYP2B6; CYP2E1; CYP2C9; CYP2C19,0.91,O-aryl dealkylation not adjacent to substituted carbon,0
7-methoxy-4-trifluoromethylcoumarin,COC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,7-Hydroxy-4-(trifluoromethyl)chromen-2-one,O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2A6;CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP2E1,0.93,O-Demethylation ,0
7-Benzyloxyresorufin,O=C1C=CC2=NC3=CC=C(OCC4=CC=CC=C4)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2; CYP1B1,0.88,O-aryl dealkylation not adjacent to substituted carbon,0
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,,ON1C2=CC=C3C=CC=CC3=C2C=C2C3=CC=CC=C3C=CC21,,CYP1A2;CYP3A4,0.11,N-Oxidation,0
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,,O=C1C2=C(C=CC3=CC=CC=C23)N=C2C=CC3=CC=CC=C3C12,,CYP1A2;CYP3A4,0.09,Aromatic Oxidation ,0
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"3,4-DHD",OC1=CC=C2C(=C1O)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,CYP1A2;CYP3A4,0.68,Aromatic Hydroxylation,0
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"1,2-DHD",OC1=CC=C2C=CC3=NC4=CC=C5C=CC=CC5=C4C=C3C2=C1O,,CYP1A2;CYP3A4,0.62,Aromatic Hydroxylation,0
"Dibenz[a,j]acridine",C1=CC=C2C(=C1)C=CC1=NC3=CC=C4C=CC=CC4=C3C=C12,,"5,6-DHD",OC1=C(O)C2=NC3=CC=C4C=CC=CC4=C3C=C2C2=CC=CC=C12,,CYP1A2;CYP3A4,0.5,Aromatic Hydroxylation,0
"Methyl N,N-diethyldithiocarbamate",CCN(CC)C(=S)SC,,MeDDC sulfine ,CCN(CC)C(SC)=S=O,,CYP1A2; CYP2A6; CYP2B6; CYP2E1; CYP3A4; CYP3A5,0.7,S-oxidation of dithiocarbamate,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C(O)=C(O)C1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.47,Aromatic Hydroxylation,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC3=CC=CC=C3C2=C(C)C2=CC=C(O)C(O)=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.47,Aromatic Hydroxylation,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=C(O)C(O)=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.59,Aromatic Hydroxylation,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=C(O)C=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.73,Aromatic Hydroxylation,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(CO)C2=CC=C3C=CC=CC3=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.74,Aliphatic Hydroxylation,0
"7,12 Dimethylbenzanthracene",CC1=C2C=CC=CC2=C(C)C2=C1C=CC1=CC=CC=C12,,,CC1=C2C=CC=CC2=C(CO)C2=C1C=CC1=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2E1;CYP3A4,0.74,Aliphatic Hydroxylation,0
DMXAA,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)O)=C3OC2=C1C,,6-Hydroxy-MXAA,CC1=C(CO)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,CYP1A2,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
4-(Aminomethyl)-7-methoxycoumarin,COC1=CC=C2C(CN)=CC(=O)OC2=C1,,7-hydroxy-4-(aminomethyl)-coumarin (HAMC),NCC1=CC(=O)OC2=CC(O)=CC=C12,,CYP1A2;CYP2C19;CYP2D6,0.93,N-Dealkylation,0
NNK,CN(CCCC(=O)C1=CC=CN=C1)N=O,,,O=NN(CO)CCCC(=O)C1=CC=CN=C1,,CYP1A1; CYP1A2; CYP1B1; CYP2A6; CYP2B6; CYP2D6; CYP2E1,0.92,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,"N,N-diethyl-m-hydroxymethylbenzamide",CCN(CC)C(=O)C1=CC=CC(CO)=C1,,CYP1A2; CYP2B6; CYP2D6; CYP2E1,0.87,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,,CCN(CCO)C(=O)C1=CC=CC(C)=C1,,CYP2A6; CYP2C19; CYP3A4; CYP3A5,0.88,Hydroxylation of terminal methyl,0
"dibenzo(a,h)anthracene",C1=CC=C2C(=C1)C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C12,,"dibenzo(a,h)anthracene 1,2-epoxide",C1=CC2OC2C2=C1C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C21,,CYP1A1; CYP1A2,0.08,ARENE_EPOXIDATION,0
"dibenzo(a,h)anthracene",C1=CC=C2C(=C1)C=CC1=CC3=C(C=CC4=CC=CC=C43)C=C12,,"dibenzo(a,h)anthracene 3,4-epoxide",C1=CC2=CC=C3C=C4C5=C(C=CC4=CC3=C2CC1)C1OC1C=C5,,CYP1A2 (major); CYP2B6 (minor); CYP2C9 (major),0.08,ARENE_EPOXIDATION,0
Alvameline,CCN1N=NC(C2=CCCN(C)C2)=N1,,,CCN1N=NC(C2=CCCNC2)=N1,,CYP1A2;CYP2A6;CYP2C19;CYP3A4,0.92,N-demethylation,0
Alvameline,CCN1N=NC(C2=CCCN(C)C2)=N1,,,CCN1N=NC(C2=CCC[N+](C)([O-])C2)=N1,,CYP1A2;CYP2C19,0.84,N-Oxidation,0
Alvameline,CCN1N=NC(C2=CCCN(C)C2)=N1,,,CN1CCC=C(C2=NNN=N2)C1,,CYP2D6,0.67,N-demethylation,0
Alvameline,CCN1N=NC(C2=CCCN(C)C2)=N1,,,CCN1N=NC(C2=CCC=[N+](C)C2)=N1,,CYP1A2;CYP2A6;CYP2C19;CYP3A4,0.7,Hydrogenation,0
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,CYP1A2,0.73,O-deethylation,0
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,,COC1=CC=C(N=CO)C=C1,,CYP1A2,0.7,C-DEALYLATION,0
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,"p-Methoxyacetanilide, O-demethyl-",CC(O)=NC1=CC=C(O)C=C1,,CYP1A2,0.85,O-aryl dealkylation not adjacent to substituted carbon,0
Terbutryn,CCN=C1N=C(NC(C)(C)C)NC(SC)=N1,,,CCN=C1N=C(NC(C)(C)C)NC(S(C)=O)=N1,,CYP1A2;CYP2B6;CYP3A4,0.83,S-Oxidation,0
Terbutryn,CCN=C1N=C(NC(C)(C)C)NC(SC)=N1,,,CSC1=NC(=NC(C)O)N=C(NC(C)(C)C)N1,,CYP1A2;CYP2B6;CYP3A4,0.91,Aliphatic Hydroxylation,0
Terbutryn,CCN=C1N=C(NC(C)(C)C)NC(SC)=N1,,,CCN=C1N=C(NC(C)(C)CO)NC(SC)=N1,,CYP1A2,0.93,Aliphatic Hydroxylation,0
MNAN,CCCCCN(C)N=O,,,CCCCCN(CO)N=O,,CYP2A6;CYP2E1,0.69,Aliphatic Hydroxylation,0
MNAN,CCCCCN(C)N=O,,,CC(O)CCCN(C)N=O,,CYP2A6;CYP2E1,0.72,Aliphatic Hydroxylation,0
NDPA,CCCN(CCC)N=O,,Alpha-OH NDPA,CCCN(N=O)C(O)CC,,CYP2A6;CYP2B6;CYP2C8;CYP2C9;CYP2D6;CYP2E1;CYP3A4,0.47,Aliphatic Hydroxylation,0
NDPA,CCCN(CCC)N=O,,Dipropylimine,CCCNCCC,,CYP2E1;CYP3A4,0.37,Aliphatic Hydroxylation,0
NPYR,O=NN1CCCC1,,,O=NN1CCCC1O,,CYP2A6;CYP2E1,0.46,Aliphatic Hydroxylation,0
RP73401,COC1=CC=C(C(=O)N=C2C(Cl)=CNC=C2Cl)C=C1OC1CCCC1,,,COC1=CC=C(C(=O)N=C2C(Cl)=CNC=C2Cl)C=C1OC1CCC(O)C1,,CYP2B6,0.96,Aliphatic Hydroxylation,0
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.93,S-Oxidation,0
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=C(O)C=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.89,Aromatic Hydroxylation,0
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,,O=C1C(CCS(=O)C2=CC=C(O)C=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,CYP2C9;CYP3A4,0.9,Aromatic Hydroxylation,0
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,,Cycloguanil,CC1(C)NC(=N)NC(=N)N1C1=CC=C(Cl)C=C1,,CYP1A2; CYP2C19; CYP2D6; CYP3A4; CYP2C9 (minor),0.51,Formation of cycloguanide,0
Proguanil,CC(C)NC(=N)NC(=N)NC1=CC=C(Cl)C=C1,,4-Chlorophenylbiguanide,N=C(N)NC(=N)NC1=CC=C(Cl)C=C1,,CYP2C19,0.79,N-deisopropylation,0
4_nitro_phenol,O=[N+]([O-])C1=CC=C(O)C=C1,,4-nitrocatechol (4NC) ,O=[N+]([O-])C1=CC=C(O)C(O)=C1,,CYP2E1,0.66,Aromatic Hydroxylation,0
Furametpyr,CC1=NN(C)C(Cl)=C1C(O)=NC1=CC=CC2=C1C(C)OC2(C)C,,,CC1=C(C(O)=NC2=CC=CC3=C2C(C)OC3(C)C)C(Cl)=NN1,,CYP1A1;CYP1A2;CYP2C19;CYP3A4,0.91,N-Demethylation ,0
Bioresmethrin,CC(C)=CC1C(C(=O)OCC2=COC(CC3=CC=CC=C3)=C2)C1(C)C,,BFA,OCC1=COC(CC2=CC=CC=C2)=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.46,Oxidation,0
TRANS-PERMETHRIN,CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC2=CC=CC=C2)=C1,,(3-Phenoxyphenyl)methanol,OCC1=CC=CC(OC2=CC=CC=C2)=C1,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.36,Oxidation,0
LOSIGAMONE,COC1=CC(=O)OC1C(O)C1=CC=CC=C1Cl,,,COC1=CC(=O)OC1C(O)C1=CC=C(O)C=C1Cl,,CYP2A6,0.93,Aromatic Hydroxylation,0
LOSIGAMONE,COC1=CC(=O)OC1C(O)C1=CC=CC=C1Cl,,,COC1=CC(=O)OC1C(O)C1=CC(O)=CC=C1Cl,,CYP2A6,0.91,Aromatic Hydroxylation,0
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,,CC(CN1C2=CC=CC=C2S(=O)C2=CC=CC=C21)N(C)C,,CYP2D6,0.83,S-Oxidation,0
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,,CNC(C)CN1C2=CC=CC=C2SC2=CC=CC=C21,,CYP2D6,0.97,N-Demethylation,0
demethylmetalaxyl,COC(=O)C(C)N(C(=O)CO)C1=C(C)C=CC=C1C,,,CC1=CC=CC(C)=C1N(C(=O)CO)C(C)C(=O)O,,CYP2B6;CYP3A4,0.91,O-Demethylation,0
L-775606,FC1=CC=CC(CCN2CCN(CCCC3=CNC4=CC=C(N5C=NN=C5)C=C34)CC2)=C1,,,OC(CN1CCN(CCCC2=CNC3=CC=C(N4C=NN=C4)C=C23)CC1)C1=CC=CC(F)=C1,,CYP3A4;CYP2C8,0.92,Aliphatic Hydroxylation,0
L-775606,FC1=CC=CC(CCN2CCN(CCCC3=CNC4=CC=C(N5C=NN=C5)C=C34)CC2)=C1,,,C1=CC2=C(C=C1N1C=NN=C1)C(CCCN1CCNCC1)=CN2,,CYP3A4;CYP2C8,0.87,N-Dealkylation,0
Deltamethrin,CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1,,4'-OH-deltamethrin,CC1(C)C(C=C(Br)Br)C1C(=O)OC(C#N)C1=CC=CC(OC2=CC=C(O)C=C2)=C1,,CYP2C8; CYP2C19; CYP3A4; CYP3A5,0.99,p-Hydroxylation of monosubstituted benzene,0
(1S)-trans-Cyfluthrin,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC2=CC=CC=C2)=C1,,,CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)C1=CC=C(F)C(OC2=CC=C(O)C=C2)=C1,,CYP1A1;CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.99,Aromatic Hydroxylation,0
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,6-hydroxy-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)C(O)CC2(C)C,,CYP3A;CYP2C9;CYP2C19,0.8,Aliphatic Hydroxylation,0
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-hydroxy-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CC(O)C2(C)C,,CYP3A;CYP2C9;CYP2C19,0.79,Aliphatic Hydroxylation,0
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-oxo-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)C(=O)CC2(C)C,,CYP3A;CYP2C9;CYP2C19,0.81,Aliphatic Hydroxylation,0
Bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CCC2(C)C,,7-oxo-bexarotene,C=C(C1=CC=C(C(=O)O)C=C1)C1=CC2=C(C=C1C)C(C)(C)CC(=O)C2(C)C,,CYP3A;CYP2C9;CYP2C19,0.81,Aliphatic Hydroxylation,0
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,Reduced dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=CC=C12,,CYP2D6;CYP3A4,0.87,Hydrogenation;Reduction,0
Halothane ,FC(F)(F)C(Cl)Br,,Trifluoroacetyl chloride,O=C(Cl)C(F)(F)F,,CYP2E1; CYP2A6,0.38,Oxidation of halotrifluoroethane,0
Halothane ,FC(F)(F)C(Cl)Br,,chlorotrifluoroethane,FC(F)(F)CCl,,CYP2A6; CYP3A4,0.55,Reduction of halotrifluoroethane,0
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,11-OH-delata-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(CO)=CC21,,CYP2C9; CYP2C19; CYP3A4,0.97,Hydroxlation of methyl carbon adjacent to an aliphatic ring,0
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,7-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1C(O)CC(C)=CC21,,CYP3A4,0.92,Hydroxylation of alicyclic secondary carbon,0
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,8-OH-delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(C)=CC21,,CYP3A4,0.91,Hydroxylation of alicyclic secondary carbon,0
S-Bioallethrin,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)C)C2(C)C)CC1=O,,,C=CCC1=C(C)C(OC(=O)C2C(C=C(C)CO)C2(C)C)CC1=O,,CYP2C9;CYP2C19;CYP3A4,0.99,Aliphatic Hydroxylation,0
Rupatadine,CC1=CN=CC(CN2CCC(=C3C4=CC=C(Cl)C=C4CCC4=CC=CN=C34)CC2)=C1,,,ClC1=CC=C2C(=C3CCNCC3)C3=NC=CC=C3CCC2=C1,,CYP3A4,0.9,N-Dealkylation,0
RL-3142,CN(C)C1=CC=C(C=CC(=O)C2=CC=C(N3C=CN=C3)C=C2)C=C1,,,CNC1=CC=C(C=CC(=O)C2=CC=C(N3C=CN=C3)C=C2)C=C1,,CYP3A,0.96,N-Dementhylation,0
zafirlukast,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,cyclopentyl NÃ¢â‚¬Â[1Ã¢â‚¬Â(hydroxymethyl)Ã¢â‚¬Â3Ã¢â‚¬Â({2Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â4Ã¢â‚¬Â[(2Ã¢â‚¬Âmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)indolÃ¢â‚¬Â5Ã¢â‚¬Âyl]carbamate,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(CO)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,CYP2C9; CYP3A4,0.98,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
zafirlukast,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCCC3)C=C12,,3Ã¢â‚¬Âhydroxycyclopentyl NÃ¢â‚¬Â[3Ã¢â‚¬Â({2Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â4Ã¢â‚¬Â[(2Ã¢â‚¬Âmethylbenzenesulfonyl)carbamoyl]phenyl}methyl)Ã¢â‚¬Â1Ã¢â‚¬ÂmethylindolÃ¢â‚¬Â5Ã¢â‚¬Âyl]carbamate,COC1=CC(C(O)=NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=CC=C(N=C(O)OC3CCC(O)C3)C=C12,,CYP2C9; CYP3A4,0.98,Hydroxylation of alicyclic secondary carbon,0
zaleplon,CCN(C(C)=O)C1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,,Dementhylazed-zaleplon,CC(O)=NC1=CC=CC(C2=CC=NC3=C(C#N)C=NN23)=C1,,CYP3A4,0.85,N-Dementhylation,0
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CC1(C)CC2=CC(Cl)=CC(C(O)=NC3CC4CCC(C3)N4)=C2O1,,CYP3A4,0.97,N-Dementhylation,0
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CC1(C)CC2=CC(Cl)=CC(C(O)=NC3CC4CCC(C3)[N+]4(C)[O-])=C2O1,,CYP3A4,0.94,N-Oxidation,0
zatosetron,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3)C2,,,CN1C2CCC1CC(N=C(O)C1=CC(Cl)=CC3=C1OC(C)(C)C3O)C2,,CYP3A4,0.91,Aliphatic Hydroxylation,0
zinc02949712,CCCCOC1=CC=C2C(C(F)(F)F)=CC(=O)OC2=C1,,HFC(7-hydroxy-4-trifluoromethylcoumarin),O=C1C=C(C(F)(F)F)C2=CC=C(O)C=C2O1,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.88,O-Demethylation,0
zinc15020070,COC1=CC=C2C(=C1)OC1=CC(O)=CC=C1C21OC(=O)C2=CC=CC=C21,,,O=C1OC2(C3=CC=C(O)C=C3OC3=CC(O)=CC=C32)C2=CC=CC=C12,,CYP1A2;CYP2B6;CYP2C8;CYP2C9;CYP2C19,0.97,O-Demethylation,0
zinc1698316,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC=CC=C45)C3CC21,,,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC=C(O)C=C45)C3CC21,,CYP2D6;CYP3A4,0.96,Aromatic Hydroxylation,0
zinc1698316,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC=CC=C45)C3CC21,,,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC(O)=CC=C45)C3CC21,,CYP2D6;CYP3A4,0.96,Aromatic Hydroxylation,0
zinc188,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,S-oxide cyamemazine,CC(CN(C)C)CN1C2=CC=CC=C2S(=O)C2=CC=C(C#N)C=C21,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.86,S-Oxidation,0
zinc188,CC(CN(C)C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,N-demethyl-cyamemazine,CNCC(C)CN1C2=CC=CC=C2SC2=CC=C(C#N)C=C21,,CYP1A2;CYP2B6;CYP2C8;CYP2C19;CYP3A4,0.98,N-demethylations,0
zinc21985223,CN(C)C1=CC=C(C2CC3(C)C(CCC3(O)C=CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,,CNC1=CC=C(C2CC3(C)C(CCC3(O)C=CCO)C3CCC4=CC(=O)CCC4=C23)C=C1,,CYP3A4,0.98,N-demethylations,0
zinc33952402,CC1=CC=C(C(=O)C(C)N2CCCC2)C=C1,,HO-MPPP,CC(C(=O)C1=CC=C(CO)C=C1)N1CCCC1,,CYP2C19;CYP2D6,0.93,Aliphatic Hydroxylation,0
zinc33952517,CC(C(=O)C1=CC=C2OCOC2=C1)N1CCCC1,,di-HO-MDPPP,CC(C(=O)C1=CC=C(O)C(O)=C1)N1CCCC1,,CYP2C19;CYP2D6,0.81,O-Demethylation,0
zinc36377943,CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(C(=O)CO)O1,,6beta - HYDROXYBUDESONIDE,CCCC(O)OC1CC2C3CCC4=CC(=O)C=CC4(C)C3C(O)CC2(C)C1C(=O)CO,,CYP3A4,0.73,O-dealkylation,0
zinc40442723,O=C1C=C2CN(C(C(=O)C3CC3)C3=CC=CC=C3F)CCC2S1,,,O=CC=C1CN(C(C(=O)C2CC2)C2=CC=CC=C2F)CCC1S,,CYP2B6;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.88,Unknown reaction,0
zinc4556587,CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(OC)=CC=C1N4,,12-hydroxyibogamine,CCC1CC2CC3C4=C(CCN(C2)C13)C1=CC(O)=CC=C1N4,,CYP2C19;CYP2D6;CYP3A4,0.98,O-DEMETHYLATION,0
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(O)C=C4C2C3=O)O1,,CYP3A4;CYP2C19,0.99,O-DEMETHYLATION,0
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2(O)C3=O)O1,,CYP3A4;CYP2C19,0.87,Aliphatic Hydroxylation,0
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,C=C(CO)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2(O)C3=O)O1,,CYP3A4,0.86,Aliphatic Hydroxylation,0
zinc8660420,C=C(C)C1CC2=C(C=CC3=C2OC2COC4=CC(OC)=C(OC)C=C4C2C3=O)O1,,,COC1=CC2=C(C=C1OC)C1(O)C(=O)C3=CC=C4OC(C5(C)CO5)CC4=C3OC1CO2,,CYP3A4,0.81,Epoxidation,0
zinc968306,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,,,CC(CC1=CC=CC=C1)NCC1=CC=CC=C1,,CYP2B6;CYP2C8;CYP3A4,0.83,N-Demethylation,0
zolmitriptan,CN(C)CCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,N-Desmethylzolmitriptan,CNCCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,CYP1A2,0.98,N-dealkylation of acyclic tertiary amine,0
zolmitriptan,CN(C)CCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,Zolmitriptan N-oxide,C[N+](C)([O-])CCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,CYP1A2,0.95,N-oxdation of aliphatic tertiary amine,0
zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,,methoxyzolpidem,CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1O,,CYP3A4(major); CYP1A2 (minor); CYP2D6 (minor); CYP2C9 (minor); CYP2C19 (minor),0.92,Hydroxylation of  carbon next to amide,0
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Norzotepine,CNCCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP3A4; CYP3A5; CYP2B6; CYP2C19,0.99,N-dealkylation of acyclic tertiary amine,0
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Zotepine N-oxide,C[N+](C)([O-])CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,CYP3A4,0.96,N-oxdation of aliphatic tertiary amine,0
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,2-OH-zotepine,CN(C)CCOC1=CC2=CC(O)=CC=C2SC2=CC=C(Cl)C=C12,,CYP1A2,0.9,Aromatic hydroxylation of fused benzene ring,0
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,3-OH-zotepine,CN(C)CCOC1=CC2=CC=C(O)C=C2SC2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP3A4; CYP2D6; CYP2C19,0.92,Aromatic hydroxylation of fused benzene ring,0
zotepine,CN(C)CCOC1=CC2=CC=CC=C2SC2=CC=C(Cl)C=C12,,Zotepine -oxide,CN(C)CCOC1=CC2=CC=CC=C2S(=O)C2=CC=C(Cl)C=C12,,CYP1A1; CYP1A2; CYP2B6; CYP3A4; CYP3A5,0.86,S-oxidation of diarylthioether to sulfoxide,0
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,"Benzo[a]pyrene-7,8-epoxide",C1=CC2OC2C2=CC3=CC=C4C=CC=C5C=CC(=C12)C3=C45,,CYP1A1; CYP1A2; CYP1B1,0.09,ARENE_EPOXIDATION,0
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,3-Hydroxybenzo[a]pyrene,C1=C2C=CC3=C4C=CC=CC4=CC4=CC=C(C2=C43)C2OC12,,CYP3A4; CYP2C8; CYP2C9;CYP2C19; CYP1A1; CYP1B1,0.08,ARENE_EPOXIDATION,0
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,9-Hydroxybenzo[a]pyrene,C1=CC2OC2C2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,CYP1A1; CYP1B1,0.08,ARENE_EPOXIDATION,0
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,1-Hydroxybenzo[a]pyrene,C1=C2C=CC3=CC4=CC=CC=C4C4=CC=C(C2=C34)C2OC12,,CYP1A1,0.08,ARENE_EPOXIDATION,0
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,"Benzo[a]pyrene-4,5-epoxide",C1=CC=C2C(=C1)C=C1C3=C2C=CC2=CC=CC(=C23)C2OC12,,CYP1A1; CYP1B1,0.13,ARENE_EPOXIDATION,0
ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,,CYP1A2;CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.96,Aliphatic Hydroxylation,0
ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4O)C3CCC21C,,CYP3A4;,0.87,Aliphatic Hydroxylation,0
1_2-dibromoethane,BrCCBr,,2-bromoacetaldehyde ,O=CCBr,,CYP2A6;CYP2B6;CYP2E1,0.43,Oxidation,0
2_2_4_4_5_5-hexachlorobiphenyl,ClC1=CC(Cl)=C(C2=CC(Cl)=C(Cl)C=C2Cl)C=C1Cl,,,OC1=C(Cl)C(Cl)=CC(C2=CC(Cl)=C(Cl)C=C2Cl)=C1Cl,,CYP2B6,0.63,Aromatic Hydroxylation,0
Nelfinavir,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)C,,Nelfinavir hydroxyl-t- butylamide,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)CO,,CYP2C19,0.99,Hydroxylation of terminal methyl,0
Nelfinavir,CC1=C(O)C=CC=C1C(O)=NC(CSC1=CC=CC=C1)C(O)CN1CC2CCCCC2CC1C(O)=NC(C)(C)C,,"3,4-Dihydroxynelfinavir",CC1=C(C(O)=NC(CSC2=CC=CC=C2)C(O)CN2CC3CCCCC3CC2C(O)=NC(C)(C)C)C=CC(O)=C1O,,CYP3A4,0.97,Hydroxylation of benzene on carbon orhto to a strongly electron donating group,0
Trichloroethane,CC(Cl)(Cl)Cl,,Trichloroethanol,OCC(Cl)(Cl)Cl,,CYP2E1,0.58,Aliphatic Hydroxylation,0
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=C(O)C2=CC=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.97,Aromatic Hydroxylation,0
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=CC2=CC(O)=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.98,Aromatic Hydroxylation,0
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=CC2=C(O)C=CC=C12)C1=CC=CS1,,CYP1A2;CYP2D6,0.96,Aromatic Hydroxylation,0
leflunomide,CC1=C(C(=O)NC2=CC=C(C(F)(F)F)C=C2)C=NO1,,,CC(O)=C(C=N)C(=O)NC1=CC=C(C(F)(F)F)C=C1,,CYP1A2;CYP2C9;CYP3A4,0.32,N-O bond cleavage,0
"N,N-Dimethylaniline",CN(C)C1=CC=CC=C1,,,CNC1=CC=CC=C1,,CYP1A2;CYP2B1;CYP4B1,0.77,N-dementhylation,0
alosetron,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC=C2N3C)NC=N1,,,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC(O)=C2N3C)NC=N1,,CYP1A2,0.91,Aromatic Hydroxylation,0
alosetron,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC=C2N3C)NC=N1,,,CC1=C(CN2CCC3=C(C2=O)C2=CC=CC(O)=C2N3C)NC(O)=N1,,CYP1A2,0.89,Aromatic Hydroxylation,0
Phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,CYP2C9; CYP2C19; CYP2E1,0.95,p-Hydroxylation of monosubstituted benzene,0
Paroxetine,FC1=CC=C(C2CCNCC2COC2=CC=C3OCOC3=C2)C=C1,,,OC1=CC=C(OCC2CNCCC2C2=CC=C(F)C=C2)C=C1O,,CYP2D6,0.91,O-Demethylenation,0
bromperidol,O=C(CCCN1CCC(O)(C2=CC=C(Br)C=C2)CC1)C1=CC=C(F)C=C1,,,OC1(C2=CC=C(Br)C=C2)CCNCC1,,CYP3A4,0.66,N-Dealkylation,0
bromperidol,O=C(CCCN1CCC(O)(C2=CC=C(Br)C=C2)CC1)C1=CC=C(F)C=C1,,,CCCC(=O)C1=CC=C(F)C=C1,,CYP3A4,0.41,N-Dealkylation,0
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,2-trans-hydroxycyclohexyl glyburide ,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2O)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.92,Hydroxylation of alicyclic secondary carbon,0
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,4-cis-hydroxycyclohexyl glyburide ,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCC(O)CC2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.97,Hydroxylation of alicyclic secondary carbon,0
Glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCCC2)C=C1,,3-trans-Hydroxycyclohexyl glyburide,COC1=CC=C(Cl)C=C1C(O)=NCCC1=CC=C(S(=O)(=O)NC(O)=NC2CCCC(O)C2)C=C1,,CYP3A4; CYP2C9; CYP2C19,0.94,Hydroxylation of alicyclic secondary carbon,0
"(r)-chloroquine, N-desethyl",CCNCCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,"(r)-chloroquine, N-desethyl",CC(CCCN)NC1=CC=NC2=CC(Cl)=CC=C12,,CYP2C8; CYP2D6; CYP3A4; CYP3A5,0.96,N-dealkylation of acyclic secondary amine,0
S-Mephenytoin,CCC1(C2=CC=CC=C2)N=C(O)N(C)C1=O,,4Ã¢â‚¬Â²-Hydroxymephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C)C1=O,,CYP2D6;  CYP2C19;  CYP1A2;  CYP2C18;  CYP3A4,0.96,p-Hydroxylation of monosubstituted benzene,0
S-Mephenytoin,CCC1(C2=CC=CC=C2)N=C(O)N(C)C1=O,,Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,,CYP2C19; CYP2C18; CYP2D6; CYP1A2; CYP3A4; CYP2B6,0.42,N-dealkylation of dicarboximide,0
"1,4-dichlorobenzene",ClC1=CC=C(Cl)C=C1,,"2,5-dichlorophenol",OC1=CC(Cl)=CC=C1Cl,,CYP2E1 (major),0.38,Hydroxylation of aromatic carbon ortho to halide group,0
P-Hydroxynefazodone,CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âylidene)Ã¢â‚¬Â4Ã¢â‚¬Â{3Ã¢â‚¬Â[3Ã¢â‚¬ÂethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â1lambda5Ã¢â‚¬ÂpiperazinÃ¢â‚¬Â1Ã¢â‚¬Âylium",CCC1=NN(CCCN2CCN(C3=CC(=[Cl+])C(=O)C=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.71,_2_ELECTRON_OXIDATION_OF_P_AMINOPHENOLS_TO_QUINONE_IMINES_PATTERN1,0
"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬Âhydroxyphenyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â1Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3(O)C=CC(=O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.69,Oxidation of 4-substituted phenol,0
"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬Âhydroxyphenyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3=CC=C(O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â[3Ã¢â‚¬Â(4Ã¢â‚¬Â{3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â7Ã¢â‚¬Âoxabicyclo[4.1.0]heptaÃ¢â‚¬Â2,4Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl}piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl)propyl]Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C34C=C(Cl)C(O)=CC3O4)CC2)C(=O)N1CCOC1=CC=CC=C1,,CYP3A4,0.62,EPOXIDATION,0
1-aminopyrene,NC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,N-hydroxy-1-aminopyrene,ONC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,CYP1A1; CYP1A2; CYP3A4,0.75,N-hydroxylation of primary arylamine,0
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,2beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=C(O)C=C4C3CCC21C,,CYP2C9; CYP3A4; CYP2C19; CYP1A2,0.97,Aromatic hydroxylation of fused benzene ring,0
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,4beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=C(C=CC(O)=C4O)C3CCC21C,,CYP2C9; CYP3A4,0.88,Aromatic hydroxylation of fused benzene ring,0
17alpha-Ethinylestradiol,C#CC1(O)CCC2C3(C)CCC4=CC(O)=CC=C4C3CCC21C,,6beta-OH-17beta-Ethinylestradiol,C#CC1(O)CCC2C3(C)CC(O)C4=CC(O)=CC=C4C3CCC21C,,CYP2C9; CYP3A4,0.83,Hydroxylation of alicyclic secondary carbon,0
"2,6-Xylidine",CC1=CC=CC(C)=C1N,,"N-(2,6-dimethylphenyl)hydroxylamine",CC1=CC=CC(C)=C1NO,,CYP2A6; CYP2E1,0.71,N-hydroxylation of primary arylamine,0
3-aminobenzanthrone,NC1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,N-hydroxy-3-aminobenzanthrone,O=C1C2=CC=CC3C2=C(C=CC3NO)C2=CC=CC=C12,,CYP1A1; CYP1A2; CYP1B1; CYP2A6; CYP2B6; ,0.96,N-hydroxylation of primary arylamine,0
3-Hydroxylidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC(O)=C1C,,3-Hydroxymonoethyl glycinexylidide,CCNCC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.95,N-dealkylation of acyclic tertiary amine,0
3'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=CC(O)=C2)C(O)=N1,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.94,Hydroxylation of benzene on carbon orhto to a strongly electron donating group,0
4'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.87,Hydroxylation of benzene on carbon orhto to a strongly electron donating group,0
7-Methoxyresorufin,COC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2,0.95,O-aryl demethylation,0
"(R)-mianserin, 8-hydroxy",CN1CCN2C3=CC(O)=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, 8-OH-N-desmethyl",OC1=CC=C2CC3=CC=CC=C3C3CNCCN3C2=C1,,CYP2D6; CYP1A2; CYP3A4,0.97,N-dealkylation of alicyclic tertiary amine,0
Acetachlor,CCOCN(C(=O)CCl)C1=C(C)C=CC=C1CC,,,CCC1=CC=CC(C)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.3,N-dealkoxylation of N-aryl-N-chloroacetamide,0
Acetachlor,CCOCN(C(=O)CCl)C1=C(C)C=CC=C1CC,,,CCOCNC1=C(C)C=CC=C1CC,,CYP2B6; CYP3A4,0.51,N-demethoxymethylation,0
Bromazepam,OC1=NC2=CC=C(Br)C=C2C(C2=CC=CC=N2)=NC1,,,OC1=NC2=CC=C(Br)C=C2C(C2=CC=CC=N2)=NC1O,,CYP1A2; CYP2D6,0.89,"3-Hydroxylation of 5-aryl-1,4-benzodiazepine",0
6-Aminochrysene,NC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,N-Hydroxychrysene,ONC1=CC2=C3C=CC=CC3=CC=C2C2=CC=CC=C12,,CYP1B1; CYP1A2; CYP1A1; CYP2A6; CYP2B6,0.75,N-hydroxylation of primary arylamine,0
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,"Aminoflavone, N4'-Hydroxy",CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,CYP1A2; CYP1A1; CYP2C9; CYP2C19,0.98,N-hydroxylation of primary arylamine,0
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,,CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,CYP1A2; CYP2C9; CYP2C19,0.94,N-hydroxylation of primary arylamine,0
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,"Aminoflavone, C3-hydroxy",CC1=C(F)C(N)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,CYP1A2,0.88,Hydroxylation of carbon alpha to conjugated carbonyl,0
"Aminoflavone, N4'-Hydroxyl",CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,"Aminoflavone, N4', N5-dihydroxy",CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,CYP1A2; CYP2C9; CYP2C19,0.95,N-hydroxylation of primary arylamine,0
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,"N-[3-(N,NDiethylamino)propyl]-N-phenyl-2-aminoindan-5-ol",CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=C(O)C=C2C1,,CYP2D6,0.87,Aromatic hydroxylation of fused benzene ring,0
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,p-Hydroxyphenylaprindine,CCN(CC)CCCN(C1=CC=C(O)C=C1)C1CC2=CC=CC=C2C1,,CYP2D6,0.93,Hydroxylation of benzene on carbon para to a strongly electron donating group,0
Aprindine,CCN(CC)CCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,Desethylaprindine,CCNCCCN(C1=CC=CC=C1)C1CC2=CC=CC=C2C1,,CYP2D6,0.97,N_DEALKYLATION_OF_ALIPHATIC_TERTIARY_AMINES_PATTERN1; N_DEALKYLATION_OF_ACYCLIC_TERTIARY_AMINES,0
Butachlor,CCCCOCN(C(=O)CCl)C1=C(CC)C=CC=C1CC,,,CCC1=CC=CC(CC)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.3,N-dealkoxylation of N-aryl-N-chloroacetamide,0
(+)-Camphor,CC12CCC(CC1=O)C2(C)C,,5-exo-hydroxycamphor,CC12CCC(CC1=O)C2(C)CO,,CYP2D6,0.74,Hydroxlation of methyl carbon adjacent to an aliphatic ring,0
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.6,NS-cleavage,0
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,dibutyl(sulfanyl)amine,CCCCN(S)CCCC,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C19; CYP3A4,0.07,NS-cleavage,0
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,,CCCCN(CCCC)S(=O)N(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,CYP1A1; CYP2B6; CYP2C19; CYP3A4,0.9,Oxidation of S adjacent to an aliphatic nitrogen,0
Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,"3,5,6-Trichloro-2-pyridinol",OC1=NC(Cl)=C(Cl)C=C1Cl,,CYP2C19; CYP2B6; CYP3A4,0.46,Dearylation of organphosphosulfur compound,0
Chlorpyrifos-oxon,CCOP(=O)(OCC)OC1=NC(Cl)=C(Cl)C=C1Cl,,Diethyl phosphate,CCOP(=O)(O)OCC,,CYP2C19; CYP2B6; CYP3A4,0.1,Dearylation of organphosphosulfur compound,0
Citalopram,CN(C)CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,Citalopram N-oxide,C[N+](C)([O-])CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,CYP2D6,0.96,N-oxdation of aliphatic tertiary amine,0
Citalopram,CN(C)CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,N-Desmethylcitalopram,CNCCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,CYP2D6; CYP2C19; CYP3A4,0.99,N-dealkylation of acyclic tertiary amine,0
D-617,CNCCCC(C#N)(C1=CC=C(OC)C(OC)=C1)C(C)C,,D-620,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP3A4; CYP3A5,0.98,N-dealkylation of acyclic secondary amine,0
D-702,COC1=CC(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)=CC=C1O,,,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP3A4; CYP3A5,0.86,N-dealkylation of acyclic tertiary amine,0
Dimethoate,CN=C(O)CSP(=S)(OC)OC,,Omethoate,CN=C(O)CSP(=O)(OC)OC,,CYP1A1; CYP1A2; CYP2A6; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP3A4,0.49,Desulfuration of organophosphorodithioate,0
DEET,CCN(CC)C(=O)C1=CC=CC(C)=C1,,N-ethyl-m-toluamide,CCN=C(O)C1=CC=CC(C)=C1,,CYP2C19; CYP3A4,0.19,N-dealkylation of tertiary carboxamide,0
Disulfoton,CCOP(=S)(OCC)SCCSCC,,Disulfoton sulfoxide,CCOP(=S)(OCC)SCCS(=O)CC,,CYP1A2; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6; CYP3A4,0.85,S-oxidation of dialkylthioether to sulfoxide,0
Diuron,CN(C)C(O)=NC1=CC=C(Cl)C(Cl)=C1,,N-demethyldiuron,CN=C(O)NC1=CC=C(Cl)C(Cl)=C1,,CYP1A1; CYP1A2; CYP2C19; CYP3A4,0.43,N-dealkylation of urea,0
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"2Ã¢â‚¬Â[(1Ã¢â‚¬ÂbenzylpiperidinÃ¢â‚¬Â4Ã¢â‚¬Âyl)methyl]Ã¢â‚¬Â5Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â6Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,CYP3A4; CYP2C9; CYP2D6,0.99,O-aryl dealkylation adjacent to substituted carbon,0
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"5,6Ã¢â‚¬ÂdimethoxyÃ¢â‚¬Â2Ã¢â‚¬Â(piperidinÃ¢â‚¬Â4Ã¢â‚¬Âylmethyl)Ã¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1OC)C(=O)C(CC1CCNCC1)C2,,CYP3A4; CYP2C9,0.89,N-dealkylation of alicyclic tertiary amine,0
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,"2Ã¢â‚¬Â[(1Ã¢â‚¬ÂbenzylpiperidinÃ¢â‚¬Â4Ã¢â‚¬Âyl)methyl]Ã¢â‚¬Â6Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â5Ã¢â‚¬ÂmethoxyÃ¢â‚¬Â2,3Ã¢â‚¬ÂdihydroindenÃ¢â‚¬Â1Ã¢â‚¬Âone",COC1=CC2=C(C=C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,CYP3A4; CYP2C9,0.99,O-aryl dealkylation adjacent to substituted carbon,0
Encainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2C)C=C1,,N-demethylencainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2)C=C1,,CYP2D6,0.95,N-dealkylation of alicyclic tertiary amine,0
Encainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2C)C=C1,,O-demethylencainide,CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1,,CYP2D6,0.96,O-aryl demethylation,0
Esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1)C1=CC=C(Cl)C=C1,,2'-OH-esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2O)=C1)C1=CC=C(Cl)C=C1,,CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.94,o-Hydroxylation of monosubstituted benzene,0
Esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=CC=C2)=C1)C1=CC=C(Cl)C=C1,,4'-OH-esfenvalerate,CC(C)C(C(=O)OC(C#N)C1=CC=CC(OC2=CC=C(O)C=C2)=C1)C1=CC=C(Cl)C=C1,,CYP2C8; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.99,p-Hydroxylation of monosubstituted benzene,0
N-Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,N-Didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,CYP2C19; CYP3A4; CYP1A2,0.99,N-dealkylation of acyclic secondary amine,0
N-Desmethylclomipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=C(Cl)C=C21,,8-OH-N-desmethylclomipramine,CNCCCN1C2=CC(Cl)=CC=C2CCC2=C(O)C=CC=C21,,CYP2D6,0.81,Aromatic hydroxylation of fused benzene ring,0
N-demethylencainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2)C=C1,,"N,O-didemethylencainide",O=C(NC1=CC=CC=C1CCC1CCCCN1)C1=CC=C(O)C=C1,,CYP2D6,0.96,O-aryl demethylation,0
O-demethylencainide,CN1CCCCC1CCC1=CC=CC=C1NC(=O)C1=CC=C(O)C=C1,,"N,O-didemethylencainide",O=C(NC1=CC=CC=C1CCC1CCCCN1)C1=CC=C(O)C=C1,,CYP2D6,0.95,N-dealkylation of alicyclic tertiary amine,0
Endosulfan-alpha,O=S1OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,,Endosulfan sulfate,O=S1(=O)OCC2C(CO1)C1(Cl)C(Cl)=C(Cl)C2(Cl)C1(Cl)Cl,,CYP2C9; CYP2C19; CYP3A4; CYP3A5; CYP3A7,0.98,S-oxidation of organosulfurous compounds,0
Fenthion,COP(=S)(OC)OC1=CC=C(SC)C(C)=C1,,Fenthion oxon,COP(=O)(OC)OC1=CC=C(SC)C(C)=C1,,CYP1A2; CYP2B6; CYP2C9; CYP2C19; CYP3A4; CYP3A5,0.71,Desulfuration of organophosphothioates,0
Flecainide,OC(=NCC1CCCCN1)C1=CC(OCC(F)(F)F)=CC=C1OCC(F)(F)F,,"2-hydroxy-N-[(piperidin-2-yl)methyl]-5-(2,2,2-trifluoroethoxy)benzamide",OC(=NCC1CCCCN1)C1=CC(OCC(F)(F)F)=CC=C1O,,CYP2D6,0.91,O-aryl dealkylation adjacent to substituted carbon,0
lansoprazole,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=CC=C2N1,,,CC1=C(OCC(F)(F)F)C=CN=C1CS(=O)C1=NC2=CC=C(O)C=C2N1,,CYP2C9;CYP2C19;CYP3A4,0.94,Aromatic Hydroxylation,0
Gavestinel,O=C(O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,p-OH-gavestinel,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(O)C=C1,,CYP2C9,0.8,Hydroxylation of benzene on carbon para to an electron donating group,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,7-OH-gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CC(O)CC3C2)C=C1,,CYP2C9,0.9,Hydroxylation of alicyclic secondary carbon,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,Methylhydroxygliclazide,O=S(=O)(NC(O)=NN1CC2CCCC2C1)C1=CC=C(CO)C=C1,,CYP2C9; CYP2C19,0.95,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,6-OH-gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCC(O)C3C2)C=C1,,CYP2C9,0.82,Hydroxylation of alicyclic secondary carbon,0
Glimepiride,CCC1=C(C)CN(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(C)CC3)C=C2)C1=O,,Cyclohexylhydroymethylglimepiride,CCC1=C(C)CN(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(CO)CC3)C=C2)C1=O,,CYP2C9,0.98,Hydroxylation of terminal methyl,0
Glipizide,CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCCCC3)C=C2)C=N1,,4-trans-OH-glipizide,CC1=CN=C(C(O)=NCCC2=CC=C(S(=O)(=O)NC(O)=NC3CCC(O)CC3)C=C2)C=N1,,CYP2C9,0.96,Hydroxylation of alicyclic secondary carbon,0
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,,Norhydromorphone,O=C1CCC2C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,CYP3A4; CYP2C9; CYP2D6,0.98,N-dealkylation of mixed tertiary amine,0
Lansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=N1,,Hydroxylansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC(O)=C3N2)=N1,,CYP2C19; CYP2C9; CYP3A4,0.89,Aromatic hydroxylation of fused benzene ring,0
Lansoprazole,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)C2=NC3=CC=CC=C3N2)=N1,,Lansoprazole sulfone,CC1=CC(OCC(F)(F)F)=C(C)C(CS(=O)(=O)C2=NC3=CC=CC=C3N2)=N1,,CYP3A4,0.94,S-oxidation of sulfoxide to sulfone,0
Imidacloprid,O=[N+]([O-])NC1=NCCN1CC1=CC=C(Cl)N=C1,,,ON=NC1=NCCN1CC1=CC=C(Cl)N=C1,,CYP2B6; CYP2D6; CYP2E1; CYP3A4,0.65,Reduction of nitroimine,0
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,,Leukotoxin,CCCCCC=CCC1OC1CCCCCCCC(=O)O,,CYP2C9; CYP2C19,0.44,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,,Isoleukotoxin,CCCCCC1OC1CC=CCCCCCCCC(=O)O,,CYP2C9; CYP2C19,0.44,EPOXIDATION_OF_12_DISUBSTITUTED_ALKLENE,0
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib metabolite 1,O=C(O)CC1=CC(CO)=CC=C1NC1=C(F)C=CC=C1Cl,,CYP2C9; CYP2C19,0.94,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring,0
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib metabolite 2,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O)=C1,,CYP2C9; CYP2C19,0.87,Hydroxylation of aromatic carbon meta to halide group,0
Malathion,CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC,,Maloxon,CCOC(=O)CC(SP(=O)(OC)OC)C(=O)OCC,,CYP1A2; CYP2B6; CYP2C19; CYP3A4,0.65,Desulfuration of organophosphorodithioate,0
Mianserine,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,8-Hydroxymianserin,CN1CCN2C3=CC=C(O)C=C3CC3=CC=CC=C3C2C1,,"CYP2D6 (major; (major, RÃ¢â€°Ë†S)); CYP2B6 (R>S); CYP3A4  (S>R) ",0.93,Aromatic hydroxylation of fused benzene ring,0
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,Mirtazapine N-oxide,C[N+]1([O-])CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2; CYP2D6; CYP3A4,0.93,N-oxidation of alicyclic tertiary amine,0
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,N-Desmethylmirtazapine,C1=CC=C2C(=C1)CC1=CC=CN=C1N1CCNCC21,,CYP1A2; CYP2D6; CYP3A4,0.97,N-dealkylation of mixed tertiary amine,0
Mirtazapine,CN1CCN2C3=NC=CC=C3CC3=CC=CC=C3C2C1,,8-OH-mirtazapine,CN1CCN2C3=NC(O)=CC=C3CC3=CC=CC=C3C2C1,,CYP1A2; CYP2D6; CYP3A4,0.94,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
(-)-Menthol,CC1CCC(C(C)C)C(O)C1,,"p-Menthane-3,-8-diol",CC1CCC(C(C)(C)O)C(O)C1,,CYP2A6,0.73,Hydroxylation of alkyl methine,0
Mestranol,C#CC1(O)CCC2C3CCC4=CC(OC)=CC=C4C3CCC21C,,Ethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=CC=C4C3CCC21C,,CYP2C9,0.94,O-aryl dealkylation not adjacent to substituted carbon,0
Mono-OH-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Catechol-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP2B6; CYP3A4; CYP3A5,0.78,o-Hydroxylation of phenol,0
Mono-OH-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Bis-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,CYP1A2; CYP2C8; CYP2C19; CYP2D6,0.89,O-aryl dealkylation not adjacent to substituted carbon,0
Monodemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(NC)C=C3)CC21C,,Didemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N)C=C3)CC21C,,CYP3A4,0.99,N-dealkylation of secondary arylalkylamine,0
Bis-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Tris-OH-methoxychlor,OC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,CYP3A4,0.76,o-Hydroxylation of phenol,0
methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,,"2ethylidene-1,5-dimethyl-3,3-diphenylpyrolidine",CCC1C(C)N(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,,CYP2D6; CYP3A4 (major); CYP2B6; CYP2C8; CYP2C19,0.49,N-dealkylation of acyclic tertiary amine,0
Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,3-Hydroxymonoethyl glycinexylidide,CCNCC(O)=NC1=C(C)C=CC(O)=C1C,,CYP1A2; CYP2D6; CYP3A4,0.71,HYDROXYLATION_OF_AROMATIC_CARBON,0
Monoethylglycinexylidide,CCNCC(O)=NC1=C(C)C=CC=C1C,,Glycinexylidide,CC1=CC=CC(C)=C1N=C(O)CN,,CYP1A2; CYP3A4,0.9,N-dealkylation of acyclic secondary amine,0
N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,N-Desdimethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN)C=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5,0.98,N-dealkylation of acyclic secondary amine,0
N-Desmethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,alpha-OH-N-desmethyltamoxifen,CNCCOC1=CC=C(C(=C(C2=CC=CC=C2)C(C)O)C2=CC=CC=C2)C=C1,,CYP3A4; CYP3A5,0.85,Hydroxylation of penultimate aliphatic secondary carbon,0
1-Naphtaldehyde,O=CC1=CC=CC2=CC=CC=C12,,1-Naphthoic acid,O=C(O)C1=CC=CC2=CC=CC=C12,,CYP3A4,0.7,Aldehyde oxidation,0
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,2Ã¢â‚¬Â{[4Ã¢â‚¬Â(1Ã¢â‚¬ÂhydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)cyclohexyl]formamido}Ã¢â‚¬Â3Ã¢â‚¬Âphenylpropanoic acid,CC(CO)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,CYP2C9; CYP3A4,0.99,Hydroxylation of terminal methyl,0
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,2Ã¢â‚¬Â{[4Ã¢â‚¬Â(2Ã¢â‚¬ÂhydroxypropanÃ¢â‚¬Â2Ã¢â‚¬Âyl)cyclohexyl]formamido}Ã¢â‚¬Â3Ã¢â‚¬Âphenylpropanoic acid,CC(C)(O)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,CYP2C9; CYP3A4,0.95,Hydroxylation of penultimate aliphatic tertiary carbon,0
Nordoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,2-Hydroxynordoxepin,CNCCC=C1C2=CC(O)=CC=C2COC2=CC=CC=C12,,CYP2D6,0.93,Aromatic hydroxylation of fused benzene ring,0
Norverapamil,COC1=CC=C(CCNCCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)C=C1OC,,D-620,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP2C8; CYP3A4; CYP2D6,0.9,N-dealkylation of acyclic secondary amine,0
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,CYP3A4; CYP2D6; CYP1A2,0.95,Aromatic hydroxylation of fused benzene ring,0
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,CYP1A2; CYP2D6; CYP3A4,0.96,Aromatic hydroxylation of fused benzene ring,0
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,CYP1A2; CYP2D6; CYP3A4,0.91,Aromatic hydroxylation of fused benzene ring,0
Phorate,CCOP(=S)(OCC)SCSCC,,Phorate sulfoxide,CCOP(=S)(OCC)SCS(=O)CC,,CYP1A2; CYP3A4; CYP2B6; CYP2C9; CYP2C18; CYP2C19; CYP2D6,0.78,S-oxidation of dialkylthioether to sulfoxide,0
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"2Ã¢â‚¬Â[6Ã¢â‚¬Â(2Ã¢â‚¬Â{4Ã¢â‚¬Â[(2,4Ã¢â‚¬ÂdioxoÃ¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidinÃ¢â‚¬Â5Ã¢â‚¬Âyl)methyl]phenoxy}ethyl)pyridinÃ¢â‚¬Â3Ã¢â‚¬Âyl]acetic acid",O=C(O)CC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.93,OXIDATION_OF_PRIM_ALCOHOL_TO_CARBOXYLIC_ACID,0
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"5Ã¢â‚¬Â[(4Ã¢â‚¬Â{2Ã¢â‚¬Â[5Ã¢â‚¬Â(1Ã¢â‚¬Âhydroxyethyl)pyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl]ethoxy}phenyl)methyl]Ã¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",CC(O)C1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.93,Hydroxylation of non-terminal aliphatic carbon adjacent to aromatic ring,0
Pioglitazone,CCC1=CC=C(CCOC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,"5Ã¢â‚¬Â({4Ã¢â‚¬Â[2Ã¢â‚¬Â(5Ã¢â‚¬ÂethylpyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl)Ã¢â‚¬Â2Ã¢â‚¬Âhydroxyethoxy]phenyl}methyl)Ã¢â‚¬Â1,3Ã¢â‚¬ÂthiazolidineÃ¢â‚¬Â2,4Ã¢â‚¬Âdione",CCC1=CC=C(C(O)COC2=CC=C(CC3SC(=O)N=C3O)C=C2)N=C1,,CYP2C8; CYP3A4,0.89,HYDROXYLATION_OF_ALIPHATIC_SECONDARY_CARBON,0
17ÃŽÂ²-OH-progesterone,CC(=O)C1(O)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,,17Beta-21-dihydroxyprogesterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)CO,,CYP2D4; CYP2D6,0.95,Alpha hydroxylation of carbonyl group,0
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,para-hydroxyrosiglitazone ,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=C(O)C=N1,,CYP2C8,0.94,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethylrosiglitazone ,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,,CYP2C8,0.92,N-dealkylation of mixed tertiary amine,0
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,ortho-hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=CC=C1O,,CYP2C8,0.89,HYDROXYLATION_OF_HETEROAROMATIC_CARBON,0
Rosuvastatin,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC(O)CC(O)CC(=O)O,,Rosuvastatin 5 S-lactone,CC(C)C1=NC(N(C)S(C)(=O)=O)=NC(C2=CC=C(F)C=C2)=C1C=CC1=CC(O)=CC(=O)O1,,CYP2C9,0.77,ESTERIFICATION,0
Simazine,CCN=C1N=C(Cl)NC(=NCC)N1,,N-Desethylsimazine,CCN=C1NC(Cl)=NC(=N)N1,,CYP1A1; CYP1A2; CYP2A6; CYP2C19; CYP2D6,0.97,N-dealkylation of secondary arylalkylamine,0
Pyributicarb,COC1=CC=CC(N(C)C(=S)OC2=CC=CC(C(C)(C)C)=C2)=N1,,Pyributicarb metabolite 1,CN(C(=S)OC1=CC=CC(C(C)(C)C)=C1)C1=CC=CC(O)=N1,,CYP2C19,0.94,O-aryl demethylation,0
Sulprofos,CCCSP(=S)(OCC)OC1=CC=C(SC)C=C1,,Sulprofos sulfoxide,CCCSP(=S)(OCC)OC1=CC=C(S(C)=O)C=C1,,CYP1A1; CYP1A2; CYP3A4; CYP2C9; CYP2C18; CYP2C19; CYP2D6,0.9,S-oxidation of dialkylthioether to sulfoxide,0
Tamoxifen N-oxide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,,alpha-OH-tamoxifen N-oxide,CC(O)C(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,,CYP3A4; CYP3A5,0.87,Hydroxylation of penultimate aliphatic secondary carbon,0
Tegafur,O=C1N=C(O)C(F)=CN1C1CCCO1,,5-Fluorouracil,OC1=NC=C(F)C(O)=N1,,CYP2A6; CYP1A2; CYP2C8,0.21,N-dealkylation of mixed tertiary amine,0
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,Thioridazine 2-sulfoxide ,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,CYP2D6; CYP3A4,0.92,S-oxidation of alkylarylthioether to sulfoxide,0
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,N-desmethylthioridazine ,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3)C2=C1,,CYP1A2; CYP3A4,0.96,N-dealkylation of mixed tertiary amine,0
Thioridazine,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3C)C2=C1,,Thioridazine 5-sulfoxide,CSC1=CC=C2C(=C1)N(CCC1CCCCN1C)C1=CC=CC=C1S2=O,,CYP1A2; CYP3A4,0.87,S-oxidation of diarylthioether to sulfoxide,0
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,"p-Cymene-2,3-diol",CC1=CC=C(C(C)C)C(O)=C1O,,CYP1A2; CYP2A6; CYP2D6,0.8,o-Hydroxylation of phenol,0
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,Thymoquinol,CC1=CC(O)=C(C(C)C)C=C1O,,CYP1A2; CYP2A6; CYP2D6,0.88,p-Hydroxylation of phenol,0
Thymol,CC1=CC=C(C(C)C)C(O)=C1,,p-Cymen-8-en-3-ol,C=C(C)C1=CC=C(C)C=C1O,,CYP1A2; CYP2A6; CYP2D6,0.62,Terminal desaturation,0
Tizanidine,ClC1=C(NC2=NCCN2)C2=NSN=C2C=C1,,"2Ã¢â‚¬Â[(5Ã¢â‚¬ÂchloroÃ¢â‚¬Â2,1,3Ã¢â‚¬ÂbenzothiadiazolÃ¢â‚¬Â4Ã¢â‚¬Âyl)amino]Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬ÂimidazolÃ¢â‚¬Â4Ã¢â‚¬Âol",OC1CN=C(NC2=C(Cl)C=CC3=NSN=C23)N1,,CYP1A2,0.93,Hydroxylation of heteroalicyclic secondary carbon,0
Trichloroethylene,ClC=C(Cl)Cl,,Chloral hydrate,OC(O)C(Cl)(Cl)Cl,,CYP2E1; CYP1A2; CYP3A4,0.09,EPOXIDATION,0
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 1,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=C(O)C=C23)N1,,CYP1A2; CYP1A1; CYP2C8,0.94,Aromatic hydroxylation of fused benzene ring,0
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 2,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=C(O)C=CC=C23)N1,,CYP1A1; CYP1A2; CYP2C8,0.9,Aromatic hydroxylation of fused benzene ring,0
TSU-68,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC=CC=C23)N1,,TSU-68 metabolite 3,CC1=C(CCC(=O)O)C(C)=C(C=C2C(O)=NC3=CC(O)=CC=C23)N1,,CYP1A1; CYP1A2; CYP2C8,0.94,Aromatic hydroxylation of fused benzene ring,0
YM-64227,CCC1=CC=C2C(C3CCCCC3)=NC(=O)N(CC)C2=N1,,"M-2 (1,3-cis)",CCC1=CC=C2C(C3CCCC(O)C3)=NC(=O)N(CC)C2=N1,,CYP1A2,0.95,Hydroxylation of alicyclic secondary carbon,0
Zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,10-OH-zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(O)CC2=C1,,CYP2C9,0.68,REDUCTION_OF_KETONES_TO_ALCOHOL,0
Zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,Zaltoprofen S-oxide,CC(C(=O)O)C1=CC=C2C(=C1)CC(=O)C1=CC=CC=C1S2=O,,CYP2C9,0.83,S-oxidation of dialkylthioether to sulfoxide,0
"VCH-1,2-epoxide",C1=CCC(C2CO2)CC1,,VCH-diepoxide,C1CC2OC2CC1C1CO1,,CYP2B6; CYP2E1,0.39,ALKENE_EPXODATION,0
"VCH-7,8-epoxide",C=CC1CCC2OC2C1,,VCH-diepoxide,C1CC2OC2CC1C1CO1,,CYP2B6; CYP2E1,0.51,ALKENE_EPXODATION,0
Medroxyprogesterone Acetate (M4),CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C(O)CC4(C)C3CCC21C,,M-1,CC(=O)OC1(C(C)=O)CCC2C3CC(C)(O)C4=CC(=O)C(O)CC4(C)C3CCC21C,,CYP3A4;,0.89,Aliphatic Hydroxylation,0
Methoxymorpholinyldoxorubicin,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC(N4CCOC(OC)C4)C(O)C(C)O3)C(O)=C1C2=O,,PNU-159682,COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(CC(O)(C(=O)CO)CC3OC3CC4C(OC5COC(OC)CN54)C(C)O3)C(O)=C1C2=O,,CYP3A,0.95,Dehydroxylation ,0
Azimilide,CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(C4=CC=C(Cl)C=C4)O3)C2=O)CC1,,,C[N+]1([O-])CCN(CCCCN2C(=O)CN(N=CC3=CC=C(C4=CC=C(Cl)C=C4)O3)C2=O)CC1,,CYP3A4;CYP3A5,0.98,N-Oxidation,0
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,COCCOC(=O)C1=C(C)N=C(C)C(C(=O)OC(C)C)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP3A4,0.35,Dehydrogenation,0
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,CC1=NC(C)=C(C(=O)OC(C)C)C(C2=CC=CC([N+](=O)[O-])=C2)=C1C(=O)OCCO,,CYP3A4,0.34,O-Dementhylation,0
Nimodipine,COCCOC(=O)C1=C(C)NC(C)=C(C(=O)OC(C)C)C1C1=CC=CC([N+](=O)[O-])=C1,,,CC1=C(C(=O)O)C(C2=CC=CC([N+](=O)[O-])=C2)C(C(=O)OC(C)C)=C(C)N1,,CYP3A4,0.98,O-dealkylation,0
nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC(C)C)=C1C1=CC=CC=C1[N+](=O)[O-],,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.38,Dehydrogenation,0
nisoldipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,,COC(=O)C1=C(C)NC(C)=C(C(=O)OC(O)C(C)C)C1C1=CC=CC=C1[N+](=O)[O-],,CYP1A2;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.96,Aliphatic Hydroxylation,0
OXODIPINE,CCOC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC2=C1OCO2,,OXODIPINE(m1),CCOC(=O)C1=C(C)N=C(C)C(C(=O)OC)=C1C1=CC=CC2=C1OCO2,,CYP3A,0.38,Dehydrogenation,0
Tasosartan,CC1=NC(C)=C2CCC(=O)N(CC3=CC=C(C4=CC=CC=C4C4=NNN=N4)C=C3)C2=N1,,enoltasosartanÃ¢â‚¬â€°,CC1=NC(C)=C2C(=N1)N(CC1=CC=C(C3=CC=CC=C3C3=NNN=N3)C=C1)C(=O)CC2O,,CYP3A4,0.92,Aromatic Hydroxylation,0
HEXACHLOROBENZENE,ClC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,Pentachlorophenol,OC1=C(Cl)C(Cl)=C(Cl)C(Cl)=C1Cl,,CYP3A4,0.46,Aliphatic Hydroxylation,0
(-)-Epigallocatechin gallate,O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,"(-)-Epigallocatechin gallate, 3p-OH-glucuronide",O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1)C1=CC(O)=C(O)C(O)=C1,,UGT1A9,0.72,Aromatic -OH glucuronidation,0
(-)-Epigallocatechin gallate,O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,"(-)-Epigallocatechin gallate, 4p-OH-glucuronide",O=C(OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1)C1=CC(O)=C(O)C(O)=C1,,UGT1A9,0.73,Aromatic -OH glucuronidation,0
(-)-Epigallocatechin,OC1=CC(O)=C2CC(O)C(C3=CC(O)=C(O)C(O)=C3)OC2=C1,,"(-)-Epigallocatechin, 3p-OH-glucuronide",O=C(O)C1OC(OC2=CC(C3OC4=CC(O)=CC(O)=C4CC3O)=CC(O)=C2O)C(O)C(O)C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation,0
2-Hydroxychalcone,O=C(C=CC1=CC=CC=C1O)C1=CC=CC=C1,,"2-Hydroxychalcone, 2-OH glucuronide",O=C(C=CC1=CC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT1A9,0.33,Aromatic -OH glucuronidation,0
4-Hydroxychalcone,O=C(C=CC1=CC=C(O)C=C1)C1=CC=CC=C1,,"4-Hydroxychalcone, 4-OH-glucuronide",O=C(C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A9,0.32,Aromatic -OH glucuronidation,0
2p-Hydroxychalcone,O=C(C=CC1=CC=CC=C1)C1=CC=CC=C1O,,"2p-Hydroxychalcone, 2p-OH-glucuronide",O=C(C=CC1=CC=CC=C1)C1=CC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.35,Aromatic -OH glucuronidation,0
4p-Hydroxychalcone,O=C(C=CC1=CC=CC=C1)C1=CC=C(O)C=C1,,"4p-Hydroxychalcone, 4p-OH-glucuronide",O=C(C=CC1=CC=CC=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.32,Aromatic -OH glucuronidation,0
Phloretin,O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(O)C=C1O,,"Phloretin, 2p-OH-glucuronide",O=CC1OC(OC2=CC(O)=CC(O)=C2C(=O)CCC2=CC=C(O)C=C2)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation,0
Phloretin,O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(O)C=C1O,,"Phloretin, 4p-OH-glucuronide",O=C(CCC1=CC=C(O)C=C1)C1=C(O)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1O,,UGT1A9,0.39,Aromatic -OH glucuronidation,0
7-Hydroxychromone,O=C1C=COC2=CC(O)=CC=C12,,"7-Hydroxychromone, 7-OH-glucuronide",O=C(O)C1OC(OC2=CC=C3C(=O)C=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation,0
4-Methylumbelliferone,CC1=CC(=O)OC2=CC(O)=CC=C12,,4-Methylumbelliferone O-glucuronide,CC1=CC(=O)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.46,Aromatic -OH glucuronidation,0
4-Hydroxy-6-methylcoumarin,CC1=CC=C2OC(=O)C=C(O)C2=C1,,"6-methylcoumarin, 4-O-glucuronide",CC1=CC=C2OC(=O)C=C(OC3OC(C(=O)O)C(O)C(O)C3O)C2=C1,,UGT1A9,0.44,Aromatic -OH glucuronidation,0
6-Hydroxy-7-methoxyl-4-phenylcoumarin,COC1=CC2=C(C=C1O)C(C1=CC=CC=C1)=CC(=O)O2,,"7-methoxyl-4-phenylcoumarin, 6-O-glucuronide",COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)C(C1=CC=CC=C1)=CC(=O)O2,,UGT1A9,0.6,Aromatic -OH glucuronidation,0
8-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC(O)=C2OC1=O,,Warfarin 8-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2OC1=O,,UGT1A9,0.74,Aromatic -OH glucuronidation,0
7-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=C(O)C=C2OC1=O,,Warfarin 7-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OC1=O,,UGT1A9,0.73,Aromatic -OH glucuronidation,0
6-Hydroxywarfarin,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC(O)=CC=C2OC1=O,,Warfarin 6-O-glucuronide,CC(=O)CC(C1=CC=CC=C1)C1=C(O)C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2OC1=O,,UGT1A9,0.75,Aromatic -OH glucuronidation,0
Scopoletin,COC1=CC2=C(C=C1O)OC(=O)C=C2,,Scopoletin OH-glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC(=O)C=C2,,UGT1A9,0.44,Aromatic -OH glucuronidation,0
Curcumin,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C(OC)=C2)=CC=C1O,,Curcumin 4-O-glucuronide,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(OC)=C2)=CC=C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation,0
Demethoxycurcumin,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C=C2)=CC=C1O,,Demethoxycurcumin O-glucuronide,COC1=CC(C=CC(=O)CC(=O)C=CC2=CC=C(O)C=C2)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.38,Aromatic -OH glucuronidation,0
Bisdemethoxycurcumin,O=C(C=CC1=CC=C(O)C=C1)CC(=O)C=CC1=CC=C(O)C=C1,,"Bisdemethoxycurcumin, 4-O-glucuronide",O=C(C=CC1=CC=C(O)C=C1)CC(=O)C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation,0
Emodin,CC1=CC(O)=C2C(=O)C3=C(O)C=C(O)C=C3C(=O)C2=C1,,Emodin 3-OH-glucuronide,CC1=CC(O)=C2C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3C(=O)C2=C1,,UGT1A9,0.55,Aromatic -OH glucuronidation,0
Endoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,Endoxifen O-glucuronide,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A9,0.51,Aromatic -OH glucuronidation,0
Endoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCNC)C=C1)C1=CC=CC=C1,,Endoxifen O-sulfate,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,,SULT,0.84,4-OH sulfonation of phenolic compound,0
Enterolactone,O=C1OCC(CC2=CC=CC(O)=C2)C1CC1=CC=CC(O)=C1,,Enterolactone O-glucuronide,O=C1OCC(CC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2)C1CC1=CC=CC(O)=C1,,UGT1A9,0.46,Aromatic -OH glucuronidation,0
1-Naphthol,OC1=CC=CC2=CC=CC=C12,,1-Naphthyl glucuronide,O=C(O)C1OC(OC2=CC=CC3=CC=CC=C23)C(O)C(O)C1O,,UGT1A9,0.14,Aromatic -OH glucuronidation,0
Raloxifene,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(O)=CC=C12,,Raloxifene 6-O-glucuronide,O=C(C1=CC=C(OCCN2CCCCC2)C=C1)C1=C(C2=CC=C(O)C=C2)SC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.78,Aromatic -OH glucuronidation,0
Tyrphostin B42,N#CC(=CC1=CC=C(O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,"Tyrphostin B42, 3-O-glucuronide",N#CC(=CC1=CC=C(O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1)C(O)=NCC1=CC=CC=C1,,UGT1A9,0.45,Aromatic -OH glucuronidation,0
Tyrphostin B42,N#CC(=CC1=CC=C(O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,"Tyrphostin B42, 4-O-glucuronide",N#CC(=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1)C(O)=NCC1=CC=CC=C1,,UGT1A9,0.46,Aromatic -OH glucuronidation,0
7-Hydroxyflavanone,O=C1CC(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,Flavanone 7-O-glucuronide,O=C1CC(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT1A9,0.63,Aromatic -OH glucuronidation,0
Hesperetin,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,Hesperetin 7-O-glucuronide,COC1=CC=C(C2CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.68,Aromatic -OH glucuronidation,0
Hesperetin,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,Hesperetin 3p-O-glucuronide,COC1=CC=C(C2CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.65,Aromatic -OH glucuronidation,0
2p-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2O)OC2=CC=CC=C12,,Flavone 2p-O-glucuronide,O=C(O)C1OC(OC2=CC=CC=C2C2=CC(=O)C3=CC=CC=C3O2)C(O)C(O)C1O,,UGT1A9,0.54,Aromatic -OH glucuronidation,0
"3,4p-Dimethoxy-5,7,3p-trihydroxyflavone",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,"3,4p-Dimethoxy-5,3p-dihydroxyflavone, 7-O-glucuronide",COC1=CC=C(C2=C(OC)C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.74,Aromatic -OH glucuronidation,0
3p-Hydroxyflavone,O=C1C=C(C2=CC=CC(O)=C2)OC2=CC=CC=C12,,Flavone 3p-O-glucuronide,O=C(O)C1OC(OC2=CC=CC(C3=CC(=O)C4=CC=CC=C4O3)=C2)C(O)C(O)C1O,,UGT1A9,0.54,Aromatic -OH glucuronidation,0
"5,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1OC,,"5-Hydroxy-3p,4p,5p-trimethoxyflavone, 7-O-glucuronide",COC1=CC(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.67,Aromatic -OH glucuronidation,0
"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C(=N)NC2=NC=C(C3=CC=CC=C3)C=C21,,"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, N2-glucuronide",CN1C(NC2OC(C(=O)O)C(O)C(O)C2O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,UGT1A1; UGT1A3; UGT1A4),0.46,Glucuronidation of primary aromatic amine,0
N2-OH-PhIP,CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,N2-OH-PhIP-N3-glucuronide,C[N+]1=C(NO)N(C2OC(C(=O)O)C(O)C(O)C2O)C2=NC=C(C3=CC=CC=C3)C=C21,,UGT,0.5,N-Glucuronidation,0
N2-OH-PhIP,CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,N2-OH-PhIP-N2-glucuronide,CN1C(NOC2OC(C(=O)O)C(O)C(O)C2O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,UGT,0.65,Hydroxylamine O-glucuronidation,0
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,Estradiol 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2O,,UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10,0.54,Aromatic -OH glucuronidation,0
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,2-O-methoxyestradiol,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,S-COMT,0.92,O-methylation,0
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,3-O-methoxyestradiol,COC1=CC2=C(C=C1O)C1CCC3(C)C(O)CCC3C1CC2,,S-COMT,0.92,O-methylation,0
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,2-O-methoxyestrone,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(=O)CCC12,,S-COMT,0.92,O-methylation,0
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,3-O-methoxyestrone,COC1=CC2=C(C=C1O)C1CCC3(C)C(=O)CCC3C1CC2,,S-COMT,0.92,O-methylation,0
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,Estrone 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2=O,,UGT1A1; UGT1A7; UGT1A8; UGT1A10,0.54,Aromatic -OH glucuronidation,0
17-beta-estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,17-beta-Estradiol glucuronide,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10,0.61,17-OH glucuronidation of sterol,0
4-hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Tamoxifen 4-O-glucuronide,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A1; UGT1A4; UGT1A6; UGT1A7; UGT1A8; UGT1A9; UGT1A10; UGT2B15; UGT2B17; UGT2B7,0.51,Aromatic -OH glucuronidation,0
tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,,Tamoxifen N-glucuronide,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)C2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,UGT1A4,0.48,N-glucuronidation of tertiary aliphatic amine,0
NÃ¢â‚¬â„¢-nitrosoanabasine,O=NN1CCCCC1C1=CC=CN=C1,,"NÃ¢â‚¬â„¢-nitrosoanabasine, N-glucuronide",O=NN1CCCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT2B10,0.47,N-Glucuronidation,0
Np-nitrosonornicotine,O=NN1CCCC1C1=CC=CN=C1,,"Np-nitrosonornicotine, N-glucuronide",O=NN1CCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT2B10,0.45,N-Glucuronidation,0
Nicotine,CN1CCCC1C1=CC=CN=C1,,Nicotine N-glucuronide,CN1CCCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT1A4; UGT1A9,0.38,N-Glucuronidation,0
Cotinine,CN1C(=O)CCC1C1=CC=CN=C1,,Cotinine N-glucuronide,CN1C(=O)CCC1C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT1A4; UGT1A9,0.46,N-Glucuronidation,0
3-Phenoxybenozoic acid,O=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,3-Phenoxybenzoic acid glucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(OC2=CC=CC=C2)=C1,,UGT,0.31,O-glucuronidation of aromatic acid,0
3-Phenoxybenozoic acid,O=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,3-Phenoxybenzoylglycine,O=C(O)CN=C(O)C1=CC=CC(OC2=CC=CC=C2)=C1,,GLYAT (EC 2.3.1.13),0.49,Glycination of aromatic acid,0
"4-hydroxy-2p,3,5-trichlorobiphenyl",OC1=C(Cl)C=C(C2=CC=CC=C2Cl)C=C1Cl,,"2p,3,5-trichlorobiphenyl, 4-sulfate",O=S(=O)(O)OC1=C(Cl)C=C(C2=CC=CC=C2Cl)C=C1Cl,,SULT1A2,0.65,4-OH sulfonation of phenolic compound,0
Dopamine,NCCC1=CC=C(O)C(O)=C1,,dopamine 3-O-sulfate,NCCC1=CC=C(O)C(OS(=O)(=O)O)=C1,,SULT,0.5,3-OH sulfonation of phenolic compound,0
Dopamine,NCCC1=CC=C(O)C(O)=C1,,Dopamine 4- D-Glucuronide,NCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,,UGT,0.22,Aromatic -OH glucuronidation,0
Gavestinel,O=C(O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,gavestinel 4-O-acyl glucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,UGT,0.73,O-glucuronidation of aromatic acid,0
p-OH-gavestinel,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(O)C=C1,,gavestinel 4-sulfate,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(OS(=O)(=O)O)C=C1,,SULT,0.95,4-OH sulfonation of phenolic compound,0
3-hydroxyguanfacine,N=C(N)N=C(O)CC1=C(Cl)C(O)=CC(O)=C1Cl,,3-hydroxyguanfacine glucuronide,N=C(N)N=C(O)CC1=C(Cl)C(O)=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,UGT,0.45,Aromatic -OH glucuronidation,0
12-Hydroxynevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1O,,12-Hydroxynevirapine O-glucuronide,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.84,Alkyl-OH glucuronidation,0
2-Hydroxynevirapine,CC1=CC(O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,2-Hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,UGT,0.82,Aromatic -OH glucuronidation,0
thymol,CC1=CC=C(C(C)C)C(O)=C1,,thymol O-glucuronide,CC1=CC=C(C(C)C)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.23,Aromatic -OH glucuronidation,0
thymol,CC1=CC=C(C(C)C)C(O)=C1,,thymol sulfate,CC1=CC=C(C(C)C)C(OS(=O)(=O)O)=C1,,SULT,0.49,3-OH sulfonation of phenolic compound,0
Catechol,OC1=CC=CC=C1O,,catechol sulfate,O=S(=O)(O)OC1=CC=CC=C1O,,SULT,0.27,O-sulfonation,0
Catechol,OC1=CC=CC=C1O,,,O=C(O)C1OC(OC2=CC=CC=C2O)C(O)C(O)C1O,,UGT,0.08,Aromatic -OH glucuronidation,0
3-OH-7-ethoxycourmarin,CCOC1=CC2=C(C=CC(=O)O2)C=C1O,,3-OH-7-ethoxycourmarin O-glucuronide,CCOC1=CC2=C(C=CC(=O)O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.48,Aromatic -OH glucuronidation,0
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone N-glucuronide (MX),CC1=C(F)C(NC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,UGT,0.72,Glucuronidation of primary aromatic amine,0
Aminoflavone MIII,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,Aminoflavone MIII O-glucuronide,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NOC4OC(C(=O)O)C(O)C(O)C4O)C(F)=C3)OC2=C1F,,UGT,0.78,Glucuronidation of primary aromatic amine,0
Aminoflavone M-IV,CC1=C(F)C(N)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone M-IV O-sulfate,CC1=C(F)C(N)=C2C(=O)C(OS(=O)(=O)O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,SULT,0.89,O-sulfonation,0
8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,ondansetron 8-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1N2C,,UGT,0.81,Aromatic -OH glucuronidation,0
8-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(O)=C1N2C,,ondansetron 8-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OS(=O)(=O)O)=C1N2C,,SULT,0.93,O-sulfonation,0
7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,ondansetron 7-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C1N2C,,UGT,0.81,Aromatic -OH glucuronidation,0
7-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(O)C=C1N2C,,ondansetron 7-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OS(=O)(=O)O)C=C1N2C,,SULT,0.95,O-sulfonation,0
6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,ondansetron 6-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C1N2C,,UGT,0.82,Aromatic -OH glucuronidation,0
6-OH-ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(O)=CC=C1N2C,,ondansetron 6-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OS(=O)(=O)O)=CC=C1N2C,,SULT,0.96,O-sulfonation,0
linoleyl alcohol,CCCCCC=CCC=CCCCCCCCCO,,linoleyl O-glucuronide,CCCCCC=CCC=CCCCCCCCCOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.12,Alkyl-OH glucuronidation,0
Bilirubin,C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,"6-[3-[2-[[3-(2-carboxyethyl)-5-[(Z)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-2-yl]methyl]-5-[(Z)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-1H-pyrrol-3-yl]propanoyloxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,UGT,0.84,O-glucuronidation of aliphatic acid,0
Bilirubin,C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,"(2S,3S,4S,5R,6S)Ã¢â‚¬Â6Ã¢â‚¬Â{[3Ã¢â‚¬Â(2Ã¢â‚¬Â{[3Ã¢â‚¬Â(2Ã¢â‚¬Âcarboxyethyl)Ã¢â‚¬Â5Ã¢â‚¬Â{[(2Z)Ã¢â‚¬Â4Ã¢â‚¬ÂethenylÃ¢â‚¬Â3Ã¢â‚¬ÂmethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âylidene]methyl}Ã¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âyl]methyl}Ã¢â‚¬Â5Ã¢â‚¬Â{[(2Z)Ã¢â‚¬Â3Ã¢â‚¬ÂethenylÃ¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â2Ã¢â‚¬Âylidene]methyl}Ã¢â‚¬Â4Ã¢â‚¬ÂmethylÃ¢â‚¬Â1HÃ¢â‚¬ÂpyrrolÃ¢â‚¬Â3Ã¢â‚¬Âyl)propanoyl]oxy}Ã¢â‚¬Â3,4,5Ã¢â‚¬ÂtrihydroxyoxaneÃ¢â‚¬Â2Ã¢â‚¬Âcarboxylic acid",C=CC1=C(C)C(O)=NC1=CC1=C(C)C(CCC(=O)O)=C(CC2=C(CCC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C(C)=C(C=C3N=C(O)C(C=C)=C3C)N2)N1,,UGT,0.84,O-glucuronidation of aliphatic acid,0
hyocholic acid,CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,hyocholic acid 24-O-glucuronide,CC(CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,UGT,0.36,Bile acid C24 acyl glucuronidation,0
hyocholic acid,CC(CCC(=O)O)C1CCC2C3C(O)C(O)C4CC(O)CCC4(C)C3CCC12C,,hyocholic acid 6-O-glucuronide,CC(CCC(=O)O)C1CCC2C3C(O)C(OC4OC(C(=O)O)C(O)C(O)C4O)C4CC(O)CCC4(C)C3CCC12C,,UGT,0.38,6-OH glucuronidation of sterol,0
Resveratrol,OC1=CC=C(C=CC2=CC(O)=CC(O)=C2)C=C1,,Resveratrol 3-O-glucuronide,O=C(O)C1OC(OC2=CC(O)=CC(C=CC3=CC=C(O)C=C3)=C2)C(O)C(O)C1O,,UGT1A9,0.24,Aromatic -OH glucuronidation,0
Entacapone,CCN(CC)C(=O)C(C#N)=CC1=CC(O)=C(O)C([N+](=O)[O-])=C1,,,CCN(CC)C(=O)C(C#N)=CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C(O)C([N+](=O)[O-])=C1,,UGT1A9,0.59,Aromatic -OH glucuronidation,0
Ezetimibe,O=C1C(CCC(O)C2=CC=C(F)C=C2)C(C2=CC=C(O)C=C2)N1C1=CC=C(F)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3C(CCC(O)C4=CC=C(F)C=C4)C(=O)N3C3=CC=C(F)C=C3)C=C2)C(O)C(O)C1O,,UGT1A9,0.75,Aromatic -OH glucuronidation,0
Mycophenolic Acid,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)O,,,COC1=C(C)C2=C(C(=O)OC2)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1CC=C(C)CCC(=O)O,,UGT1A9,0.65,Aromatic -OH glucuronidation,0
1-(1-pyrenyl)ethanol,CC(O)C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,,CC(OS(=O)(=O)O)C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,SULT1A1; SULT1E1,0.62,Sulfation of secondary alcohol,0
1-hydroxymethylpyrene,OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,,O=S(=O)(O)OCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,"SULT1A1; SULT1B1, SULT2A1",0.64,Sulfation of primary alcohol,0
1-methoxy-3-indolylmethyl-alcohol,CON1C=C(CO)C2=CC=CC=C21,,,CON1C=C(COS(=O)(=O)O)C2=CC=CC=C21,,SULT1A1,0.81,Sulfation of primary alcohol,0
"2,4-dinitrobenzylalcohol",O=[N+]([O-])C1=CC=C(CO)C([N+](=O)[O-])=C1,,,O=[N+]([O-])C1=CC=C(COS(=O)(=O)O)C([N+](=O)[O-])=C1,,SULT1A1,0.78,Sulfation of primary alcohol,0
2-aminobenzylalcohol,NC1=CC=CC=C1CO,,,NC1=CC=CC=C1COS(=O)(=O)O,,SULT1A1,0.55,Sulfation of primary alcohol,0
"2-hydroxylamino-3-methyl-9H-pyrido[2,3-b]indole",CC1=CC2=C(N=C1NO)NC1=CC=CC=C12,,,CC1=CC2=C(N=C1NOS(=O)(=O)O)NC1=CC=CC=C12,,SULT1A1,0.85,Hydroxylamine O-sulfonation,0
2-hydroxylamino-5-phenylpyridine,ONC1=CC=C(C2=CC=CC=C2)C=N1,,,O=S(=O)(O)ONC1=CC=C(C2=CC=CC=C2)C=N1,,SULT1A1,0.73,Hydroxylamine O-sulfonation,0
5-hydroxymethylfurfural,O=CC1=CC=C(CO)O1,,,O=CC1=CC=C(COS(=O)(=O)O)O1,,SULT1A1,0.57,Sulfation of primary alcohol,0
"7-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene",OC1CCCC2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,O=S(=O)(O)OC1CCCC2=C1C=C1C=CC3=CC=CC4=CC=C2C1=C34,,SULT1A1,0.68,Sulfation of secondary alcohol,0
N-acetyl-N-hydroxy-3-aminobenzanthrone,CC(=O)N(O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,,CC(=O)N(OS(=O)(=O)O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,SULT1A1,0.94,O-sulfonation,0
N-acetyl-N-hydroxy-3-aminobenzanthrone,CC(=O)N(O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,,CC(=O)ON(C(C)=O)C1C=CC2=C3C(=CC=CC31)C(=O)C1=CC=CC=C21,,NAT1; NAT2,0.95,O-acetylation,0
6-hydroxymethylanthanthrene,OCC1=C2C=CC=C3C=CC4=CC5=CC=CC6=CC=C1C(=C65)C4=C32,,,O=S(=O)(O)OCC1=C2C=CC=C3C=CC4=CC5=CC=CC6=CC=C1C(=C65)C4=C32,,SULT1C3,0.64,Sulfation of primary alcohol,0
N-hydroxy-aminophenylnorharman,ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC=C32)C=C1,,,CC(=O)ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC=C32)C=C1,,NAT1; NAT2,0.92,O-acetylation of N-hydroxylarylamine,0
N-hydroxy-aminophenylharman,CC1=NC=CC2=C1N(C1=CC=C(NO)C=C1)C1=CC=CC=C21,,,CC(=O)ONC1=CC=C(N2C3=CC=CC=C3C3=CC=NC(C)=C32)C=C1,,NAT1; NAT2,0.94,O-acetylation of N-hydroxylarylamine,0
N-hydroxy-benzidine,NC1=CC=C(C2=CC=C(NO)C=C2)C=C1,,N-hydroxy-benzidine O-acetyl,CC(=O)ONC1=CC=C(C2=CC=C(N)C=C2)C=C1,,NAT1,0.69,O-acetylation of N-hydroxylarylamine,0
N-hydroxy-2-aminofluorene,ONC1=CC=C2C(=C1)CC1=CC=CC=C12,,"N-hydroxy-2-aminofluorene, O-acetyl",CC(=O)ONC1=CC=C2C(=C1)CC1=CC=CC=C12,,NAT1,0.87,O-acetylation of N-hydroxylarylamine,0
"N-[4-(2,4-dichlorophenoxy)phenyl]hydroxylamine",ONC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1,,"N-[4-(2,4-dichlorophenoxy)phenyl]hydroxylamine O-acetyl",CC(=O)ONC1=CC=C(OC2=CC=C(Cl)C=C2Cl)C=C1,,NAT1,0.82,O-acetylation of N-hydroxylarylamine,0
N‐(2‐methoxyphenyl)hydroxylamine,COC1=CC=CC=C1NO,,"NÃ¢â‚¬Â(2Ã¢â‚¬Âmethoxyphenyl)hydroxylamine, O-acetyl",COC1=CC=CC=C1NOC(C)=O,,NAT1,0.65,O-acetylation of N-hydroxylarylamine,0
isoniazid,NNC(=O)C1=CC=NC=C1,,isoniazid N-acetyl,CC(O)=NNC(=O)C1=CC=NC=C1,,NAT2,0.67,N-acetylation of Hydrazine derivative,0
hydralazine,NN=C1NN=CC2=CC=CC=C12,,hydralazine N-acetyl,CC(O)=NNC1=NN=CC2=CC=CC=C12,,NAT,0.29,N-acetylation of Hydrazine derivative,0
mesalazine,NC1=CC=C(O)C(C(=O)O)=C1,,"mesalazine, N-acetyl",CC(O)=NC1=CC=C(O)C(C(=O)O)=C1,,NAT,0.71,N-acetylation of arylamine,0
Sulfapyridine,NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,,"Sulfapyridine, N-acetyl",CC(O)=NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,,NAT,0.85,N-acetylation of arylamine,0
4-aminobenzoate,NC1=CC=C(C(=O)[O-])C=C1,,4-acetylaminobenzoate,CC([O-])=NC1=CC=C(C(=O)O)C=C1,,NAT,0.63,N-acetylation of arylamine,0
4-amino-3-methylbenzoic acid,CC1=CC(C(=O)O)=CC=C1N,,,CC(O)=NC1=CC=C(C(=O)O)C=C1C,,NAT1; NAT2,0.65,N-acetylation of arylamine,0
"2,3-dimethylaniline",CC1=CC=CC(N)=C1C,," 2,3Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC=CC(C)=C1C,,NAT1; NAT2,0.47,N-acetylation of arylamine,0
"2,4-dimethylaniline",CC1=CC=C(N)C(C)=C1,," 2,4Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC=C(C)C=C1C,,NAT1; NAT2,0.48,N-acetylation of arylamine,0
"2,5-dimethylaniline",CC1=CC=C(C)C(N)=C1,," 2,5Ã¢â‚¬Âdimethylacetanilide",CC(O)=NC1=CC(C)=CC=C1C,,NAT1; NAT2,0.46,N-acetylation of arylamine,0
2-(4-aminobenzamido)pyridine,NC1=CC=C(C(=O)NC2=CC=CC=N2)C=C1,,4Ã¢â‚¬ÂacetamidoÃ¢â‚¬ÂNÃ¢â‚¬Â(pyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl)benzamide,CC(O)=NC1=CC=C(C(=O)NC2=CC=CC=N2)C=C1,,GST,0.84,N-acetylation of arylamine,0
(+)-2-bromo-3-(4-nitrophenyl)propanoic acid,O=C(O)C(Br)CC1=CC=C([N+](=O)[O-])C=C1,,2-(glutathion-S-yl)-3-(4-nitrophenyl)propanoic acid,NC(CCC(O)=NC(CSC(CC1=CC=C([N+](=O)[O-])C=C1)C(=O)O)C(O)=NCC(=O)O)C(=O)O,,GST,0.33,GSH-conjugation of organohalide,0
"1,3,5-trinitrobenzene",O=[N+]([O-])C1=CC([N+](=O)[O-])=CC([N+](=O)[O-])=C1,,"S-(2,4,6-trinitrocyclohexa-2,5-dien-1-yl)glutathione",NC(CCC(O)=NC(CSC1C([N+](=O)[O-])=CC([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GSTA1,0.07,GSH-conjugation of benzene substituted with an electron donating group,0
"1-chloro-2,3-dinitrobenzene",O=[N+]([O-])C1=CC=CC(Cl)=C1[N+](=O)[O-],,"S-(2,3-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=CC([N+](=O)[O-])=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.26,GSH-conjugation,0
"1-chloro-2,4-dinitrobenzene",O=[N+]([O-])C1=CC=C(Cl)C([N+](=O)[O-])=C1,,"S-(2,4-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=C([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.24,GSH-conjugation,0
"1-Chloro-2,4-dinitrobenzene",O=[N+]([O-])C1=CC=C(Cl)C([N+](=O)[O-])=C1,,,NC(CCC(O)=NC(CSC1(Cl)C=CC([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.12,GSH-conjugation,0
Pefloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,,Pefloxacin O-glucuronide,CCN1C=C(C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,,GST,0.75,O-glucuronidation of aromatic acid,0
Brodifacoum,O=C1OC2=CC=CC=C2C(O)=C1C1CC(C2=CC=C(C3=CC=C(Br)C=C3)C=C2)CC2=CC=CC=C21,,Brodifacoum O-glucuronide,O=C(O)C1OC(OC2=C(C3CC(C4=CC=C(C5=CC=C(Br)C=C5)C=C4)CC4=CC=CC=C43)C(=O)OC3=CC=CC=C23)C(O)C(O)C1O,,UGT,0.77,Aromatic -OH glucuronidation,0
Nornalmefene,C=C1CCC2(O)C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,Nornalmefene O-glucuronide,C=C1CCC2(O)C3CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C2(CCN3)C1O5,,UGT,0.9,Aromatic -OH glucuronidation,0
Prechrysophanol,CC1=CC(O)=C2C(O)=C3CC(O)CCC3=CC2=C1,,Prechrysophanol O-glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(O)=C3CC(O)CCC3=CC2=C1,,UGT,0.51,Aromatic -OH glucuronidation,0
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,Lumiracoxib O-glucuronide,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.57,O-glucuronidation of aliphatic acid,0
4-Hydroxy-alpha-thujone,CC(C)C12CC(=O)C(C)(O)C1C2,,"alpha-thujone, 4-O-glucuronide",CC(C)C12CC1C(C)(O)C(=O)C2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.43,Alkyl-OH glucuronidation,0
Scutellarein,O=C1C=C(C2=CC=C(O)C=C2)OC2=CC(O)=C(O)C(O)=C12,,Scutellarein 7-O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C(O)=C2O)C(=O)C=C(C2=CC=C(O)C=C2)O3)C(O)C(O)C1O,,UGT,0.61,Alkyl-OH glucuronidation,0
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,Desogestrel 17-O-glucuronide,C#CC1(OC2OC(C(=O)O)C(O)C(O)C2O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,,UGT,0.49,O-glucuronidation,0
4-Iodobenzoic acid,O=C(O)C1=CC=C(I)C=C1,,4-Iodobenzoyl glyucuronide,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(I)C=C1,,UGT,0.2,O-glucuronidation of aromatic acid,0
Oxoprenolol,C=CCOC1=CC=CC=C1OCC(O)CNC(C)C,,Oxprenolol glucuronide,C=CCOC1=CC=CC=C1OCC(CNC(C)C)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,Alkyl-OH glucuronidation,0
Zomepirac,CC1=C(C(=O)C2=CC=C(Cl)C=C2)N(C)C(CC(=O)O)=C1,,Zomepirac O-glucuronide,CC1=C(C(=O)C2=CC=C(Cl)C=C2)N(C)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.72,O-glucuronidation of aliphatic acid,0
Clioquinol,OC1=C(I)C=C(Cl)C2=CC=CN=C12,,Clioquinol O-glucuronide,O=C(O)C1OC(OC2=C(I)C=C(Cl)C3=CC=CN=C23)C(O)C(O)C1O,,UGT,0.48,Aromatic -OH glucuronidation,0
Quinotolast,O=C1C(C(O)=NC2=NNN=N2)=CC(OC2=CC=CC=C2)=C2C=CC=CN12,,Quinotolast N-glucuronide,O=C(N=C1N=NN(OC2OC(C(=O)O)C(O)C(O)C2O)N1)C1=CC(OC2=CC=CC=C2)=C2C=CC=CN2C1=O,,UGT,0.53,N-glucuronidation,0
RG12525,C1=CC=C(C2=NNN=N2)C(COC2=CC=C(OCC3=CC=C4C=CC=CC4=N3)C=C2)=C1,,RG12525 N2-glucuronide,O=C(O)C1OC(N2N=NC(C3=CC=CC=C3COC3=CC=C(OCC4=CC=C5C=CC=CC5=[NH+]4)C=C3)=N2)C(O)C(O)C1O,,UGT1A1; UGT2B7,0.54,N-glucuronidation of azole,0
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide B,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.67,N-glucuronidation of azole,0
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide C,COC1=CC2=C(C=C1OC)C1=C(C2)C(=[NH+]C2=CC=CC(F)=C2)N(C2OC(C(=O)O)C(O)C([OH2+])C2O)[N-]1,,UGT,0.67,N-glucuronidation of azole,0
JNJ-10198409,COC1=CC2=C(C=C1OC)C1=C(C2)C(=NC2=CC=CC(F)=C2)NN1,,JNJ-10198409 N-glucuronide C,COC1=CC2=C(C=C1OC)C1=C(C2)C(N(C2=CC=CC(F)=C2)C2OC(C(=O)O)C(O)C(O)C2O)=NN1,,UGT1A4; UGT1A9,0.62,N-glucuronidation of azole,0
Midazolam,CC1=NC=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,Midazolam N-glucuronide,CC1=[N+](C2OC(C(=O)O)C(O)C(O)C2O)C=C2CN=C(C3=CC=CC=C3F)C3=CC(Cl)=CC=C3N21,,UGT1A4,0.7,N-glucuronidation of azole,0
Afloqualone,CC1=CC=CC=C1N1C(CF)=NC2=CC=C(N)C=C2C1=O,,Afloqualone N-glucuronide,CC1=CC=CC=C1N1C(CF)=NC2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2C1=O,,UGT1A4,0.73,Glucuronidation of primary aromatic amine,0
N-Acetylbenzidine,CC(O)=NC1=CC=C(C2=CC=C(N)C=C2)C=C1,,"N-Acetylbenzidine, N-glucuronide",CC(O)=NC1=CC=C(C2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,UGT1A1; UGT1A4; UGT1A9,0.25,Glucuronidation of primary aromatic amine,0
retigabine,CCOC(O)=NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1N,,retigabine N2-glucuronide,CCOC(O)=NC1=CC=C(NCC2=CC=C(F)C=C2)C=C1NC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A1; UGT1A9,0.41,Glucuronidation of primary aromatic amine,0
Desmethylclozapine,ClC1=CC=C2NC3=CC=CC=C3C(N3CCNCC3)=NC2=C1,,Desmethylclozapine N-glucuronide,O=C(O)C1OC(N2CCN(C3=NC4=CC(Cl)=CC=C4NC4=CC=CC=C34)CC2)C(O)C(O)C1O,,UGT1A3,0.68,N-glucuronidation,0
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,Desipramine N-glucuronide,CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.51,N-glucuronidation,0
Promethazine,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)N(C)C,,Promethazine N-glucuronide,CC(CN1C2=CC=CC=C2SC2=CC=CC=C21)[N+](C)(C)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.52,N-glucuronidation of tertiary aliphatic amine,0
Loxepine,CN1CCN(C2=NC3=CC=CC=C3OC3=CC=C(Cl)C=C23)CC1,,Loxepine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCN(C2=NC3=CC=CC=C3OC3=CC=C(Cl)C=C23)CC1,,UGT1A3,0.69,N-glucuronidation of tertiary aliphatic amine,0
Clozapine,CN1CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,Clozapine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCN(C2=NC3=CC(Cl)=CC=C3NC3=CC=CC=C23)CC1,,UGT1A3,0.67,N-glucuronidation of tertiary aliphatic amine,0
Ketotifen,CN1CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,Ketotifen N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCC(=C2C3=CC=CC=C3CC(=O)C3=C2C=CS3)CC1,,UGT1A3,0.73,N-glucuronidation of tertiary aliphatic amine,0
Chlorpromazine,CN(C)CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21,,Chlorpromazine N-glucuronide,C[N+](C)(CCCN1C2=CC=CC=C2SC2=CC=C(Cl)C=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.57,N-glucuronidation of tertiary aliphatic amine,0
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,,Doxepin N-glucuronide,C[N+](C)(CCC=C1C2=CC=CC=C2COC2=CC=CC=C12)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.61,N-glucuronidation of tertiary aliphatic amine,0
Tripelennamine,CN(C)CCN(CC1=CC=CC=C1)C1=CC=CC=N1,,Tripelennamine N-glucuronide,C[N+](C)(CCN(CC1=CC=CC=C1)C1=CC=CC=N1)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.45,N-glucuronidation of tertiary aliphatic amine,0
Cyproheptadine,CN1CCC(=C2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1,,Cyproheptadine N-glucuronide,C[N+]1(C2OC(C(=O)O)C(O)C(O)C2O)CCC(=C2C3=CC=CC=C3C=CC3=CC=CC=C23)CC1,,UGT1A3,0.51,N-glucuronidation of tertiary aliphatic amine,0
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,,Imipramine N-glucuronide,C[N+](C)(CCCN1C2=CC=CC=C2CCC2=CC=CC=C21)C1OC(C(=O)O)C(O)C(O)C1O,,UGT1A3,0.51,N-glucuronidation of tertiary aliphatic amine,0
Nirvanol,CCC1(C2=CC=CC=C2)N=C(O)N=C1O,,Nirvanol N-glucuronide,CCC1(C2=CC=CC=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,UGT,0.38,N-glucuronidation,0
Isonicotinoylhydrazine,NNC(=O)C1=CC=NC=C1,,,O=C(NNC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=NC=C1,,UGT,0.21,O-glucuronidation,0
Ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Ketobemidone O-glucuronide,CCC(=O)C1(C2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)CCN(C)CC1,,UGT,0.49,Aromatic -OH glucuronidation,0
Ketobemidone,CCC(=O)C1(C2=CC=CC(O)=C2)CCN(C)CC1,,Ketobemidone sulfate,CCC(=O)C1(C2=CC=CC(OS(=O)(=O)O)=C2)CCN(C)CC1,,SULT,0.81,3-OH sulfonation of phenolic compound,0
4-nitrobenzyl chloride,O=[N+]([O-])C1=CC=C(CCl)C=C1,,S-(4-Nitrobenzyl)glutathione,NC(CCC(O)=NC(CSCC1=CC=C([N+](=O)[O-])C=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.24,GSH-conjugation of organohalide,0
4-nitrobenzyl chloride,O=[N+]([O-])C1=CC=C(CCl)C=C1,,"S-(2,4-dinitrophenyl)glutathione",NC(CCC(O)=NC(CSC1=CC=C([N+](=O)[O-])C=C1[N+](=O)[O-])C(O)=NCC(=O)O)C(=O)O,,GST,0.16,GSH-conjugation,0
monochlorobimane,CC1=C(C)N2C(CCl)=C(C)C(=O)N2C1=O,,Bimane-glutathione,CC1=C(C)N2C(CSCC(N=C(O)CCC(N)C(=O)O)C(=O)CNC(=O)O)=C(C)C(=O)N2C1=O,,GST,0.56,GSH-conjugation of organohalide,0
Prunetin,COC1=CC(O)=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,,COC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)C(C3=CC=C(O)C=C3)=COC2=C1,,UGT1A9,0.61,O-glucuronidation,0
Triiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1)C(=O)O,,,NC(CC1=CC(I)=C(OC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(I)=C2)C(I)=C1)C(=O)O,,UGT,0.48,Aromatic -OH glucuronidation,0
"3-Hydroxy-2p,3p-dimethoxyflavone",COC1=CC=CC(C2=C(O)C(=O)C3=CC=CC=C3O2)=C1OC,,,COC1=CC=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)=C1OC,,UGT1A9,0.67,O-glucuronidation,0
"8-aminoisoindolo (1,2-b)quinazolin-12(10H)-one",NC1=CC=C2N=C3C4=CC=CC=C4C(=O)N3CC2=C1,,,CC(O)=NC1=CC=C2N=C3C4=CC=CC=C4C(=O)N3CC2=C1,,NAT,0.94,N-acetylation of arylamine,0
Irbesartan M8,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2N=N[N+](C3C(O)C(O)C(O)C(C(=O)O)C3O)=N2)C=C1,,UGT,0.63,O-glucuronidation,0
Resokaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C(C3=C(O)C(=O)C4=CC=C(O)C=C4O3)C=C2)C(O)C(O)C1O,,UGT1A9,0.64,Aromatic -OH glucuronidation,0
7-Hydroxy-beta-thujone,CC1C(=O)CC2(C(C)(C)O)CC12,,,CC1C(=O)CC2(C(C)(C)OC3OC(C(=O)O)C(O)C(O)C3O)CC12,,UGT,0.43,Alkyl-OH glucuronidation,0
4-Hydroxy-beta-thujone,CC(C)C12CC(=O)C(C)(O)C1C2,,,CC(C)C12CC(=O)C(C)(OC3OC(C(=O)O)C(O)C(O)C3O)C1C2,,UGT,0.45,Alkyl-OH glucuronidation,0
2-iodobenzyl bromide,BrCC1=CC=CC=C1I,,,NC(CCC(O)=NC(CSC1=CC=CC=C1CBr)C(O)=NCC(=O)O)C(=O)O,,GST,0.12,GSH-conjugation,0
Hexafluoroisopropanol,OC(C(F)(F)F)C(F)(F)F,,,O=C(O)C1OC(OC(C(F)(F)F)C(F)(F)F)C(O)C(O)C1O,,UGT,0.1,Alkyl-OH glucuronidation,0
"2,4-diene-VPA",C=CC=C(CCC)C(=O)O,,,C=CC=C(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.19,O-glucuronidation of aliphatic acid,0
"3,7-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C(O)=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.62,Aromatic -OH glucuronidation,0
"3,7-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,Aromatic -OH glucuronidation,0
Indole-3-acetic-acid,O=C(O)CC1=CNC2=CC=CC=C12,,,O=C(CC1=CNC2=CC=CC=C12)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.47,O-glucuronidation of aliphatic acid,0
Paeonol,COC1=CC=C(C(C)=O)C(O)=C1,,,COC1=CC=C(C(C)=O)C(OS(=O)(=O)O)=C1,,SULT,0.56,Aromatic -OH glucuronidation,0
8-Hydroxy-7-methoxyisoflavone,COC1=CC(O)=C2OC=C(C3=CC=CC=C3)C(=O)C2=C1,,,COC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C2OC=C(C3=CC=CC=C3)C(=O)C2=C1,,UGT1A9,0.6,O-glucuronidation,0
"8,14-diOH-efavirenz",OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2(O)CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2(C#CC3(C(F)(F)F)OC(O)=NC4=C(O)C=C(Cl)C=C43)CC2)C(O)C(O)C1O,,UGT,0.83,O-glucuronidation,0
"4p-hydroxy-2,3p,4-trichlorobiphenyl",OC1=CC=C(C2=CC=C(Cl)C=C2Cl)C=C1Cl,,,O=S(=O)(O)OC1=CC=C(C2=CC=C(Cl)C=C2Cl)C=C1Cl,,SULT,0.66,4-OH sulfonation of phenolic compound,0
Hydroxyoxid acid,CC1(C)C2CCC3(C)C(C2)C(C(=O)O)CCC13O,,,CC1(C)C2CCC3(C)C(C2)C(C(=O)O)CCC13OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.38,Alkyl-OH glucuronidation,0
N-Desmethyl-4-OH- atomoxetine,CC1=CC(O)=CC=C1OC(CCN)C1=CC=CC=C1,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1OC(CCN)C1=CC=CC=C1,,UGT,0.47,Aromatic -OH glucuronidation,0
cis-6-(2-acetylvinylthio)purine,CC(=O)C=CSC1=NC=NC2=C1N=CN2,,,CC([O-])=CC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)SC1=NC=NC2=C1N=CN2,,GST,0.4,GSH-conjugation,0
benzoic acid,O=C(O)C1=CC=CC=C1,,,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT,0.14,O-glucuronidation of aromatic acid,0
N-Desmethyl p-hydroxyrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCN=C3C=CC(O)=CN3)C=C2)S1,,,O=C1N=C(O)C(CC2=CC=C(OCCN=C3C=CC(OS(=O)(=O)O)=CN3)C=C2)S1,,SULT,0.85,O-sulfonation,0
Tizoxanide,O=[N+]([O-])C1=CN=C(N=C(O)C2=CC=CC=C2O)S1,,,O=C(O)C1OC(OC2=CC=CC=C2C(O)=NC2=NC=C([N+](=O)[O-])S2)C(O)C(O)C1O,,UGT,0.55,Aromatic -OH glucuronidation,0
epicatechin metabo5,O=C1CCC(CC2=CC=CC(O)=C2)O1,,,O=C1CCC(CC2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)O1,,UGT,0.41,Aromatic -OH glucuronidation,0
carvone metabo6,C=C(C)C1CC=C(C)C(=O)C1O,,,C=C(C)C1CC=C(C)C(=O)C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.46,Alkyl-OH glucuronidation,0
"5,7,2p-Trihydroxyflavone",O=C1C=C(C2=CC=CC=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=CC=C4O)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation,0
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,,UGT,0.67,17-OH glucuronidation of sterol,0
"N-hydroxy-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine",CN1C(NO)=NC2=NC=C(C3=CC=CC=C3)C=C21,,,CN1C(NOS(=O)(=O)O)=NC2=NC=C(C3=CC=CC=C3)C=C21,,SULT1A1,0.91,Hydroxylamine O-sulfonation,0
Carboxy celecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,,,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,UGT,0.74,O-glucuronidation of aromatic acid,0
Carvedilol,COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2,,,COC1=CC=CC=C1OCCNCC(COC1=CC=CC2=C1C1=CC=CC=C1N2)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.6,Alkyl-OH glucuronidation,0
6-gingerol,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(O)=C1,,,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.38,Aromatic -OH glucuronidation,0
6-gingerol,CCCCCC(O)CC(=O)CCC1=CC=C(OC)C(O)=C1,,,CCCCCC(CC(=O)CCC1=CC=C(OC)C(O)=C1)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.47,O-glucuronidation,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=CC2=C1,,UGT,0.34,Aromatic -OH glucuronidation,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2C=C(O)C=CC2=C1,,UGT,0.35,O-glucuronidation of aliphatic acid,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OS(=O)(=O)O)C=CC2=C1,,SULT1A1; SULT1B1; SULT1E1,0.74,O-sulfonation,0
O-Desmethylnaproxen,CC(C(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,CC(C(=O)OS(=O)(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,SULT1A1; SULT1B1; SULT1E1,0.67,O-sulfonation,0
4-hydroxycyclopenta[def]chrysene,OC1C2=CC=CC3=CC=C4C5=CC=CC=C5C=C1C4=C23,,,O=S(=O)(O)OC1C2=CC=CC3=CC=C4C5=CC=CC=C5C=C1C4=C23,,SULT1E1,0.69,Sulfation of secondary alcohol,0
Rhamnetin,COC1=CC(O)=C2C(=O)C(O)=C(C3=CC=C(O)C(O)=C3)OC2=C1,,,COC1=CC(O)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=C(O)C(O)=C3)OC2=C1,,UGT1A9,0.66,Aromatic -OH glucuronidation,0
4-Fluorophenol,OC1=CC=C(F)C=C1,,,O=C(O)C1OC(OC2=CC=C(F)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,Aromatic -OH glucuronidation,0
"7,3p-Dihydroxyflavone",O=C1C=C(C2=CC=CC(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.57,Aromatic -OH glucuronidation,0
Methyl-4-hydroxybenzoate,CCOC(=O)C1=CC=C(O)C=C1,,,CCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.26,Aromatic -OH glucuronidation,0
13-hydroxyoctadecadienoic acid,CCCCCC(O)C=CC=CCCCCCCCC(=O)O,,,CCCCCC(C=CC=CCCCCCCCC(=O)O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.21,Alkyl-OH glucuronidation,0
13-hydroxyoctadecadienoic acid,CCCCCC(O)C=CC=CCCCCCCCC(=O)O,,,CCCCCC(O)C=CC=CCCCCCCCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.21,O-glucuronidation of aliphatic acid,0
Dihydrodaidzein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,O=C1C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OCC1C1=CC=C(O)C=C1,,UGT1A9,0.63,Aromatic -OH glucuronidation,0
Aminoflavone M-VI,CC1=C(F)C(NO)=C2C(=O)C(O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,,CC1=C(F)C(NO)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,UGT,0.79,Aromatic -OH glucuronidation,0
Etodolac,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,,,CCC1=CC=CC2=C1NC1=C2CCOC1(CC)CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.82,O-glucuronidation of aliphatic acid,0
fenchone metabo3,CC1(C)C(=O)C2(C)CC1CC2O,,,CC1(C)C(=O)C2(C)CC1CC2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.42,Alkyl-OH glucuronidation,0
FYX-051,N#CC1=CC(C2=NC(C3=CC=NC=C3)=NN2)=CC=N1,,,N#CC1=CC(C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)C(C3=CC=NC=C3)=N2)=CC=N1,,UGT1A9,0.32,N-glucuronidation of azole,0
FYX-051,N#CC1=CC(C2=NC(C3=CC=NC=C3)=NN2)=CC=N1,,,[NH+]#CC1=CC(C2=NC(C3=CC=NC=C3)=NN2C2OC(C(=O)O)C(O)C(O)C2O)=CC=N1,,UGT1A9,0.32,N-glucuronidation,0
"3-Hydroxy-7,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(OC)C=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(OC)C=C3O2)C=C1,,UGT1A9,0.61,O-glucuronidation,0
10-hydroxycarbazepine,N=C(O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21,,,N=C(O)N1C2=CC=CC=C2CC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C21,,UGT,0.6,Alkyl-OH glucuronidation,0
O-Desmethyl-2p-OH-Indomethacin phenethylamide,CC1=C(CC(O)=NCC(O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,UGT,0.81,O-glucuronidation,0
5-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC=CC(O)=C12,,,O=C(O)C1OC(OC2=CC=CC3=C2C(=O)C=C(C2=CC=CC=C2)O3)C(O)C(O)C1O,,UGT1A9,0.55,Aromatic -OH glucuronidation,0
Oroxylin A,COC1=C(O)C=C2OC(C3=CC=CC=C3)=CC(=O)C2=C1O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2OC(C3=CC=CC=C3)=CC(=O)C2=C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation,0
7-ethyl-10-hydroxycamptothecin,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(O)C=C12,,,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT1A9,0.93,Aromatic -OH glucuronidation,0
Fenretinide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(O)C=C1,,,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.48,Aromatic -OH glucuronidation,0
"3-Hydroxy-6-methyl-3p,4p-methylenedioxyflavone",CC1=CC=C2OC(C3=CC=C4OCOC4=C3)=C(O)C(=O)C2=C1,,,CC1=CC=C2OC(C3=CC=C4OCOC4=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.66,Aromatic -OH glucuronidation,0
6-Hydroxymelatonin,COC1=CC2=C(C=C1O)NC=C2CCN=C(C)O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCN=C(C)O,,UGT,0.57,Aromatic -OH glucuronidation,0
Sinapinic acid,COC1=CC(C=CC(=O)O)=CC(OC)=C1O,,,COC1=CC(C=CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=CC(OC)=C1O,,UGT,0.4,O-glucuronidation,0
Licofelone M2,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.8,O-glucuronidation of aliphatic acid,0
O-methoxycatechol,COOC1=CC=CC=C1O,,,COC1=CC=CC=C1OS(=O)(=O)O,,SULT,0.2,Aromatic -OH glucuronidation,0
phenethyl isothiocyanate,S=C=NCCC1=CC=CC=C1,,,NC(CCC(O)=NC(CSC([S])=NCCC1=CC=CC=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.17,GSH-conjugation,0
6-hydroxymethylbenzo[a]pyrene,OCC1=C2C=CC=CC2=C2C=CC3=CC=CC4=CC=C1C2=C43,,,O=S(=O)(O)OCC1=C2C=CC=CC2=C2C=CC3=CC=CC4=CC=C1C2=C43,,SULT1B1; SULT1C3,0.64,O-sulfonation,0
Lonidamine,O=C(O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2=CC=CC=C12,,,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=NN(CC2=CC=C(Cl)C=C2Cl)C2=CC=CC=C12,,UGT,0.67,O-glucuronidation,0
"2,2‐dichloro‐2‐fluoroethanol",OCC(F)(Cl)Cl,,,O=C(O)C1OC(OCC(F)(Cl)Cl)C(O)C(O)C1O,,UGT,0.06,O-glucuronidation,0
Geraniol,CC(C)=CCCC(C)=CCO,,,CC(C)=CCCC(C)=CCOS(=O)(=O)O,,GST,0.51,GSH-conjugation,0
Nateglinide,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)O)CC1,,,CC(C)C1CCC(C(O)=NC(CC2=CC=CC=C2)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC1,,UGT,0.49,O-glucuronidation,0
trans-isoeugenol,CC=CC1=CC=C(O)C(OC)=C1,,,CC=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(OC)=C1,,UGT,0.29,O-glucuronidation,0
Clofibric acid,CC(C)(OC1=CC=C(Cl)C=C1)C(=O)O,,,CC(C)(OC1=CC=C(Cl)C=C1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.32,O-glucuronidation,0
N-Hydroxymexiletine,CC1=CC=CC(C)=C1OCC(C)NO,,,CC1=CC=CC(C)=C1OCC(C)NOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.33,O-glucuronidation,0
4-hydroxymethyl ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)O,,,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.74,O-glucuronidation,0
N-OH-ABA,O=C1C2=CC=CC=C2C2=C3C1=CC=CC3=C(NO)C=C2,,,O=C1C2=CC=CC=C2C2=C3C1=CC=CC3=C(NOS(=O)(=O)O)C=C2,,"SULT1A1, SULT1A2",0.93,O-sulfonation,0
"3,5-Dihydroxyflavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation,0
"2-amino-6- methyldipyrido[1,2-a:3p,2p-d]- imidazole (Glu-P-1)",CC1=CC=CN2C1=NC1=C2NC(=N)C=C1,,,CC(O)=NC1=CC=C2N=C3C(C)=CC=CN3C2=N1,,"NAT1,NAT2",0.64,N-acetylation,0
1-iodoethane,CCI,,ethylglutathione,CCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.01,GSH-conjugation,0
Dihydroferulic acid,COC1=CC(CCC(=O)O)=CC=C1O,,,COC1=CC(CCC(=O)O)=CC=C1OS(=O)(=O)O,,SULT,0.64,O-sulfonation,0
4-Propoxyphenol,CCCOC1=CC=C(O)C=C1,,,CCCOC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,Aromatic -OH glucuronidation,0
valproic acid,CCCC(CCC)C(=O)O,,,CCCC(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.13,O-glucuronidation of aliphatic acid,0
Eugenol,C=CCC1=CC=C(O)C(OC)=C1,,,C=CCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(OC)=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation,0
3-ethylphenol,CCC1=CC=CC(O)=C1,,,CCC1=CC=CC(OS(=O)(=O)O)=C1,,SULT,0.47,3-OH sulfonation of phenolic compound,0
Wogonin,COC1=C(O)C=C(O)C2=C1OC(C1=CC=CC=C1)=CC2=O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C(O)C2=C1OC(C1=CC=CC=C1)=CC2=O,,UGT1A9,0.67,O-glucuronidation,0
"3,3p,4p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
fenchone metabo4,CC12CC(O)C(C1)C(C)(C)C2=O,,,CC12CC(OC3OC(C(=O)O)C(O)C(O)C3O)C(C1)C(C)(C)C2=O,,UGT,0.41,O-glucuronidation,0
Sorafenib,CNC(=O)C1=CC(OC2=CC=C(NC(O)=NC3=CC=C(Cl)C(C(F)(F)F)=C3)C=C2)=CC=N1,,,CNC(=O)C1=CC(OC2=CC=C(NC(=O)N(C3=CC=C(Cl)C(C(F)(F)F)=C3)C3OC(C(=O)O)C(O)C(O)C3O)C=C2)=CC=N1,,UGT,0.51,O-glucuronidation,0
4-Iodophenol,OC1=CC=C(I)C=C1,,,O=C(O)C1OC(OC2=CC=C(I)C=C2)C(O)C(O)C1O,,UGT1A9,0.1,O-glucuronidation,0
4-Hydroxyacetophenone,CC(=O)C1=CC=C(O)C=C1,,,CC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.2,O-glucuronidation,0
Triclosan,OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,,O=C(O)C1OC(OC2=CC(Cl)=CC=C2OC2=CC=C(Cl)C=C2Cl)C(O)C(O)C1O,,UGT,0.32,O-glucuronidation,0
Triclosan,OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,,O=S(=O)(O)OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl,,SULT,0.62,Aromatic -OH glucuronidation,0
Combretastatin A4,COC1=CC=C(C=CC2=CC(OC)=C(OC)C(OC)=C2)C=C1O,,,COC1=CC=C(C=CC2=CC(OC)=C(OC)C(OC)=C2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.34,O-glucuronidation,0
2-aminofluorene,NC1=CC=C2C(=C1)CC1=CC=CC=C12,,,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC=C12,,NAT,0.78,N-acetylation,0
Berberrubine,COC1=C(O)C=CC2=CC3=[N+](C=C12)CCC1=CC2=C(C=C13)OCO2,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC2=CC3=[N+](C=C12)CCC1=CC2=C(C=C13)OCO2,,UGT,0.79,O-glucuronidation,0
7-Hydroxy-3-methylflavone,CC1=C(C2=CC=CC=C2)OC2=CC(O)=CC=C2C1=O,,,CC1=C(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2C1=O,,UGT1A9,0.64,O-glucuronidation,0
4-aminoveratrole,COC1=CC=C(N)C=C1OC,,,COC1=CC=C(N=C(C)O)C=C1OC,,NAT,0.62,N-acetylation,0
phentolamine,CC1=CC=C(N(CC2=NCCN2)C2=CC=CC(O)=C2)C=C1,,,CC1=CC=C(N(CC2=NCCN2)C2=CC=CC(OS(=O)(=O)O)=C2)C=C1,,SULT1A3; SULT1A5,0.79,O-sulfonation,0
Resacetophenone,CC(=O)C1=CC=C(O)C=C1O,,,CC(=O)C1=CC=C(O)C=C1OS(=O)(=O)O,,SULT,0.52,O-sulfonation,0
Epinephrine,CNCC(O)C1=CC=C(O)C(O)=C1,,,CNCC(O)C1=CC=C(OS(=O)(=O)O)C(O)=C1,,SULT,0.66,O-sulfonation,0
Diallyl disulfide,C=CCSSCC=C,,,C=CCSSCC=CSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.06,GSH-conjugation,0
"10-hydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene",OC1CCCC2=CC3=CC=C4C=CC=C5C=CC(=C21)C3=C45,,,O=S(=O)(O)OC1CCCC2=CC3=CC=C4C=CC=C5C=CC(=C21)C3=C45,,SULT1E1,0.68,O-sulfonation,0
trovafloxacin,NC1C2CN(C3=NC4=C(C=C3F)C(=O)C(C(=O)O)=CN4C3=CC=C(F)C=C3F)CC12,,,NC1C2CN(C3=NC4=C(C=C3F)C(=O)C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=CN4C3=CC=C(F)C=C3F)CC12,,UGT,0.86,O-glucuronidation,0
2-hydroxymethylpyrene,OCC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,,O=S(=O)(O)OCC1=CC2=CC=C3C=CC=C4C=CC(=C1)C2=C34,,SULT2A1,0.61,O-sulfonation,0
alpha-methyl benzyl alcohol,CC(O)C1=CC=CC=C1,,,CC(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT,0.15,O-glucuronidation,0
Kaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(O)=C(C4=CC=C(O)C=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.66,O-glucuronidation,0
Kaempferol,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.62,O-glucuronidation,0
2-ethylaniline,CCC1=CC=CC=C1N,,,CCC1=CC=CC=C1N=C(C)O,,NAT,0.47,N-acetylation,0
"N-hydroxy-2-amino-6-methyldipyrido[1,2-a:3p,2p-d]-imidazole",CC1=CC=CN2C1=NC1=CC=C(NO)N=C12,,,CC1=CC=CN2C1=NC1=CC=C(NOS(=O)(=O)O)N=C12,,SULT1A1,0.88,O-sulfonation,0
4-nonylphenol,CCCCCCCCCC1=CC=C(O)C=C1,,,CCCCCCCCCC1=CC=C(OS(=O)(=O)O)C=C1,,SULT1C1; SULT1C2,0.59,O-sulfonation,0
Tizanidine M6,OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,,O=C(O)C1OC(OC2=CC(Cl)=C(NC3=NCCN3)C3=NSN=C23)C(O)C(O)C1O,,UGT,0.67,O-glucuronidation,0
Tizanidine M6,OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,,O=S(=O)(O)OC1=CC(Cl)=C(NC2=NCCN2)C2=NSN=C12,,SULT,0.85,O-sulfonation,0
Dulcin,CCOC1=CC=C(NC(=N)O)C=C1,,,CCOC1=CC=C(NC(O)=NC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.26,O-glucuronidation,0
S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)SC=C1,,UGT,0.5,O-glucuronidation,0
S-2-[4-(3-methyl-2-thienyl)phenyl]propionic acid,CC1=C(C2=CC=C(C(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)C(=O)ONCCS(=O)(=O)O)C=C2)SC=C1,,TAU,0.76,Taurine conjugation of aliphatic acid,0
Jaceidin,COC1=CC(C2=C(OC)C(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC)C(=O)C3=C(O)C(OC)=C(O)C=C3O2)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.76,O-glucuronidation,0
menthol,CC1CCC(C(C)C)C(O)C1,,,CC1CCC(C(C)C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,UGT,0.19,O-glucuronidation,0
"5,6-O-DiDesmethyl Donepezil",O=C1C2=CC(O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,,O=C1C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,UGT,0.57,O-glucuronidation,0
"5,6-O-DiDesmethyl Donepezil",O=C1C2=CC(O)=C(O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,,O=C1C2=CC(O)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2CC1CC1CCN(CC2=CC=CC=C2)CC1,,UGT,0.57,O-glucuronidation,0
"3,6,4p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC=C(O)C=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation,0
4p-Carboxylumiracoxib,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O)=C1,,,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.62,O-glucuronidation,0
Norbuprenorphine,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(O)C5=C4C3(CCN1)C2O5,,,COC12CCC3(CC1C(C)(O)C(C)(C)C)C1CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C3(CCN1)C2O5,,UGT,0.91,O-glucuronidation,0
O-Desmethylvenlafaxine,NCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,,,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,,UGT,0.49,O-glucuronidation,0
"2,8-Dihydroxyquinoline",OC1=CC=C2C=CC=C(O)C2=N1,,,O=C(O)C1OC(OC2=CC=C3C=CC=C(O)C3=N2)C(O)C(O)C1O,,UGT,0.34,O-glucuronidation,0
Ketoprofen,CC(C(=O)O)C1=CC=CC(C(=O)C2=CC=CC=C2)=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC(C(=O)C2=CC=CC=C2)=C1,,UGT,0.43,O-glucuronidation,0
1-iodopropane,CCCI,,propyl-glutathione,CCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.01,O-glucuronidation,0
7-hydroxy-12-methylbenz[a]anthracene,CC1=C2C=CC=CC2=C(O)C2=CC=C3C=CC=CC3=C12,,,CC1=C2C=CC=CC2=C(OS(=O)(=O)O)C2=CC=C3C=CC=CC3=C12,,SULT2A1,0.59,O-sulfonation,0
1-iodo-3-phenylpropane,ICCCC1=CC=CC=C1,,3-phenylpropyl-glutathione,NC(CCC(O)=NC(CSCCCC1=CC=CC=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.16,GSH-conjugation,0
4p-OH-aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.56,O-glucuronidation,0
4p-OH-aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.84,O-sulfonation,0
"4-Hydroxy-5-(3p,5p-dihydroxyphenyl)-valeric acid",O=C(O)CCC(O)CC1=CC(O)=CC(O)=C1,,,O=C(CCC(O)CC1=CC(O)=CC(O)=C1)OCOC1OC(C(O)O)C(O)C(O)C1O,,UGT,0.46,O-glucuronidation,0
1-iodobutane,CCCCI,,butyl-glutathione,CCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.02,GSH-conjugation,0
4-hydroxyatomoxetine,CNCCC(OC1=CC=C(O)C=C1C)C1=CC=CC=C1,,,CNCCC(OC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1C)C1=CC=CC=C1,,UGT,0.49,O-glucuronidation,0
7-Hydoxy-5-methylflavone,CC1=CC(O)=CC2=C1C(=O)C=C(C1=CC=CC=C1)O2,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC2=C1C(=O)C=C(C1=CC=CC=C1)O2,,UGT1A9,0.62,O-glucuronidation,0
"6,7,3p-Trihydroxflavone",O=C1C=C(C2=CC=CC(O)=C2)OC2=CC(O)=C(O)C=C12,,,O=C(O)C1OC(OC2=CC3=C(C=C2O)C(=O)C=C(C2=CC=CC(O)=C2)O3)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
Pentaerythritol Dibromide,OCC(CO)(CBr)CBr,,,O=C(O)C1OC(OCC(CO)(CBr)CBr)C(O)C(O)C1O,,UGT,0.1,O-glucuronidation,0
"5-(3p,4p-Dihydroxyphenyl)-gamma-valerolactone-4p-O-methyl",COC1=CC=C(CC2CCC(=O)O2)C=C1O,,,COC1=CC=C(CC2CCC(=O)O2)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.45,O-glucuronidation,0
2-Methoxyestrone,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(=O)CCC12,,,COC1=CC2=C(C=C1OC1OC(O)C(O)C(O)C1O)CCC1C2CCC2(C)C(=O)CCC12,,UGT,0.67,O-glucuronidation,0
Carveol,C=C(C)C1CC=C(C)C(O)C1,,,C=C(C)C1CC=C(C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,UGT,0.32,O-glucuronidation,0
7-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.54,O-glucuronidation,0
Bisphenol A,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(O)C=C1,,,CC(C)(C1=CC=C(O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.28,O-glucuronidation,0
25-Hydroxyvitamin D2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)(C)O,,,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)(C)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.5,O-glucuronidation,0
Edaravone,CC1=NN(C2=CC=CC=C2)C(O)=C1,,,CC1=NN(C2=CC=CC=C2)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.4,O-glucuronidation,0
"6,7-Dihydroxyflavone",O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=C(O)C=C12,,,O=C(O)C1OC(OC2=CC3=C(C=C2O)C(=O)C=C(C2=CC=CC=C2)O3)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation,0
Flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(C2=CC=CC=C2)C(F)=C1,,"UGT2B7, UGT1A1, UGT1A3, UGT1A9, UGT2B4",0.46,O-glucuronidation,0
Losartan,CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCCCC1=[NH+]C(Cl)=C(CO)N1CC1=CC=C(C2=CC=CC=C2C2N=NN(C3OC(C(O)O)C(O)C(O)C3O)N2)C=C1,,"UGT1A1, UGT1A3, UGT1A10. UGT2B7, UGT2B17",0.58,O-glucuronidation,0
N-hydroxy-2-acetylamino-3-methyl-5-phenylpyridine,CC(=O)N(O)C1=NC=C(C2=CC=CC=C2)C=C1C,,,CC(=O)N(OC1OC(C(=O)O)C(O)C(O)C1O)C1=NC=C(C2=CC=CC=C2)C=C1C,,SULT1A1,0.54,O-sulfonation,0
5-OH-paeonol,COC1=CC(O)=C(C(C)=O)C=C1O,,,COC1=CC(OS(=O)(=O)O)=C(C(C)=O)C=C1O,,SULT,0.61,O-sulfonation,0
4-phenoxyaniline,NC1=CC=C(OC2=CC=CC=C2)C=C1,,,CC(O)=NC1=CC=C(OC2=CC=CC=C2)C=C1,,NAT,0.59,N-acetylation,0
N-hydroxy-2-aminobenzanthrone,O=C1C=C2C=C3C=CC4=CC=C(NO)C=C4C3=CC2=CC1,,,O=C1C=C2C=C3C=CC4=CC=C(NOC5OC(C(=O)O)C(O)C(O)C5O)C=C4C3=CC2=CC1,,SULT1A1,0.45,O-sulfonation,0
xanthurenic acid,O=C(O)C1=CC(O)=C2C=CC=C(O)C2=N1,,,O=C(O)C1=CC(O)=C2C=CC=C(OS(=O)(=O)O)C2=N1,,SULT,0.79,O-sulfonation,0
Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,SULT,0.6,O-sulfonation,0
Acetaminophen,CC(O)=NC1=CC=C(O)C=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.22,O-glucuronidation,0
serotonin,NCCC1=CNC2=CC=C(O)C=C12,,,NCCC1=CNC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT,0.47,O-glucuronidation,0
Misonidazole,COCC(O)CN1C=CN=C1[N+](=O)[O-],,,COCC(CN1C=CN=C1[N+](=O)[O-])OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.51,O-glucuronidation,0
3-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,,C#CC1(O)CCC2C3CCC4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC4C3C(=C)CC21CC,,UGT,0.55,O-glucuronidation,0
3-alpha-hydroxydesogestrel,C#CC1(O)CCC2C3CCC4=CC(O)CCC4C3C(=C)CC21CC,,,C#CC1(O)CCC2C3CCC4=CC(OS(=O)(=O)O)CCC4C3C(=C)CC21CC,,SULT,0.8,O-sulfonation,0
"B[a]P 7,8-epoxide",C1=CC2OC2C2=CC3=CC=C4C=CC=C5C=CC(=C12)C3=C45,,,NC(CCC(O)=NC(CSOC1C2=CC3=CC=C4C=CC=C5C=CC(=C2C=CC1O)C3=C45)C(O)=NCC(=O)O)C(=O)O,,GST,0.53,GSH-conjugation,0
4-Chlorophenol,OC1=CC=C(Cl)C=C1,,,O=C(O)C1OC(OC2=CC=C(Cl)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,O-glucuronidation,0
Tyramine,NCCC1=CC=C(O)C=C1,,,NCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT,0.17,O-glucuronidation,0
Minoxidil,N=C1N=C(N2CCCCC2)C=C(N)N1O,,,N=C1N=C(N2CCCCC2)C=C(N)N1OS(=O)(=O)O,,SULT,0.72,O-sulfonation,0
3p-Oxohexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(=O)CCC2)C1=O,,,CN1C(=O)N=C(O)C(C)(C2(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)CCCC(=O)C2)C1=O,,GST,0.56,GSH-conjugation,0
Vitamin D2,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,,C=C1CCC(OC2OC(C(=O)O)C(O)C(O)C2O)CC1=CC=C1CCCC2(C)C1CCC2C(C)C=CC(C)C(C)C,,UGT,0.48,O-glucuronidation,0
5-O-Desmethyl Donepezil,COC1=CC2=C(C=C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,UGT,0.62,O-glucuronidation,0
6-Hydroxyflavone,O=C1C=C(C2=CC=CC=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=CC=C3OC(C4=CC=CC=C4)=CC(=O)C3=C2)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation,0
"4-OH-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,UGT,0.23,O-glucuronidation,0
3-Hydroxy-6-methylflavone,CC1=CC=C2OC(C3=CC=CC=C3)=C(O)C(=O)C2=C1,,,CC1=CC=C2OC(C3=CC=CC=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.59,O-glucuronidation,0
1-iodoheptane,CCCCCCCI,,heptyl-glutathione,CCCCCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.03,GSH-conjugation,0
Tolcapone,CC1=CC=C(C(=O)C2=CC(O)=C(O)C([N+](=O)[O-])=C2)C=C1,,,CC1=CC=C(C(=O)C2=CC(O)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C([N+](=O)[O-])=C2)C=C1,,UGT1A9,0.51,O-glucuronidation,0
4-Nitrophenol,O=[N+]([O-])C1=CC=C(O)C=C1,,,O=C(O)C1OC(OC2=CC=C([N+](=O)[O-])C=C2)C(O)C(O)C1O,,UGT1A9,0.21,O-glucuronidation,0
3-Indole carboxylic acid,O=C(O)C1=CNC2=CC=CC=C12,,,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CNC2=CC=CC=C12,,UGT,0.43,O-glucuronidation,0
Fisetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation,0
Ornidazole,CC1=NC=C([N+](=O)[O-])N1CC(O)CCl,,,CC1=NC=C([N+](=O)[O-])N1CC(CCl)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.58,O-glucuronidation,0
"3-Hydroxy-6,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC(OC)=CC=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC(OC)=CC=C3O2)C=C1,,UGT1A9,0.6,O-glucuronidation,0
3p-Amino-3p-deoxythimidine,CC1=CN(C2CC(N)C(CO)O2)C(=O)N=C1O,,,CC1=CN(C2CC(N)C(COC3C(O)C(O)OC(C(=O)O)C3O)O2)C(=O)N=C1O,,UGT,0.77,O-glucuronidation,0
4-Ethylphenol,CCC1=CC=C(O)C=C1,,,CCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.15,O-glucuronidation,0
MaxiPost,COC1=CC=C(Cl)C=C1C1(F)C(O)=NC2=CC(C(F)(F)F)=CC=C21,,,COC1=CC=C(Cl)C=C1C1(F)C(=O)N(C2OC(C(=O)O)C(O)C(O)C2O)C2=CC(C(F)(F)F)=CC=C21,,UGT2B7,0.6,O-glucuronidation,0
4p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.51,O-glucuronidation,0
4p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.82,O-sulfonation,0
Farnesol,CC(C)=CCCC(C)=CCCC(C)=CCO,,,CC(C)=CCCC(C)=CCCC(C)=CCOC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.14,O-glucuronidation,0
4-n-Butylphenol,CCCCC1=CC=C(O)C=C1,,,CCCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.19,O-glucuronidation,0
Arbidol,CCOC(=O)C1=C(CSC2=CC=CC=C2)N(C)C2=CC(Br)=C(O)C(CN(C)C)=C12,,,CCOC(=O)C1=C(CSC2=CC=CC=C2)N(C)C2=CC(Br)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(CN(C)C)=C12,,UGT,0.83,Aromatic -OH glucuronidation,0
"2,3-Dihydroxynaphthalene",OC1=CC2=CC=CC=C2C=C1O,,,COC1=CC2=CC=CC=C2C=C1O,,COMT,0.69,O-methylation,0
3-Hydroxy-4-aminopyridine,N=C1C=CNC=C1O,,,N=C1C=CNC=C1OS(=O)(=O)O,,SULT,0.41,O-sulfonation,0
Lorazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2Cl)=NC1O,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3Cl)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,UGT,0.68,O-glucuronidation,0
fenchone metabo2,CC1(C)C(=O)C2(C)CCC1C2O,,,CC1(C)C(=O)C2(C)CCC1C2OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.43,O-glucuronidation,0
4-Phenylphenol,OC1=CC=C(C2=CC=CC=C2)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3=CC=CC=C3)C=C2)C(O)C(O)C1O,,UGT1A9,0.16,O-glucuronidation,0
3p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,UGT,0.52,O-glucuronidation,0
3p-OH-diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,,,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OS(=O)(=O)O)=C1Cl,,SULT,0.77,O-sulfonation,0
Irinotecan,CCC1=C2CN3C(=CC4=C(COC(=O)C4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,,,CCC1=C2CN3C(=CC4=C(COC(=O)C4(CC)OC4OC(C(=O)O)C(O)C(O)C4O)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(N4CCCCC4)CC3)C=C12,,UGT,0.94,O-glucuronidation,0
Syringetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1O,,UGT1A9,0.72,O-glucuronidation,0
Syringetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC(OC)=C1O,,UGT1A9,0.67,O-glucuronidation,0
6-Methoxyluteolin,COC1=C(O)C=C2OC(C3=CC=C(O)C(O)=C3)=CC(=O)C2=C1O,,,COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2OC(C3=CC=C(O)C(O)=C3)=CC(=O)C2=C1O,,UGT1A9,0.66,O-glucuronidation,0
morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,,,CN1CCC23C4=C5C=CC(O)=C4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,,UGT,0.9,O-glucuronidation,0
morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,,,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)C=CC3C1C5,,UGT,0.9,O-glucuronidation,0
Chrysin,O=C1C=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.58,O-glucuronidation,0
Quinagolide,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2CC3=C(O)C=CC=C3CC21,,,CCCN1CC(NS(=O)(=O)N(CC)CC)CC2CC3=C(C=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)CC21,,UGT,0.69,O-glucuronidation,0
"4,5-Dihydrodrospirenone",CC12CCC(O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,,,CC12CCC(S(=O)(=O)O)CC1C1CC1C1C2CCC2(C)C1C1CC1C21CCC(=O)O1,,SULT,0.75,O-sulfonation,0
fenchone metabo1,CC12CCC(C1)C(C)(CO)C2=O,,,CC12CCC(C1)C(C)(COC1OC(C(=O)O)C(O)C(O)C1O)C2=O,,UGT,0.37,O-glucuronidation,0
"7,3p,4p-Trihydroxyflavone",O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=C(O)C(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
Caffeic Acid,O=C(O)C=CC1=CC=C(O)C(O)=C1,,,O=C(O)C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,,UGT1A9,0.28,O-glucuronidation,0
Caffeic Acid,O=C(O)C=CC1=CC=C(O)C(O)=C1,,,O=C(O)C=CC1=CC=C(O)C(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT1A9,0.27,O-glucuronidation,0
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation,0
sulfamerazine,CC1=CC=NC(NS(=O)(=O)C2=CC=C(N)C=C2)=N1,,,CC(O)=NC1=CC=C(S(=O)(=O)NC2=NC=CC(C)=N2)C=C1,,NAT,0.87,N-acetylation,0
Dihyroxy-1H-indole,OC1=CC2=C(C=C1O)NC=C2,,,O=C(O)C1OC(OC2=CC3=C(C=CN3)C=C2O)C(O)C(O)C1O,,UGT,0.31,O-glucuronidation,0
5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,UGT,0.51,O-glucuronidation,0
5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,SULT,0.81,O-sulfonation,0
M23OH,CCCCC1=NC2=C(O)C=NN2C(N)=C1,,,CCCCC1=NC2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=NN2C(N)=C1,,UGT,0.64,O-glucuronidation,0
M23OH,CCCCC1=NC2=C(O)C=NN2C(N)=C1,,,CCCCC1=NC2=C(OS(=O)(=O)O)C=NN2C(N)=C1,,SULT,0.86,O-sulfonation,0
Fraxetin,COC1=CC2=C(OC(=O)C=C2)C(O)=C1O,,,COC1=CC2=C(OC(=O)C=C2)C(O)=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.5,O-glucuronidation,0
17-beta estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2O,,"UGT1A1, UGT1A3",0.55,O-glucuronidation,0
"3,2p-Dihydroxyflavone",O=C1C(O)=C(C2=CC=CC=C2O)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3O)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
Dexmedetomidine,CC1=CC=CC(C(C)C2=CN=CN2)=C1C,,,CC1=CC=CC(C(C)C2=CN(C3OC(C(=O)O)C(O)C(O)C3O)C=[NH+]2)=C1C,,UGT2B20; UGT1A4,0.4,O-glucuronidation,0
Dexmedetomidine,CC1=CC=CC(C(C)C2=CN=CN2)=C1C,,,CC1=CC=CC(C(C)C2=CN=CN2C2OC(C(=O)O)C(O)C(O)C2O)=C1C,,UGT2B20; UGT1A4,0.37,O-glucuronidation,0
4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol,CN(CCCC(O)C1=CC=CN=C1)N=O,,,CN(CCCC(O)C1=CC=C[N+](C2OC(C(=O)O)C(O)C(O)C2O)=C1)N=O,,UGT,0.33,O-glucuronidation,0
3-Hydroxy-4p-methoxyflavone,COC1=CC=C(C2=C(O)C(=O)C3=CC=CC=C3O2)C=C1,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)C=C1,,UGT1A9,0.58,O-glucuronidation,0
"Aflatoxin B1 exo 8,9-epoxide",COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC2OC21,,,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C1O,,GST1A1; GST1A2; GSTM1; GSTM3; GSTP1,0.88,GSH-conjugation,0
Gypsogenin,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(O)C(C)(C=O)C5CCC43C)C2C1,,,CC1(C)CCC2(C(=O)O)CCC3(C)C(=CCC4C5(C)CCC(OC6OC(C(=O)O)C(O)C(O)C6O)C(C)(C=O)C5CCC43C)C2C1,,UGT,0.55,O-glucuronidation,0
p-Toluidine,CC1=CC=C(N)C=C1,,,CC(O)=NC1=CC=C(C)C=C1,,NAT,0.45,N-acetylation,0
Geraldol,COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)=CC=C1O,,UGT1A9,0.63,O-glucuronidation,0
3-Hydroxyflavone,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.55,O-glucuronidation,0
Myricetin,O=C1C(O)=C(C2=CC(O)=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC(O)=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation,0
4-Methylphenol,CC1=CC=C(O)C=C1,,,CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.11,O-glucuronidation,0
Biochanin A,COC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1O,,,COC1=CC=C2C(=O)C(C3=CC=CC=C3)=COC2=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation,0
Datiscetin,O=C1C(O)=C(C2=CC=CC=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3O)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation,0
"3,7,3p-Trihydroxyflavone",O=C1C(O)=C(C2=CC=CC(O)=C2)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC(O)=C3)OC3=CC(O)=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
Limonen-10-ol,C=C(C)C1CC=C(CO)CC1,,,C=C(C)C1CC=C(COC2OC(C(=O)O)C(O)C(O)C2O)CC1,,UGT,0.27,O-glucuronidation,0
Nirvanol (N-demethylmephenytoin,CCC1(C2=CC=C(O)C=C2)N=C(O)N=C1O,,,CCC1(C2=CC=C(O)C=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,UGT,0.41,O-glucuronidation,0
Galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(O)=C(C4=CC=CC=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.65,O-glucuronidation,0
Galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation,0
7-Hydroxy-4p-methoxyflavone,COC1=CC=C(C2=CC(=O)C3=CC=C(O)C=C3O2)C=C1,,,COC1=CC=C(C2=CC(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1,,UGT1A9,0.58,O-glucuronidation,0
3-Hydroxy-3p-methoxyflavone,COC1=CC=CC(C2=C(O)C(=O)C3=CC=CC=C3O2)=C1,,,COC1=CC=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=CC=C3O2)=C1,,UGT1A9,0.59,O-glucuronidation,0
1-iodomethane,CI,,methylglutathione,CSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.0,GSH-conjugation of organohalide,0
cis-Dibromochrysanthemic acid,CC1(C)C(C=C(Br)Br)C1C(=O)O,,,CC1(C)C(C=C(Br)Br)C1C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.36,O-glucuronidation,0
N-Acetyl-5-HT,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,,CC(O)=NCCC1=CNC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT,0.51,O-glucuronidation,0
N-Acetyl-5-HT,CC(O)=NCCC1=CNC2=CC=C(O)C=C12,,,CC(O)=NCCC1=CNC2=CC=C(OS(=O)(=O)O)C=C12,,SULT,0.82,O-sulfonation,0
4-Cyclopentylphenol,OC1=CC=C(C2CCCC2)C=C1,,,O=C(O)C1OC(OC2=CC=C(C3CCCC3)C=C2)C(O)C(O)C1O,,UGT1A9,0.25,O-glucuronidation,0
2-Methoxy-estradiol-17beta,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CCC1C2CCC2(C)C(O)CCC12,,UGT,0.59,O-glucuronidation,0
"5-Hydroxy, 6-methoxy duloxetine",CNCCC(OC1=CC=CC2=C(O)C(OC)=CC=C12)C1=CC=CO1,,,CNCCC(OC1=CC=CC2=C(OS(=O)(=O)O)C(OC)=CC=C12)C1=CC=CO1,,SULT,0.8,O-sulfonation,0
4-Bromophenol,OC1=CC=C(Br)C=C1,,,O=C(O)C1OC(OC2=CC=C(Br)C=C2)C(O)C(O)C1O,,UGT1A9,0.11,O-glucuronidation,0
Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,,Hydromorphone 3-sulfate,CN1CCC23C4=C5C=CC(OS(=O)(=O)O)=C4OC2C(=O)CCC3C1C5,,SULT,0.94,O-sulfonation,0
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.78,O-glucuronidation,0
2-Hydroxymethyatomoxetine,CNCCC(OC1=CC=CC=C1CO)C1=CC=CC=C1,,,CNCCC(OC1=CC=CC=C1COC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,UGT,0.49,O-glucuronidation,0
1-iodopentane,CCCCCI,,pentyl-glutathione,CCCCCSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.02,GSH-conjugation,0
O-Desmethyl-tramado,CN(C)CC1CCCCC1(O)C1=CC=CC(O)=C1,,,CN(C)CC1CCCCC1(O)C1=CC=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.56,O-glucuronidation,0
7-Hydroxy-6-methoxyisoflavone,COC1=CC2=C(C=C1O)OC=C(C1=CC=CC=C1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC=C(C1=CC=CC=C1)C2=O,,UGT1A9,0.6,O-glucuronidation,0
OT-7100 M5,CCCCC1=NC2=CC=NN2C(N)=C1,,,CCCCC1=NC2=CC=NN2C(NC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.51,O-glucuronidation,0
OT-7100 M5,CCCCC1=NC2=CC=NN2C(N)=C1,,,CCCCC1=NC2=CC=NN2C(NS(=O)(=O)O)=C1,,SULT,0.75,O-sulfonation,0
Erlotinib M18,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC)=C(O)C=C23)=C1,,,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC)=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C23)=C1,,UGT,0.66,O-glucuronidation,0
zaltoprofen,CC(C(=O)O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2SC3=CC=CC=C3C(=O)CC2=C1,,UGT,0.59,O-glucuronidation,0
4p-OH-triamterene,N=C1NC2=NC(=N)C(C3=CC=C(O)C=C3)=NC2=C(N)N1,,,N=C1NC2=NC(=N)C(C3=CC=C(OS(=O)(=O)O)C=C3)=NC2=C(N)N1,,SULT,0.93,O-sulfonation,0
4-Ethoxyphenol,CCOC1=CC=C(O)C=C1,,,CCOC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.15,O-glucuronidation,0
4-Hydroxyduloxetine,CNCCC(OC1=CC=C(O)C2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C12)C1=CC=CS1,,UGT,0.57,O-glucuronidation,0
Pterostilbene,COC1=CC(C=CC2=CC=C(O)C=C2)=CC(OC)=C1,,,COC1=CC(C=CC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)=CC(OC)=C1,,UGT1A9,0.31,O-glucuronidation,0
6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,UGT,0.49,O-glucuronidation,0
6-OH-harmaline,CC1=NC=CC2=C1NC1=CC(O)=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OS(=O)(=O)O)=CC=C12,,SULT,0.82,O-sulfonation,0
7-OH-efavirenz,OC1=NC2=CC(O)=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2=CC3=C(C=C2Cl)C(C#CC2CC2)(C(F)(F)F)OC(O)=N3)C(O)C(O)C1O,,UGT,0.78,O-glucuronidation,0
6-O-Desmethyl Donepezil,COC1=CC2=C(C=C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,UGT,0.61,O-glucuronidation,0
Morin,O=C1C(O)=C(C2=CC=C(O)C=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3O)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.65,O-glucuronidation,0
6-OH-MXAA,CC1=C(CO)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,,CC1=C(COC2OC(C(=O)O)C(O)C(O)C2O)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,UGT,0.62,O-glucuronidation,0
Procainamide,CCN(CC)CCNC(=O)C1=CC=C(N)C=C1,,,CCN(CC)CCNC(=O)C1=CC=C(N=C(C)O)C=C1,,NAT,0.76,N-acetylation of arylamine,0
"3,4p-Dihydroxyfavone",O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC=CC=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC=CC=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.56,O-glucuronidation,0
Glycitein,COC1=CC2=C(C=C1O)OC=C(C1=CC=C(O)C=C1)C2=O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)OC=C(C1=CC=C(O)C=C1)C2=O,,UGT1A9,0.61,7-O-glucuronidation of isoflavone,0
N-Desmethyl o-hydroxyrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3O)C=C2)S1,,,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OS(=O)(=O)O)C=C2)S1,,SULT,0.82,O-sulfonation,0
(11S)-11-hydroperoxylinoleic acid,CCCCCC=CC(C=CCCCCCCCC(=O)O)OO,,,CCCCCC=CC(C=CCCCCCCCC(=O)O)OOSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.25,GSH-conjugation,0
Naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,COC1=CC=C2C=C(C(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=CC2=C1,,UGT,0.37,O-glucuronidation of aliphatic acid,0
Flavopiridol,CN1CCC(C2=C(O)C=C(O)C3=C2OC(C2=CC=CC=C2Cl)=CC3=O)C(O)C1,,,CN1CCC(C2=C3OC(C4=CC=CC=C4Cl)=CC(=O)C3=C(O)C=C2OC2OC(C(=O)O)C(O)C(O)C2O)C(O)C1,,UGT1A9,0.8,Aromatic -OH glucuronidation,0
5-OH-resacetophenone,CC(=O)C1=CC(O)=C(O)C=C1O,,,CC(=O)C1=CC(OS(=O)(=O)O)=C(O)C=C1O,,SULT,0.61,O-sulfonation,0
15-alpha-hydroxydesogestrel,C#CC1(O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,,,C#CC1(OC2OC(C(=O)O)C(O)C(O)C2O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,,UGT,0.54,O-glucuronidation,0
cyclic N-Acetylserotonin,CC(=O)N1CCC2=C1NC1=CC=C(O)C=C21,,,CC(=O)N1CCC2=C1NC1=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C21,,UGT,0.71,O-glucuronidation,0
7-Hydroxy-2p-methoxyflavone,COC1=CC=CC=C1C1=CC(=O)C2=CC=C(O)C=C2O1,,,COC1=CC=CC=C1C1=CC(=O)C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2O1,,UGT1A9,0.65,O-glucuronidation,0
8-OH efivarenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2=CC(Cl)=CC3=C2N=C(O)OC3(C#CC2CC2)C(F)(F)F)C(O)C(O)C1O,,UGT,0.78,O-glucuronidation,0
fenchone metabo5,CC12CCC(O)(C1)C(C)(C)C2=O,,,CC12CCC(OC3OC(C(=O)O)C(O)C(O)C3O)(C1)C(C)(C)C2=O,,UGT,0.44,O-glucuronidation,0
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
Maackiain,OC1=CC=C2C(=C1)OCC1C3=CC4=C(C=C3OC21)OCO4,,,O=C(O)C1OC(OC2=CC=C3C(=C2)OCC2C4=CC5=C(C=C4OC32)OCO5)C(O)C(O)C1O,,UGT1A9,0.77,O-glucuronidation,0
O-Desmethylgalantamine,CN1CCC23C=CC(O)CC2OC2=C(O)C=CC(=C23)C1,,,CN1CCC23C=CC(O)CC2OC2=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=CC(=C23)C1,,UGT,0.86,O-glucuronidation,0
O-Desmethylgalantamine,CN1CCC23C=CC(O)CC2OC2=C(O)C=CC(=C23)C1,,,CN1CCC23C=CC(O)CC2OC2=C(OS(=O)(=O)O)C=CC(=C23)C1,,SULT,0.92,O-sulfonation,0
Diosmetin,COC1=CC=C(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,,COC1=CC=C(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1O,,UGT1A9,0.64,Aromatic O-glucuronidation,0
"5-(3p,4p,5p-Trihydroxyphenyl)-gamma-valerolactone",O=C1CCC(CC2=CC(O)=C(O)C(O)=C2)O1,,,O=C1CCC(CC2=CC(O)=C(O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C2)O1,,UGT,0.42,O-glucuronidation,0
carvacrol,CC1=CC=C(C(C)C)C=C1O,,,CC1=CC=C(C(C)C)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.22,O-glucuronidation,0
carvacrol,CC1=CC=C(C(C)C)C=C1O,,,CC1=CC=C(C(C)C)C=C1OS(=O)(=O)O,,SULT,0.5,O-sulfonation,0
11-Hydroxyprogesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3C(O)CC12C,,,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3C(OC3OC(C(=O)O)C(O)C(O)C3O)CC12C,,UGT,0.55,O-glucuronidation,0
2-Hydroxydoxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(O)C=C12,,,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,UGT,0.64,O-glucuronidation,0
N-Carbamoyllorcaserin,CC1CN(C(=O)O)CCC2=CC=C(Cl)C=C21,,,CC1CN(C(=O)OC2OC(C(=O)O)C(C)C(C)C2C)CCC2=CC=C(Cl)C=C21,,UGT,0.49,O-glucuronidation,0
Suprofen,CC(C(=O)O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(C(=O)C2=CC=CS2)C=C1,,UGT,0.49,O-glucuronidation,0
Indomethacin,COC1=CC=C2C(=C1)C(CC(=O)O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,UGT,0.8,O-glucuronidation,0
Norpatchoulenol,CC1(C)C2CCC3(C)C(C=CCC13O)C2,,,CC1(C)C2CCC3(C)C(C=CCC13OC1OC(C(=O)O)C(O)C(O)C1O)C2,,UGT,0.39,O-glucuronidation,0
5-OH-aceclofenac,O=C(O)COC(=O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)COC(=O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,UGT,0.56,O-glucuronidation,0
5-OH-aceclofenac,O=C(O)COC(=O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)COC(=O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,SULT,0.84,O-sulfonation,0
3-Hydroxy-2p-methoxyflavone,COC1=CC=CC=C1C1=C(O)C(=O)C2=CC=CC=C2O1,,,COC1=CC=CC=C1C1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(=O)C2=CC=CC=C2O1,,UGT1A9,0.64,O-glucuronidation,0
Licofelone M4,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,,,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,UGT,0.78,O-glucuronidation,0
Chrysoeriol,COC1=CC(C2=CC(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=CC(=O)C3=C(O)C=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC=C1O,,UGT1A9,0.65,O-glucuronidation,0
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,,,NC1=CC=C(S(=O)(=O)C2=CC=C([NH+]([O-])SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C=C2)C=C1,,GST,0.3,GSH-conjugation,0
S-MTPPA,CC1=C(C2=CC=C(C(C)(C)C(=O)O)C=C2)SC=C1,,,CC1=C(C2=CC=C(C(C)(C)C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)SC=C1,,UGT,0.51,O-glucuronidation,0
"8-OH-2,3,7-TriCDD",OC1=CC2=C(C=C1Cl)OC1=CC(Cl)=C(Cl)C=C1O2,,,O=C(O)C1OC(OC2=CC3=C(C=C2Cl)OC2=CC(Cl)=C(Cl)C=C2O3)C(O)C(O)C1O,,UGT,0.36,O-glucuronidation,0
Oxazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,UGT,0.64,O-glucuronidation,0
3p-OH-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,,,CN1C(=O)N=C(O)C(C)(C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)CCC2)C1=O,,UGT,0.78,O-glucuronidation,0
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(O)=NC(=O)N=C1O,,UGT (primary),0.61,O-glucuronidation,0
p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(O)=NC(=O)N=C1O,,SULT,0.89,O-sulfonation,0
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,,,CC1=CC(NS(=O)(=O)C2=CC=C(NC3OC(C(=O)O)C(O)C(O)C3O)C=C2)=NO1,,UGT,0.5,O-glucuronidation,0
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,,,CC(O)=NC1=CC=C(S(=O)(=O)NC2=NOC(C)=C2)C=C1,,"NAT1, NAT2",0.88,N-acetylation of arylamine,0
4-n-Propylphenol,CCCC1=CC=C(O)C=C1,,,CCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,O-glucuronidation,0
Butyl-4-hydroxybenzoate,CCCCOC(=O)C1=CC=C(O)C=C1,,,CCCCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.3,O-glucuronidation,0
Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.64,O-glucuronidation,0
Taurocholic acid,CC(CCC(O)=NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CC(O)C12C,,,CC(CCC(O)=NCCS(=O)(=O)O)C1CCC2C3C(O)CC4CC(OS(=O)(=O)O)CCC4(C)C3CC(O)C12C,,SULT,0.78,O-sulfonation,0
Propranolol,CC(C)NCC(O)COC1=CC=CC2=CC=CC=C12,,,CC(C)NCC(COC1=CC=CC2=CC=CC=C12)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation,0
"3,7-Dihydroxy-3p,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,,COC1=CC=C(C2=C(O)C(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)C=C1OC,,UGT1A9,0.69,O-glucuronidation,0
"3,7-Dihydroxy-3p,4p-dimethoxyflavone",COC1=CC=C(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,,COC1=CC=C(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)C=C1OC,,UGT1A9,0.64,O-glucuronidation,0
Erlotinib M16,C#CC1=CC(NC2=NC=NC3=CC(OCCOC)=C(OCCOC)C=C23)=CC=C1O,,,C#CC1=CC(NC2=NC=NC3=CC(OCCOC)=C(OCCOC)C=C23)=CC=C1OS(=O)(=O)O,,SULT,0.88,O-sulfonation,0
Equol,OC1=CC=C(C2COC3=CC(O)=CC=C3C2)C=C1,,,O=C(O)C1OC(OC2=CC=C3CC(C4=CC=C(O)C=C4)COC3=C2)C(O)C(O)C1O,,UGT1A9,0.52,O-glucuronidation,0
4-Hydroxybenzophenone,O=C(C1=CC=CC=C1)C1=CC=C(O)C=C1,,,O=C(C1=CC=CC=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.25,O-glucuronidation,0
4p-Hydroxyfenoprofen,CC(C(=O)O)C1=CC=CC(OC2=CC=C(O)C=C2)=C1,,,CC(C(=O)O)C1=CC=CC(OC2=CC=C(OC3C(O)C(O)OC(C(=O)O)C3O)C=C2)=C1,,UGT,0.41,O-glucuronidation,0
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,,,NC(CCC(O)=NC(CSOC1CCOP(=O)(NCCCl)N1CCCl)C(O)=NCC(=O)O)C(=O)O,,GST,0.57,GSH-conjugation,0
"4p,5-diOH-diclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.54,O-glucuronidation,0
"4p,5-diOH-diclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,SULT,0.83,O-sulfonation,0
15-Hydroxypatchoulol,CC1(C)C2CCC3(C)C(C2)C(CO)CCC13O,,,CC1(C)C2CCC3(C)C(C2)C(COC2OC(C(=O)O)C(O)C(O)C2O)CCC13O,,UGT,0.3,O-glucuronidation,0
Seratrodast,CC1=C(C)C(=O)C(C(CCCCCC(=O)O)C2=CC=CC=C2)=C(C)C1=O,,,CC1=C(C)C(=O)C(C(CCCCCC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)=C(C)C1=O,,UGT,0.65,O-glucuronidation,0
Isorhamnetin,COC1=CC(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=C(O)C=C(O)C=C3O2)=CC=C1O,,UGT1A9,0.66,O-glucuronidation,0
Thienorphine,COC12CCC3(CC1C(C)(O)CCC1=CC=CS1)C1CC4=CC=C(O)C5=C4C3(CCN1CC1CC1)C2O5,,,COC12CCC3(CC1C(C)(O)CCC1=CC=CS1)C1CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C3(CCN1CC1CC1)C2O5,,UGT,0.92,O-glucuronidation,0
Luteolin,O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=C(O)C(O)=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.62,O-glucuronidation,0
Luteolin,O=C1C=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(C3=CC(=O)C4=C(O)C=C(O)C=C4O3)=CC=C2O)C(O)C(O)C1O,,UGT1A9,0.61,O-glucuronidation,0
3-Hydroxy-6-methoxyflavone,COC1=CC=C2OC(C3=CC=CC=C3)=C(O)C(=O)C2=C1,,,COC1=CC=C2OC(C3=CC=CC=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.59,O-glucuronidation,0
"7,2p-Dihydroxyflavone",O=C1C=C(C2=CC=CC=C2O)OC2=CC(O)=CC=C12,,,O=C(O)C1OC(OC2=CC=C3C(=O)C=C(C4=CC=CC=C4O)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.6,O-glucuronidation,0
4-Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,,,O=C(O)C1OC(OC2=CC=C(C3(C4=CC=CC=C4)N=C(O)N=C3O)C=C2)C(O)C(O)C1O,,UGT,0.63,O-glucuronidation,0
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCOC1=NC2=CC=CC(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,UGT1A3,0.79,O-glucuronidation,0
Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,,,CCOC1=[NH+]C2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)N=N2)C=C1,,UGT1A3,0.75,O-glucuronidation,0
Formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,,COC1=CC=C(C2=COC3=CC(OC4OC(C(=O)O)C(O)C(O)C4O)=CC=C3C2=O)C=C1,,UGT1A9,0.58,O-glucuronidation,0
Phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,,O=C(O)C1OC(N2C(=O)C(C3=CC=CC=C3)(C3=CC=CC=C3)N=C2O)C(O)C(O)C1O,,UGT,0.37,O-glucuronidation,0
"benzo[a]pyrene-7,8-diol",OC1=CC=C2C(=C1O)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,O=C(O)C1OC(OC2=C(O)C=CC3=C2C=C2C=CC4=CC=CC5=CC=C3C2=C45)C(O)C(O)C1O,,UGT1A1,0.18,O-glucuronidation,0
6-Hydroxymethyletoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(CO)N=C2)C=C1,,,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(COC3OC(C(=O)O)C(O)C(O)C3O)N=C2)C=C1,,UGT,0.68,O-glucuronidation,0
"N-hydroxy-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline",CC1=CN=C2C=CC3=C(N=C(NO)N3C)C2=N1,,,CC1=CN=C2C=CC3=C(N=C(NOC4OC(C(=O)O)C(O)C(O)C4O)N3C)C2=N1,,UGT1A1,0.61,O-glucuronidation,0
Galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,,CN1CCC23C=CC(O)CC2OC2=C(OS(=O)(=O)O)C=CC(=C23)C1,,UGT,0.92,O-glucuronidation,0
4-Isopropylphenol,CC(C)C1=CC=C(O)C=C1,,,CC(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.17,O-glucuronidation,0
"3,6-Dihydroxyfavone",O=C1C(O)=C(C2=CC=CC=C2)OC2=CC=C(O)C=C12,,,O=C(O)C1OC(OC2=C(C3=CC=CC=C3)OC3=CC=C(O)C=C3C2=O)C(O)C(O)C1O,,UGT1A9,0.57,O-glucuronidation,0
4-Oxo-9-cis-retinoic acid,CC(C=CC1=C(C)CCC(=O)C1(C)C)=CC=CC(C)=CC(=O)O,,,CC(C=CC1=C(C)CCC(=O)C1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.48,O-glucuronidation,0
Tetrahydrocurcumin,COC1=CC(CCC(=O)C=C(O)CCC2=CC=C(O)C(OC)=C2)=CC=C1O,,,COC1=CC(CCC(O)=CC(=O)CCC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(OC)=C2)=CC=C1O,,UGT,0.43,O-glucuronidation,0
7-Hydroxy-3p-methoxyflavone,COC1=C(C2=CC=CC=C2)OC2=CC(O)=CC=C2C1=O,,,COC1=C(C2=CC=CC=C2)OC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C2C1=O,,UGT1A9,0.68,O-glucuronidation,0
"3-Hydroxy-5,7-dimethoxyflavone",COC1=CC(OC)=C2C(=O)C(O)=C(C3=CC=CC=C3)OC2=C1,,,COC1=CC(OC)=C2C(=O)C(OC3OC(C(=O)O)C(O)C(O)C3O)=C(C3=CC=CC=C3)OC2=C1,,UGT1A9,0.65,O-glucuronidation,0
Psilocin,CN(C)CCC1=CNC2=CC=CC(O)=C12,,,CN(C)CCC1=CNC2=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C12,,UGT1A9,0.51,O-glucuronidation,0
Apigenin,O=C1C=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=C(O)C=C4)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.59,O-glucuronidation,0
4-sec-Butylphenol,CCC(C)C1=CC=C(O)C=C1,,,CCC(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.21,O-glucuronidation,0
Isoferulic Acid,COC1=CC=C(C=CC(=O)O)C=C1O,,,COC1=CC=C(C=CC(=O)O)C=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.31,O-glucuronidation,0
DMXAA,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)O)=C3OC2=C1C,,,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)OC4OC(C(=O)O)C(O)C(O)C4O)=C3OC2=C1C,,"UGT1A9, UGT2B7",0.59,O-glucuronidation,0
"3,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,,COC1=CC(C2=C(O)C(=O)C3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.7,O-glucuronidation,0
"3,7-Dihydroxy-3p,4p,5p-trimethoxyflavone",COC1=CC(C2=C(O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,,COC1=CC(C2=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C3=CC=C(O)C=C3O2)=CC(OC)=C1OC,,UGT1A9,0.65,O-glucuronidation,0
4-nitrophenethyl bromide,O=[N+]([O-])C1=CC=C(CCBr)C=C1,,4-nitrophenethyl-glutathione,NC(CCC(O)=NC(CSCCC1=CC=C([N+](=O)[O-])C=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.29,GSH-conjugation of organohalide,0
Erlotinib M14,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCO)=C(OCCOC)C=C23)=C1,,,C#CC1=CC=CC(NC2=NC=NC3=CC(OCCOC4OC(C(=O)O)C(O)C(O)C4O)=C(OCCOC)C=C23)=C1,,UGT,0.74,O-glucuronidation,0
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,,,CC(O)=NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,,NAT2,0.72,N-acetylation of arylamine,0
Phenylephrine,CNCC(O)C1=CC=CC(O)=C1,,,CNCC(O)C1=CC=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.29,O-glucuronidation,0
4-tert-Butylphenol,CC(C)(C)C1=CC=C(O)C=C1,,,CC(C)(C)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.19,O-glucuronidation,0
Melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,,COC1=CC=C2C(=C1)C(CCN=C(C)O)=CN2C1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.45,O-glucuronidation,0
Propyl-4-hydroxybenzoate,CCCOC(=O)C1=CC=C(O)C=C1,,,CCCOC(=O)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,UGT1A9,0.29,Aromatic -OH glucuronidation,0
rac-4-hydroxynonenal,CCCCCC(O)C=CC=O,,S-(4-hydroxy-1-oxononan-3-yl)glutathione,CCCCCC(O)C(CC=O)SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O,,GST,0.09,"GSH-conjugation of apha,beta-unsaturated carbonyl",0
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,Dihydrodazein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.22,4'-Deydroxylation of substitued benzene,0
Dihydrodazein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Tetrahydrodaidzein,OC1=CC=C(C2COC3=CC(O)=CC=C3C2O)C=C1,,Unspecified gut bacterial enzyme,0.64,Dehydration of isoflavanone,0
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,L-Rhamnose,CC1OC(O)C(O)C(O)C1O,,EC 3.2.1.X,0.22,Glycoside hydrolysis,0
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,EC 3.2.1.X,0.68,Glycoside hydrolysis,0
Quercetin,O=C1C(O)=C(C2=CC=C(O)C(O)=C2)OC2=CC(O)=CC(O)=C12,,Dihydroquercetin,O=C1C2=C(O)C=C(O)C=C2OC(C2=CC=C(O)C(O)=C2)C1O,,Unspecified gut bacterial enzyme,0.31,Flavonoid C-ring reduction,0
3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,2-Phenylacetic acid,O=C(O)CC1=CC=CC=C1,,Unspecified bacterial dehydroxylase,0.62,3'-Deydroxylation of substitued benzene,0
4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,2-Phenylacetic acid,O=C(O)CC1=CC=CC=C1,,Unspecified bacterial dehydroxylase,0.72,4'-Deydroxylation of substitued benzene,0
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,Unspecified bacterial dehydroxylase,0.82,Dehydroxylation of catechol,0
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.7,Dehydroxylation of catechol,0
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Protocatehuic acid,O=C(O)C1=CC=C(O)C(O)=C1,,Unspecified gut bacterial enzyme,0.39,Alpha-oxidation of carboxylic acid,0
"3,4-dihydroxyphenylpropionic acid",O=C(O)CCC1=CC=C(O)C(O)=C1,,3-(3-hydroxyphenyl)propanoic acid,O=C(O)CCC1=CC=CC(O)=C1,,Unspecified bacterial dehydroxylase,0.83,Dehydroxylation of catechol,0
"3,4-dihydroxyphenylpropionic acid",O=C(O)CCC1=CC=C(O)C(O)=C1,,4-hydroxy- 4-Hydroxyphenylpropionic acid,O=C(O)CCC1=CC=C(O)C=C1,,Unspecified bacterial dehydroxylase,0.73,Dehydroxylation of catechol,0
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,"2,4,6-Trihydroxybenzaldehyde",O=CC1=C(O)C=C(O)C=C1O,,Unspecified gut bacterial enzyme,0.12,Anthocyanidin C-ring fission,0
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,"3,4-Dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Unspecified gut bacterial enzyme,0.14,Anthocyanidin C-ring fission,0
Genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Unspecified bacterial isoflavone reductase,0.24,Reduction of isoflavone to isoflavanone,0
Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,Unspecified gut bacterial enzyme,0.47,Isoflavanone C-ring fission,0
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,6'-Hydroxy-O-desmethylangolensin,CC(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,EC 1.6.99.1,0.62,"Reduction of alpha,beta unsaturated carbon-carbon double bond adjacent to an electron withdrawing group",0
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,4-hydroxyphenyl-2-propenoic acid,C=C(C(=O)O)C1=CC=C(O)C=C1,,Unspecified gut bacterial enzyme,0.37,Keto hydrolysis,0
,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,Unspecified gut bacterial enzyme,0.11,Keto hydrolysis,0
Sudan I,OC1=CC=C2C=CC=CC2=C1N=NC1=CC=CC=C1,,1-Amino-2-naphthol,NC1=C(O)C=CC2=CC=CC=C12,,EC 1.7.1.6,0.64,Reduction of azobenzene,0
Cholecalciferol,C=C1CCC(O)CC1=CC=C1CCCC2(C)C1CCC2C(C)CCCC(C)C,"InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1",Calcitriol,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,"InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1",,0.85,,1
Amphetamine,CC(N)CC1=CC=CC=C1,"InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.48,,1
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",,O=NN(CO)CCCC(=O)C1=CC=CN=C1,,,0.37,,1
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.69,,1
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,,0.63,,1
Nicotine,CN1CCCC1C1=CN=CC=C1,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,,0.36,,1
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.46,,1
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,,0.44,,1
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Nornicotine,C1=CN=CC(C2CCCN2)=C1,MYKUKUCHPMASKF-UHFFFAOYSA-N,,0.59,,1
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,,0.48,,1
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,,0.32,,1
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M3,NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,KTQJEBWLYWKXRA-NSHDSACASA-N,,0.69,,1
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M5,CC(C)(O)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,OPMJHASCCIGLJS-GOEBONIOSA-N,,0.74,,1
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M8,CC(C)CC(O)NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,BLVVPFHWFHYTBM-PYNWJHIZSA-N,,0.68,,1
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M25,CC(C)C(O)C(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,IVVZGLULYNUZDU-BZELLKQSSA-N,,0.72,,1
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M33,NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,ASDAHTNZOSVDNQ-PXYINDEMSA-N,,0.62,,2
Bortezomib,CC(C)CC(NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1)B(O)O,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",Bortezomib metabolite M4,O=C(NC(CC1=CC=CC=C1)C(=O)O)C1=CN=CC=N1,DWYZPDHMMZGQAP-NSHDSACASA-N,,0.56,,2
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M33,NC(=O)C(NC(=O)C1=CN=CC=N1)C(O)C1=CC=CC=C1,ASDAHTNZOSVDNQ-PXYINDEMSA-N,,0.66,,1
Bortezomib metabolite M1,CC(C)CC(O)NC(=O)C(CC1=CC=CC=C1)NC(=O)C1=CN=CC=N1,NEIDLJIPMZVISC-DOTOQJQBSA-N,Bortezomib metabolite M4,O=C(NC(CC1=CC=CC=C1)C(=O)O)C1=CN=CC=N1,DWYZPDHMMZGQAP-NSHDSACASA-N,,0.59,,1
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",,CN(C)CC1CCCCC1(O)C1=CC=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,,0.6,,1
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3","N,O-didesmethyltramadol",CNCC1CCCCC1(O)C1=CC(O)=CC=C1,CJXNQQLTDXASSR-OCCSQVGLSA-N,,0.9,,1
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3","N,N-didesmethyltramadol",COC1=CC=CC(C2(C)CCCCC2CN)=C1,ZEXALIOABWHLJM-UKRRQHHQSA-N,,0.59,,1
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3","N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.82,,2
Tramadol,COC1=CC=CC(C2(O)CCCCC2CN(C)C)=C1,"InChI=1S/C16H25NO2/c1-17(2)12-14-7-4-5-10-16(14,18)13-8-6-9-15(11-13)19-3/h6,8-9,11,14,18H,4-5,7,10,12H2,1-3H3",O-Desmethyl-tramado glucuronide,CN(C)CC1CCCCC1(O)C1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1,DSBGQRZOJXSECT-UHFFFAOYSA-N,,0.6,,1
O-Desmethyltramadol,CN(C)CC1CCCCC1(O)C1=CC(O)=CC=C1,UWJUQVWARXYRCG-UHFFFAOYSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.88,,1
N-Desmethyltramadol,CNCC1CCCCC1(O)C1=CC(OC)=CC=C1,VUMQHLSPUAFKKK-UHFFFAOYSA-N,"N,N,O-tridesmethyl-tramadol",NCC1CCCCC1(O)C1=CC(O)=CC=C1,MJTYLDGVLFSXDG-YPMHNXCESA-N,,0.85,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,3-Dimethyluric acid",CN1C(=O)C2=C(NC(O)=N2)N(C)C1=O,,,0.81,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",1-Methylxanthine ,CN1C(O)=NC2=C(N=CN2)C1=O,,,0.55,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",,CN1C(=O)N=C(O)C2=C1NC=N2,,,0.54,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,7-Dimethyluric acid",CN1C(=O)NC2=C(C1=O)N(C)C(=O)N2,NOFNCLGCUJJPKU-UHFFFAOYSA-N,,0.82,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC=O)NC(=O)N(C)C1=O,RDZNZFGKEVDNPK-UHFFFAOYSA-N,,0.35,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",1-Methylxanthine,CN1C(=O)NC2=C(NC=N2)C1=O,MVOYJPOZRLFTCP-UHFFFAOYSA-N,,0.75,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,,0.74,,2
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",3-methylxanthine,CN1C(=O)NC(=O)C2=C1N=CN2,GMSNIKWWOQHZGF-UHFFFAOYSA-N,,0.78,,1
Caffeine,CN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3","1,3-dimethyluric acid",CN1C(=O)C2=C(NC(=O)N2)N(C)C1=O,OTSBKHHWSQYEHK-UHFFFAOYSA-N,,0.88,,1
"1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,,0.86,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Theobromine,CN1C=NC2=C1C(=O)NC(=O)N2C,"InChI=1S/C7H8N4O2/c1-10-3-8-5-4(10)6(12)9-7(13)11(5)2/h3H,1-2H3,(H,9,12,13)",,0.82,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,3,7-Trimethyluric acid",CN1C(=O)C2=C(NC(=O)N2C)N(C)C1=O,BYXCFUMGEBZDDI-UHFFFAOYSA-N,,0.86,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,7-dimethylxanthine",CN1C(=O)NC2=C(C1=O)N(C)C=N2,QUNWUDVFRNGTCO-UHFFFAOYSA-N,,0.78,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Paraxanthine,CN1C(O)=NC2=C(C1=O)N(C)C=N2,,,0.57,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Theobromine,CC1C(O)=NC(=O)C2=C1N=CN2C,,,0.26,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",Theophylline,CN1C(=O)C2=C(NC=N2)N(C)C1=O,,,1.0,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,3,7-Trimethyluric acid",CN1C(=O)C2=C(N=C(O)N2C)N(C)C1=O,,,0.78,,1
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,3-Dimethyluric acid",CN1C(=O)C2=C(NC(O)=N2)N(C)C1=O,,,0.87,,2
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",1-Methylxanthine ,CN1C(O)=NC2=C(N=CN2)C1=O,,,0.58,,2
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",,CN1C(=O)N=C(O)C2=C1NC=N2,,,0.57,,2
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)","1,7-Dimethyluric acid",CN1C(=O)NC2=C(C1=O)N(C)C(=O)N2,NOFNCLGCUJJPKU-UHFFFAOYSA-N,,0.75,,2
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC=O)NC(=O)N(C)C1=O,RDZNZFGKEVDNPK-UHFFFAOYSA-N,,0.34,,2
Theophylline,CN1C(=O)C2=C(N=CN2)N(C)C1=O,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",1-Methyluric acid,CN1C(=O)NC2=C(NC(=O)N2)C1=O,QFDRTQONISXGJA-UHFFFAOYSA-N,,0.79,,3
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Ticlopidine S-oxide dimer,O=S1C2=C(CN(CC3=C(Cl)C=CC=C3)CC2)C2C1C1C3=C(CCN(CC4=C(Cl)C=CC=C4)C3)C2S1=O,YIQPCHDIFABADG-UHFFFAOYSA-N,,0.29,,1
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Thienopyridinium,ClC1=CC=CC=C1C[N+]1=CC2=C(C=C1)SC=C2,OQXLLGWEACZMFD-UHFFFAOYSA-N,,0.21,,1
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Ticlopidine lactam analog (M8),O=C1C2=C(CCN1CC1=CC=CC=C1Cl)SC=C2,KQQBLQBNIVSMLU-UHFFFAOYSA-N,,0.75,,1
Ticlopidine,ClC1=CC=CC=C1CN1CCC2=C(C=CS2)C1,"InChI=1S/C14H14ClNS/c15-13-4-2-1-3-11(13)9-16-7-5-14-12(10-16)6-8-17-14/h1-4,6,8H,5,7,9-10H2",Active metabolite of Ticlopidine,O=C(O)CC1CN(CC2=CC=CC=C2Cl)CCC1S,LDXFVLBQZWBGBA-UHFFFAOYSA-N,,0.32,,1
Glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C)CC3)C=C2)C1=O,"InChI=1S/C24H34N4O5S/c1-4-21-17(3)15-28(22(21)29)24(31)25-14-13-18-7-11-20(12-8-18)34(32,33)27-23(30)26-19-9-5-16(2)6-10-19/h7-8,11-12,16,19H,4-6,9-10,13-15H2,1-3H3,(H,25,31)(H2,26,27,30)/t16-,19-",Cyclohexyl carboxyl glimepiride,CCC1=C(C)CN(C(=O)NCCC2=CC=C(S(=O)(=O)NC(=O)NC3CCC(C(=O)O)CC3)C=C2)C1=O,MMZLACCSCMGVHL-UHFFFAOYSA-N,,0.94,,1
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",3-hydroxynevirapine glucuronide,CC1=C2N=C(OC3OC(C(=O)O)C(O)C(O)C3O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1O,GDAAYOYNGMRKSI-IQSUWLOCSA-N,,0.63,,1
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",8-hydroxynevirapine glucuronide,CC1=CC=NC2=C1NC(=O)C1=C(N=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1)N2C1CC1,IVZWGLRSSHUFTI-WCYOCWRHSA-N,,0.78,,1
Nevirapine,CC1=C2NC(=O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",2-hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=C(N=CC=C1)N2C1CC1,RNMZKTLILDCQOC-KUSYAZKWSA-N,,0.62,,1
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,,0.87,,1
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,,0.3,,2
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",,NC1=CC=C(S(=O)(=O)C2=CC=C([NH+]([O-])SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C=C2)C=C1,,,0.3,,2
Dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N)C=C2)C=C1,"InChI=1S/C12H12N2O2S/c13-9-1-5-11(6-2-9)17(15,16)12-7-3-10(14)4-8-12/h1-8H,13-14H2",Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.31,,3
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,Dapsone mercaptal intermediate,NC1=CC=C(S(=O)(=O)C2=CC=C(N(O)SSCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,ILXGRDMMHISXAH-ROUUACIJSA-N,,0.35,,1
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,,NC1=CC=C(S(=O)(=O)C2=CC=C([NH+]([O-])SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C=C2)C=C1,,,0.34,,1
dapsone hydroxylamine,NC1=CC=C(S(=O)(=O)C2=CC=C(NO)C=C2)C=C1,IYDSJDWESCGRKW-UHFFFAOYSA-N,Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.31,,2
Nitroso-dapsone,NC1=CC=C(S(=O)(=O)C2=CC=C(N=O)C=C2)C=C1,UAQFAHXMXOCEAD-UHFFFAOYSA-N,Dapsone GSH conjugate,NC1=CC=C(S(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)C=C1,IHKJTFLXUFDQKZ-OZTHWQDPSA-N,,0.31,,1
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,,0.4,,1
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",Hydroxyphenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C=C2)C(O)=N1,XEEDURHPFVXALT-UHFFFAOYSA-N,,0.33,,1
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.81,,2
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)","3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,,0.33,,2
Phenytoin,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC=CC=C2)N1,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",,O=C(O)C1OC(OC2=CC=C(C3(C4=CC=CC=C4)N=C(O)N=C3O)C=C2)C(O)C(O)C1O,,,0.32,,2
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.44,,1
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,,0.35,,1
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,,O=C(O)C1OC(OC2=CC=C(C3(C4=CC=CC=C4)N=C(O)N=C3O)C=C2)C(O)C(O)C1O,,,0.43,,1
Anagrelide,O=C1CN2CC3=C(Cl)C(Cl)=CC=C3N=C2N1,"InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)","2-amino-5,6-dichloro-3,4,-dihydroquinazoline",NC1=NCC2=C(C=CC(Cl)=C2Cl)N1,VBKOTIVQMCTTAQ-UHFFFAOYSA-N,,0.42,,1
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.3,,1
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)","4-Hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,GCWYXRHXGLFVFE-UHFFFAOYSA-N,,0.31,,1
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)","N-(2,6-dimethylphenyl)hydroxylamine",CC1=CC=CC(C)=C1NO,,,0.31,,1
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,,0.21,,2
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",3-Hydroxymonoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC(O)=C1C,YITCMQBVWIHTTA-UHFFFAOYSA-N,,0.67,,1
Lidocaine,CCN(CC)CC(=O)NC1=C(C)C=CC=C1C,"InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,,0.81,,1
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.31,,2
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"4-Hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,GCWYXRHXGLFVFE-UHFFFAOYSA-N,,0.33,,2
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,"N-(2,6-dimethylphenyl)hydroxylamine",CC1=CC=CC(C)=C1NO,,,0.34,,2
monoethylglycinexylidide,CCNCC(=O)NC1=C(C)C=CC=C1C,WRMRXPASUROZGT-UHFFFAOYSA-N,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,,0.2,,3
"2,6-Dimethylaniline (2,6-Xylidine)",CC1=CC=CC(C)=C1N,UFFBMTHBGFGIHF-UHFFFAOYSA-N,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,,0.14,,1
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,2-Amino-3-methylbenzoate,CC1=C(N)C(C(=O)O)=CC=C1,WNAJXPYVTFYEST-UHFFFAOYSA-N,,0.34,,1
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,"4-Hydroxy-2,6-dimethylaniline",CC1=CC(O)=CC(C)=C1N,GCWYXRHXGLFVFE-UHFFFAOYSA-N,,0.35,,1
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,"N-(2,6-dimethylphenyl)hydroxylamine",CC1=CC=CC(C)=C1NO,,,0.37,,1
Glycinexylidide (GX),CC1=CC=CC(C)=C1NC(=O)CN,IXYVBZOSGGJWCW-UHFFFAOYSA-N,,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC(C)=C1N,,,0.2,,2
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3","N,O-Didesmethylvenlafaxine",CNCC(C1=CC=C(O)C=C1)C1(O)CCCCC1,MMSWXJSQCAEDLK-UHFFFAOYSA-N,,0.91,,1
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",O-Desmethylvenlafaxine glucuronide,NCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,VNRFTNKWISCOMJ-KUIQUDTGSA-N,,0.51,,1
Venlafaxine,COC1=CC=C(C(CN(C)C)C2(O)CCCCC2)C=C1,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3","N,O-didesmethylvenlafaxine glucuronide",CNCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,UDNAJOOLWIWCAW-SQBZNDFJSA-N,,0.54,,2
Desvenlafaxine,CN(C)CC(C1=CC=C(O)C=C1)C1(O)CCCCC1,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3","N,O-didesmethylvenlafaxine glucuronide",CNCC(C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1(O)CCCCC1,UDNAJOOLWIWCAW-SQBZNDFJSA-N,,0.52,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.75,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.68,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.67,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.59,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.5,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.47,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.54,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.5,,1
Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.61,,1
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,,0.98,,1
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,,0.89,,1
Tenofovir disoproxil,CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C(N)N=CN=C21)OCOC(=O)OC(C)C,"InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1",Tenofovir Diphosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,IACQCQDWSIQSRP-ZCFIWIBFSA-N,,0.73,,1
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",Etonogestrel,C#CC1(O)CCC2C3CCC4=CC(=O)CCC4C3C(=C)CC21CC,"InChI=1S/C22H28O2/c1-4-21-13-14(3)20-17-9-7-16(23)12-15(17)6-8-18(20)19(21)10-11-22(21,24)5-2/h2,12,17-20,24H,3-4,6-11,13H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",,0.87,,1
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",,C#CC1(O)CCC2C3CCC4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC4C3C(=C)CC21CC,,,0.5,,1
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",,C#CC1(O)CCC2C3CCC4=CC(OS(=O)(=O)O)CCC4C3C(=C)CC21CC,,,0.72,,1
Desogestrel,C#CC1(O)CCC2C3CCC4=CCCCC4C3C(=C)CC21CC,"InChI=1S/C22H30O/c1-4-21-14-15(3)20-17-9-7-6-8-16(17)10-11-18(20)19(21)12-13-22(21,23)5-2/h2,8,17-20,23H,3-4,6-7,9-14H2,1H3/t17-,18-,19-,20+,21-,22-/m0/s1",,C#CC1(OC2OC(C(=O)O)C(O)C(O)C2O)CC(O)C2C3CCC4=CCCCC4C3C(=C)CC21CC,,,0.47,,1
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,PPYHXKUZTSZTQU-UHFFFAOYSA-N,,0.56,,2
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",2-n-Propyl-4-oxopentanoic acid,CCCC(CC(C)=O)C(=O)O,HJRMYVTYHORJKC-UHFFFAOYSA-N,,0.65,,1
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",2-Propylsuccinic acid,CCCC(CC(=O)O)C(=O)O,QLTZBYGZXPKHLF-UHFFFAOYSA-N,,0.6,,2
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",2-Propylglutaric acid,CCCC(CCC(=O)O)C(=O)O,IFNXFIJXYVEYLF-UHFFFAOYSA-N,,0.7,,1
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)","2,4-Diene-VPA",C=CC=C(CCC)C(=O)O,UUILWXIBBZVJDU-FNORWQNLSA-N,,0.23,,1
Valproic acid,CCCC(CCC)C(=O)O,"InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",,C=CC=C(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.07,,2
4-ene-Valproic acid,C=CCC(CCC)C(=O)O,UMYDNZXEHYSVFY-UHFFFAOYSA-N,,C=CC=C(CCC)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.1,,1
4-Hydroxyvalproic acid,CCCC(CC(C)O)C(=O)O,OASKNPCLIHUTTL-UHFFFAOYSA-N,2-Propylsuccinic acid,CCCC(CC(=O)O)C(=O)O,QLTZBYGZXPKHLF-UHFFFAOYSA-N,,0.65,,1
2-ene-Valproic acid,CCC=C(CCC)C(=O)O,ZKNJEOBYOLUGKJ-FNORWQNLSA-N,3-Oxovalproic acid,CCCC(C(=O)O)C(=O)CC,PPYHXKUZTSZTQU-UHFFFAOYSA-N,,0.21,,1
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.97,,1
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1",,0.9,,1
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,,0.8,,1
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,CN1CCC23C4=C5C=CC(O)=C4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,,,0.9,,1
Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)C=CC3C1C5,,,0.91,,1
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",E-10-Hydroxynortriptyline,CNCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,VAGXZGJKNUNLHK-LFIBNONCSA-N,,0.72,,1
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.71,,2
Amitriptyline,CN(C)CCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",Desmethylnortriptyline,NCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,PTQFRALDEONNOA-UHFFFAOYSA-N,,0.97,,1
E-10-Hydroxyamitriptyline,CN(C)CCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,GHWBJXOKAFHZAI-SFQUDFHCSA-N,E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.98,,1
Nortriptyline,CNCCC=C1C2=CC=CC=C2CCC2=CC=CC=C12,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",E-10-Hydroxydesmethylnortriptyline,NCCC=C1C2=CC=CC=C2CC(O)C2=CC=CC=C12,PIEVJGJKDMQGSG-XNTDXEJSSA-N,,0.71,,1
Ipratropium,CC(C)[N+]1(C)C2CCC1CC(OC(=O)C(CO)C1=CC=CC=C1)C2,"InChI=1S/C20H30NO3/c1-14(2)21(3)16-9-10-17(21)12-18(11-16)24-20(23)19(13-22)15-7-5-4-6-8-15/h4-8,14,16-19,22H,9-13H2,1-3H3/q+1/t16-,17+,18+,19?,21?",Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.27,,1
Methadone,CCC(=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3","2-Ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP)",CCC1=NC(C)CC1(C1=CC=CC=C1)C1=CC=CC=C1,UPZKJIHNKKJIKX-UHFFFAOYSA-N,,0.5,,1
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,,0.19,,1
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.33,,1
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.32,,2
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.36,,2
Tioguanine,NC1=NC(=S)C2=C(N=CN2)N1,"InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.35,,3
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.95,,1
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.89,,1
Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.88,,2
Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.91,,1
Progesterone,CC(=O)C1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",17Beta-21-dihydroxyprogesterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)CO,,,0.68,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.84,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",ortho-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,YDRMOALONMVDNG-TUCRDTSBSA-N,,0.55,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",ortho-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=C(OS(=O)(=O)O)C=CC=N1,ZVSPRKOUHTZIGH-UHFFFAOYSA-N,,0.75,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.71,,2
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.87,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",para-O-Glucuronide rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=N1,QGESYIGEZXWVIN-AZNQAGSMSA-N,,0.59,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",para-O-Sulfate rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=C(OS(=O)(=O)O)C=N1,WAGUBJKZLRLKGR-UHFFFAOYSA-N,,0.82,,1
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.76,,2
Rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=CC=CC=N1,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",N-Desmethyl glucuronide rosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)S1,NLGMKXBTZZJJFK-UHFFFAOYSA-N,,0.43,,1
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.52,,1
N-Desmethylrosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=CC=CC=N3)C=C2)S1,ZJQTVMXUIGXRMR-UHFFFAOYSA-N,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.49,,1
ortho-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=C(O)C=CC=N1,KQXWMUFVDAFGPU-UHFFFAOYSA-N,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.55,,1
para-Hydroxyrosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=NC=C(O)C=C1,AGQGGZNSVNKGDU-UHFFFAOYSA-N,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.56,,1
Zolpidem,CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C)C=CC3=N2)C=C1,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",Zolpidem carboxylic acid derivative (M2),CC1=CC=C(C2=C(CC(=O)N(C)C)N3C=C(C(=O)O)C=CC3=N2)C=C1,RFUGIBAONXDHRM-UHFFFAOYSA-N,,0.91,,1
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1","2′,2′-difluorodeoxyuridine monophosphate",O=C1C=CN(C2OC(COP(=O)(O)O)C(O)C2(F)F)C(=O)N1,APSMIPKDENVCML-WETFRILZSA-N,,0.81,,1
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",Gemcitabine diphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,FRQISCZGNNXEMD-QPPQHZFASA-N,,0.87,,1
Gemcitabine,NC1=NC(=O)N(C2OC(CO)C(O)C2(F)F)C=C1,"InChI=1S/C9H11F2N3O4/c10-9(11)6(16)4(3-15)18-7(9)14-2-1-5(12)13-8(14)17/h1-2,4,6-7,15-16H,3H2,(H2,12,13,17)/t4-,6-,7-/m1/s1",Gemcitabine triphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,YMOXEIOKAJSRQX-QPPQHZFASA-N,,0.84,,2
Gemcitabine Monophosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)O)C(O)C2(F)F)C=C1,KNTREFQOVSMROS-QPPQHZFASA-N,Gemcitabine triphosphate,NC1=NC(=O)N(C2OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C2(F)F)C=C1,YMOXEIOKAJSRQX-QPPQHZFASA-N,,0.92,,1
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",Monoiodothyronine,NC(CC1=CC(I)=C(OC2=CC=C(O)C=C2)C=C1)C(=O)O,,,0.88,,1
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",Tiratricol,O=C(O)CC1=CC(I)=C(OC2=CC=C(O)C(I)=C2)C(I)=C1,"InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)",,0.69,,1
Levothyroxine,NC(CC1=CC(I)=C(OC2=CC(I)=C(O)C(I)=C2)C(I)=C1)C(=O)O,"InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m0/s1",Triiodothyronine sulfate,NC(CC1=CC(I)=C(OC2=CC(I)=C(OS(=O)(=O)O)C=C2)C(I)=C1)C(=O)O,XBQYQXVJBNDCGY-LBPRGKRZSA-N,,0.79,,1
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",2-hydroxy-imipramine glucuronide,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,CBEJFHYWZSCYSD-LYVDORBWSA-N,,0.49,,1
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",2-hydroxydesipramine,CNCCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,NVJBOLMRGMDGLD-UHFFFAOYSA-N,,0.85,,1
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",Desipramine N-glucuronide,CN(CCCN1C2=CC=CC=C2CCC2=CC=CC=C21)C1OC(C(=O)O)C(O)C(O)C1O,,,0.52,,1
Imipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C21,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",2-hydroxy-desipramine glucuronide,CNCCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,XJHAOJJEVSPMBA-QMDPOKHVSA-N,,0.48,,2
Desipramine,CNCCCN1C2=CC=CC=C2CCC2=CC=CC=C21,HCYAFALTSJYZDH-UHFFFAOYSA-N,2-hydroxy-desipramine glucuronide,CNCCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,XJHAOJJEVSPMBA-QMDPOKHVSA-N,,0.48,,1
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1","8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.89,,1
Dronabinol,CCCCCC1=CC2=C(C(O)=C1)C1C=C(C)CCC1C(C)(C)O2,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",11-Nor-9-carboxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C(=O)O)=CC21,YOVRGSHRZRJTLZ-UHFFFAOYSA-N,,0.91,,1
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.16,,1
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",Norfluoxetine alcohol,OCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WMLVVHKCLDWGLW-UHFFFAOYSA-N,,0.83,,1
Fluoxetine,CNCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",Norfluoxetine glucuronide,O=C(O)C1OC(ONCCC(OC2=CC=C(C(F)(F)F)C=C2)C2=CC=CC=C2)C(O)C(O)C1O,LUIHTMWIRNJSNW-FRYOACGXSA-N,,0.45,,1
Norfluoxetine,NCCC(OC1=CC=C(C(F)(F)F)C=C1)C1=CC=CC=C1,WIQRCHMSJFFONW-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.16,,1
Celecoxib,CC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",Carboxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)O)C=C2)C=C1,WTHNOVFEXONZMI-UHFFFAOYSA-N,,0.94,,1
Celecoxib,CC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",Celecoxib glucuronide,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,BMBHPAUFWUKYDR-AVPDHNOJSA-N,,0.69,,2
Celecoxib,CC1=CC=C(C2=CC(C(F)(F)F)=NN2C2=CC=C(S(N)(=O)=O)C=C2)C=C1,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,,0.7,,2
Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,Celecoxib glucuronide,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,BMBHPAUFWUKYDR-AVPDHNOJSA-N,,0.69,,1
Hydroxycelecoxib,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(CO)C=C2)C=C1,ICRSYPPLGADZKA-UHFFFAOYSA-N,,NS(=O)(=O)C1=CC=C(N2N=C(C(F)(F)F)C=C2C2=CC=C(C(=O)OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,,,0.71,,1
Buspirone,O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(C2=NC=CC=N2)CC1,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",,OC1=CN=C(N2CCNCC2)N=C1,,,0.39,,1
Oxycodone,COC1=C2OC3C(=O)CCC4(O)C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",alpha-noroxycodol,COC1=C2OC3C(O)CCC4(O)C5CC(=C2C34CCN5)C=C1,KFWOOLJUSYSBAD-NZQXGWJPSA-N,,0.91,,1
Haloperidol,O=C(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",Haloperidol reduced pyridinium ion derivative,OC(CCC[N+]1=CC=C(C2=CC=C(Cl)C=C2)C=C1)C1=CC=C(F)C=C1,CESYFZMRVQIRNB-UHFFFAOYSA-N,,0.36,,1
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-pyridinium (HPP+),O=C(CCCN1C=CC(=C2C=CC(=[Cl+])C=C2)C=C1)C1=CC=C(F)C=C1,KAPIKUHBALFONG-UHFFFAOYSA-N,,0.32,,1
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,Haloperidol glucuronide,O=C(CCCN1CCC(OC2OC(C(=O)O)C(O)C(O)C2O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZFNLYKVTHNLKNZ-BFZHNPFYSA-N,,0.43,,1
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,"Haloperidol 1,2,3,6-tetrahydropyridine",O=C(CCCN1CC=C(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,ZNOLNAPJKOYTHY-UHFFFAOYSA-N,,0.4,,1
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,fluorobenzoylpropionic acid,O=C(O)CCC(=O)C1=CC(F)=C(F)C=C1,GYDFFFKCUNUZEL-UHFFFAOYSA-N,,0.28,,1
Reduced haloperidol,OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1,WNZBBTJFOIOEMP-UHFFFAOYSA-N,p-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine,O=C(O)CCC(=O)C1=CC=C(F)C=C1,,,0.29,,1
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,,0.9,,1
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,,0.67,,2
Dextromethorphan,COC1=CC2=C(C=C1)CC1C3CCCCC23CCN1C,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.82,,2
(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,,0.68,,1
(+)-3-Methoxymorphinan,COC1=CC=C2CC3NCCC4(CCCCC34)C2=C1,ILNSWVUXAPSPEH-PVAVHDDUSA-N,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.85,,1
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",4-Ketocyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,VBMZHOCORXMDJU-UHFFFAOYSA-N,,0.75,,1
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,,0.68,,1
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.64,,2
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,,0.69,,2
Cyclophosphamide,O=P1(N(CCCl)CCCl)NCCCO1,"InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.43,,2
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.54,,1
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,,0.57,,1
4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.33,,1
Mephenytoin,CCC1(C2=CC=CC=C2)NC(=O)N(C)C1=O,"InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)",Nirvanol N-glucuronide,CCC1(C2=CC=CC=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,,0.43,,1
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",cis-Dihydrorofecoxib,CS(=O)(=O)C1=CC=C(C2COC(=O)C2C2=CC=CC=C2)C=C1,PHCFUFKRCHEUTJ-CVEARBPZSA-N,,0.44,,1
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",5-Hydroxyrofecoxib O-glucuronide,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,LHTQNDXIYIUWMV-JSXGDUDQSA-N,,0.54,,1
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,,0.93,,1
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,,0.91,,2
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.85,,3
Zafirlukast,COC1=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=CC=C1CC1=CN(C)C2=C1C=C(NC(=O)OC1CCCC1)C=C2,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",Zafirlukast metabolite M8,COC1=C(CC2=CNC3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,FJVVJMGKCIJNGX-UHFFFAOYSA-N,,0.93,,1
Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,Zafirlukast metabolite M4,COC1=C(CC2=CN(CO)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,NWOVAURISFBNOF-UHFFFAOYSA-N,,0.93,,1
Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.87,,2
Zafirlukast metabolite M5,COC1=C(CC2=CN(CO)C3=C2C=C(NC(=O)OC2CCCC2)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HZAQOSFFIGVMDH-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.83,,1
Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,Zafirlukast metabolite M3,COC1=C(CC2=CNC3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,TVYYLXWJXOTTDN-UHFFFAOYSA-N,,0.92,,1
Bosentan,COC1=CC=CC=C1OC1=C(OCCO)N=C(C2=NC=CC=N2)N=C1NS(=O)(=O)C1=CC=C(C(C)(C)C)C=C1,"InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)",Bosentan metabolite Ro 64-1056,CC(C)(CO)C1=CC=C(S(=O)(=O)NC2=NC(C3=NC=CC=N3)=NC(OCCO)=C2OC2=CC=CC=C2O)C=C1,JXXCMZWROOURSZ-UHFFFAOYSA-N,,0.97,,1
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","2,3-Dihydroxycarbamazepine",NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=C(O)C=C21,YITIUNLDWDJVSI-UHFFFAOYSA-N,,0.75,,1
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",2-hydroxycarbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC(O)=CC=C21,VPZIYMMSJFWLSP-UHFFFAOYSA-N,,0.86,,1
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",2-hydroxyiminostilbene,OC1=CC=C2NC3=CC=CC=C3C=CC2=C1,FKCUOSGTQJAUQX-UHFFFAOYSA-N,,0.51,,2
Carbamazepine,NC(=O)N1C2=CC=CC=C2C=CC2=CC=CC=C21,"InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)","10,11-Dihydroxycarbamazepine",N=C(O)N1C2=CC=CC=C2C(O)C(O)C2=CC=CC=C21,PRGQOPPDPVELEG-KBPBESRZSA-N,,0.37,,1
"Carbamazepine 2,3-epoxide",NC(=O)N1C2=CC3OC3C=C2C=CC2=CC=CC=C21,AUCXBTOAZTYKIN-UHFFFAOYSA-N,2-hydroxyiminostilbene,OC1=CC=C2NC3=CC=CC=C3C=CC2=C1,FKCUOSGTQJAUQX-UHFFFAOYSA-N,,0.21,,1
Fenfluramine,CCNC(C)CC1=CC=CC(C(F)(F)F)=C1,"InChI=1S/C12H16F3N/c1-3-16-9(2)7-10-5-4-6-11(8-10)12(13,14)15/h4-6,8-9,16H,3,7H2,1-2H3",,NCCC1=CC=CC(C(F)(F)F)=C1,,,0.73,,1
Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,Valdecoxib metabolite M8,CC1=C(C2=CC=C(S(=O)(=O)O)C=C2)C(C2=CC=CC=C2)=NO1,LLWOSCPRJRUVST-UHFFFAOYSA-N,,0.85,,1
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",4-Hydroxyvoriconazole 4-O-glucuronide,O=C(O)C1OC(OCC(C2=NC=NC=C2F)C(O)(CN2C=NC=N2)C2=C(F)C=C(F)C=C2)C(O)C(O)C1O,RTNOBOYTQNLUHP-ORKWUBDLSA-N,,0.81,,1
Voriconazole,CC(C1=NC=NC=C1F)C(O)(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,"InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1","UK-51,060",O=C(CN1C=NC=N1)C1=C(F)C=C(F)C=C1,XCHRPVARHBCFMJ-UHFFFAOYSA-N,,0.33,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)","4',5-Dihydroxydiclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,0.8,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.44,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.69,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.43,,2
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.67,,2
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,,0.41,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OS(=O)(=O)O)=C1Cl,,,0.61,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.44,,1
Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.71,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.23,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.29,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.21,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.22,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.24,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.23,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.26,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.25,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.23,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.29,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.28,,1
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.3,,3
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.23,,3
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.22,,3
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.22,,3
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.22,,3
Testosterone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.31,,4
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.95,,2
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.67,,2
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.49,,2
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.62,,2
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.58,,2
Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.96,,3
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.21,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.21,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.28,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.23,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.28,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.27,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.25,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.3,,1
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.21,,2
Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.2,,2
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",Oxazepam,O=C1NC2=C(C=C(Cl)C=C2)C(C2=CC=CC=C2)=NC1O,ADIMAYPTOBDMTL-UHFFFAOYSA-N,,0.74,,1
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",p-Hydroxynordiazepam,O=C1CN=C(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C2N1,WVHIBVZUJQMFON-UHFFFAOYSA-N,,0.77,,1
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",Nordiazepam O-glucuronide,O=C(O)C1OC(OC2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N2)C(O)C(O)C1O,HIENWGUIYHGOPI-QHKDLCCSSA-N,,0.56,,1
Clorazepic acid,O=C(O)C1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)NC1=O,"InChI=1S/C16H11ClN2O3/c17-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)19-14(16(21)22)15(20)18-12/h1-8,14H,(H,18,20)(H,21,22)",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.47,,2
Nordazepam,O=C1CN=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C2N1,"InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.43,,1
Adenosine,NC1=C2N=CN(C3OC(CO)C(O)C3O)C2=NC=N1,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,,0.2,,1
Trazodone,O=C1N(CCCN2CCN(C3=CC(Cl)=CC=C3)CC2)N=C2C=CC=CN12,"InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,,0.3,,1
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Verapamil metabolite D-715 (PR-22),COC1=C(O)C=C(C(C#N)(CCCNCCC2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,VAUMWVGUBVPENJ-UHFFFAOYSA-N,,0.94,,1
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Verapamil metabolite D-620,COC1=C(OC)C=C(C(C#N)(CCCN)C(C)C)C=C1,UCWOSFAANAZHKR-UHFFFAOYSA-N,,0.86,,1
Verapamil,COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C2=CC(OC)=C(OC)C=C2)C(C)C)C=C1,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",Verapamil metabolite PR-25,CNCCCC(C#N)(C1=CC(OC)=C(O)C=C1)C(C)C,VNRFDZGJCSCHFU-UHFFFAOYSA-N,,0.86,,1
Aprepitant,CC(OC1OCCN(CC2=NNC(=O)N2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,"InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1",aprepitant_M2,CC(OC1OCC=NC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,,0.58,,1
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",alpha-OH-tamoxifen N-oxide,CC(O)C(=C(C1=CC=CC=C1)C1=CC=C(OCC[N+](C)(C)[O-])C=C1)C1=CC=CC=C1,,,0.82,,1
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",N-Desdimethyltamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN)C=C1)C1=CC=CC=C1,,,0.96,,1
Tamoxifen,CCC(=C(C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,"InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",alpha-OH-N-desmethyltamoxifen,CNCCOC1=CC=C(C(=C(C2=CC=CC=C2)C(C)O)C2=CC=CC=C2)C=C1,,,0.84,,1
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,Endoxifen O-glucuronide,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,,0.51,,2
4-Hydroxytamoxifen,CCC(=C(C1=CC=C(O)C=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1,TXUZVZSFRXZGTL-OCEACIFDSA-N,Endoxifen O-sulfate,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,,,0.82,,2
4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,Endoxifen O-glucuronide,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1)C1=CC=CC=C1,,,0.51,,1
4-hydroxytamoxifen sulfate,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,CFSXIBDXCWVFJR-QPLCGJKRSA-N,Endoxifen O-sulfate,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=C(OS(=O)(=O)O)C=C1)C1=CC=CC=C1,,,0.98,,1
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",6-O-desmethyl-mycophenolic acid,CC(=CCC1=C(O)C(C)=C2COC(=O)C2=C1O)CCC(=O)O,MHSRNZSBNXFMLF-UHFFFAOYSA-N,,0.84,,1
Mycophenolate mofetil,COC1=C(CC=C(C)CCC(=O)OCCN2CCOCC2)C(O)=C2C(=O)OCC2=C1C,"InChI=1S/C23H31NO7/c1-15(5-7-19(25)30-13-10-24-8-11-29-12-9-24)4-6-17-21(26)20-18(14-31-23(20)27)16(2)22(17)28-3/h4,26H,5-14H2,1-3H3/b15-4+",Mycophenolic acid-acyl glucuronide,COC1=C(C)C2=C(C(=O)OC2)C(O)=C1CC=C(C)CCC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBMSTEZXAMABFF-UEARNRKISA-N,,0.74,,1
Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C21)OCOC(=O)C(C)(C)C,"InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)",Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,,0.74,,1
Adefovir dipivoxil,CC(C)(C)C(=O)OCOP(=O)(COCCN1C=NC2=C(N)N=CN=C21)OCOC(=O)C(C)(C)C,"InChI=1S/C20H32N5O8P/c1-19(2,3)17(26)30-11-32-34(28,33-12-31-18(27)20(4,5)6)13-29-8-7-25-10-24-14-15(21)22-9-23-16(14)25/h9-10H,7-8,11-13H2,1-6H3,(H2,21,22,23)",Adefovir Diphosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2=NC=N1,MELHEUHXJKQZNC-UHFFFAOYSA-N,,0.69,,2
Adefovir,NC1=C2N=CN(CCOCP(=O)(O)O)C2=NC=N1,SUPKOOSCJHTBAH-UHFFFAOYSA-N,Adefovir Diphosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2=NC=N1,MELHEUHXJKQZNC-UHFFFAOYSA-N,,0.79,,1
Nateglinide,CC(C)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,"InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.87,,1
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",Tetrahydrocortisone,CC12CCC(O)CC1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,,,0.58,,1
Hydrocortisone,CC12CCC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,"InChI=1S/C21H30O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h9,14-16,18,22,24,26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",Dihydrocortisol,CC12CCC(=O)CC1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,,,0.65,,1
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Dehydroxyzileuton sulfoxide,CC(NC(N)=O)C1=CC2=CC=CC=C2S1=O,KGUIRZVMBWMQQZ-UHFFFAOYSA-N,,0.21,,1
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",Dehydroxyzyleuton sulfoxide,CC(NC(=N)O)C1=CC2=CC=CC=C2S1=O,,,0.21,,1
Zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(N)=O,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",(1S)â€1â€(6â€hydroxyâ€1â€benzothiophenâ€2â€yl)ethylurea,CC(NC(=N)O)C1=CC2=CC=C(O)C=C2S1,,,0.58,,1
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+","rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.24,,1
Tretinoin,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,"InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,,0.75,,1
Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,"InChI=1S/C15H12N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8H,9H2,(H2,16,19)",Eslicarbazepine-O-glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=C1C=CC=C2,NRSIPYUVLOFFHV-GOEBONIOSA-N,,0.54,,1
Phenelzine,NNCCC1=CC=CC=C1,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.21,,2
Phenethylamine,NCCC1=CC=CC=C1,"InChI=1S/C8H11N/c9-7-6-8-4-2-1-3-5-8/h1-5H,6-7,9H2",Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.22,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.72,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.73,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.75,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.51,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.57,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.72,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.68,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.6,,1
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.72,,2
"17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.67,,2
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",O-Desmethylnaproxen sulfate,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OS(=O)(=O)O)C=C2,BNKMSCMOWGCUOF-UHFFFAOYSA-N,,0.69,,1
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",O-Desmethylnaproxen acyl glucuronide,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC2=C(C=C1)C=C(O)C=C2,WKYUVCYFVJKWHF-FVNSOWSRSA-N,,0.35,,1
Naproxen,COC1=CC2=C(C=C1)C=C(C(C)C(=O)O)C=C2,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",O-Desmethylnaproxen O-glucuronide,CC(C(=O)O)C1=CC2=C(C=C1)C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,BFGOTVVWSNGSME-FVNSOWSRSA-N,,0.37,,1
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,,0.83,,1
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.73,,2
Primidone,CCC1(C2=CC=CC=C2)C(=O)NCNC1=O,"InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)",Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.49,,2
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+","Sulfapyridine, N-acetyl",CC(O)=NC1=CC=C(S(=O)(=O)NC2=CC=CC=N2)C=C1,,,0.59,,1
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,,0.39,,1
Sulfasalazine,O=C(O)C1=CC(N=NC2=CC=C(S(=O)(=O)NC3=NC=CC=C3)C=C2)=CC=C1O,"InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.39,,1
Pentoxifylline,CC(=O)CCCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,"InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3","lisofylline 4,5-diol",CC(O)C(O)CCCN1C(=O)C2=C(N=CN2C)N(C)C1=O,,,0.95,,1
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M6,CC1CC2=C(C=CC(O)C2O)N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,CZPZKXRBEJAROA-UHFFFAOYSA-N,,0.5,,1
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M3,CC1=CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,NYONMYACEVMMGW-UHFFFAOYSA-N,,0.49,,1
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,,0.83,,2
Indapamide,CC1CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",Indapamide metabolite M4,CC1C(=O)C2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,WTWDWHYDLVHLPL-UHFFFAOYSA-N,,0.88,,1
Indapamide metabolite M5,CC1=CC2=CC=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,LWCDXWWLUHMMJI-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,,0.47,,1
Indapamide metabolite M1,CC1CC2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,ARPVNNMMMDXBBF-UHFFFAOYSA-N,Indapamide metabolite M2,CC1C(=O)C2=CC(O)=CC=C2N1NC(=O)C1=CC(S(N)(=O)=O)=C(Cl)C=C1,AHVOGCBKNVSCRL-UHFFFAOYSA-N,,0.89,,1
Meloxicam,CC1=CN=C(NC(=O)C2=C(O)C3=C(C=CC=C3)S(=O)(=O)N2C)S1,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",5'-carboxy meloxicam,CN1C(C(O)=NC2=NC=C(C(=O)O)S2)=C(O)C2=CC=CC=C2S1(=O)=O,MTQQFYLGAZXHTB-UHFFFAOYSA-N,,0.69,,1
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,,0.24,,1
Propofol,CC(C)C1=CC=CC(C(C)C)=C1O,"InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",4-Quinol sulfate,CC(C)C1=CC(OS(=O)(=O)O)=CC(C(C)C)=C1O,RKAQPQOYAJQIAA-UHFFFAOYSA-N,,0.54,,1
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Oxazepam glucuronide,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N=C2O)C(O)C(O)C1O,FIKQKGFUBZQEBL-IFBJMGMISA-N,,0.44,,1
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",p-Hydroxynordiazepam,O=C1CN=C(C2=CC=C(O)C=C2)C2=CC(Cl)=CC=C2N1,WVHIBVZUJQMFON-UHFFFAOYSA-N,,0.84,,1
Diazepam,CN1C(=O)CN=C(C2=CC=CC=C2)C2=C1C=CC(Cl)=C2,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",Nordiazepam O-glucuronide,O=C(O)C1OC(OC2CN=C(C3=CC=CC=C3)C3=C(C=CC(Cl)=C3)N2)C(O)C(O)C1O,HIENWGUIYHGOPI-QHKDLCCSSA-N,,0.55,,1
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,"InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)",p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(=O)NC(=O)NC1=O,IEPXMKJNWPXDBP-UHFFFAOYSA-N,,0.8,,1
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,"InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)",Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.74,,2
Methylphenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)N(C)C1=O,"InChI=1S/C13H14N2O3/c1-3-13(9-7-5-4-6-8-9)10(16)14-12(18)15(2)11(13)17/h4-8H,3H2,1-2H3,(H,14,16,18)",Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.55,,2
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",1-Naphthoic acid,O=C(O)C1=C2C=CC=CC2=CC=C1,LNETULKMXZVUST-UHFFFAOYSA-N,,0.28,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",1-Naphthalenemethanol,OCC1=CC=CC2=CC=CC=C12,PBLNHHSDYFYZNC-UHFFFAOYSA-N,,0.32,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",1-Naphthoic acid,O=C(O)C1=CC=CC2=CC=CC=C12,,,0.28,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",N-Desmethylhydroxyterbinafine,CC(C)(C#CC=CCNCC1=CC=CC2=CC=CC=C12)CO,CKGLMMKXUSSSAA-XVNBXDOJSA-N,,0.82,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",N-Desmethylterbinafine dihydrodiol derivative (1),CC(C)(C)C#CC=CCNCC1=CC(O)=C(O)C2=CC=CC=C12,PQMBQNSIJJFKTL-XBXARRHUSA-N,,0.59,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",N-Desmethylterbinafine dihydrodiol derivative (2),CC(C)(C)C#CC=CCNCC1=CC=CC2=C(O)C(O)=CC=C12,QNITXIUZLIXMAL-GQCTYLIASA-N,,0.63,,1
Terbinafine,CN(CC=CC#CC(C)(C)C)CC1=CC=CC2=CC=CC=C12,"InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",Carboxyterbinafine,CN(CC=CC#CC(C)(C)C(=O)O)CC1=CC=CC2=CC=CC=C12,DSPCPJFHUUUMEV-XBXARRHUSA-N,,0.83,,1
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.35,,1
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.4,,1
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.41,,1
Benzphetamine,CC(CC1=CC=CC=C1)N(C)CC1=CC=CC=C1,"InChI=1S/C17H21N/c1-15(13-16-9-5-3-6-10-16)18(2)14-17-11-7-4-8-12-17/h3-12,15H,13-14H2,1-2H3/t15-/m0/s1",4-hydroxymethamphetamine,CNC(C)CC1=CC=C(O)C=C1,SBUQZKJEOOQSBV-UHFFFAOYSA-N,,0.48,,1
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,,0.46,,1
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",Atropaldehyde,C=C(C=O)C1=CC=CC=C1,ZFBRJUBOJXNIQM-UHFFFAOYSA-N,,0.22,,2
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)","4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,,0.36,,2
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)",3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.46,,2
Felbamate,NC(=O)OCC(COC(N)=O)C1=CC=CC=C1,"InChI=1S/C11H14N2O4/c12-10(14)16-6-9(7-17-11(13)15)8-4-2-1-3-5-8/h1-5,9H,6-7H2,(H2,12,14)(H2,13,15)","5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,,0.48,,3
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,Atropaldehyde,C=C(C=O)C1=CC=CC=C1,ZFBRJUBOJXNIQM-UHFFFAOYSA-N,,0.23,,1
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,,0.5,,1
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.71,,1
"2-Phenyl-1,3-propanediol monocarbamate",N=C(O)OCC(CO)C1=CC=CC=C1,JQVQIZWJBLGVRW-UHFFFAOYSA-N,"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,,0.34,,2
3-Carbamoyl-2-phenylpropionaldehyde,N=C(O)OCC(C=O)C1=CC=CC=C1,XUCMSYZLYLONTH-UHFFFAOYSA-N,"5-Phenyl-1,3-oxazinane-2,4-dione",O=C1N=C(O)C(C2=CC=CC=C2)CO1,YPIQXPKZXKWWSZ-UHFFFAOYSA-N,,0.31,,1
"4-Hydroxy-5-phenyltetrahydro-1,3-oxazin-2-one",OC1=NC(O)C(C2=CC=CC=C2)CO1,XZZMJRBYVRSAOS-UHFFFAOYSA-N,3-Carbamoyl-2-phenylpropionic acid,N=C(O)OCC(C(=O)O)C1=CC=CC=C1,AYRIVCKWIAUVOO-UHFFFAOYSA-N,,0.44,,1
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Hydromorphone-3-glucuronide,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(=O)CCC3C1C5,VLSHIBYUEOPPRX-UHFFFAOYSA-N,,0.88,,1
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Norhydromorphone,O=C1CCC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,SWIRXSKBBSJXGY-UIHHKEIPSA-N,,0.97,,1
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Norhydromorphone,O=C1CCC2C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,,0.97,,1
Hydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3,6,11-12,17H,4-5,7-9H2,1-2H3/t11-,12+,17-,18-/m0/s1",Hydromorphone 3-sulfate,CN1CCC23C4=C5C=CC(OS(=O)(=O)O)=C4OC2C(=O)CCC3C1C5,,,0.93,,1
Methyldopa,CC(N)(CC1=CC=C(O)C(O)=C1)C(=O)O,"InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",3-O-methyl-alpha-methyldopa sulfate,COC1=CC=C(CC(C)(N)C(=O)O)C=C1OS(=O)(=O)O,NKCGFFAMYYALPZ-NSHDSACASA-N,,0.59,,1
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3","N,N-Didesmethyldiphenhydramine",NCCOC(C1=CC=CC=C1)C1=CC=CC=C1,NFJFUDGBWGXTHS-UHFFFAOYSA-N,,0.9,,1
Diphenhydramine,CN(C)CCOC(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",Diphenylmethoxyacetic acid,O=C(O)COC(C1=CC=CC=C1)C1=CC=CC=C1,KWGQOJWITMQEOT-UHFFFAOYSA-N,,0.71,,2
N-Desmethyldiphenhydramine,CNCCOC(C1=CC=CC=C1)C1=CC=CC=C1,AGSLYHYWLYGAOU-UHFFFAOYSA-N,Diphenylmethoxyacetic acid,O=C(O)COC(C1=CC=CC=C1)C1=CC=CC=C1,KWGQOJWITMQEOT-UHFFFAOYSA-N,,0.74,,1
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",Norepinephrine sulfate,NCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,CVJMZWLHUCMEKO-ZETCQYMHSA-N,,0.44,,1
Dopamine,NCCC1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",3-Methoxy-4-Hydroxyphenylglycol sulfate,COC1=C(O)C=CC(C(CO)OS(=O)(=O)O)=C1,SBKADJXSGGTEPN-UHFFFAOYSA-N,,0.33,,1
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-thiouric acid,OC1=NC2=C(N=C(O)N2)C(S)=N1,SXHQUGJSTGOXMD-UHFFFAOYSA-N,,0.36,,1
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,,0.4,,1
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,,0.4,,1
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",8-hydroxythioguanine,OC1=NC2=C(N1)C(=S)N=CN2,OIZCDCVIFRRJFF-UHFFFAOYSA-N,,0.26,,1
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,,0.4,,2
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,,0.4,,2
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,,0.4,,3
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,,0.41,,3
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,,0.36,,3
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,,0.37,,4
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.37,,4
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.37,,5
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.36,,5
Azathioprine,CN1C=NC([N+](=O)[O-])=C1SC1=NC=NC2=C1NC=N2,"InChI=1S/C9H7N7O2S/c1-15-4-14-7(16(17)18)9(15)19-8-5-6(11-2-10-5)12-3-13-8/h2-4H,1H3,(H,10,11,12,13)",Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.36,,6
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,,0.19,,1
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,,0.2,,1
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,,0.2,,2
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,,0.18,,2
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,,0.25,,2
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,,0.14,,3
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.24,,3
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.23,,4
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.25,,4
6-Mercaptopurine,S=C1N=CNC2=C1NC=N2,GLVAUDGFNGKCSF-UHFFFAOYSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.25,,5
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,,0.6,,1
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.77,,1
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.77,,2
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.71,,2
6-Thiosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,WMRIOGFRJLQENF-UUOKFMHZSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.71,,3
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,,0.5,,1
Balsalazide,O=C(O)CCNC(=O)C1=CC=C(N=NC2=CC=C(O)C(C(=O)O)=C2)C=C1,"InChI=1S/C17H15N3O6/c21-14-6-5-12(9-13(14)17(25)26)20-19-11-3-1-10(2-4-11)16(24)18-8-7-15(22)23/h1-6,9,21H,7-8H2,(H,18,24)(H,22,23)(H,25,26)/b20-19+",N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.5,,1
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",Nitroso-sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N=O)C=C2)=NO1,GHNQGDUYHCZZPT-UHFFFAOYSA-N,,0.96,,1
Sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N)C=C2)=NO1,"InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",N4-Acetyl-5-OH-sulfamethoxazole,CC(=O)NC1=CC=C(S(=O)(=O)NC2=NOC(CO)=C2)C=C1,YKWZTWOYFWCVKH-UHFFFAOYSA-N,,0.81,,1
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M1,CC(O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,LIDZWACDVHJFLD-UHFFFAOYSA-N,,0.91,,1
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.91,,2
Irbesartan,CCCCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,"InChI=1S/C25H28N6O/c1-2-3-10-22-26-25(15-6-7-16-25)24(32)31(22)17-18-11-13-19(14-12-18)20-8-4-5-9-21(20)23-27-29-30-28-23/h4-5,8-9,11-14H,2-3,6-7,10,15-17H2,1H3,(H,27,28,29,30)",Irbesartan derivative M6,CC(=O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,MIGTZGLTQNODIS-UHFFFAOYSA-N,,0.99,,1
Irbesartan derivative M4,CC(O)CCC1=NC2(CCCC2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,YASLDPAAWWZGIP-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.92,,1
Irbesartan derivative M7,CCCCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,SGLAKMDXJPVHBY-UHFFFAOYSA-N,Irbesartan derivative M2,CC(=O)CCC1=NC2(CCC(O)C2)C(=O)N1CC1=CC=C(C2=CC=CC=C2C2=NNN=N2)C=C1,VYPCFUKCQSQGKN-UHFFFAOYSA-N,,0.99,,1
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,6-Methylmercaptopurine-riboside,CSC1=NC=NC2=C1N=CN2C1OC(CO)C(O)C1O,ZDRFDHHANOYUTE-IOSLPCCCSA-N,,0.89,,1
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,6-thioxanthylic acid,O=P(O)(O)C(O)C1OC(N2C=NC3=C2N=C(O)N=C3S)C(O)C1O,GRTRLPZIJODDLV-BQGLTYQTSA-N,,0.77,,1
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioguanosine monophosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)O)C(O)C1O)C=N2,BPZXYEUJBFHASJ-UUOKFMHZSA-N,,0.81,,1
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Methyl-thioguanosine monophosphate,CSC1N=C(N)NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,VLFVFMNOAJKLEN-AFPKLJJXSA-N,,0.59,,2
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,IUTNWRFYTFZSEK-UUOKFMHZSA-N,,0.79,,2
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thioguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1OC(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)C(O)C1O)C=N2,QENYANNAQSWPLM-UUOKFMHZSA-N,,0.78,,3
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thiodeoxyguanosine diphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)O)O1)C=N2,ZVLMDCYHIBYREW-KVQBGUIXSA-N,,0.72,,3
6-Thioinosine 5'-monophosphate,O=P(O)(O)OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,ZKRFOXLVOKTUTA-KQYNXXCUSA-N,Thiodeoxyguanosine triphosphate,NC1=NC(=S)C2=C(N1)N(C1CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O1)C=N2,BXZRFHUVVWIHMV-KVQBGUIXSA-N,,0.72,,4
6-Mercaptopurine riboside,OCC1OC(N2C=NC3=C2N=CN=C3S)C(O)C1O,NKGPJODWTZCHGF-KQYNXXCUSA-N,Methyl-thioinosine 5'-monophospate,CSC1=NC=NC2=C1N=CN2C1OC(COP(=O)(O)O)C(O)C1O,BMYFUCYXRGTQQL-IOSLPCCCSA-N,,0.89,,1
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",N-Dealkylated 5-hydroxymethyl tolterodine,CC(C)NCCC(C1=CC=CC=C1)C1=C(O)C=CC(CO)=C1,CCZYBOXFQXWQIF-QGZVFWFLSA-N,,0.87,,1
Tolterodine,CC1=CC(C(CCN(C(C)C)C(C)C)C2=CC=CC=C2)=C(O)C=C1,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",5-Carboxylic acid tolterodine,CC(C)N(CCC(C1=CC=CC=C1)C1=C(O)C=CC(C(=O)O)=C1)C(C)C,NKTNTJFTBRPQIZ-LJQANCHMSA-N,,0.82,,1
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.38,,1
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.44,,1
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",Amphetamine,CC(N)CC1=CC=CC=C1,KWTSXDURSIMDCE-UHFFFAOYSA-N,,0.57,,1
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.49,,1
Selegiline,C#CCN(C)C(C)CC1=CC=CC=C1,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",4-hydroxymethamphetamine,CNC(C)CC1=CC=C(O)C=C1,SBUQZKJEOOQSBV-UHFFFAOYSA-N,,0.57,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)","5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,,0.88,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,,0.52,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.16,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",L-Glutamine,NC(=O)CCC(N)C(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",,0.11,,2
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.49,,2
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.08,,3
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.7,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,,0.58,,1
Thalidomide,O=C1CCC(N2C(=O)C3=CC=CC=C3C2=O)C(=O)N1,"InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",Isoglutamine,NC(=O)C(N)CCC(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1",,0.12,,2
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,L-Glutamine,NC(=O)CCC(N)C(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",,0.13,,1
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.69,,1
alpha-(o-carboxybenzamido)glutarimide,O=C1CCC(NC(=O)C2=C(C(=O)O)C=CC=C2)C(=O)N1,QTUSGYNZYGYXIN-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.09,,2
Thalidomide arene oxide,O=C1N=C(O)CCC1N1C(=O)C2=CC3OC3C=C2C1=O,MNALUCRLHVMELD-UHFFFAOYSA-N,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,,0.35,,1
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,L-Glutamine,NC(=O)CCC(N)C(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H2,7,8)(H,9,10)/t3-/m0/s1",,0.18,,1
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.18,,1
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.63,,1
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.13,,2
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,Isoglutamine,NC(=O)C(N)CCC(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1",,0.17,,1
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.18,,1
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,2-(o-carboxybenzamido)glutaric acid,O=C(O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,QIWKCQDJZPRXNS-UHFFFAOYSA-N,,0.57,,1
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.12,,2
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.15,,1
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.14,,1
2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,Glutamic acid,NC(CCC(=O)O)C(=O)O,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",,0.15,,1
2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,Phthalic Acid,O=C(O)C1=CC=CC=C1C(=O)O,"InChI=1S/C8H6O4/c9-7(10)5-3-1-2-4-6(5)8(11)12/h1-4H,(H,9,10)(H,11,12)",,0.18,,1
Ibuprofen,CC(C)CC1=CC=C(C(C)C(=O)O)C=C1,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",Carboxy-ibuprofen,CC(CC1=CC=C(C(C)C(=O)O)C=C1)C(=O)O,DIVLBIVDYADZPL-UHFFFAOYSA-N,,0.82,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",N-Acetyl-5-hydroxytryptamine sulfate,CC(=O)NCCC1=CNC2=C1C=C(OS(=O)(=O)O)C=C2,UCAJZNVFRVLULS-UHFFFAOYSA-N,,0.78,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",N-Acetyl-5-hydroxytryptamine glucuronide,CC(=O)NCCC1=CNC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,DRKQFNYKSNWOTC-PDHYLSHYSA-N,,0.55,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",Pinoline,COC1=CC2=C(C=C1)NC1=C2CCNC1,QYMDEOQLJUUNOF-UHFFFAOYSA-N,,0.68,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",Bufotenine,CN(C)CCC1=CNC2=C1C=C(O)C=C2,VTTONGPRPXSUTJ-UHFFFAOYSA-N,,0.85,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)","N,N-Dimethyltryptamine",CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,,0.69,,2
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",6-Hydroxymelatonin sulfate,COC1=C(OS(=O)(=O)O)C=C2NC=C(CCN=C(C)O)C2=C1,QQEILXDLZRLTME-UHFFFAOYSA-N,,0.62,,1
Melatonin,COC1=CC2=C(C=C1)NC=C2CCNC(C)=O,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",6-Hydroxymelatonin glucuronide,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCNC(C)=O,BIRHYNBRXCOXLU-OOHXRKOZSA-N,,0.49,,1
5-Methoxytryptamine,COC1=CC2=C(C=C1)NC=C2CCN,JTEJPPKMYBDEMY-UHFFFAOYSA-N,"N,N-Dimethyltryptamine",CN(C)CCC1=CNC2=CC=CC=C12,DMULVCHRPCFFGV-UHFFFAOYSA-N,,0.69,,1
Gliclazide,CC1=CC=C(S(=O)(=O)NC(=O)NN2CC3CCCC3C2)C=C1,"InChI=1S/C15H21N3O3S/c1-11-5-7-14(8-6-11)22(20,21)17-15(19)16-18-9-12-3-2-4-13(12)10-18/h5-8,12-13H,2-4,9-10H2,1H3,(H2,16,17,19)/t12-,13+",Carboxygliclazide,O=C(NN1CC2CCCC2C1)NS(=O)(=O)C1=CC=C(C(=O)O)C=C1,DSNDPTBTZSQWJS-TXEJJXNPSA-N,,0.9,,1
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-III,CC(=O)C1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,JMLKLMFMQRAJNI-UHFFFAOYSA-N,,0.92,,1
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Pioglitazone metabolite M-XI,CC(O)C1=CN=C(C(O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,YYDPBNAZWVLEQF-UHFFFAOYSA-N,,0.85,,1
Pioglitazone,CCC1=CN=C(CCOC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",Mitoglitazone,CCC1=CN=C(C(=O)COC2=CC=C(CC3SC(=O)NC3=O)C=C2)C=C1,IRNJSRAGRIZIHD-UHFFFAOYSA-N,,0.88,,1
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,"InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2",,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=C(O)C=C2)N1C1=CC=CC=C1,,,0.96,,1
Sulfinpyrazone,O=C1C(CCS(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,"InChI=1S/C23H20N2O3S/c26-22-21(16-17-29(28)20-14-8-3-9-15-20)23(27)25(19-12-6-2-7-13-19)24(22)18-10-4-1-5-11-18/h1-15,21H,16-17H2",,O=C1C(CCS(=O)C2=CC=C(O)C=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,,0.97,,1
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Hydroxydoxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,RECOUBTVNVWWDB-IUXPMGMMSA-N,,0.6,,1
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Hydroxydesmethyl doxepin,CNCCC=C1C2=C(C=CC=C2)COC2=C1C=C(O)C=C2,LUWRONBNZDYVBL-APSNUPSMSA-N,,0.92,,1
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.6,,2
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Doxepin N-oxide glucuronide,C[N+](C)(CCC=C1C2=C(C=CC=C2)COC2=C1C=CC=C2)OC1OC(C(=O)O)C(O)C(O)C1O,NLZMYODDTAMNJM-GOSZAKIASA-O,,0.63,,1
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",Didesmethyl doxepin,NCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HLUSHBJOSPBFOC-OQLLNIDSSA-N,,0.98,,1
Doxepin,CN(C)CCC=C1C2=CC=CC=C2COC2=CC=CC=C12,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",2-Hydroxynordoxepin,CNCCC=C1C2=CC(O)=CC=C2COC2=CC=CC=C12,,,0.92,,1
N-desmethyldoxepin,CNCCC=C1C2=CC=CC=C2COC2=CC=CC=C12,HVKCEFHNSNZIHO-YBEGLDIGSA-N,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.59,,1
(E)-2-hydroxydoxepin,CN(C)CCC=C1C2=C(C=CC=C2)COC2=CC=C(O)C=C12,GRQPGTWGEQWMMM-IUXPMGMMSA-N,Hydroxydesmethyl doxepin glucuronide,CN(C)CCC=C1C2=C(C=CC=C2)COC2=C1C=C(OC1OC(C(=O)O)C(O)C(O)C1O)C=C2,RECOUBTVNVWWDB-CAOOACKPSA-N,,0.64,,1
Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,"InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",Phenobarbital O-sulfate,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(=O)NC(=O)NC1=O,SBVMQBDFNZJWGL-UHFFFAOYSA-N,,0.83,,1
Phenobarbital,CCC1(C2=CC=CC=C2)C(=O)NC(=O)NC1=O,"InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",Phenobarbital O-glucuronide,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(=O)NC(=O)NC1=O,RQTUXVFRLKPUJG-ZAOAHOKWSA-N,,0.55,,1
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",4-Ketoifosfamide,O=C1CCOP(=O)(NCCCl)N1CCCl,PEZLCTIXHCOEOG-UHFFFAOYSA-N,,0.69,,1
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,,0.46,,1
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",4-Thioifosfamide,NC(CCC(=O)NC(CSC1CCOP(=O)(NCCCl)N1CCCl)C(=O)NCC(=O)O)C(=O)O,UINSPYHKZALITP-XNZWOTSQSA-N,,0.4,,1
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",,NC(CCC(O)=NC(CSOC1CCOP(=O)(NCCCl)N1CCCl)C(O)=NCC(=O)O)C(=O)O,,,0.39,,1
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.47,,2
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,,0.45,,2
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.26,,2
Ifosfamide,O=P1(NCCCl)OCCCN1CCCl,"InChI=1S/C7H15Cl2N2O2P/c8-2-4-10-14(12)11(6-3-9)5-1-7-13-14/h1-7H2,(H,10,12)",Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.33,,3
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.35,,1
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,,0.34,,1
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.18,,1
4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.23,,2
aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.41,,1
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",4-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CC(O)CCC1=O,SNESGYGKISOJIN-UHFFFAOYSA-N,,0.74,,1
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",5-Hydroxynorketamine,NC1(C2=CC=CC=C2Cl)CCC(O)CC1=O,JNIMTHZVAYLUSL-UHFFFAOYSA-N,,0.77,,1
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,"InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",,NC1(C2=CC=CC=C2Cl)CCCC(O)C1=O,CFBVGSWSOJBYGC-UHFFFAOYSA-N,,0.72,,1
Levacetylmethadol,CCC(OC(C)=O)C(CC(C)N(C)C)(C1=CC=CC=C1)C1=CC=CC=C1,"InChI=1S/C23H31NO2/c1-6-22(26-19(3)25)23(17-18(2)24(4)5,20-13-9-7-10-14-20)21-15-11-8-12-16-21/h7-16,18,22H,6,17H2,1-5H3/t18-,22-/m0/s1",Dinor-levomethadyl acetate,CCC(OC(C)=O)C(CC(C)N)(C1=CC=CC=C1)C1=CC=CC=C1,FYQILXMAOLDNOY-JXFKEZNVSA-N,,0.91,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",6-Hydroxydopamine,NCCC1=C(O)C=C(O)C(O)=C1,DIVDFFZHCJEHGG-UHFFFAOYSA-N,,0.53,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Dopamine 4-sulfate,NCCC1=CC(O)=C(OS(=O)(=O)O)C=C1,DEKNNWJXAQTLFA-UHFFFAOYSA-N,,0.43,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Dopamine 3-O-sulfate,NCCC1=CC(OS(=O)(=O)O)=C(O)C=C1,NZKRYJGNYPYXJZ-UHFFFAOYSA-N,,0.4,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Dopamine glucuronide,NCCC1=CC(O)=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,CQASRCDNLNMIJY-BYNIDDHOSA-N,,0.25,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",3-Methoxytyramine,COC1=C(O)C=CC(CCN)=C1,,,0.54,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Norepinephrine,NCC(O)C1=CC(O)=C(O)C=C1,"InChI=1S/C8H11NO3/c9-4-8(12)5-1-2-6(10)7(11)3-5/h1-3,8,10-12H,4,9H2/t8-/m0/s1",,0.52,,1
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",Norepinephrine sulfate,NCC(O)C1=CC(O)=C(OS(=O)(=O)O)C=C1,CVJMZWLHUCMEKO-ZETCQYMHSA-N,,0.39,,2
Levodopa,NC(CC1=CC(O)=C(O)C=C1)C(=O)O,"InChI=1S/C9H11NO4/c10-6(9(13)14)3-5-1-2-7(11)8(12)4-5/h1-2,4,6,11-12H,3,10H2,(H,13,14)/t6-/m0/s1",3-Methoxy-4-Hydroxyphenylglycol sulfate,COC1=C(O)C=CC(C(CO)OS(=O)(=O)O)=C1,SBKADJXSGGTEPN-UHFFFAOYSA-N,,0.32,,2
Sevoflurane,FCOC(C(F)(F)F)C(F)(F)F,"InChI=1S/C4H3F7O/c5-1-12-2(3(6,7)8)4(9,10)11/h2H,1H2",,O=C(O)C1OC(OC(C(F)(F)F)C(F)(F)F)C(O)C(O)C1O,,,0.14,,1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",didesmethylclomipramine,NCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,LHDZEFLZJRLKPT-UHFFFAOYSA-N,,0.97,,1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",2-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C(O)=C2,BTEFPKOBUHDJSN-UHFFFAOYSA-N,,0.84,,1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",2-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FHDAIUXAPWZOKI-LYVDORBWSA-N,,0.48,,1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",2-hydroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FFAZHDSFJXPRMI-QMDPOKHVSA-N,,0.48,,2
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",8-hydroxyclomipramine glucuronide,CN(C)CCCN1C2=C(C=CC(Cl)=C2)CCC2=C1C=CC(O)=C2OC1OC(C(=O)O)C(O)C(O)C1O,UQBOPEJATBRQRS-MDYSUIJBSA-N,,0.47,,1
Clomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=C1C=C(Cl)C=C2,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",8-hydroxydesmethyl clomipramine,CNCCCN1C2=CC=C(O)C=C2CCC2=CC=C(Cl)C=C21,MRLCQGACIDFFSH-UHFFFAOYSA-N,,0.88,,1
2-hydroxyclomipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=C(Cl)C=C21,QXZNSJJZRXNDJQ-UHFFFAOYSA-N,2-hydroxydesmethyl clomipramine glucuronide,CNCCCN1C2=C(C=C(O)C(Cl)=C2)CCC2=C1C=CC=C2OC1OC(C(=O)O)C(O)C(O)C1O,FFAZHDSFJXPRMI-QMDPOKHVSA-N,,0.56,,1
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",N-acetyl-5-ASA (Ac-5-ASA),CC(=O)NC1=CC(C(=O)O)=C(O)C=C1,GEFDRROBUCULOD-UHFFFAOYSA-N,,0.6,,1
Olsalazine,O=C(O)C1=CC(N=NC2=CC=C(O)C(C(=O)O)=C2)=CC=C1O,"InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",N-acetyl-5-aminosalicylic acid,CC(=O)NC1=CC=C(O)C(C(=O)O)=C1,,,0.6,,1
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.33,,1
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.32,,1
Lisdexamfetamine,CC(CC1=CC=CC=C1)NC(=O)C(N)CCCCN,"InChI=1S/C15H25N3O/c1-12(11-13-7-3-2-4-8-13)18-15(19)14(17)9-5-6-10-16/h2-4,7-8,12,14H,5-6,9-11,16-17H2,1H3,(H,18,19)/t12-,14-/m0/s1",4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.3,,2
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",,0.27,,1
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,,0.22,,2
Nelarabine,COC1=NC(N)=NC2=C1N=CN2C1OC(CO)C(O)C1O,"InChI=1S/C11H15N5O5/c1-20-9-5-8(14-11(12)15-9)16(3-13-5)10-7(19)6(18)4(2-17)21-10/h3-4,6-7,10,17-19H,2H2,1H3,(H2,12,14,15)/t4-,6-,7+,10-/m1/s1",Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.23,,3
9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,,0.29,,1
9-β-D-arabinofuranosylguanine,NC1=NC2=C(N=[C]N2C2OC(CO)C(O)C2O)C(=O)N1,QFXYYZOMRMBRPL-FJFJXFQQSA-N,Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.29,,2
Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Uric acid,O=C1NC(=O)C2=C(N1)NC(=O)N2,LEHOTFFKMJEONL-UHFFFAOYSA-N,,0.59,,1
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,,0.89,,1
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M2,O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,NDKGEYRNJBCHHS-UHFFFAOYSA-N,,0.78,,2
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.58,,2
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.55,,3
4'-hydroxylumiracoxib (M23),CC1=CC(CC(=O)O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1,LUNFHOZKXHTOLG-UHFFFAOYSA-N,Lumiracoxib metabolite M25 glucuronide (M20),CC1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1F,SETAFJOLASRPRK-DAZJWRSOSA-N,,0.48,,1
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,Lumiracoxib metabolite M2,O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,NDKGEYRNJBCHHS-UHFFFAOYSA-N,,0.82,,1
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,Lumiracoxib metabolite M8,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(O)C=C1F,LFXDWINKKUWAOT-UHFFFAOYSA-N,,0.61,,1
Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.57,,2
4'-Hydroxy-5-carboxylumiracoxib (M5),O=C(O)CC1=CC(C(=O)O)=CC=C1NC1=C(Cl)C=C(O)C=C1F,MNDQIDSPYXYALX-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.61,,1
Lumiracoxib metabolite M15,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=CC=C1F,CYWNCAUMMWNHKA-UHFFFAOYSA-N,Lumiracoxib metabolite M4/M6,O=C(O)C1=CC=C2C(=C1)CC(=O)N2C1=C(Cl)C=C(OS(=O)(=O)O)C=C1F,YMUCSRFAMQITFI-UHFFFAOYSA-N,,0.87,,1
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,,0.93,,1
Hexobarbital,CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O,"InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",,CN1C(=O)N=C(O)C(C)(C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)CCC2)C1=O,,,0.42,,1
Mestranol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC)=C4)C3CCC21C,"InChI=1S/C21H26O2/c1-4-21(22)12-10-19-18-7-5-14-13-15(23-3)6-8-16(14)17(18)9-11-20(19,21)2/h1,6,8,13,17-19,22H,5,7,9-12H2,2-3H3/t17-,18-,19+,20+,21+/m1/s1",2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,,0.91,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",,0.59,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Testosterone sulfate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,WAQBISPOEAOCOG-DYKIIFRCSA-N,,0.65,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,,0.41,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Testosterone glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,NIKZPECGCSUSBV-HMAFJQTKSA-N,,0.58,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.41,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",6-beta-hydroxytestosterone,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,XSEGWEUVSZRCBC-ZVBLRVHNSA-N,,0.69,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.32,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2ÃŽÂ±-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,,0.69,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",15ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,,0.74,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",16ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,,0.74,,1
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.25,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.3,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.25,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.25,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.3,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.29,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.34,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.33,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.25,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.3,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.3,,2
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.31,,4
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.25,,4
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.27,,4
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.25,,4
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.25,,4
Testosterone propionate,CCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C22H32O3/c1-4-20(24)25-19-8-7-17-16-6-5-14-13-15(23)9-11-21(14,2)18(16)10-12-22(17,19)3/h13,16-19H,4-12H2,1-3H3/t16-,17-,18-,19-,21-,22-/m0/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.31,,5
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,0.94,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.92,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1",,0.94,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,,0.79,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,,CN1CCC23C4=C5C=CC(O)=C4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,,,0.94,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)C=CC3C1C5,,,0.9,,1
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,,0.92,,2
6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,,0.94,,2
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Hydroxymethyletoricoxib 1'-N'-oxide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=C[N+]([O-])=C(CO)C=C2)C=C1,SSTJTMIIIMAQMR-UHFFFAOYSA-N,,0.84,,1
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Carboxy-etoricoxib,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(C(=O)O)C=C2)C=C1,QIHJKHCGJLIAGS-UHFFFAOYSA-N,,0.88,,1
Etoricoxib,CC1=NC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=C1,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",6-Hydroxymethyletoricoxib glucuronide,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CN=C(COC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C=C1,UJWKCNOGFMSHNK-NDUFDKTRSA-N,,0.65,,1
Propanoyl-CoA,CCC(=O)SCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O,"InChI=1S/C24H40N7O17P3S/c1-4-15(33)52-8-7-26-14(32)5-6-27-22(36)19(35)24(2,3)10-45-51(42,43)48-50(40,41)44-9-13-18(47-49(37,38)39)17(34)23(46-13)31-12-30-16-20(25)28-11-29-21(16)31/h11-13,17-19,23,34-35H,4-10H2,1-3H3,(H,26,32)(H,27,36)(H,40,41)(H,42,43)(H2,25,28,29)(H2,37,38,39)/t13-,17-,18-,19+,23-/m1/s1",Succinyl-Coenzyme A,CC(C)(COP(=O)(O)OP(=O)(O)OCC1OC(N2C=NC3=C2N=CN=C3N)C(O)C1OP(=O)(O)O)C(O)C(=O)NCCC(=O)NCCSC(=O)CCC(=O)O,"InChI=1S/C25H40N7O19P3S/c1-25(2,20(38)23(39)28-6-5-14(33)27-7-8-55-16(36)4-3-15(34)35)10-48-54(45,46)51-53(43,44)47-9-13-19(50-52(40,41)42)18(37)24(49-13)32-12-31-17-21(26)29-11-30-22(17)32/h11-13,18-20,24,37-38H,3-10H2,1-2H3,(H,27,33)(H,28,39)(H,34,35)(H,43,44)(H,45,46)(H2,26,29,30)(H2,40,41,42)/t13-,18-,19-,20+,24-/m1/s1",,0.99,,1
Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",Acetaminophen glucuronide,CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,IPROLSVTVHAQLE-BYNIDDHOSA-N,,0.29,,1
Phenacetin,CCOC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",Acetaminophen sulfate,CC(=O)NC1=CC=C(OS(=O)(=O)O)C=C1,IGTYILLPRJOVFY-UHFFFAOYSA-N,,0.53,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.67,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.73,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.92,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.83,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.8,,1
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.65,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.6,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.83,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.57,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.51,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.49,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.53,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.61,,2
Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,"InChI=1S/C18H22O5S/c1-18-9-8-14-13-5-3-12(23-24(20,21)22)10-11(13)2-4-15(14)16(18)6-7-17(18)19/h3,5,10,14-16H,2,4,6-9H2,1H3,(H,20,21,22)/t14-,15-,16+,18+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.75,,2
Quinestrol,C#CC1(O)CCC2C3CCC4=C(C=CC(OC5CCCC5)=C4)C3CCC21C,"InChI=1S/C25H32O2/c1-3-25(26)15-13-23-22-10-8-17-16-19(27-18-6-4-5-7-18)9-11-20(17)21(22)12-14-24(23,25)2/h1,9,11,16,18,21-23,26H,4-8,10,12-15H2,2H3/t21-,22-,23+,24+,25+/m1/s1",2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,,0.85,,1
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C(O)=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,,0.75,,1
Licofelone,CC1(C)CC2=C(C3=CC=CC=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)O)N2C1,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",,CC1(C)CC2=C(C3=CC=C(O)C=C3)C(C3=CC=C(Cl)C=C3)=C(CC(=O)OC3OC(C(=O)O)C(O)C(O)C3O)N2C1,,,0.77,,1
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",4-hydroxymethyl ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(CO)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,HYNPRXQATWYSER-UDFRSJDBSA-N,,0.71,,1
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,"InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(CO)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.71,,1
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M3 (Odanacatib),CC(F)(COC1OC(C(=O)O)C(O)C(O)C1O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,XHSMOYVDHUJUTE-XNMFSWTPSA-N,,0.71,,1
Odanacatib,CC(C)(F)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",M7-B (Odanacatib),CC(F)(C=O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,HJVPPQGUHTYYIX-MMBKUXRPSA-N,,0.96,,1
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",4-Hydroxypropofol,CC(C)C1=CC(O)=CC(C(C)C)=C1O,UFWIJKBKROBWTG-UHFFFAOYSA-N,,0.53,,1
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",Propofol glucuronide,CC(C)C1=CC=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,JZSJIASBMOIIKI-RUKPJNHUSA-N,,0.36,,1
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",1-Quinol glucuronide,CC(C)C1=CC(O)=CC(C(C)C)=C1OC1OC(C(=O)O)C(O)C(O)C1O,OCSNDZGMSQTRGL-RUKPJNHUSA-N,,0.35,,2
Fospropofol,CC(C)C1=CC=CC(C(C)C)=C1OCOP(=O)(O)O,"InChI=1S/C13H21O5P/c1-9(2)11-6-5-7-12(10(3)4)13(11)17-8-18-19(14,15)16/h5-7,9-10H,8H2,1-4H3,(H2,14,15,16)",4-Quinol sulfate,CC(C)C1=CC(OS(=O)(=O)O)=CC(C(C)C)=C1O,RKAQPQOYAJQIAA-UHFFFAOYSA-N,,0.43,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)COC(=O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.49,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)COC(=O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.73,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.5,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.75,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",4'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,KGVXVPRLBMWZLG-UHFFFAOYSA-N,,0.76,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",Diclofenac acyl glucuronide,O=C(CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl)OC1OC(C(=O)O)C(O)C(O)C1O,JXIKYYSIYCILNG-HBWRTXEVSA-N,,0.55,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",3'-Hydroxydiclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(O)=C1Cl,HYPJZSYXUWYJDG-UHFFFAOYSA-N,,0.72,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",5-OH-diclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.75,,1
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)","4',5-Dihydroxydiclofenac",O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(O)C=C1Cl,,,0.72,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.46,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC(OS(=O)(=O)O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,0.63,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.45,,3
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.61,,3
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1Cl,,,0.43,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC(OS(=O)(=O)O)=C1Cl,,,0.58,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.46,,2
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,"InChI=1S/C16H13Cl2NO4/c17-11-5-3-6-12(18)16(11)19-13-7-2-1-4-10(13)8-15(22)23-9-14(20)21/h1-7,19H,8-9H2,(H,20,21)",,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.64,,2
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",Dihydroxy norketobemidone,CCC(=O)C1(C2=CC(O)=C(O)C=C2)CCNCC1,XOZROGPZDNSCPU-UHFFFAOYSA-N,,0.89,,1
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",p-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(OC)=C(O)C=C2)CCN(C)CC1,QNSHRSXJXIHEDC-UHFFFAOYSA-N,,0.85,,1
Ketobemidone,CCC(=O)C1(C2=CC(O)=CC=C2)CCN(C)CC1,"InChI=1S/C15H21NO2/c1-3-14(18)15(7-9-16(2)10-8-15)12-5-4-6-13(17)11-12/h4-6,11,17H,3,7-10H2,1-2H3",m-Hydroxymethoxy ketobemidone,CCC(=O)C1(C2=CC(O)=C(OC)C=C2)CCN(C)CC1,YMCUUJLOWHXMHJ-UHFFFAOYSA-N,,0.88,,1
Bendamustine,CN1C(CCCC(=O)O)=NC2=CC(N(CCCl)CCCl)=CC=C21,"InChI=1S/C16H21Cl2N3O2/c1-20-14-6-5-12(21(9-7-17)10-8-18)11-13(14)19-15(20)3-2-4-16(22)23/h5-6,11H,2-4,7-10H2,1H3,(H,22,23)",dihydroxy-bendamustine (bendamustine metabolite HP2),CN1C(CCCC(=O)O)=NC2=C1C=CC(N(CCO)CCO)=C2,XQMDIDKYVZPCNV-UHFFFAOYSA-N,,0.93,,1
Phenylbutyric acid,O=C(O)CCCC1=CC=CC=C1,"InChI=1S/C10H12O2/c11-10(12)8-4-7-9-5-2-1-3-6-9/h1-3,5-6H,4,7-8H2,(H,11,12)",Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.22,,1
Nandrolone decanoate,CCCCCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4C3CCC12C,"InChI=1S/C28H44O3/c1-3-4-5-6-7-8-9-10-27(30)31-26-16-15-25-24-13-11-20-19-21(29)12-14-22(20)23(24)17-18-28(25,26)2/h19,22-26H,3-18H2,1-2H3/t22-,23+,24+,25-,26-,28-/m0/s1",19-Norandrosterone,CC12CCC3C4CCC(O)CC4CCC3C1CCC2=O,,,0.33,,1
Icosapent ethyl,CCC=CCC=CCC=CCC=CCC=CCCCC(=O)OCC,"InChI=1S/C22H34O2/c1-3-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-22(23)24-4-2/h5-6,8-9,11-12,14-15,17-18H,3-4,7,10,13,16,19-21H2,1-2H3/b6-5-,9-8-,12-11-,15-14-,18-17-",,CCC=CCC=CCC=CCCCCC=CCCCC(=O)O,,,0.66,,1
Dimethyl fumarate,COC(=O)C=CC(=O)OC,"InChI=1S/C6H8O4/c1-9-5(7)3-4-6(8)10-2/h3-4H,1-2H3/b4-3+",Fumaric acid,O=C(O)C=CC(=O)O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",,0.63,,1
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",,C=C(C)C1CC=C(C)C(OC2OC(C(=O)O)C(O)C(O)C2O)C1,,,0.19,,1
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Uroterpenol-O-glucuronide,CC1=CCC(C(C)(O)COC2OC(C(=O)O)C(O)C(O)C2O)CC1,QLUXQCRCCGIUTP-LVSORJHWSA-N,,0.16,,1
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",Perillyl acid,C=C(C)C1=CCC(CO)CC1,HBYMEORZYADIJJ-UHFFFAOYSA-N,,0.39,,1
(4R)-limonene,C=C(C)C1CC=C(C)CC1,"InChI=1S/C10H16/c1-8(2)10-6-4-9(3)5-7-10/h4,10H,1,5-7H2,2-3H3/t10-/m0/s1",,C=C(C)C1CC=C(COC2OC(C(=O)O)C(O)C(O)C2O)CC1,,,0.21,,1
Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC1=CC=CC=C1,"InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1",GS-606965,CC1(F)C(O)C(COP(=O)(O)O)OC1N1C=CC(=O)NC1=O,JAJZLQMRDFLNSW-WDKMEHGUSA-N,,0.8,,1
Sofosbuvir,CC(C)OC(=O)C(C)NP(=O)(OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O)OC1=CC=CC=C1,"InChI=1S/C22H29FN3O9P/c1-13(2)33-19(29)14(3)25-36(31,35-15-8-6-5-7-9-15)32-12-16-18(28)22(4,23)20(34-16)26-11-10-17(27)24-21(26)30/h5-11,13-14,16,18,20,28H,12H2,1-4H3,(H,25,31)(H,24,27,30)/t14-,16+,18+,20+,22+,36-/m0/s1",GS-461203,CC1(F)C(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1N1C=CC(O)=NC1=O,IPHULAIUXUVCHH-WDKMEHGUSA-N,,0.74,,2
GS-56650,CC(C)OC(=O)C(C)NP(=O)(O)OCC1OC(N2C=CC(=O)NC2=O)C(C)(F)C1O,IPNWIJCJSQLNQC-YAWKKRDBSA-N,GS-461203,CC1(F)C(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)OC1N1C=CC(O)=NC1=O,IPHULAIUXUVCHH-WDKMEHGUSA-N,,0.77,,1
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,,0.57,,1
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",Eslicarbazepine-O-glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=C1C=CC=C2,NRSIPYUVLOFFHV-GOEBONIOSA-N,,0.55,,1
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",(R)-MHD,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=CC=CC=C21,BMPDWHIDQYTSHX-AWEZNQCLSA-N,,0.81,,2
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",Eslicarbazepine,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=C1C=CC=C2,"InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1",,0.81,,2
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",10-hydroxycarbazepine sulfate,NC(=O)N1C2=CC=CC=C2CC(OS(=O)(=O)O)C2=CC=CC=C21,DQCMJSSQBFEDHL-UHFFFAOYSA-N,,0.71,,2
Eslicarbazepine acetate,CC(=O)OC1CC2=CC=CC=C2N(C(N)=O)C2=CC=CC=C21,"InChI=1S/C17H16N2O3/c1-11(20)22-16-10-12-6-2-4-8-14(12)19(17(18)21)15-9-5-3-7-13(15)16/h2-9,16H,10H2,1H3,(H2,18,21)/t16-/m0/s1",10-hydroxycarbazepine glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=CC=CC=C21,NRSIPYUVLOFFHV-LBAUFKAWSA-N,,0.55,,2
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,(R)-MHD,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=CC=CC=C21,BMPDWHIDQYTSHX-AWEZNQCLSA-N,,1.0,,1
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Eslicarbazepine,NC(=O)N1C2=C(C=CC=C2)CC(O)C2=C1C=CC=C2,"InChI=1S/C15H14N2O2/c16-15(19)17-12-7-3-1-5-10(12)9-14(18)11-6-2-4-8-13(11)17/h1-8,14,18H,9H2,(H2,16,19)/t14-/m0/s1",,1.0,,1
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,10-hydroxycarbazepine sulfate,NC(=O)N1C2=CC=CC=C2CC(OS(=O)(=O)O)C2=CC=CC=C21,DQCMJSSQBFEDHL-UHFFFAOYSA-N,,0.8,,1
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,10-hydroxycarbazepine glucuronide,NC(=O)N1C2=CC=CC=C2CC(NC(C=O)CCC(=O)O)C2=CC=CC=C21,NRSIPYUVLOFFHV-LBAUFKAWSA-N,,0.56,,1
Etoperidone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CC,"InChI=1S/C19H28ClN5O/c1-3-18-21-25(19(26)24(18)4-2)10-6-9-22-11-13-23(14-12-22)17-8-5-7-16(20)15-17/h5,7-8,15H,3-4,6,9-14H2,1-2H3",2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,,0.3,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,0.98,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.96,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1",,0.9,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,,0.79,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",,CN1CCC23C4=C5C=CC(O)=C4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,,,0.9,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)C=CC3C1C5,,,0.9,,1
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,,0.97,,2
Pholcodine,CN1CCC23C4=C5C=CC(OCCN6CCOCC6)=C4OC2C(O)C=CC3C1C5,"InChI=1S/C23H30N2O4/c1-24-7-6-23-16-3-4-18(26)22(23)29-21-19(5-2-15(20(21)23)14-17(16)24)28-13-10-25-8-11-27-12-9-25/h2-5,16-18,22,26H,6-14H2,1H3/t16-,17+,18-,22-,23-/m0/s1",Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,,0.9,,2
Droxicam,CN1C2=C(OC(=O)N(C3=CC=CC=N3)C2=O)C2=CC=CC=C2S1(=O)=O,"InChI=1S/C16H11N3O5S/c1-18-13-14(10-6-2-3-7-11(10)25(18,22)23)24-16(21)19(15(13)20)12-8-4-5-9-17-12/h2-9H,1H3",5'-Hydroxypiroxicam,CN1C(C(O)=NC2=NC=C(O)C=C2)=C(O)C2=CC=CC=C2S1(=O)=O,CCKOORANQAQKKV-UHFFFAOYSA-N,,0.56,,1
Propacetamol,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)",Acetaminophen glucuronide,CC(=O)NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,IPROLSVTVHAQLE-BYNIDDHOSA-N,,0.31,,1
Propacetamol,CCN(CC)CC(=O)OC1=CC=C(NC(C)=O)C=C1,"InChI=1S/C14H20N2O3/c1-4-16(5-2)10-14(18)19-13-8-6-12(7-9-13)15-11(3)17/h6-9H,4-5,10H2,1-3H3,(H,15,17)",Acetaminophen sulfate,CC(=O)NC1=CC=C(OS(=O)(=O)O)C=C1,IGTYILLPRJOVFY-UHFFFAOYSA-N,,0.41,,1
Tenofovir,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)O,SGOIRFVFHAKUTI-ZCFIWIBFSA-N,Tenofovir Diphosphate,CC(CN1C=NC2=C1N=CN=C2N)OCP(=O)(O)OP(=O)(O)OP(=O)(O)O,IACQCQDWSIQSRP-ZCFIWIBFSA-N,,0.82,,1
Xylose,O=CC(O)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h1,3-5,7-10H,2H2/t3-,4+,5+/m0/s1",D-Xylulose,O=C(CO)C(O)C(O)CO,"InChI=1S/C5H10O5/c6-1-3(8)5(10)4(9)2-7/h3,5-8,10H,1-2H2/t3-,5-/m0/s1",,0.57,,1
Cetyl alcohol,CCCCCCCCCCCCCCCCO,"InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3",,CC(O)CCCCCCCCCCCCCC(=O)O,,,0.44,,1
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",Prostaglandin E1,CCCCCC(O)C=CC1C(O)CC(=O)C1CCCCCCC(=O)O,,,0.2,,1
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",Arachidonic Acid,CCCCCC=CCC=CCC=CCC=CCCCC(=O)O,"InChI=1S/C20H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13,15-16H,2-5,8,11,14,17-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-,16-15-",,0.8,,1
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",5-HETE,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,,,0.62,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",7-HETE,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,,,0.62,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",10-HETE,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,,,0.64,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",13-HETE,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,,,0.62,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",17-HETE,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,,,0.61,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",15-HETE,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,,,0.54,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",12-HETE,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,,,0.53,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",9-HETE,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,,,0.54,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",8-HETE,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,,,0.53,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,0.2,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",20-HETE,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,,,0.84,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",19-HETE,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.72,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",18-HETE,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.66,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",16-HETE,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,,,0.61,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-","14,15-EET",CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,,,0.41,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-","11,12-EET",CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,,,0.44,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-","8,9-EET",CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,,,0.44,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-","5,6-EET",CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,,,0.41,,2
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10,12-13H,2-5,8,11,14-17H2,1H3,(H,19,20)/b7-6-,10-9-,13-12-",11-HETE,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,,,0.54,,2
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",5-HETE,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,,,0.55,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",7-HETE,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,,,0.59,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",10-HETE,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,,,0.61,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",13-HETE,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,,,0.59,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",17-HETE,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,,,0.58,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",15-HETE,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,,,0.56,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",12-HETE,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,,,0.51,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",9-HETE,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,,,0.52,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",8-HETE,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,,,0.51,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,0.21,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",20-HETE,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,,,0.76,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",19-HETE,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.68,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",18-HETE,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.63,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",16-HETE,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,,,0.58,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","14,15-EET",CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,,,0.46,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","11,12-EET",CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,,,0.43,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","8,9-EET",CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,,,0.43,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","5,6-EET",CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,,,0.46,,1
Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-",11-HETE,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,,,0.52,,1
Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,Rhein,O=C(O)C1=CC2C(=O)C3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,HHQNGUQUHZYDEP-UHFFFAOYSA-N,,0.37,,1
Benzyl alcohol,OCC1=CC=CC=C1,"InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.18,,1
Benzyl alcohol,OCC1=CC=CC=C1,"InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",,O=C(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=CC=C1,,,0.08,,1
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",4-Hydroxycyclophosphamide,O=P1(N(CCCl)CCCl)NC(O)CCO1,RANONBLIHMVXAJ-UHFFFAOYSA-N,,0.69,,1
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Dechloroethyl cyclophosphamide,O=P1(NCCCl)NCCCO1,DZKGMGPLDJOVCX-UHFFFAOYSA-N,,0.57,,1
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",4-Ketocyclophosphamide,O=C1CCOP(=O)(N(CCCl)CCCl)N1,VBMZHOCORXMDJU-UHFFFAOYSA-N,,0.68,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Aldophosphamide,NP(=O)(OCCC=O)N(CCCl)CCCl,QMGUSPDJTPDFSF-UHFFFAOYSA-N,,0.59,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Carboxyphosphamide,NP(=O)(OCCC(=O)O)N(CCCl)CCCl,QLAKAJLYYGOZQL-UHFFFAOYSA-N,,0.57,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Alcophosphamide,NP(=O)(OCCCO)N(CCCl)CCCl,BZGFIGVSVQRQBJ-UHFFFAOYSA-N,,0.6,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Phosphoramide Mustard,NP(=O)(O)N(CCCl)CCCl,RJXQSIKBGKVNRT-UHFFFAOYSA-N,,0.37,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Dechloroethylifosfamide,NP1(=O)OCCCN1CCCl,ROGLJLJCDSTWBN-UHFFFAOYSA-N,,0.8,,1
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",4-Hydroxyifosfamide,O=P1(NCCCl)OCCC(O)N1CCCl,JHUJMHKRHQPBRG-UHFFFAOYSA-N,,0.67,,1
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",4-Ketoifosfamide,O=C1CCOP(=O)(NCCCl)N1CCCl,PEZLCTIXHCOEOG-UHFFFAOYSA-N,,0.67,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",aldoifosfamide,O=CCCOP(=O)(NCCCl)NCCCl,IPTJZZUYNOWWHM-UHFFFAOYSA-N,,0.44,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",4-Thioifosfamide,NC(CCC(=O)NC(CSC1CCOP(=O)(NCCCl)N1CCCl)C(=O)NCC(=O)O)C(=O)O,UINSPYHKZALITP-XNZWOTSQSA-N,,0.4,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",,NC(CCC(O)=NC(CSOC1CCOP(=O)(NCCCl)N1CCCl)C(O)=NCC(=O)O)C(=O)O,,,0.39,,2
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Alcoifosfamide,O=P(NCCCl)(NCCCl)OCCCO,JOAQXFLTMDRBOD-UHFFFAOYSA-N,,0.45,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Carboxylifosfamide,O=C(O)CCOP(=O)(NCCCl)NCCCl,DNDBVHDNSYHKLI-UHFFFAOYSA-N,,0.43,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Isophosphamide mustard,O=P(O)(NCCCl)NCCCl,BKCJZNIZRWYHBN-UHFFFAOYSA-N,,0.25,,3
Trofosfamide,O=P1(N(CCCl)CCCl)OCCCN1CCCl,"InChI=1S/C9H18Cl3N2O2P/c10-2-6-13-5-1-9-16-17(13,15)14(7-3-11)8-4-12/h1-9H2",Ifosforamide Aziridinium,O=P(O)(NCCCl)[NH+]1CC1,NAFVGKNCETZZFN-UHFFFAOYSA-O,,0.32,,4
Nicoboxil,CCCCOCCOC(=O)C1=CN=CC=C1,"InChI=1S/C12H17NO3/c1-2-3-7-15-8-9-16-12(14)11-5-4-6-13-10-11/h4-6,10H,2-3,7-9H2,1H3",Niacinamide,NC(=O)C1=CC=CN=C1,,,0.32,,1
Nicoboxil,CCCCOCCOC(=O)C1=CN=CC=C1,"InChI=1S/C12H17NO3/c1-2-3-7-15-8-9-16-12(14)11-5-4-6-13-10-11/h4-6,10H,2-3,7-9H2,1H3",Trigonelline,C[N+]1=CC=CC(C(=O)[O-])=C1,,,0.5,,1
Rheinanthrone,O=C(O)C1=CC(O)=C2C(=O)C3=C(C=CC=C3O)CC2=C1,"InChI=1S/C15H10O5/c16-10-3-1-2-7-4-8-5-9(15(19)20)6-11(17)13(8)14(18)12(7)10/h1-3,5-6,16-17H,4H2,(H,19,20)",Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,,0.31,,1
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",5-Hydroxyindomethacin,CC1=C(CC(=O)O)C2=C(C=CC(O)=C2)N1C(=O)C1=CC=C(Cl)C=C1,KMLNWQPYFBIALN-UHFFFAOYSA-N,,0.93,,1
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",Indomethacin acyl glucuronide,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QCBWEVBGELGABM-CZLVRFMKSA-N,,0.82,,1
Acemetacin,COC1=CC2=C(C=C1)N(C(=O)C1=CC=C(Cl)C=C1)C(C)=C2CC(=O)OCC(=O)O,"InChI=1S/C21H18ClNO6/c1-12-16(10-20(26)29-11-19(24)25)17-9-15(28-2)7-8-18(17)23(12)21(27)13-3-5-14(22)6-4-13/h3-9H,10-11H2,1-2H3,(H,24,25)",Deacyl indomethacin,COC1=CC2=C(C=C1)NC(C)=C2CC(=O)O,TXWGINUZLBAKDF-UHFFFAOYSA-N,,0.57,,1
Methyl nicotinate,COC(=O)C1=CN=CC=C1,"InChI=1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3",Niacinamide,NC(=O)C1=CC=CN=C1,,,0.4,,1
Methyl nicotinate,COC(=O)C1=CN=CC=C1,"InChI=1S/C7H7NO2/c1-10-7(9)6-3-2-4-8-5-6/h2-5H,1H3",Trigonelline,C[N+]1=CC=CC(C(=O)[O-])=C1,,,0.61,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",,0.58,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Testosterone sulfate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,WAQBISPOEAOCOG-DYKIIFRCSA-N,,0.64,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,,0.4,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Testosterone glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,NIKZPECGCSUSBV-HMAFJQTKSA-N,,0.58,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.42,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",6-beta-hydroxytestosterone,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,XSEGWEUVSZRCBC-ZVBLRVHNSA-N,,0.68,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.31,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2ÃŽÂ±-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,,0.68,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",15ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,,0.73,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",16ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,,0.73,,1
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.25,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.3,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.25,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.25,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.3,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.29,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.35,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.33,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.25,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.3,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.3,,2
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.31,,4
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.25,,4
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.28,,4
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.25,,4
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.25,,4
Testosterone cypionate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC(=O)CCC3CCCC3)CCC12,"InChI=1S/C27H40O3/c1-26-15-13-20(28)17-19(26)8-9-21-22-10-11-24(27(22,2)16-14-23(21)26)30-25(29)12-7-18-5-3-4-6-18/h17-18,21-24H,3-16H2,1-2H3/t21-,22-,23-,24-,26-,27-/m0/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.31,,5
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Androstenedione,CC12CCC3C(CCC4=CC(=O)CCC43C)C1CCC2=O,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",,0.58,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Testosterone sulfate,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OS(=O)(=O)O)CCC12,WAQBISPOEAOCOG-DYKIIFRCSA-N,,0.64,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Dihydrotestosterone,CC12CCC3C(CCC4CC(=O)CCC43C)C1CCC2O,NVKAWKQGWWIWPM-ABEVXSGRSA-N,,0.4,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Testosterone glucuronide,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,NIKZPECGCSUSBV-HMAFJQTKSA-N,,0.58,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",5-alpha-Dihydrotestosterone glucuronide,CC12CCC(=O)CC1CCC1C2CCC2(C)C(OC3OC(C(=O)O)C(O)C(O)C3O)CCC12,CLQMBSSRTBUNDV-CPKOJWPQSA-N,,0.42,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",6-beta-hydroxytestosterone,CC12CCC(=O)C=C1C(O)CC1C2CCC2(C)C(O)CCC12,XSEGWEUVSZRCBC-ZVBLRVHNSA-N,,0.68,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estradiol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2O,VOXZDWNPVJITMN-ZBRFXRBCSA-N,,0.31,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2ÃŽÂ±-Hydroxytestosterone ,CC12CC(O)C(=O)C=C1CCC1C2CCC2(C)C(O)CCC12,,,0.69,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",15ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)CC(O)C12,,,0.73,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",16ÃŽÂ±-Hydroxytestosterone ,CC12CCC(=O)C=C1CCC1C2CCC2(C)C(O)C(O)CC12,,,0.73,,1
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.25,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.3,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.25,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.25,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.3,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.29,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.35,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.33,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.25,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.3,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.3,,2
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.31,,4
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.25,,4
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.28,,4
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.25,,4
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.25,,4
Testosterone enanthate,CCCCCCC(=O)OC1CCC2C3CCC4=CC(=O)CCC4(C)C3CCC12C,"InChI=1S/C26H40O3/c1-4-5-6-7-8-24(28)29-23-12-11-21-20-10-9-18-17-19(27)13-15-25(18,2)22(20)14-16-26(21,23)3/h17,20-23H,4-16H2,1-3H3/t20-,21-,22-,23-,25-,26-/m0/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.31,,5
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.7,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.75,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.57,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.64,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.61,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.57,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.61,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.57,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.69,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.77,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.68,,1
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.84,,3
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.62,,3
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,,3
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.6,,3
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.56,,3
Estradiol acetate,CC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,"InChI=1S/C20H26O3/c1-12(21)23-14-4-6-15-13(11-14)3-5-17-16(15)9-10-20(2)18(17)7-8-19(20)22/h4,6,11,16-19,22H,3,5,7-10H2,1-2H3/t16-,17-,18+,19+,20+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.84,,4
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.65,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.71,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.55,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.6,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.6,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.57,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.6,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.57,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.64,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.71,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.65,,1
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.76,,3
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.61,,3
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.55,,3
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.58,,3
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.55,,3
Estradiol benzoate,CC12CCC3C4=CC=C(OC(=O)C5=CC=CC=C5)C=C4CCC3C1CCC2O,"InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.76,,4
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.71,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.74,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.53,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.64,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.59,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.55,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.68,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.63,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.69,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.75,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.68,,1
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.82,,3
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.63,,3
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.54,,3
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.61,,3
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.57,,3
Estradiol cypionate,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC(=O)CCC1CCCC1,"InChI=1S/C26H36O3/c1-26-15-14-21-20-10-8-19(27)16-18(20)7-9-22(21)23(26)11-12-24(26)29-25(28)13-6-17-4-2-3-5-17/h8,10,16-17,21-24,27H,2-7,9,11-15H2,1H3/t21-,22-,23+,24+,26+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.82,,4
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.64,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.67,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.59,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.6,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.66,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.62,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.66,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.62,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.63,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.68,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.63,,1
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.72,,3
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.59,,3
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.61,,3
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.58,,3
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.55,,3
Estradiol dienanthate,CCCCCCC(=O)OC1=CC=C2C(=C1)CCC1C2CCC2(C)C(OC(=O)CCCCCC)CCC12,"InChI=1S/C32H48O4/c1-4-6-8-10-12-30(33)35-24-15-17-25-23(22-24)14-16-27-26(25)20-21-32(3)28(27)18-19-29(32)36-31(34)13-11-9-7-5-2/h15,17,22,26-29H,4-14,16,18-21H2,1-3H3/t26-,27-,28+,29+,32+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.72,,4
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estrone,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2=O,DNXHEGUUPJUMQT-CBZIJGRNSA-N,,0.71,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estradiol-17beta 3-sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2O,QZIGLSSUDXBTLJ-QGPAGSFOSA-N,,0.74,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",2-Methoxyestrone 3-glucuronide,COC1=C(OC2OC(O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(=O)CCC34)C2=C1,CLTGLDLWQUZPJU-OOJOVCNMSA-N,,0.53,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",4-hydroxyestrone,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(O)C=C4,XQZVQQZZOVBNLU-KQWCVQSUSA-N,,0.64,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",17-beta-Estradiol-3-glucuronide,CC12CCC3C4=C(C=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4)CCC3C1CCC2O,MUOHJTRCBBDUOW-BFXFFQJBSA-N,,0.59,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",2-methoxy-17beta-estradiol 3-O-(beta-D-glucuronide),COC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C2CCC3C(CCC4(C)C(O)CCC34)C2=C1,LLCPFVIBUZJITJ-GVEMAFOVSA-N,,0.55,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",17-beta-Estradiol glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,MTKNDAQYHASLID-RNFKDHMMSA-N,,0.68,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",17-beta-estradiol 3-sulfate-17-(beta-D-glucuronide),CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,VRMSCBRLZUCJBX-QXYWQCSFSA-N,,0.63,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",2-hydroxyestrone,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2=O,SWINWPBPEKHUOD-JPVZDGGYSA-N,,0.69,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",4-Hydroxyestradiol,CC12CCC3C4=C(CCC3C1CCC2O)C(O)=C(O)C=C4,,,0.76,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1","17-Beta-Estradiol-3,17-beta-sulfate",CC12CCC3C4=CC=C(OS(=O)(=O)O)C=C4CCC3C1CCC2OS(=O)(=O)O,VPLAJGAMHNQZIY-ZBRFXRBCSA-N,,0.68,,1
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,,0.82,,3
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)O)C=C4)CCC3C1CCC2=O,JKKFKPJIXZFSSB-CBZIJGRNSA-N,,0.63,,3
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",Estrone glucuronide,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2=O,FJAZVHYPASAQKM-JBAURARKSA-N,,0.54,,3
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",2-Hydroxyestrone sulfate,CC12CCC3C4=C(C=C(OS(=O)(=O)[O-])C(O)=C4)CCC3C1CCC2=O,DTMWSKSAMRZGQH-PEDDLLMLSA-M,,0.6,,3
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",4-Hydroxyestrone sulfate,CC12CCC3C4=C(CCC3C1CCC2=O)C(O)=C(OS(=O)(=O)O)C=C4,QIJNCQNMZUTUIF-KQWCVQSUSA-N,,0.57,,3
Estradiol valerate,CCCCC(=O)OC1CCC2C3CCC4=C(C=CC(O)=C4)C3CCC12C,"InChI=1S/C23H32O3/c1-3-4-5-22(25)26-21-11-10-20-19-8-6-15-14-16(24)7-9-17(15)18(19)12-13-23(20,21)2/h7,9,14,18-21,24H,3-6,8,10-13H2,1-2H3/t18-,19-,20+,21+,23+/m1/s1",2-hydroxyestradiol,CC12CCC3C4=C(C=C(O)C(O)=C4)CCC3C1CCC2O,DILDHNKDVHLEQB-XSSYPUMDSA-N,,0.83,,4
alpha-Linolenic acid,CCC=CCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-",,CCC=CCC=CCC=CCCCCC=CCCCC(=O)O,,,0.74,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",5-HETE,CCCCCC=CCC=CCC=CC=CC(O)CCCC(=O)O,,,0.54,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",7-HETE,CCCCCC=CCC=CCC=CC(O)C=CCCCC(=O)O,,,0.58,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",10-HETE,CCCCCC=CCC=CC(O)C=CCC=CCCCC(=O)O,,,0.6,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",13-HETE,CCCCCC=CC(O)C=CCC=CCC=CCCCC(=O)O,,,0.58,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",17-HETE,CCCC(O)CC=CCC=CCC=CCC=CCCCC(=O)O,,,0.57,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",15-HETE,CCCCCC(O)C=CC=CCC=CCC=CCCCC(=O)O,,,0.55,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",12-HETE,CCCCCC=CCC(O)C=CC=CCC=CCCCC(=O)O,,,0.49,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",9-HETE,CCCCCC=CCC=CCC(O)C=CC=CCCCC(=O)O,,,0.5,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",8-HETE,CCCCCC=CCC=CC=CC(O)CC=CCCCC(=O)O,,,0.49,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",Dinoprostone,CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(=O)O,"InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",,0.21,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",20-HETE,O=C(O)CCCC=CCC=CCC=CCC=CCCCCCO,,,0.74,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",19-HETE,CC(O)CCCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.67,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",18-HETE,CCC(O)CCC=CCC=CCC=CCC=CCCCC(=O)O,,,0.61,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",16-HETE,CCCCC(O)C=CCC=CCC=CCC=CCCCC(=O)O,,,0.56,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-","14,15-EET",CCCCCC1OC1CC=CCC=CCC=CCCCC(=O)O,,,0.45,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-","11,12-EET",CCCCCC=CCC1OC1CC=CCC=CCCCC(=O)O,,,0.43,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-","8,9-EET",CCCCCC=CCC=CCC1OC1CC=CCCCC(=O)O,,,0.43,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-","5,6-EET",CCCCCC=CCC=CCC=CCC1OC1CCCC(=O)O,,,0.45,,1
Linoleic acid,CCCCCC=CCC=CCCCCCCCC(=O)O,"InChI=1S/C18H32O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h6-7,9-10H,2-5,8,11-17H2,1H3,(H,19,20)/b7-6-,10-9-",11-HETE,CCCCCC=CC=CC(O)CC=CCC=CCCCC(=O)O,,,0.5,,1
Isopropyl myristate,CCCCCCCCCCCCCC(=O)OC(C)C,"InChI=1S/C17H34O2/c1-4-5-6-7-8-9-10-11-12-13-14-15-17(18)19-16(2)3/h16H,4-15H2,1-3H3",,CC(O)CCCCCCCCCCCC(=O)O,,,0.51,,1
Betamethasone phosphate,CC1CC2C3CCC4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)COP(=O)(O)O,"InChI=1S/C22H30FO8P/c1-12-8-16-15-5-4-13-9-14(24)6-7-19(13,2)21(15,23)17(25)10-20(16,3)22(12,27)18(26)11-31-32(28,29)30/h6-7,9,12,15-17,25,27H,4-5,8,10-11H2,1-3H3,(H2,28,29,30)/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",6-alpha-OH DEXAMETHASONE,CC1CC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC2(C)C1(O)C(=O)CO,,,0.83,,1
Diroximel fumarate,COC(=O)C=CC(=O)OCCN1C(=O)CCC1=O,"InChI=1S/C11H13NO6/c1-17-10(15)4-5-11(16)18-7-6-12-8(13)2-3-9(12)14/h4-5H,2-3,6-7H2,1H3/b5-4+",Fumaric acid,O=C(O)C=CC(=O)O,"InChI=1S/C4H4O4/c5-3(6)1-2-4(7)8/h1-2H,(H,5,6)(H,7,8)/b2-1+",,0.16,,1
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Hydromorphone,CN1CCC23C4=C5C=CC(O)=C4OC2C(=O)CCC3C1C5,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2,4,10-11,16,19H,3,5-8H2,1H3/t10-,11+,16-,17-/m0/s1",,0.8,,1
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",norhydrocodone,COC1=C2OC3C(=O)CCC4C5CC(=C2C34CCN5)C=C1,JGORUXKMRLIJSV-ZWUPXRALSA-N,,0.79,,1
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Hydromorphone-3-glucuronide,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(=O)CCC3C1C5,VLSHIBYUEOPPRX-UHFFFAOYSA-N,,0.8,,2
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Norhydromorphone,O=C1CCC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,SWIRXSKBBSJXGY-UIHHKEIPSA-N,,0.78,,2
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Norhydromorphone,O=C1CCC2C3CC4=CC=C(O)C5=C4C2(CCN3)C1O5,,,0.78,,2
Benzhydrocodone,COC1=C2OC3C(OC(=O)C4=CC=CC=C4)=CCC4C5CC(=C2C34CCN5C)C=C1,"InChI=1S/C25H25NO4/c1-26-13-12-25-17-9-11-20(29-24(27)15-6-4-3-5-7-15)23(25)30-22-19(28-2)10-8-16(21(22)25)14-18(17)26/h3-8,10-11,17-18,23H,9,12-14H2,1-2H3/t17-,18-,23+,25+/m1/s1",Hydromorphone 3-sulfate,CN1CCC23C4=C5C=CC(OS(=O)(=O)O)=C4OC2C(=O)CCC3C1C5,,,0.79,,2
Serdexmethylphenidate,COC(=O)C(C1=CC=CC=C1)C1CCCCN1C(=O)OC[N+]1=CC=CC(C(=O)NC(CO)C(=O)[O-])=C1,"InChI=1S/C25H29N3O8/c1-35-24(33)21(17-8-3-2-4-9-17)20-11-5-6-13-28(20)25(34)36-16-27-12-7-10-18(14-27)22(30)26-19(15-29)23(31)32/h2-4,7-10,12,14,19-21,29H,5-6,11,13,15-16H2,1H3,(H-,26,30,31,32)/t19-,20+,21+/m0/s1",Ritalinic acid,O=C(O)C(C1=CC=CC=C1)C1CCCCN1,INGSNVSERUZOAK-UHFFFAOYSA-N,,0.48,,1
"(R)-3,4-Methylenedioxymethamphetamine",CNC(C)CC1=CC=C2OCOC2=C1,,Alpha-methyldopamine,CC(N)CC1=CC=C(O)C(O)=C1,,,0.63,,1
(R)-1-(4-Methoxyphenyl)propan-2-amine,COC1=CC=C(CC(C)N)C=C1,,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.61,,1
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,5-Hydroxythalidomide,O=C1CCC(N2C(=O)C3=C(C=C(O)C=C3)C2=O)C(=O)N1,LJBQRRQTZUJWRC-UHFFFAOYSA-N,,0.67,,1
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,"5,6-dihydroxythalidomide",O=C1CCC(N2C(=O)C3=CC(O)=C(O)C=C3C2=O)C(=O)N1,JBCNYDFXFUMCRO-UHFFFAOYSA-N,,0.66,,2
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,,CC1C(=O)CC2(C(C)(C)OC3OC(C(=O)O)C(O)C(O)C3O)CC12,,,0.26,,1
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,"alpha-thujone, 4-O-glucuronide",CC(C)C12CC1C(C)(O)C(=O)C2OC1OC(C(=O)O)C(O)C(O)C1O,,,0.24,,1
(+)-isothujone,CC1C(=O)CC2(C(C)C)CC12,,,CC(C)C12CC(=O)C(C)(OC3OC(C(=O)O)C(O)C(O)C3O)C1C2,,,0.25,,1
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,2-Hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,,0.9,,1
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,4-Hydroxyestradiol ,CC12CCC3C4=CC=C(O)C(O)=C4CCC3C1CCC2O,,,0.81,,1
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,17-beta-Estradiol glucuronide,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2OC1OC(C(=O)O)C(O)C(O)C1O,,,0.6,,1
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,,CC12CCC3C4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C=C4CCC3C1CCC2O,,,0.59,,1
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,Estradiol 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2O,,,0.55,,2
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,2-O-methoxyestradiol,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,,0.94,,2
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,3-O-methoxyestradiol,COC1=CC2=C(C=C1O)C1CCC3(C)C(O)CCC3C1CC2,,,0.94,,2
"(13alpha)-3-methoxy-estra-1,3,5(10)-triene-17alpha-ol",COC1=CC=C2C(=C1)CCC1C2CCC2(C)C(O)CCC12,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CCC1C2CCC2(C)C(O)CCC12,,,0.55,,3
(R)-(-)-Mexiletine,CC1=CC=CC(C)=C1OCC(C)N,,,CC1=CC=CC(C)=C1OCC(C)NOC1OC(C(=O)O)C(O)C(O)C1O,,,0.3,,1
(r)-chloroquine,CCN(CC)CCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,"(r)-chloroquine, N-desethyl",CC(CCCN)NC1=CC=NC2=CC(Cl)=CC=C12,,,0.93,,1
(s)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CCCCC2)C1=O,,3'-Oxohexobarbital,CN1C(=O)NC(=O)C(C)(C2=CC(=O)CCC2)C1=O,JLDHHLBFGIBRGN-UHFFFAOYSA-N,,0.49,,1
(s)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CCCCC2)C1=O,,,CN1C(=O)N=C(O)C(C)(C2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)CCC2)C1=O,,,0.74,,1
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,p-Hydroxyphenobarbital,CCC1(C2=CC=C(O)C=C2)C(O)=NC(=O)N=C1O,,,0.46,,1
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(O)=NC(=O)N=C1O,,,0.48,,2
(s)-mephobarbital,CCC1(C2=CC=CC=C2)C(=O)N(C)C(=O)N=C1O,,,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(O)=NC(=O)N=C1O,,,0.46,,2
4-(butylaminomethyl)-7-methoxycoumarin,CCCCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,7-hydroxy-4-(aminomethyl)-coumarin (HAMC),NCC1=CC(=O)OC2=CC(O)=CC=C12,,,0.82,,1
4-(ethylaminomethyl)-7-methoxycoumarin,CCNCC1=CC(=O)OC2=CC(OC)=CC=C12,,7-hydroxy-4-(aminomethyl)-coumarin (HAMC),NCC1=CC(=O)OC2=CC(O)=CC=C12,,,0.85,,1
4-nitroanisole,COC1=CC=C([N+](=O)[O-])C=C1,,4-nitrocatechol (4NC) ,O=[N+]([O-])C1=CC=C(O)C(O)=C1,,,0.59,,1
4-nitroanisole,COC1=CC=C([N+](=O)[O-])C=C1,,,O=C(O)C1OC(OC2=CC=C([N+](=O)[O-])C=C2)C(O)C(O)C1O,,,0.25,,1
5-hydroxydiclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,,0.51,,1
5-hydroxydiclofenac,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=CC=C1Cl,,,O=C(O)CC1=CC(O)=CC=C1NC1=C(Cl)C=C(OS(=O)(=O)O)C=C1Cl,,,0.79,,1
5-methoxytryptamine,COC1=CC=C2NC=C(CCN)C2=C1,,,CCC1=CNC2=CC=C(O)C=C12,,,0.84,,1
5-methoxytryptamine,COC1=CC=C2NC=C(CCN)C2=C1,,,NCCC1=CNC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,,0.51,,1
8-hydroxyefavirenz,OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2(C#CC3(C(F)(F)F)OC(O)=NC4=C(O)C=C(Cl)C=C43)CC2)C(O)C(O)C1O,,,0.81,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,,0.67,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,18-Hydroxyretinoic acid,CC(C=CC1=C(CO)CCCC1(C)C)=CC=CC(C)=CC(=O)O,XSJOIRFEYHJNAW-FCKHSPHMSA-N,,0.78,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,,0.3,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,Retinoyl beta-glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,MTGFYEHKPMOVNE-NEFMKCFNSA-N,,0.34,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,,CC(C=CC(O)=C(C)C=CC1=C(C)CCCC1(C)C)=CC(=O)O,,,0.74,,1
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.21,,2
9-cis-retinal,CC(C=CC=C(C)C=CC1=C(C)CCCC1(C)C)=CC=O,,4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,,0.67,,2
ac1ldic9,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(C=CS2)C1,,,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC=O)C1,,,0.54,,1
acetanilide,CC(O)=NC1=CC=CC=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,,0.05,,1
acetanilide,CC(O)=NC1=CC=CC=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,,0.51,,1
acetanilide,CC(O)=NC1=CC=CC=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,,0.44,,1
acetanilide,CC(O)=NC1=CC=CC=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,,0.16,,1
aflatoxin b1,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C=COC1O2,,,COC1=CC2=C(C3=C1C1=C(C(=O)CC1)C(=O)O3)C1C(O2)OC(SCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C1O,,,0.82,,1
aprepitant,CC(OC1OCCN(CC2=NC(O)=NN2)C1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,aprepitant_M2,CC(OC1OCC=NC1C1=CC=C(F)C=C1)C1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1,,,0.59,,1
barnidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OC2CCN(CC3=CC=CC=C3)C2)C1C1=CC=CC([N+](=O)[O-])=C1,,OPC-13463,COC(=O)C1=C(C)N=C(C)C(C(=O)O)=C1C1=CC=CC([N+](=O)[O-])=C1,,,0.34,,1
beta-methylstyrene,CC=CC1=CC=CC=C1,,Cinnamaldehyde,O=CC=CC1=CC=CC=C1,InChI=1S/C9H8O/c10-8-4-7-9-5-2-1-3-6-9/h1-8H/b7-4+,,0.84,,1
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,Orobol,O=C1C(C2=CC=C(O)C(O)=C2)=COC2=CC(O)=CC(O)=C12,,,0.91,,1
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,,0.61,,1
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,0.26,,1
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,,0.21,,2
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,6'-Hydroxy-O-desmethylangolensin,CC(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,,0.2,,3
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,4-hydroxyphenyl-2-propenoic acid,C=C(C(=O)O)C1=CC=C(O)C=C1,,,0.14,,3
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,,0.08,,3
4Ã¢â‚¬Â[(dimethylamino)methyl]Ã¢â‚¬Â7Ã¢â‚¬ÂmethoxychromenÃ¢â‚¬Â2Ã¢â‚¬Âone,COC1=CC=C2C(CN(C)C)=CC(=O)OC2=C1,,N-methyl 7-hydroxy-4-(aminomethyl)-coumarin,CNCC1=CC(=O)OC2=CC(O)=CC=C12,,,0.91,,1
2prime_hydroxy_indomethacin_phenethylamide,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,,0.81,,1
"(2S)-1-(1,3-Benzodioxol-5-yl)-N-methyl-2-butanamine",CCC(CC1=CC=C2OCOC2=C1)NC,,DHABB,CCC(N)CC1=CC=C(O)C(O)=C1,,,0.65,,1
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,"CP-919,230",NCC1=CC(OC(F)(F)F)=CC=C1O,,,0.39,,1
cp_122_721,COC1=CC=C(OC(F)(F)F)C=C1CNC1CCCNC1C1=CC=CC=C1,,quinone,O=C1CC=C(O)C=C1CNC1CCCNC1C1=CC=CC=C1,,,0.52,,1
"cyclohexene, 4-ethenyl-, (s)-",C=CC1CC=CCC1,,VCH-diepoxide,C1CC2OC2CC1C1CO1,,,0.11,,1
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,3-Hydroxymorphinan,OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,IYNWSQDZXMGGGI-KBMXLJTQSA-N,,0.9,,1
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,3-Hydroxymorphinan O-glucuronide,O=C(O)C1OC(OC2=CC3=C(C=C2)CC2NCCC34CCCCC24)C(O)C(O)C1O,QYVMECDBFFRIEZ-DESFNQSRSA-N,,0.67,,2
dextromethorphan,COC1=CC=C2CC3C4CCCCC4(CCN3C)C2=C1,,3-Hydroxymorphinan sulfate,O=S(=O)(O)OC1=CC2=C(C=C1)CC1NCCC23CCCCC13,KYOWUZONPGRBFN-KBMXLJTQSA-N,,0.82,,2
efavirenz,OC1=NC2=CC=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,"8,14-diOH-efavirenz",OC1=NC2=C(O)C=C(Cl)C=C2C(C#CC2(O)CC2)(C(F)(F)F)O1,,,0.86,,1
efavirenz,OC1=NC2=CC=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2=CC(Cl)=CC3=C2N=C(O)OC3(C#CC2CC2)C(F)(F)F)C(O)C(O)C1O,,,0.69,,1
efavirenz,OC1=NC2=CC=C(Cl)C=C2C(C#CC2CC2)(C(F)(F)F)O1,,,O=C(O)C1OC(OC2(C#CC3(C(F)(F)F)OC(O)=NC4=C(O)C=C(Cl)C=C43)CC2)C(O)C(O)C1O,,,0.72,,2
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,Estradiol 2-O-glucuronide,CC12CCC3C4=CC(OC5OC(C(=O)O)C(O)C(O)C5O)=C(O)C=C4CCC3C1CCC2O,,,0.52,,1
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,2-O-methoxyestradiol,COC1=CC2=C(C=C1O)CCC1C2CCC2(C)C(O)CCC12,,,0.88,,1
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,3-O-methoxyestradiol,COC1=CC2=C(C=C1O)C1CCC3(C)C(O)CCC3C1CC2,,,0.88,,1
estradiol,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CCC1C2CCC2(C)C(O)CCC12,,,0.52,,2
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,"InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",,1.0,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Normorphine,OC1=C2OC3C(O)C=CC4C5CC(=C2C43CCN5)C=C1,ONBWJWYUHXVEJS-UHFFFAOYSA-N,,0.97,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Morphine glucuronide,CN1CCC23C4=C5OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1CC4=CC=C5O,"InChI=1S/C23H27NO9/c1-24-7-6-23-10-3-5-13(31-22-17(28)15(26)16(27)19(33-22)21(29)30)20(23)32-18-12(25)4-2-9(14(18)23)8-11(10)24/h2-5,10-11,13,15-17,19-20,22,25-28H,6-8H2,1H3,(H,29,30)/t10-,11+,13-,15-,16-,17+,19-,20-,22+,23-/m0/s1",,0.9,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,morphine-3-glucuronide,CCCN(C)C(CC)C1C=CC(O)C2OC3=C(OC4OC(C)C(O)C(O)C4O)C=CC=C3C12,VTXHJADFMAGEOX-MHOAFJCYSA-N,,0.8,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,,CN1CCC23C4=C5C=CC(O)=C4OC2C(OC2OC(C(=O)O)C(O)C(O)C2O)C=CC3C1C5,,,0.9,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)C=CC3C1C5,,,0.91,,1
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,norcodeine,COC1=CC=C2CC3NCCC45C2=C1OC4C(O)C=CC35,HKOIXWVRNLGFOR-KUYPYUECSA-N,,0.98,,2
ethylmorphine,CCOC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,,Codeine-6-glucuronide,COC1=CC=C2CC3C4C=CC(OC5OC(C(=O)O)C(O)C(O)C5O)C5OC1=C2C45CCN3C,CRWVOYRJXPDBPM-HSCJLHHPSA-N,,0.9,,2
etoricoxib,CC1=CC=C(C2=NC=C(Cl)C=C2C2=CC=C(S(C)(=O)=O)C=C2)C=N1,,,CS(=O)(=O)C1=CC=C(C2=CC(Cl)=CN=C2C2=CC=C(COC3OC(C(=O)O)C(O)C(O)C3O)N=C2)C=C1,,,0.65,,1
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,"CP-611,781",COC1=CC=C(C(C)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,0.97,,1
ezlopitant,COC1=CC=C(C(C)C)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,"CP-616,762",COC1=CC=C(C(C)(O)CO)C=C1CNC1C2CCN(CC2)C1C(C1=CC=CC=C1)C1=CC=CC=C1,,,0.91,,1
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,,O=C(O)C1OC(OC2=CC=C3C(=O)C(C4=CC=C(O)C=C4)=COC3=C2)C(O)C(O)C1O,,,0.58,,1
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,Dihydrodazein,O=C1C2=CC=C(O)C=C2OCC1C1=CC=C(O)C=C1,,,0.25,,1
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,,O=C1C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OCC1C1=CC=C(O)C=C1,,,0.27,,2
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,Tetrahydrodaidzein,OC1=CC=C(C2COC3=CC(O)=CC=C3C2O)C=C1,,,0.24,,2
galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C(O)=C(C4=CC=C(O)C=C4)OC3=C2)C(O)C(O)C1O,,,0.65,,1
galangin,O=C1C(O)=C(C2=CC=CC=C2)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,,0.61,,1
galantamine,COC1=CC=C2CN(C)CCC34C=CC(O)CC3OC1=C24,,,CN1CCC23C=CC(O)CC2OC2=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=CC(=C23)C1,,,0.87,,1
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,,C=C(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,,0.21,,1
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,6'-Hydroxy-O-desmethylangolensin,CC(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,,0.2,,2
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,4-hydroxyphenyl-2-propenoic acid,C=C(C(=O)O)C1=CC=C(O)C=C1,,,0.13,,2
genistein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,,0.08,,2
gepirone,CC1(C)CC(=O)N(CCCCN2CCN(C3=NC=CC=N3)CC2)C(=O)C1,,,OC1=CN=C(N2CCNCC2)N=C1,,,0.43,,1
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C12,,,0.53,,1
harmine,COC1=CC=C2C(=C1)NC1=C(C)N=CC=C12,,,CC1=NC=CC2=C1NC1=CC(OS(=O)(=O)O)=CC=C12,,,0.78,,1
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,3-Hydroxymonoethyl glycinexylidide,CCNCC(O)=NC1=C(C)C=CC(O)=C1C,,,0.68,,1
lidocaine,CCN(CC)CC(O)=NC1=C(C)C=CC=C1C,,Glycinexylidide,CC1=CC=CC(C)=C1N=C(O)CN,,,0.83,,1
meiqx,CC1=CN=C2C=CC3=C(NC(=N)N3C)C2=N1,,,CC1=CN=C2C=CC3=C(N=C(NOC4OC(C(=O)O)C(O)C(O)C4O)N3C)C2=N1,,,0.47,,1
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,,CC(O)=NCCC1=CNC2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C12,,,0.55,,1
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,,CC(O)=NCCC1=CNC2=CC=C(OS(=O)(=O)O)C=C12,,,0.78,,1
melatonin,COC1=CC=C2NC=C(CCN=C(C)O)C2=C1,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCN=C(C)O,,,0.5,,1
meloxicam,CC1=CN=C(N=C(O)C2=C(O)C3=CC=CC=C3S(=O)(=O)N2C)S1,,5'-carboxy meloxicam,CN1C(C(O)=NC2=NC=C(C(=O)O)S2)=C(O)C2=CC=CC=C2S1(=O)=O,MTQQFYLGAZXHTB-UHFFFAOYSA-N,,0.96,,1
mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N(C)C)C=C3)CC21C,,Didemethylated mifepristone,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(C3=CC=C(N)C=C3)CC21C,,,0.97,,1
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,,0.95,,1
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NCC(=O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,0.97,,1
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,CC1=C(CC(O)=NCC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C2)C2=CC(O)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1,,,0.78,,2
naphthalene,C1=CC=C2C=CC=CC2=C1,,1-Naphthyl glucuronide,O=C(O)C1OC(OC2=CC=CC3=CC=CC=C23)C(O)C(O)C1O,,,0.06,,1
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=CC2=C1,,,0.37,,1
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,CC(C(=O)OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2C=C(O)C=CC2=C1,,,0.35,,1
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,CC(C(=O)O)C1=CC=C2C=C(OS(=O)(=O)O)C=CC2=C1,,,0.69,,1
naproxen,COC1=CC=C2C=C(C(C)C(=O)O)C=CC2=C1,,,CC(C(=O)OS(=O)(=O)O)C1=CC=C2C=C(O)C=CC2=C1,,,0.65,,1
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,,0.29,,1
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âylidene)Ã¢â‚¬Â4Ã¢â‚¬Â{3Ã¢â‚¬Â[3Ã¢â‚¬ÂethylÃ¢â‚¬Â5Ã¢â‚¬ÂoxoÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â1lambda5Ã¢â‚¬ÂpiperazinÃ¢â‚¬Â1Ã¢â‚¬Âylium",CCC1=NN(CCCN2CCN(C3=CC(=[Cl+])C(=O)C=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,0.73,,1
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â{3Ã¢â‚¬Â[4Ã¢â‚¬Â(3Ã¢â‚¬ÂchloroÃ¢â‚¬Â1Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â4Ã¢â‚¬ÂoxocyclohexaÃ¢â‚¬Â2,5Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl)piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl]propyl}Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C3(O)C=CC(=O)C(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,,0.71,,1
nefazodone,CCC1=NN(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)C(=O)N1CCOC1=CC=CC=C1,,"1Ã¢â‚¬Â[3Ã¢â‚¬Â(4Ã¢â‚¬Â{3Ã¢â‚¬ÂchloroÃ¢â‚¬Â4Ã¢â‚¬ÂhydroxyÃ¢â‚¬Â7Ã¢â‚¬Âoxabicyclo[4.1.0]heptaÃ¢â‚¬Â2,4Ã¢â‚¬ÂdienÃ¢â‚¬Â1Ã¢â‚¬Âyl}piperazinÃ¢â‚¬Â1Ã¢â‚¬Âyl)propyl]Ã¢â‚¬Â3Ã¢â‚¬ÂethylÃ¢â‚¬Â4Ã¢â‚¬Â(2Ã¢â‚¬Âphenoxyethyl)Ã¢â‚¬Â4,5Ã¢â‚¬ÂdihydroÃ¢â‚¬Â1HÃ¢â‚¬Â1,2,4Ã¢â‚¬ÂtriazolÃ¢â‚¬Â5Ã¢â‚¬Âone",CCC1=NN(CCCN2CCN(C34C=C(Cl)C(O)=CC3O4)CC2)C(=O)N1CCOC1=CC=CC=C1,,,0.62,,1
nevirapine,CC1=CC=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,2-Hydroxynevirapine glucuronide,CC1=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,,0.76,,1
nicotine,CN1CCCC1C1=CC=CN=C1,,Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,,0.79,,1
nicotine,CN1CCCC1C1=CC=CN=C1,,Cotinine N-oxide,CN1C(=O)CCC1C1=C[N+]([O-])=CC=C1,CIPULDKLIIVIER-VIFPVBQESA-N,,0.69,,2
nicotine,CN1CCCC1C1=CC=CN=C1,,3'-Hydroxycotinine,CN1C(=O)C(O)CC1C1=CN=CC=C1,XOKCJXZZNAUIQN-IENPIDJESA-N,,0.63,,2
nicotine,CN1CCCC1C1=CC=CN=C1,,Nicotine-1'-N-oxide,C[N+]1([O-])CCCC1C1=CN=CC=C1,RWFBQHICRCUQJJ-UHFFFAOYSA-N,,0.75,,2
nicotine,CN1CCCC1C1=CC=CN=C1,,Cotinine glucuronide,CN1C(=O)CCC1C1=C[N+](C2OC(C(=O)[O-])C(O)C(O)C2O)=CC=C1,XWZCZWKUGIQPJD-UHFFFAOYSA-N,,0.36,,2
nordiazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,,0.56,,1
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,,0.06,,1
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,,0.6,,1
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,,0.53,,1
phenacetin,CCOC1=CC=C(N=C(C)O)C=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,,0.28,,1
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,Phenytoin catechol,O=C1NC(=O)C(C2=CC=CC=C2)(C2=CC(O)=C(O)C=C2)N1,WWEKVOUOQUHVHS-UHFFFAOYSA-N,,0.33,,1
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,,0.81,,1
phenytoin,OC1=NC(C2=CC=CC=C2)(C2=CC=CC=C2)C(O)=N1,,,O=C(O)C1OC(OC2=CC=C(C3(C4=CC=CC=C4)N=C(O)N=C3O)C=C2)C(O)C(O)C1O,,,0.59,,1
(R)-mianserin,CN1CCN2C3=CC=CC=C3CC3=CC=CC=C3C2C1,,"(R)-mianserin, 8-OH-N-desmethyl",OC1=CC=C2CC3=CC=CC=C3C3CNCCN3C2=C1,,,0.9,,1
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,4-hydroxy-9-cis-retinals,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)O,,,0.9,,1
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,4-Hydroxyretinoic acid,CC(C=CC1=C(C)C(O)CCC1(C)C)=CC=CC(C)=CC(=O)O,KGUMXGDKXYTTEY-FRCNGJHJSA-N,,0.67,,2
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,18-Hydroxyretinoic acid,CC(C=CC1=C(CO)CCCC1(C)C)=CC=CC(C)=CC(=O)O,XSJOIRFEYHJNAW-FCKHSPHMSA-N,,0.78,,2
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,"5,6-Epoxyretinoic acid",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)O,KEEHJLBAOLGBJZ-WEDZBJJJSA-N,,0.3,,2
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,Retinoyl beta-glucuronide,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,MTGFYEHKPMOVNE-NEFMKCFNSA-N,,0.34,,2
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,,CC(C=CC(O)=C(C)C=CC1=C(C)CCCC1(C)C)=CC(=O)O,,,0.74,,2
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,"rac-5,6-Epoxy-retinoyl-beta-D-glucuronide",CC(C=CC12OC1(C)CCCC2(C)C)=CC=CC(C)=CC(=O)OC1OC(C(=O)O)C(O)C(O)C1O,,,0.21,,3
retinol,CC(C=CC1=C(C)CCCC1(C)C)=CC=CC(C)=CCO,,4-Oxoretinoic acid,CC(C=CC1=C(C)C(=O)CCC1(C)C)=CC=CC(C)=CC(=O)O,GGCUJPCCTQNTJF-FRCNGJHJSA-N,,0.67,,3
risperidone,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CCCCC2=N1,,,CC1=C(CCN2CCC(C3=NOC4=CC(F)=CC=C34)CC2)C(=O)N2CC(O)CC(O)C2=N1,,,0.9,,1
schembl149458,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,N-desmethylthioridazine ,CSC1=CC=C2SC3=CC=CC=C3N(CCC3CCCCN3)C2=C1,,,0.88,,1
schembl149458,CN1CCCCC1CCN1C2=CC=CC=C2SC2=CC=C(S(C)=O)C=C21,,Thioridazine 5-sulfoxide,CSC1=CC=C2C(=C1)N(CCC1CCCCN1C)C1=CC=CC=C1S2=O,,,0.86,,1
schembl29464,CN1C(=O)C(O)N=C(C2=CC=CC=C2)C2=CC(Cl)=CC=C21,,,O=C(O)C1OC(OC2N=C(C3=CC=CC=C3)C3=CC(Cl)=CC=C3N=C2O)C(O)C(O)C1O,,,0.49,,1
tamarixetin,COC1=CC=C(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,,0.65,,1
tamarixetin,COC1=CC=C(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1O,,Dihydroquercetin,O=C1C2=C(O)C=C(O)C=C2OC(C2=CC=C(O)C(O)=C2)C1O,,,0.33,,1
trazodone,O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C2C=CC=CN12,,2‐chloro‐4‐(piperazin‐1‐yl)phenol,OC1=CC=C(N2CCNCC2)C=C1Cl,,,0.3,,1
tyramine,NCCC1=CC=C(O)C=C1,,dopamine 3-O-sulfate,NCCC1=CC=C(O)C(OS(=O)(=O)O)=C1,,,0.34,,1
tyramine,NCCC1=CC=C(O)C=C1,,Dopamine 4- D-Glucuronide,NCCC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,,,0.15,,1
(S)-Methylenedioxyethylamphetamine,CCNC(C)CC1=CC=C2OCOC2=C1,,Alpha-methyldopamine,CC(N)CC1=CC=C(O)C(O)=C1,,,0.61,,1
Fenproporex,CC(CC1=CC=CC=C1)NCCC#N,,4-hydroxyamphetamine,CC(N)CC1=CC=C(O)C=C1,GIKNHHRFLCDOEU-UHFFFAOYSA-N,,0.52,,1
Fenproporex,CC(CC1=CC=CC=C1)NCCC#N,,Norephedrine,CC(N)C(O)C1=CC=CC=C1,DLNKOYKMWOXYQA-VXNVDRBHSA-N,,0.47,,1
Fenproporex,CC(CC1=CC=CC=C1)NCCC#N,,4-Hydroxynorephedrine,CC(N)C(O)C1=CC=C(O)C=C1,JAYBQRKXEFDRER-HZGVNTEJSA-N,,0.4,,2
(S)-Sibutramine,CC(C)CC(N(C)C)C1(C2=CC=C(Cl)C=C2)CCC1,,1-[1-(4-chlorophenyl)cyclobutyl]-3-methylbutylamine,CC(C)CC(N)C1(C2=CC=C(Cl)C=C2)CCC1,,,0.79,,1
DMXAA,CC1=CC=C2C(=O)C3=CC=CC(CC(=O)O)=C3OC2=C1C,,,CC1=C(COC2OC(C(=O)O)C(O)C(O)C2O)C=CC2=C1OC1=C(CC(=O)O)C=CC=C1C2=O,,,0.57,,1
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,,0.07,,1
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,,0.57,,1
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,,0.5,,1
O-isopropyl acetaminophen,CC(O)=NC1=CC=C(OC(C)C)C=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,,0.29,,1
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,N-Acetyl-p-benzoquinone,CC(=O)N=C1C=CC(=O)C=C1,,,0.06,,1
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,3-Hydroxyacetaminophen,CC(O)=NC1=CC=C(O)C(O)=C1,,,0.64,,1
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,,CC(O)=NC1=CC=C(OS(=O)(=O)O)C=C1,,,0.55,,1
p-Methoxyacetanilide,COC1=CC=C(N=C(C)O)C=C1,,,CC(O)=NC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1,,,0.26,,1
sulfinpyrazone_sulfide,O=C1C(CCSC2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,,Sulfinpyrazone sulfone,O=C1C(CCS(=O)(=O)C2=CC=CC=C2)C(=O)N(C2=CC=CC=C2)N1C1=CC=CC=C1,DQUYGWDNTAETLI-UHFFFAOYSA-N,,0.9,,1
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,Dolasetron N-oxide,O=C(OC1CC2CC3CC(C1)[N+]2([O-])CC3O)C1=CNC2=CC=CC=C12,,,0.81,,1
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,6-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC(O)=CC=C12,,,0.82,,1
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,5-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=CC=C(O)C=C12,,,0.81,,1
Dolasetron,O=C(OC1CC2CC3CC(C1)N2CC3=O)C1=CNC2=CC=CC=C12,,7-Hydroxydolasetron,O=C(OC1CC2CC3CC(C1)N2CC3O)C1=CNC2=C(O)C=CC=C12,,,0.78,,1
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,"8,11-Dihydroxy-delta-9-THC",CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC(O)C(CO)=CC21,XTDYIISRNODHHT-UHFFFAOYSA-N,,0.89,,1
delta-9-Tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C)=CC21,,11-Nor-9-carboxy-delta-9-THC,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CCC(C(=O)O)=CC21,YOVRGSHRZRJTLZ-UHFFFAOYSA-N,,0.91,,1
Benzo[a]pyrene,C1=CC=C2C(=C1)C=C1C=CC3=CC=CC4=CC=C2C1=C34,,,NC(CCC(O)=NC(CSOC1C2=CC3=CC=C4C=CC=C5C=CC(=C2C=CC1O)C3=C45)C(O)=NCC(=O)O)C(=O)O,,,0.05,,1
Duloxetine,CNCCC(OC1=CC=CC2=CC=CC=C12)C1=CC=CS1,,,CNCCC(OC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C12)C1=CC=CS1,,,0.55,,1
Phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(O)=NC(=O)N=C1O,,,0.57,,1
Phenobarbital,CCC1(C2=CC=CC=C2)C(O)=NC(=O)N=C1O,,,CCC1(C2=CC=C(OS(=O)(=O)O)C=C2)C(O)=NC(=O)N=C1O,,,0.84,,1
S-Mephenytoin,CCC1(C2=CC=CC=C2)N=C(O)N(C)C1=O,,Nirvanol N-glucuronide,CCC1(C2=CC=CC=C2)N=C(O)N(C2OC(C(=O)O)C(O)C(O)C2O)C1=O,,,0.59,,1
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone M-IV O-sulfate,CC1=C(F)C(N)=C2C(=O)C(OS(=O)(=O)O)=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,,0.79,,1
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,"Aminoflavone, N4', N5-dihydroxy",CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,,0.93,,1
Aminoflavone,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone MIII O-glucuronide,CC1=C(F)C(N)=C2C(=O)C=C(C3=CC=C(NOC4OC(C(=O)O)C(O)C(O)C4O)C(F)=C3)OC2=C1F,,,0.76,,1
Carbosulfan,CCCCN(CCCC)SN(C)C(=O)OC1=CC=CC2=C1OC(C)(C)C2,,e-hydroxy-carbofuran,CN=C(O)OC1=CC=CC2=C1OC(C)(C)C2O,,,0.54,,1
Citalopram,CN(C)CCCC1(C2=CC=C(F)C=C2)OCC2=CC(C#N)=CC=C21,,"N,N-Didesmethylcitalopram",N#CC1=CC=C2C(=C1)COC2(CCCN)C1=CC=C(F)C=C1,,,0.98,,1
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,,0.62,,1
donepezil,COC1=CC2=C(C=C1OC)C(=O)C(CC1CCN(CC3=CC=CC=C3)CC1)C2,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CC(CC1CCN(CC3=CC=CC=C3)CC1)C2=O,,,0.62,,1
Encainide,COC1=CC=C(C(=O)NC2=CC=CC=C2CCC2CCCCN2C)C=C1,,"N,O-didemethylencainide",O=C(NC1=CC=CC=C1CCC1CCCCN1)C1=CC=C(O)C=C1,,,0.91,,1
Gavestinel,O=C(O)C1=C(C=CC(O)=NC2=CC=CC=C2)C2=C(Cl)C=C(Cl)C=C2N1,,gavestinel 4-sulfate,O=C(C=CC1=C(C(=O)O)NC2=CC(Cl)=CC(Cl)=C12)NC1=CC=C(OS(=O)(=O)O)C=C1,,,0.77,,1
Gliclazide,CC1=CC=C(S(=O)(=O)NC(O)=NN2CC3CCCC3C2)C=C1,,Carboxygliclazide,O=C(NN1CC2CCCC2C1)NS(=O)(=O)C1=CC=C(C(=O)O)C=C1,DSNDPTBTZSQWJS-TXEJJXNPSA-N,,0.52,,1
Lumiracoxib,CC1=CC=C(NC2=C(F)C=CC=C2Cl)C(CC(=O)O)=C1,,,CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,,0.54,,1
Mestranol,C#CC1(O)CCC2C3CCC4=CC(OC)=CC=C4C3CCC21C,,2-hydroxyethinylestradiol,C#CC1(O)CCC2C3CCC4=CC(O)=C(O)C=C4C3CCC21C,KQJCDKMHNQVWDV-GJRSTEQNSA-N,,0.91,,1
Mestranol,C#CC1(O)CCC2C3CCC4=CC(OC)=CC=C4C3CCC21C,,,C#CC1(O)CCC2C3CCC4=C(C=CC(O)=C4O)C3CCC21C,,,0.84,,1
Mono-OH-methoxychlor,COC1=CC=C(C(C2=CC=C(O)C=C2)C(Cl)(Cl)Cl)C=C1,,Tris-OH-M methoxychlor,OC1=CC=C(C(C2=CC=C(O)C(O)=C2)C(Cl)(Cl)Cl)C=C1,,,0.7,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 8-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=C1N2C,,,0.74,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 8-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC(OS(=O)(=O)O)=C1N2C,,,0.85,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 7-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C1N2C,,,0.77,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 7-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=C(OS(=O)(=O)O)C=C1N2C,,,0.91,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 6-O-glucuronide,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C1N2C,,,0.78,,1
Ondansetron,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC=CC=C1N2C,,ondansetron 6-O-sulfate,CC1=NC=CN1CC1CCC2=C(C1=O)C1=CC(OS(=O)(=O)O)=CC=C1N2C,,,0.91,,1
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethyl-ortho-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(O)C=CC=N3)C=C2)S1,GWVBGLUFILBNNY-UHFFFAOYSA-N,,0.53,,1
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethyl-para-hydroxy rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(O)C=N3)C=C2)S1,SVUUNTJZVPNZSL-UHFFFAOYSA-N,,0.54,,1
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethyl glucuronide rosiglitazone,O=C1N=C(O)C(CC2=CC=C(OCCNC3=NC=CC=C3OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)S1,NLGMKXBTZZJJFK-UHFFFAOYSA-N,,0.54,,1
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethyl para-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=CC=C(OS(=O)(=O)O)C=N3)C=C2)S1,ULPCBLHRDLQTTD-UHFFFAOYSA-N,,0.51,,2
rosiglitazone,CN(CCOC1=CC=C(CC2SC(=O)N=C2O)C=C1)C1=CC=CC=N1,,N-Desmethyl-ortho-O-sulfate rosiglitazone,O=C1NC(=O)C(CC2=CC=C(OCCNC3=C(OS(=O)(=O)O)C=CC=N3)C=C2)S1,HOMPAUSQZJYDFA-UHFFFAOYSA-N,,0.49,,2
2-hydroxyestradiol,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)CCC1C2CCC2(C)C(O)CCC12,,,0.54,,1
2-hydroxyestrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,,COC1=CC2=C(C=C1OC1OC(O)C(O)C(O)C1O)CCC1C2CCC2(C)C(=O)CCC12,,,0.61,,1
2-aminofluorene,NC1=CC=C2C(=C1)CC1=CC=CC=C12,,N-Hydroxy-2-acetamidofluorene,CC(=O)N(O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,,0.66,,1
2-aminofluorene,NC1=CC=C2C(=C1)CC1=CC=CC=C12,,1-OH-AFF,CC(O)=NC1=CC=C2C(=C1)CC1=CC=CC(O)=C12,,,0.6,,1
2-aminofluorene,NC1=CC=C2C(=C1)CC1=CC=CC=C12,,5-OH-AFF,CC(O)=NC1=CC=C2C3=CC=CCC3(O)CC2=C1,,,0.21,,1
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,,O=C1C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2OCC1C1=CC=C(O)C=C1,,,0.25,,1
Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,Tetrahydrodaidzein,OC1=CC=C(C2COC3=CC(O)=CC=C3C2O)C=C1,,,0.22,,1
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,,O=C(O)C1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,,0.95,,1
Quercitrin,CC1OC(OC2=C(C3=CC=C(O)C(O)=C3)OC3=CC(O)=CC(O)=C3C2=O)C(O)C(O)C1O,,Dihydroquercetin,O=C1C2=C(O)C=C(O)C=C2OC(C2=CC=C(O)C(O)=C2)C1O,,,0.39,,1
3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.24,,1
4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.23,,1
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.51,,1
"3,4-dihydroxyphenylacetic acid",O=C(O)CC1=CC=C(O)C(O)=C1,,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.23,,2
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,3-hydroxyphenylacetic acid,O=C(O)CC1=CC=CC(O)=C1,,,0.11,,1
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,4-hydroxyphenylacetic acid,O=C(O)CC1=CC=C(O)C=C1,,,0.11,,1
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,Protocatehuic acid,O=C(O)C1=CC=C(O)C(O)=C1,,,0.13,,1
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,Phenylacetic acid,O=C(O)CC1=CC=CC=C1,"InChI=1S/C8H8O2/c9-8(10)6-7-4-2-1-3-5-7/h1-5H,6H2,(H,9,10)",,0.06,,2
Cyanidin,OC1=CC(O)=C2C=C(O)C(C3=CC=C(O)C(O)=C3)=[O+]C2=C1,,Phenylacetylglutamine,NC(=O)CCC(NC(=O)CC1=CC=CC=C1)C(=O)O,,,0.13,,3
Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,6'-Hydroxy-O-desmethylangolensin,CC(C(=O)C1=C(O)C=C(O)C=C1O)C1=CC=C(O)C=C1,,,0.64,,1
Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,4-hydroxyphenyl-2-propenoic acid,C=C(C(=O)O)C1=CC=C(O)C=C1,,,0.23,,1
Dihydrogenistein,O=C1C2=C(O)C=C(O)C=C2OCC1C1=CC=C(O)C=C1,,Phloroglucinol,OC1=CC(O)=CC(O)=C1,,,0.08,,1
